[
 {
  "pmid": "37212950",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with pQTLs of circulating proteins on AF.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 429,
   "end": 579
  },
  "claim": {
   "protein_as_written": "TES",
   "gene": "TES",
   "disease_as_written": "AF",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 950,
    "end": 1081
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "37398343",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of serum ADAM-12 levels, instrumented by its GWAS variants, on gestational hypertension, with an OR below 1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1447,
   "end": 1686
  },
  "claim": {
   "protein_as_written": "ADAM-12",
   "gene": "ADAM12",
   "disease_as_written": "gestational hypertension",
   "direction": "lowers",
   "estimate": {
    "or": 0.78,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2049,
    "end": 2228
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "37639066",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Instruments are brain pQTLs (ROSMAP, Banner), not circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 298,
   "end": 686
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "37703945",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Sensitivity analyses use circulating PCSK9 instruments, but outcomes are liver enzymes and bilirubin, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 507,
   "end": 1011
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "37715107",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "SMR used brain (DLPFC) eQTL and pQTL data, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 521,
   "end": 793
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "37778897",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma mTOR-dependent proteins on NAFLD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1398,
   "end": 1537
  },
  "claim": {
   "protein_as_written": "eIF4E",
   "gene": "EIF4E",
   "disease_as_written": "NAFLD",
   "direction": "raises",
   "estimate": {
    "or": 1.339,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1187,
    "end": 1339
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "37779362",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are genetically predicted gene expression from a TWAS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 502,
   "end": 905
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "37889424",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Among the circulating lipid traits analysed by MR is apolipoprotein B level, a circulating protein, with ALS as the outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1803,
   "end": 1964
  },
  "claim": {
   "protein_as_written": "ApoB",
   "gene": "APOB",
   "disease_as_written": "ALS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1803,
    "end": 1964
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2056,
    "end": 2204
   }
  }
 },
 {
  "pmid": "37904919",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is birth weight, a continuous trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 471,
   "end": 640
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "37922010",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Phenome-wide MR includes 159 plasma proteins but names no protein-ARDS pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 668,
   "end": 1070
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "37931855",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are genes instrumented by cis-eQTLs from GTEx and eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 422,
   "end": 640
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "37935012",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma NeGR1 on type 2 diabetes; higher NeGR1 reduces risk (OR per SD 0.92).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 810,
   "end": 1060
  },
  "claim": {
   "protein_as_written": "NeGR1",
   "gene": "NEGR1",
   "disease_as_written": "T2D",
   "direction": "lowers",
   "estimate": {
    "or": 0.92,
    "low": null,
    "high": null,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 810,
    "end": 1060
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "37938820",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A review that estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1981,
   "end": 2083
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "37945330",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of HMGCR inhibition whose instruments the abstract does not name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 784,
   "end": 1012
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "cholelithiasis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1482,
    "end": 1634
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1482,
    "end": 1634
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1829,
    "end": 1881
   }
  }
 },
 {
  "pmid": "37950809",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 plasma proteins on PSC; AIF1 and HLA-DQA2 named without a direction anywhere, so the first pair the conclusions name, unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 416,
   "end": 739
  },
  "claim": {
   "protein_as_written": "AIF1",
   "gene": "AIF1",
   "disease_as_written": "PSC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1728,
    "end": 1806
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1276,
    "end": 1492
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1011,
    "end": 1275
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1728,
    "end": 1806
   }
  }
 },
 {
  "pmid": "37971626",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins are tested against PD-1/PD-L1 levels, which are measurements, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 939,
   "end": 1048
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38019415",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Instruments pool cis-eQTLs and cis-pQTLs; MARK3 not tied to circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 459,
   "end": 610
  },
  "claim": {
   "protein_as_written": "MARK3",
   "gene": "MARK3",
   "disease_as_written": "ALS",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 817,
    "end": 1090
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 817,
    "end": 1090
   }
  }
 },
 {
  "pmid": "38030236",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is antipsychotic drug target gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 764,
   "end": 985
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38031970",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Apolipoproteins are among the MR exposures, but the abstract states only HDL-C with ITP and ABCA1 from drug-target MR of lipids, no pair from MR of a circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1182,
   "end": 1240
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38039160",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are named only with 'cross-cancer effects'; no named protein is paired with a named cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1192,
   "end": 1401
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38061333",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted circulating complement levels on non-viral liver diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 584,
   "end": 940
  },
  "claim": {
   "protein_as_written": "C1S",
   "gene": "C1S",
   "disease_as_written": "hepatocellular carcinoma",
   "direction": "lowers",
   "estimate": {
    "or": 0.111,
    "low": 0.018,
    "high": 0.672,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1298,
    "end": 1466
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1758,
    "end": 1966
   }
  }
 },
 {
  "pmid": "38078460",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of genetically proxied ACE inhibition; instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 710,
   "end": 845
  },
  "claim": {
   "protein_as_written": "angiotensin-converting enzyme",
   "gene": "ACE",
   "disease_as_written": "psoriasis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 710,
    "end": 845
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 710,
    "end": 845
   }
  }
 },
 {
  "pmid": "38103512",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Includes MR of circulating protein levels on IBD, which the abstract reports apart from the other omics.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1844,
   "end": 2326
  },
  "claim": {
   "protein_as_written": "PARK7",
   "gene": "PARK7",
   "disease_as_written": "IBD",
   "direction": "lowers",
   "estimate": {
    "or": 0.36,
    "low": 0.25,
    "high": 0.52,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1844,
    "end": 2326
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 683,
    "end": 881
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38104003",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR meets E2, but the outcome, multisite chronic pain, is a count of body sites with chronic pain that the abstract sets apart from the 'common diseases' it studies, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 582,
   "end": 732
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38124156",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "PCSK9 inhibition is proxied by variants of genes encoding lipid-lowering drug targets; the abstract names neither a weighting biomarker nor pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 683,
   "end": 895
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "PAP",
   "direction": "raises",
   "estimate": {
    "or": 0.03,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1411,
    "end": 1508
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1411,
    "end": 1508
   }
  }
 },
 {
  "pmid": "38143258",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma-protein MR on autoimmune diseases reports only counts of protein-AID pairs; no protein is paired with a named disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1453,
   "end": 1712
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38152968",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Genetically proxied circulating CXCL10 levels are tested in mediation MR against coronary artery disease, and the abstract gives the mediator's own association with the end points.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1722,
   "end": 2088
  },
  "claim": {
   "protein_as_written": "CXCL10",
   "gene": "CXCL10",
   "disease_as_written": "coronary artery disease",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1722,
    "end": 2088
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2592,
    "end": 2814
   }
  }
 },
 {
  "pmid": "38159276",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The protein MR exposures (CFHR2, C7, ABO) have complement pathway activities, which are traits, as outcomes; the only disease outcome (mouth ulcers) has a pathway activity as its exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 781,
   "end": 1026
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38160582",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Exposures are brain proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 119
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38166458",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets are instrumented by expression QTLs and by lipid-associated variants (APOB-mediated LDL cholesterol), not by protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1384,
   "end": 1729
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38167102",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are antidiabetic drug target genes whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 604,
   "end": 736
  },
  "claim": {
   "protein_as_written": "ETFDH",
   "gene": "ETFDH",
   "disease_as_written": "epilepsy",
   "direction": "raises",
   "estimate": {
    "or": 1.018,
    "low": 1.004,
    "high": 1.033,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 737,
    "end": 1237
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 396,
    "end": 603
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1463,
    "end": 1621
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38167131",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are gut microbiota taxa (and eQTL-based SMR genes), not circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 366,
   "end": 571
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38170504",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of SCALLOP proteins on hypertensive disorders of pregnancy; MR pairs given without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1390,
   "end": 1541
  },
  "claim": {
   "protein_as_written": "cluster of differentiation 40",
   "gene": "CD40",
   "disease_as_written": "gestational hypertension",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2129,
    "end": 2412
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38173028",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "All cytokine-IA pairs are said not to survive Bonferroni correction, so no counting pair remains.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1234,
   "end": 1358
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38180753",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR of drug-target genes on NSCLC without naming the instruments (gene, not circulating level).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1485,
   "end": 1697
  },
  "claim": {
   "protein_as_written": "CCNA2",
   "gene": "CCNA2",
   "disease_as_written": "NSCLC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1485,
    "end": 1697
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1698,
    "end": 1833
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38181731",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "SMR of unspecified multi-omic exposures; the abstract names counts of target genes but no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 919,
   "end": 1216
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38184718",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating proteins on age at menarche and age at natural menopause, which are traits, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 419,
   "end": 663
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38184974",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The protein MR outcome is bone mineral density, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1559,
   "end": 1766
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38191425",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target instruments come from lipid GWAS (Global Lipids Genetics Consortium), and SMR uses gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 430,
   "end": 632
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38211557",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins (deCODE, ARIC) on diabetic kidney disease; no direction stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1231,
   "end": 1331
  },
  "claim": {
   "protein_as_written": "TGFBI",
   "gene": "TGFBI",
   "disease_as_written": "DKD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1332,
    "end": 1542
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1332,
    "end": 1542
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1543,
    "end": 1693
   }
  }
 },
 {
  "pmid": "38225249",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is said to support effects of 10 proteins on HF, HF risk factors, or LV measures without saying which protein holds for HF, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 793,
   "end": 1043
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38228698",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR uses XDH variants as instruments for uric acid reduction (biomarker-weighted).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 457,
   "end": 665
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38230624",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by LDL-C-associated variants near the genes and by eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 602,
   "end": 847
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38237596",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Transcriptome-wide MR uses gene expression, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 287,
   "end": 533
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38238732",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcome is FEV1, a lung function measure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 679,
   "end": 980
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38240717",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "SMR/PWAS pools pQTLs from brain, plasma and CSF; the pair is not tied to the plasma analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 309,
   "end": 543
  },
  "claim": {
   "protein_as_written": "CD38",
   "gene": "CD38",
   "disease_as_written": "PD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1279,
    "end": 1420
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38243829",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma ANGPTL3 levels from deCODE instrument the MR (E2 met) and the outcomes are diseases, but the MR found no effect on CAD or any other disease, so the abstract states no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1562,
   "end": 1882
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38246286",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR screens 2992 plasma proteins and gives five proteins' own causal associations with psychiatric disorders; the class stands for anorexia nervosa, the member disease the abstract pairs with STOM.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 566,
   "end": 802
  },
  "claim": {
   "protein_as_written": "STOM",
   "gene": "STOM",
   "disease_as_written": "AN",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1406,
    "end": 1529
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38254961",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Exposures are cerebrospinal fluid proteins, not circulating ones.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 703,
   "end": 878
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38258565",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38260284",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The bi-directional MR of serum proteins and LOAD includes the protein-to-disease direction, but the abstract states only proteins upregulated as a consequence of LOAD (reverse MR), so no protein-to-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1012,
   "end": 1275
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38274228",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Proteomic association analysis in UK Biobank; no MR of a protein on a disease is described.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 392,
   "end": 519
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38274229",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein levels instrumented by ARIC and deCODE pQTLs on diabetic retinopathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 346,
   "end": 539
  },
  "claim": {
   "protein_as_written": "WARS",
   "gene": "WARS1",
   "disease_as_written": "DR",
   "direction": "raises",
   "estimate": {
    "or": 1.16,
    "low": 0.095,
    "high": 0.208,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 928,
    "end": 1304
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1305,
    "end": 1372
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38274231",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 685,
   "end": 872
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38275613",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PCSK9 instruments are variants near the gene weighted by their effect on LDL-C.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 340,
   "end": 497
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38287401",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of lipid-lowering target genes ('genetically proxied APOC3 inhibition'); the abstract doesn't name a biomarker the variants were weighted by or otherwise name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 510,
   "end": 802
  },
  "claim": {
   "protein_as_written": "APOC3",
   "gene": "APOC3",
   "disease_as_written": "UC",
   "direction": "raises",
   "estimate": {
    "or": 0.83,
    "low": 0.73,
    "high": 0.94,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1247,
    "end": 1426
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 803,
    "end": 1076
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2103,
    "end": 2296
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38290287",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of predicted circulating furin on breast cancer; OR 0.81 with only an uncorrected p-value.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2223,
   "end": 2618
  },
  "claim": {
   "protein_as_written": "furin",
   "gene": "FURIN",
   "disease_as_written": "breast cancer",
   "direction": "lowers",
   "estimate": {
    "or": 0.81,
    "low": 0.67,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2223,
    "end": 2618
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38293137",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is between personality traits and psychiatric traits; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1953,
   "end": 2160
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38293198",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR on psychiatric disorders, but the abstract names no specific protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1303,
   "end": 1420
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38293563",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of thrombopoietin-related drugs, whose shared target is the thrombopoietin receptor (MPL); the abstract doesn't name the instruments, so they could be gene variants weighted by a biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 329,
   "end": 621
  },
  "claim": {
   "protein_as_written": "TPORDs",
   "gene": "MPL",
   "disease_as_written": "VTE",
   "direction": "raises",
   "estimate": {
    "or": 1.193,
    "low": 1.001,
    "high": 1.423,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1736,
    "end": 1858
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 119
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38294056",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides LDL-weighted PCSK9 variants, uses pQTLs of circulating PCSK9 as instruments, with congenital malformations as outcomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 827,
   "end": 1053
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "malformations affecting multiple systems",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1780,
    "end": 1853
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1866,
    "end": 1995
   }
  }
 },
 {
  "pmid": "38296402",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of a plasma protein, C1QTNF1, on aortic stenosis; no direction is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1891,
   "end": 2006
  },
  "claim": {
   "protein_as_written": "C1QTNF1",
   "gene": "C1QTNF1",
   "disease_as_written": "AS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1891,
    "end": 2006
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2020,
    "end": 2167
   }
  }
 },
 {
  "pmid": "38302118",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are drug-target eQTLs and LDL-C-associated variants, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 582,
   "end": 858
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38302401",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Commentary on causal effects of plasma proteins on metabolites; the outcomes are metabolites, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 208,
   "end": 444
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38302916",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The paper uses pQTLs among its instruments, so it does not fail E2. The genes it names all come from MWAS and TWAS (methylation and expression), and it states no pair from the protein MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1275,
   "end": 1601
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38304232",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on breast cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1184,
   "end": 1289
  },
  "claim": {
   "protein_as_written": "PEX14",
   "gene": "PEX14",
   "disease_as_written": "breast cancer",
   "direction": "raises",
   "estimate": {
    "or": 1.201,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1290,
    "end": 1433
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1913,
    "end": 1999
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38310303",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on incident CHD names hepatocyte growth factor as causal, without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1675,
   "end": 1760
  },
  "claim": {
   "protein_as_written": "hepatocyte growth factor",
   "gene": "HGF",
   "disease_as_written": "CHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1675,
    "end": 1760
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38317018",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Blood pQTLs meet E2, but the outcome is suicide attempt, a behaviour rather than a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 128,
   "end": 288
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38317717",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory cytokine levels on hypothyroidism; IL-7 and MIP-1beta named with no direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 302,
   "end": 445
  },
  "claim": {
   "protein_as_written": "IL-7",
   "gene": "IL7",
   "disease_as_written": "hypothyroidism",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1510,
    "end": 1702
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38324182",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets (APOB, APOA1, LDLR) are proxied through their LDL- or TC-lowering effects.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1277,
   "end": 1474
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38326855",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 288,
   "end": 525
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38332312",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are blood metabolites (lipoprotein lipid fractions), not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 351,
   "end": 786
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38333712",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR on lung cancer names no protein, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 599,
   "end": 796
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38335406",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of medication classes whose targets' instruments the abstract doesn't name (some targets, such as ACE, are circulating proteins), so E2 is unsettled rather than failed; every association is null and no protein-disease pair is stated, which fails E4.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1850,
   "end": 2233
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38341104",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites and metabolite ratios.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 101,
   "end": 180
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38341813",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is 'genetically represented PCSK9 inhibition'; the abstract does not name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 969,
   "end": 1201
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "psoriatic arthritis",
   "direction": "raises",
   "estimate": {
    "or": 0.51,
    "low": 0.14,
    "high": 0.88,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1705,
    "end": 1855
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1705,
    "end": 1855
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38352469",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of 1,463 plasma proteins on subsequent MACE after stroke; conclusions name no protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 745,
   "end": 921
  },
  "claim": {
   "protein_as_written": "CCL27",
   "gene": "CCL27",
   "disease_as_written": "subsequent MACE",
   "direction": "lowers",
   "estimate": {
    "or": 0.77,
    "low": 0.66,
    "high": 0.88,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1170,
    "end": 1377
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38360195",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38361503",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteome MR (35,559 participants) of senescence-related proteins on AMD; high C3b raises risk at a Bonferroni threshold (0.05/110).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 609,
   "end": 817
  },
  "claim": {
   "protein_as_written": "C3b",
   "gene": "C3",
   "disease_as_written": "AMD",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1370,
    "end": 1656
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 818,
    "end": 1017
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38363475",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "HMGCR is proxied by cholesterol-weighted variants and by expression; no circulating protein level is instrumented.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1178,
   "end": 1411
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38365286",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Protocol for MR of circulating PD-1/PD-L1 levels on cancer survival; survival is not a disease outcome (and no results are given).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 861,
   "end": 1189
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38374155",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Inflammatory protein pQTLs are tested only against LDL-C; the abstract states no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 878,
   "end": 971
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38378567",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is circulating caffeine, with proteins as outcomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 538,
   "end": 734
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38379245",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Methods paper using GLP1R-region variants weighted by BMI and T2D, not GLP1R protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 881,
   "end": 1047
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38383373",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "ARIC plasma pQTL MR; conclusions name PCSK9 without direction, results give positive relation with HF in CHD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 540,
   "end": 753
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "HF in the context of CHD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1408,
    "end": 1595
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38390206",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR from variants in lipid-lowering target genes, instruments not named; conclusions name APOC3 first, results say APOC3 inhibitors reduce ED risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 332,
   "end": 557
  },
  "claim": {
   "protein_as_written": "APOC3",
   "gene": "APOC3",
   "disease_as_written": "ED",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 757,
    "end": 888
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1671,
    "end": 1755
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38396187",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood eQTLs of antihypertensive drug target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 413,
   "end": 657
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38397929",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Primary MR is of CSF and brain proteins, but follow-up MR of plasma protein levels is tied to the LRP8-bipolar disorder finding: higher plasma abundance with lower risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 512,
   "end": 626
  },
  "claim": {
   "protein_as_written": "low-density lipoprotein receptor-related protein 8",
   "gene": "LRP8",
   "disease_as_written": "bipolar disorder",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 756,
    "end": 1025
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 756,
    "end": 1025
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38410417",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by LDL-cholesterol-associated variants near their genes and by expression loci, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 469,
   "end": 679
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38414129",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposures are oxidative stress biomarkers (uric acid, total glutathione transferase); the druggable genes are proxied by variants associated with those biomarkers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 678,
   "end": 880
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38416763",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug targets proxied by LDL cholesterol-associated variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 861,
   "end": 1118
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38416767",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid drug targets (HMGCR, APOC3, LDLR, APOB) were proxied by variants weighted by LDL-C or triglycerides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1570,
   "end": 2032
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38420755",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are death and death or HF hospitalization among HF patients, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1597,
   "end": 1780
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38424453",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are circulating metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 524,
   "end": 684
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38425755",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Main exposure is HMGCR inhibition weighted by LDL-C; IGF-1 appears only as a mediator with no own effect on hyperthyroidism stated, so no counting pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1534,
   "end": 1788
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38426414",
  "eligibility": "E0",
  "e2_kind": null,
  "eligibility_reason": "The record is flagged as retracted (Retracted Publication).",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38429412",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2004 plasma proteins on GERD; the conclusions name C1-INH without a direction, and the results call it detrimental under Bonferroni correction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 349,
   "end": 564
  },
  "claim": {
   "protein_as_written": "C1-INH",
   "gene": "SERPING1",
   "disease_as_written": "GERD",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1205,
    "end": 1367
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1368,
    "end": 1494
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1667,
    "end": 1872
   }
  }
 },
 {
  "pmid": "38430374",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating apolipoprotein A-I level (per mg/dL) on breast cancer, beside lipid traits and biomarker-proxied drug targets.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 547,
   "end": 853
  },
  "claim": {
   "protein_as_written": "APOA-I",
   "gene": "APOA1",
   "disease_as_written": "BC",
   "direction": "raises",
   "estimate": {
    "or": 1.085,
    "low": null,
    "high": null,
    "unit": "per unit",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 547,
    "end": 853
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38431573",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is telomere length, a trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 661,
   "end": 987
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38439655",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins are MR exposures for bladder cancer, but the abstract names no specific protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 797,
   "end": 1038
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38443977",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable gene cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 380,
   "end": 679
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38445514",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcome is systolic blood pressure, a trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1032,
   "end": 1142
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38448677",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 441,
   "end": 577
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38450887",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by SNPs associated with blood pressure near target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 670,
   "end": 1087
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38475831",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins (pQTLs) on HLA-B27-associated anterior uveitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 880,
   "end": 980
  },
  "claim": {
   "protein_as_written": "AIF1",
   "gene": "AIF1",
   "disease_as_written": "SpA/HLA-B27-associated AAU",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1392,
    "end": 1634
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1635,
    "end": 1684
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38476469",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Antidiabetic target genes are instrumented by blood and colon eQTLs and by glucose-trait-weighted SNPs; no protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 380,
   "end": 690
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38479056",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating cytokines with cis-pQTL instruments on infertility (FinnGen).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1131,
   "end": 1304
  },
  "claim": {
   "protein_as_written": "GROa",
   "gene": "CXCL1",
   "disease_as_written": "female infertility",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1131,
    "end": 1304
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38487880",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins appear only as mediators of blood pressure's effect; no protein's own effect on heart failure is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1598,
   "end": 1754
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38493415",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of ninety circulating cardiovascular proteins on membranous nephropathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 339,
   "end": 487
  },
  "claim": {
   "protein_as_written": "fatty acid-binding protein",
   "gene": "FABP4",
   "disease_as_written": "MN",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 842,
    "end": 1032
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38499600",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 706,
   "end": 890
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38504335",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Glucose-lowering drug targets were proxied by variants weighted by HbA1c lowering.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1110,
   "end": 1476
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38505796",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Gene MR uses eQTLs; the other MR exposure is phenylalanine.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 463,
   "end": 696
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38508395",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Mediation MR with deCODE pQTLs and circulating cytokines; CXCL9's own effect on OCPC given as an OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 874,
   "end": 1113
  },
  "claim": {
   "protein_as_written": "CXCL9",
   "gene": "CXCL9",
   "disease_as_written": "OCPC",
   "direction": "raises",
   "estimate": {
    "or": 1.218,
    "low": 1.016,
    "high": 1.461,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1507,
    "end": 1725
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38510702",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PCSK9 and HMGCR inhibition are proxied by LDL-C-associated variants near the genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1104,
   "end": 1252
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38515381",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on autoimmune diseases; conclusions name no pair, first directed result is IL12B as a risk factor for ankylosing spondylitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 653,
   "end": 744
  },
  "claim": {
   "protein_as_written": "IL12B",
   "gene": "IL12B",
   "disease_as_written": "ankylosing spondylitis",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 745,
    "end": 840
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38516410",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma eIF4G level instrumented by INTERVAL pQTLs, outcome central precocious puberty.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1257,
   "end": 1326
  },
  "claim": {
   "protein_as_written": "eIF4G",
   "gene": "EIF4G1",
   "disease_as_written": "CPP",
   "direction": "lowers",
   "estimate": {
    "or": 0.45,
    "low": 0.22,
    "high": 0.91,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1007,
    "end": 1243
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38517045",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Metformin targets are proxied by cis-eQTL variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 647,
   "end": 798
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38517150",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating ENPP2/Autotaxin levels on alcoholic liver disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1219,
   "end": 1385
  },
  "claim": {
   "protein_as_written": "ENPP2/Autotaxin",
   "gene": "ENPP2",
   "disease_as_written": "ALD",
   "direction": "raises",
   "estimate": {
    "or": 2.28,
    "low": 1.64,
    "high": 3.16,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 855,
    "end": 1042
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1219,
    "end": 1385
   }
  }
 },
 {
  "pmid": "38521370",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "CETP is proxied by its LDL-C-lowering effect (biomarker-weighted) and by eQTLs, not by its circulating level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 912,
   "end": 1186
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38521921",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Separate cis-pQTL MR of blood proteins on myasthenia gravis names CTSH, PRSS8 and CPN2; no direction given, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 989,
   "end": 1193
  },
  "claim": {
   "protein_as_written": "CTSH",
   "gene": "CTSH",
   "disease_as_written": "MG",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1565,
    "end": 1773
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38523609",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants are weighted by LDL cholesterol rather than by the protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 408,
   "end": 663
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38531334",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PCSK9 and HMGCR inhibition proxied by LDL-C-associated variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 573,
   "end": 817
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38538601",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "S100A8/A9 is a heterodimer of two genes' products.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 831,
   "end": 961
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38540773",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on knee and hip OA after FDR correction; MAPK3 protective for knee OA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1234,
   "end": 1357
  },
  "claim": {
   "protein_as_written": "MAPK3",
   "gene": "MAPK3",
   "disease_as_written": "knee OA",
   "direction": "lowers",
   "estimate": {
    "or": 0.855,
    "low": 0.791,
    "high": 0.923,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1502,
    "end": 1759
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1358,
    "end": 1501
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1502,
    "end": 1759
   }
  }
 },
 {
  "pmid": "38541004",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4719 blood proteins on primary liver cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 592,
   "end": 771
  },
  "claim": {
   "protein_as_written": "MICB",
   "gene": "MICB",
   "disease_as_written": "PLC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1605,
    "end": 1771
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38547584",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTLs of apoC3 blood protein levels on cardiometabolic diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 515,
   "end": 849
  },
  "claim": {
   "protein_as_written": "apoC3",
   "gene": "APOC3",
   "disease_as_written": "coronary artery disease",
   "direction": "raises",
   "estimate": {
    "or": 0.86,
    "low": 0.8,
    "high": 0.93,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1748,
    "end": 1956
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 173,
    "end": 331
   }
  }
 },
 {
  "pmid": "38566994",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with UKB-PPP plasma proteins on AS; directions given only for unnamed groups, so unsigned on the first named protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 632,
   "end": 780
  },
  "claim": {
   "protein_as_written": "AIF1",
   "gene": "AIF1",
   "disease_as_written": "AS",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1508,
    "end": 1742
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H3 + PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1508,
    "end": 1742
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1508,
    "end": 1742
   }
  }
 },
 {
  "pmid": "38572516",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is aging, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1279,
   "end": 1383
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38572634",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets (NPC1L1, HMGCR, PCSK9) proxied by LDL-c lowering variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1335,
   "end": 1623
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38573314",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR on allergic disease; conclusions name TNFAIP3 and LAYN without direction, results give TNFAIP3 a protective OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 855,
   "end": 1122
  },
  "claim": {
   "protein_as_written": "TNFAIP3",
   "gene": "TNFAIP3",
   "disease_as_written": "allergic diseases",
   "direction": "lowers",
   "estimate": {
    "or": 0.82,
    "low": 0.76,
    "high": 0.88,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1783,
    "end": 2043
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.93,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 2367,
    "end": 2539
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1123,
    "end": 1219
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2553,
    "end": 2788
   }
  }
 },
 {
  "pmid": "38575325",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 1,361 plasma proteins on COVID-19 outcomes; COVID pairs without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 428,
   "end": 849
  },
  "claim": {
   "protein_as_written": "SFTPD",
   "gene": "SFTPD",
   "disease_as_written": "severe COVID-19",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1059,
    "end": 1477
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38576019",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR on lung adenocarcinoma; conclusions lead with RNASET2, whose results OR is 1.15.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 471,
   "end": 592
  },
  "claim": {
   "protein_as_written": "RNASET2",
   "gene": "RNASET2",
   "disease_as_written": "LUAD",
   "direction": "raises",
   "estimate": {
    "or": 1.15,
    "low": 1.08,
    "high": 1.21,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1723,
    "end": 1936
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 2010,
    "end": 2107
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2592,
    "end": 2751
   }
  }
 },
 {
  "pmid": "38577173",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are circulating metabolites (alanine, fatty acids), not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 286,
   "end": 443
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38579440",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The exposure is cerebrospinal fluid NAAA protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 476,
   "end": 598
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38581229",
  "eligibility": "E0",
  "e2_kind": null,
  "eligibility_reason": "The record is flagged as retracted.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 143
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38585769",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "PWAS pools brain, CSF, and plasma pQTLs; MR-validated genes are only counted, no protein-disease pair from MR named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2041,
   "end": 2111
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38589550",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory proteins with cis-pQTL instruments on calcific aortic valve stenosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 821,
   "end": 1005
  },
  "claim": {
   "protein_as_written": "matrix metallopeptidase-1 (MMP1)",
   "gene": "MMP1",
   "disease_as_written": "CAVS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1319,
    "end": 1499
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38590415",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR uses eQTLs and mQTLs, not pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 432,
   "end": 589
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38599098",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteome (4907 plasma proteins) on biopsy-confirmed IgAN.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 372,
   "end": 601
  },
  "claim": {
   "protein_as_written": "neuraminidase 1 (NEU1)",
   "gene": "NEU1",
   "disease_as_written": "IgAN",
   "direction": "raises",
   "estimate": {
    "or": 11.8,
    "low": 4.03,
    "high": 34.54,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1031,
    "end": 1207
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1303,
    "end": 1394
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1713,
    "end": 1818
   }
  }
 },
 {
  "pmid": "38601164",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted circulating proteins on XP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 788,
   "end": 967
  },
  "claim": {
   "protein_as_written": "FN1",
   "gene": "FN1",
   "disease_as_written": "XP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 788,
    "end": 967
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38605099",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR for sepsis; the abstract does not name the instruments (pQTL or eQTL) or circulating level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 400,
   "end": 474
  },
  "claim": {
   "protein_as_written": "PSMA4",
   "gene": "PSMA4",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": {
    "or": 1.32,
    "low": 1.2,
    "high": 1.45,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1316,
    "end": 1389
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.74,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1009,
    "end": 1194
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 475,
    "end": 677
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1195,
    "end": 1315
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38614964",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are visceral and ectopic fat traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 342,
   "end": 515
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38623319",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PCSK9 and HMGCR are proxied by variants weighted by LDL-C, or by eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 967,
   "end": 1237
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38623619",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with cis-pQTLs of plasma proteins on type 2 diabetes; the pairs are stated without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 862,
   "end": 1194
  },
  "claim": {
   "protein_as_written": "ENTR1",
   "gene": "ENTR1",
   "disease_as_written": "T2D",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1550,
    "end": 1720
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38626182",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically determined plasma angiogenin on DKD progression; raises odds.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1576,
   "end": 1690
  },
  "claim": {
   "protein_as_written": "angiogenin",
   "gene": "ANG",
   "disease_as_written": "DKD progression",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1576,
    "end": 1690
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38644354",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are sarcopenia-related traits (appendicular lean mass, grip strength, walking pace), measurements rather than a diagnosed disease; E2, pooling eQTL and pQTL, would only be unsettled.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 307,
   "end": 591
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38644415",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with variants associated with circulating druggable protein levels on aplastic anemia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 620,
   "end": 758
  },
  "claim": {
   "protein_as_written": "IFN-γ",
   "gene": "IFNG",
   "disease_as_written": "AA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1527,
    "end": 1647
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1527,
    "end": 1647
   }
  }
 },
 {
  "pmid": "38651149",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR whose instruments for the drug targets are not named; the conclusions name statins as HMGCR blockers with a therapeutic role, and the results give HMGCR a positive correlation with ovarian cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 286,
   "end": 496
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "ovarian cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 684,
    "end": 906
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 907,
    "end": 1130
   }
  }
 },
 {
  "pmid": "38652661",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "GPR84 comes from MR integrated with brain transcriptomic and proteomic profiles; the abstract doesn't name the MR's exposure or instruments, so full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 667,
   "end": 917
  },
  "claim": {
   "protein_as_written": "GPR84",
   "gene": "GPR84",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 667,
    "end": 917
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 667,
    "end": 917
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38657291",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Bidirectional MR includes genetically predicted apolipoprotein A concentration (a circulating protein) on endometriosis; the drug-target pairs rest on lipid-mediated effects and don't count, so the apolipoprotein A pair is the first directed counting pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 749,
   "end": 1116
  },
  "claim": {
   "protein_as_written": "apolipoprotein A",
   "gene": "APOA1",
   "disease_as_written": "endometriosis",
   "direction": "lowers",
   "estimate": {
    "or": 0.9,
    "low": 0.83,
    "high": 0.96,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 749,
    "end": 1116
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38659038",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Whatever its instruments, the abstract names no protein paired with a cancer from MR of a circulating protein; the one proteomic gene is unnamed.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 876,
   "end": 1000
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38659056",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "A pQTL MR analysis gives protein-level pairs (TNFSF12, CD226) with myasthenia gravis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1340,
   "end": 1436
  },
  "claim": {
   "protein_as_written": "TNFSF12",
   "gene": "TNFSF12",
   "disease_as_written": "MG",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1340,
    "end": 1436
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1194,
    "end": 1339
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1645,
    "end": 1751
   }
  }
 },
 {
  "pmid": "38660492",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Primary MR uses cis-eQTLs; genes 'confirmed' by pooled eQTL MR and protein SMR (pQTL tissue unstated).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1685,
   "end": 1815
  },
  "claim": {
   "protein_as_written": "MMP15",
   "gene": "MMP15",
   "disease_as_written": "COPD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1685,
    "end": 1815
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1946,
    "end": 2083
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38660673",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on vitiligo; IRF3 named with no direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 611,
   "end": 757
  },
  "claim": {
   "protein_as_written": "IRF3",
   "gene": "IRF3",
   "disease_as_written": "vitiligo",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1749,
    "end": 1863
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1372,
    "end": 1510
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1749,
    "end": 1863
   }
  }
 },
 {
  "pmid": "38671846",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments drawn from eQTL and pQTL panels without saying which gave each pair, and pQTL tissue not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 489,
   "end": 611
  },
  "claim": {
   "protein_as_written": "OGFOD2",
   "gene": "OGFOD2",
   "disease_as_written": "SCZ",
   "direction": "lowers",
   "estimate": {
    "or": 0.784,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 997,
    "end": 1181
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 997,
    "end": 1181
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38682216",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by LDL cholesterol-associated variants in target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 513,
   "end": 714
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38684708",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis protein MR of 2,074 circulating proteins on nine cancers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 212,
   "end": 452
  },
  "claim": {
   "protein_as_written": "PLAUR",
   "gene": "PLAUR",
   "disease_as_written": "breast cancer",
   "direction": "raises",
   "estimate": {
    "or": 2.27,
    "low": 1.88,
    "high": 2.74,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 589,
    "end": 837
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38685026",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "POR, HSPA1B and BRD2 are exposures in the second step of a two-step MR, so the paper has protein exposures, but they are named only as mediators toward a class of diseases with no member disease paired and no own effect given, so no counting pair remains.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2011,
   "end": 2116
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38687828",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on IgA nephropathy; CFHR1 named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 634,
   "end": 833
  },
  "claim": {
   "protein_as_written": "CFHR1",
   "gene": "CFHR1",
   "disease_as_written": "IgA nephropathy",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1320,
    "end": 1405
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38689297",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on CHD and MI; conclusions give FES protective first.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 556,
   "end": 707
  },
  "claim": {
   "protein_as_written": "FES",
   "gene": "FES",
   "disease_as_written": "CHD",
   "direction": "lowers",
   "estimate": {
    "or": 0.68,
    "low": 0.59,
    "high": 0.79,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1932,
    "end": 2078
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2084,
    "end": 2199
   }
  }
 },
 {
  "pmid": "38697224",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Exposures are brain protein abundances.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 311,
   "end": 544
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38699366",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "A methods paper whose exposures are gene sets aggregated across xQTLs, not one protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1116,
   "end": 1326
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38701318",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "PCSK9 and HMGCR inhibition are proxied by SNPs whose source (pQTL or biomarker-weighted) the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 313,
   "end": 649
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "GC",
   "direction": "raises",
   "estimate": {
    "or": 0.482,
    "low": 0.264,
    "high": 0.879,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1095,
    "end": 1249
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1095,
    "end": 1249
   }
  }
 },
 {
  "pmid": "38703763",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is weight (BMI) gain, a quantitative trait; the MR's exposures (metabolomic and proteomic molecules) aren't named, so E2 isn't shown to fail.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 814,
   "end": 1098
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38707900",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR (Zheng et al.) on membranous nephropathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 442,
   "end": 550
  },
  "claim": {
   "protein_as_written": "ABO",
   "gene": "ABO",
   "disease_as_written": "MN",
   "direction": "raises",
   "estimate": {
    "or": 1.12,
    "low": 1.05,
    "high": 1.19,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 896,
    "end": 1800
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.79,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 896,
    "end": 1800
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2307,
    "end": 2396
   }
  }
 },
 {
  "pmid": "38710118",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are immune cell traits and, by SMR, gene expression and methylation; no protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1141,
   "end": 1292
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38719509",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein levels on frozen shoulder.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1057,
   "end": 1192
  },
  "claim": {
   "protein_as_written": "parathyroid hormone-related protein (PTHLH)",
   "gene": "PTHLH",
   "disease_as_written": "frozen shoulder",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1193,
    "end": 1514
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.68,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1193,
    "end": 1514
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38720515",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma pQTLs (alongside brain and CSF) on bipolar disorder; plasma pairs analysed separately.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 240,
   "end": 432
  },
  "claim": {
   "protein_as_written": "LMAN2L",
   "gene": "LMAN2L",
   "disease_as_written": "BD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1100,
    "end": 1231
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1465,
    "end": 1667
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1681,
    "end": 1923
   }
  }
 },
 {
  "pmid": "38721027",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 618,
   "end": 832
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38724566",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Brain proteome pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 439,
   "end": 647
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38725646",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 734 plasma proteins on insomnia; conclusions state elevated plasma TGFBI raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1676,
   "end": 1863
  },
  "claim": {
   "protein_as_written": "TGFBI",
   "gene": "TGFBI",
   "disease_as_written": "insomnia",
   "direction": "raises",
   "estimate": {
    "or": 1.01,
    "low": 1.01,
    "high": 1.02,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1676,
    "end": 1863
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1676,
    "end": 1863
   }
  }
 },
 {
  "pmid": "38725835",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with deCODE circulating proteins on HF; LRRTM2's own association with HF (the mediator step) is stated without its sign (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1027,
   "end": 1179
  },
  "claim": {
   "protein_as_written": "leucine rich repeat transmembrane protein 2 (LRRTM2)",
   "gene": "LRRTM2",
   "disease_as_written": "HF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1027,
    "end": 1179
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1368,
    "end": 1451
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38726270",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating cytokine levels (pQTL GWAS, 14,824 individuals) on follicular lymphoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 691,
   "end": 822
  },
  "claim": {
   "protein_as_written": "CXCL5",
   "gene": "CXCL5",
   "disease_as_written": "FL",
   "direction": "lowers",
   "estimate": {
    "or": 0.73,
    "low": 0.545,
    "high": 0.979,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1684,
    "end": 1928
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38729796",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of genetically predicted circulating protein levels on periodontitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 865,
   "end": 1128
  },
  "claim": {
   "protein_as_written": "VWA1",
   "gene": "VWA1",
   "disease_as_written": "periodontitis",
   "direction": "lowers",
   "estimate": {
    "or": 0.94,
    "low": 0.92,
    "high": 0.97,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 865,
    "end": 1128
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 670,
    "end": 734
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1700,
    "end": 1841
   }
  }
 },
 {
  "pmid": "38730525",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on childhood asthma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 897,
   "end": 989
  },
  "claim": {
   "protein_as_written": "TLR4",
   "gene": "TLR4",
   "disease_as_written": "childhood asthma",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 990,
    "end": 1231
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38735387",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Brain eQTL and pQTL exposures; the result is TPMT expression in the amygdala.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 881,
   "end": 1100
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38737575",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A methods paper whose applications estimate no named protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1233,
   "end": 1549
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38742978",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 323,
   "end": 504
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38754433",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating REG1 proteins on pancreatic cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 967,
   "end": 1070
  },
  "claim": {
   "protein_as_written": "REG1 proteins",
   "gene": "REG1A",
   "disease_as_written": "PC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 967,
    "end": 1070
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1071,
    "end": 1219
   }
  }
 },
 {
  "pmid": "38757060",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug target variants are weighted by LDL-C, HDL-C or TG (e.g. PCSK9-mediated LDL-C).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1032,
   "end": 1168
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38757788",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating SomaScan proteins on incident heart failure, the abstract's one outcome; the named MR proteins have no direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1373,
   "end": 1507
  },
  "claim": {
   "protein_as_written": "FCG2B",
   "gene": "FCGR2B",
   "disease_as_written": "HF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1373,
    "end": 1507
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1373,
    "end": 1507
   }
  }
 },
 {
  "pmid": "38760735",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "PCSK9 proxied by expression-level polymorphisms (SMR) and LDL-cholesterol-linked variants; the result is for PCSK9 expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 732,
   "end": 987
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38762535",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein levels; CA14 raises stroke risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 858,
   "end": 1054
  },
  "claim": {
   "protein_as_written": "CA14",
   "gene": "CA14",
   "disease_as_written": "stroke",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 858,
    "end": 1054
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38762700",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR of circulating proteins on FinnGen cancers; conclusions give directed pairs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 600,
   "end": 959
  },
  "claim": {
   "protein_as_written": "S100 calcium binding protein A14 (S100A14)",
   "gene": "S100A14",
   "disease_as_written": "HER-positive breast cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2066,
    "end": 2315
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.92,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1652,
    "end": 1888
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2442,
    "end": 2596
   }
  }
 },
 {
  "pmid": "38769320",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Blood osteocalcin levels instrumented by blood proteome GWAS variants; the outcome is Alzheimer's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 588,
   "end": 802
  },
  "claim": {
   "protein_as_written": "OCN",
   "gene": "BGLAP",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": {
    "or": 0.83,
    "low": 0.72,
    "high": 0.96,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2056,
    "end": 2206
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38769606",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The plasma proteins' MR outcome is lifespan, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1003,
   "end": 1189
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38773393",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-MR of plasma proteins on allergic diseases; abstract pairs proteins with diseases but gives no direction (unsigned claim).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 548,
   "end": 667
  },
  "claim": {
   "protein_as_written": "STAT6",
   "gene": "STAT6",
   "disease_as_written": "AA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1444,
    "end": 1596
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1444,
    "end": 1596
   }
  }
 },
 {
  "pmid": "38775562",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on EC subtypes; named proteins have no direction, so an unsigned claim from the results.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 638,
   "end": 826
  },
  "claim": {
   "protein_as_written": "RGMA",
   "gene": "RGMA",
   "disease_as_written": "endometrioid subtype",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1533,
    "end": 1850
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38778174",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 734 plasma proteins' pQTLs on diabetic retinopathy; conclusions name CFH without a direction, which the results give (OR 0.8).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 932,
   "end": 1211
  },
  "claim": {
   "protein_as_written": "CFH",
   "gene": "CFH",
   "disease_as_written": "DR",
   "direction": "lowers",
   "estimate": {
    "or": 0.8,
    "low": 0.75,
    "high": 0.86,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 932,
    "end": 1211
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.534,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1265,
    "end": 1419
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1634,
    "end": 1753
   }
  }
 },
 {
  "pmid": "38778378",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTLs of 85 cardiovascular plasma proteins used as instruments for colorectal cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 573,
   "end": 802
  },
  "claim": {
   "protein_as_written": "LOX-1",
   "gene": "OLR1",
   "disease_as_written": "CRC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1198,
    "end": 1368
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38779730",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposure is insulin receptor \"expression\" instrumented by \"genetic variants of the insulin receptor\"; the abstract does not say they are pQTLs of a circulating level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 987,
   "end": 1133
  },
  "claim": {
   "protein_as_written": "insulin receptor",
   "gene": "INSR",
   "disease_as_written": "UTI",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1829,
    "end": 1958
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38782984",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins with cis-pQTLs on NAFLD; pairs stated without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 968,
   "end": 1172
  },
  "claim": {
   "protein_as_written": "CSPG3",
   "gene": "NCAN",
   "disease_as_written": "NAFLD",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 968,
    "end": 1172
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1173,
    "end": 1288
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1648,
    "end": 1761
   }
  }
 },
 {
  "pmid": "38783236",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "A pQTL analysis estimates the effect of plasma IL-7 level on IPF, a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1408,
   "end": 1561
  },
  "claim": {
   "protein_as_written": "IL-7",
   "gene": "IL7",
   "disease_as_written": "IPF",
   "direction": "lowers",
   "estimate": {
    "or": 0.67,
    "low": 0.47,
    "high": 0.97,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1408,
    "end": 1561
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1307,
    "end": 1407
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1574,
    "end": 1662
   }
  }
 },
 {
  "pmid": "38795402",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step, proteome-wide MR of circulating plasma proteins on insomnia; the abstract reports Ap4A's own step on insomnia (linked to insomnia) without its sign, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1347,
   "end": 1489
  },
  "claim": {
   "protein_as_written": "Ap4A",
   "gene": "NUDT2",
   "disease_as_written": "insomnia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1347,
    "end": 1489
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38795606",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with cis-pQTLs of circulating inflammatory cytokines on pregnancy outcomes from FinnGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 625,
   "end": 845
  },
  "claim": {
   "protein_as_written": "soluble intercellular adhesion molecule (sICAM-1)",
   "gene": "ICAM1",
   "disease_as_written": "excessive vomiting in pregnancy",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1388,
    "end": 1938
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38797322",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "deCODE plasma proteins used as MR exposures on keloids.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 282,
   "end": 525
  },
  "claim": {
   "protein_as_written": "neurotrimin [NTM]",
   "gene": "NTM",
   "disease_as_written": "keloids",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 974,
    "end": 1167
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1489,
    "end": 1596
   }
  }
 },
 {
  "pmid": "38800057",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "CCB targets proxied by variants associated with systolic blood pressure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 548,
   "end": 697
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38800635",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTLs for BGAT protein level from deCODE used as instruments for pregnancy-related diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 486,
   "end": 800
  },
  "claim": {
   "protein_as_written": "BGAT",
   "gene": "ABO",
   "disease_as_written": "venous complications and haemorrhoids in pregnancy",
   "direction": "raises",
   "estimate": {
    "or": 1.19,
    "low": 1.12,
    "high": 1.27,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 877,
    "end": 1177
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.91,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 877,
    "end": 1177
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1648,
    "end": 1801
   }
  }
 },
 {
  "pmid": "38809509",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTLs from deCODE instrument circulating proteins against PBC and PSC from FinnGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 571,
   "end": 693
  },
  "claim": {
   "protein_as_written": "LEFTY2",
   "gene": "LEFTY2",
   "disease_as_written": "PBC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1586,
    "end": 1736
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1218,
    "end": 1388
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1586,
    "end": 1736
   }
  }
 },
 {
  "pmid": "38809565",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract says MR found effects of 'several proteins' on HF and frailty but names no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2469,
   "end": 2546
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38811930",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Gene MR uses peripheral blood eQTLs; other MR is periodontitis to T2D.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 612,
   "end": 766
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38814292",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract (a commentary).",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38814898",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 512,
   "end": 720
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38818040",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are genes instrumented by cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 497,
   "end": 712
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38819656",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target inhibition proxied genetically; the abstract does not name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 373,
   "end": 500
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "melanoma",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 373,
    "end": 500
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 903,
    "end": 1039
   }
  }
 },
 {
  "pmid": "38820305",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR on 20 cardio-cerebral diseases; pairs named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 548,
   "end": 719
  },
  "claim": {
   "protein_as_written": "PILRA",
   "gene": "PILRA",
   "disease_as_written": "sick sinus syndrome",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1557,
    "end": 1717
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1386,
    "end": 1556
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38820493",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposures are serum lipids; ANGPTL3 drug-target MR is mediated through (weighted by) triglycerides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1931,
   "end": 2103
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38822303",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "HMGCR and PCSK9 inhibition proxied by 'genetic variations associated with HMGCR and PCSK9' from published GWAS, without naming what they are associated with.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 726,
   "end": 906
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "OC",
   "direction": "lowers",
   "estimate": {
    "or": 1.815,
    "low": 1.316,
    "high": 2.315,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1583,
    "end": 1760
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1583,
    "end": 1760
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38824092",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with deCODE pQTLs on lung cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 594,
   "end": 712
  },
  "claim": {
   "protein_as_written": "ICAM5",
   "gene": "ICAM5",
   "disease_as_written": "lung cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1478,
    "end": 1705
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1058,
    "end": 1143
   }
  }
 },
 {
  "pmid": "38826220",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR between sociability and fMRI traits; genes prioritised through eQTL MR, no circulating protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 824,
   "end": 1101
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38828357",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on CKD states INHBC and SNUPN as causal without a direction anywhere: an unsigned claim on the first pair the conclusions name (INHBC-CKD).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1070,
   "end": 1180
  },
  "claim": {
   "protein_as_written": "INHBC",
   "gene": "INHBC",
   "disease_as_written": "CKD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1070,
    "end": 1180
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1181,
    "end": 1301
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1410,
    "end": 1606
   }
  }
 },
 {
  "pmid": "38828408",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating cytokine levels on thymic tumours; conclusions name IL-12 subunit beta without direction, results call it protective for thymic malignant tumors.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 304,
   "end": 504
  },
  "claim": {
   "protein_as_written": "interleukin-12 subunit beta",
   "gene": "IL12B",
   "disease_as_written": "thymic malignant tumors",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 983,
    "end": 1166
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38830831",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "INTERVAL pQTL MR on pulmonary heart disease; CAMK1's OR above 1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 766,
   "end": 910
  },
  "claim": {
   "protein_as_written": "CAMK1",
   "gene": "CAMK1",
   "disease_as_written": "pulmonary heart disease",
   "direction": "raises",
   "estimate": {
    "or": 1.1056,
    "low": 1.019,
    "high": 1.095,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1322,
    "end": 1458
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1322,
    "end": 1458
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38831433",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by LDL cholesterol-associated variants at target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1013,
   "end": 1158
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38834983",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLGen gene expression QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 320,
   "end": 438
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38835753",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein pQTLs on ankylosing spondylitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1272,
   "end": 1377
  },
  "claim": {
   "protein_as_written": "AGER",
   "gene": "AGER",
   "disease_as_written": "AS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1378,
    "end": 1643
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1378,
    "end": 1643
   }
  }
 },
 {
  "pmid": "38835791",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "IL6R inhibition proxied by variants weighted by CRP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 785,
   "end": 913
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38837845",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PCSK9 inhibition is proxied by PCSK9 SNPs from GWAS without naming what they are associated with.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 560,
   "end": 820
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "ALS",
   "direction": "raises",
   "estimate": {
    "or": 0.89,
    "low": 0.77,
    "high": 1,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1171,
    "end": 1351
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1463,
    "end": 1545
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38844506",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR finds 33 blood proteins associated with MVP but names none; the actionable targets listed come from druggability and receptor analyses, not attributed to MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 791,
   "end": 934
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38844880",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR of metformin targets on breast cancer; the abstract doesn't name the targets' instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 346,
   "end": 609
  },
  "claim": {
   "protein_as_written": "ETFDH",
   "gene": "ETFDH",
   "disease_as_written": "ER-positive BC",
   "direction": "lowers",
   "estimate": {
    "or": 0.867,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1527,
    "end": 1682
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1527,
    "end": 1682
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38846092",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of SGLT2-inhibitor 'drug targets' whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1337,
   "end": 1483
  },
  "claim": {
   "protein_as_written": "LCN2",
   "gene": "LCN2",
   "disease_as_written": "IgAN",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1484,
    "end": 1565
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1337,
    "end": 1483
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2111,
    "end": 2200
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38850595",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target genes instrumented by eQTLs and pQTLs together, PRKAB1 result not tied to a circulating protein analysis; PRKAB1 lowers lung adenocarcinoma risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 320,
   "end": 672
  },
  "claim": {
   "protein_as_written": "PRKAB1",
   "gene": "PRKAB1",
   "disease_as_written": "lung adenocarcinoma",
   "direction": "lowers",
   "estimate": {
    "or": 0.85,
    "low": 0.76,
    "high": 0.96,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1131,
    "end": 1283
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1131,
    "end": 1283
   }
  }
 },
 {
  "pmid": "38851763",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating lipoprotein(a) levels (apolipoprotein(a), LPA) on atrial fibrillation, a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1158,
   "end": 1268
  },
  "claim": {
   "protein_as_written": "lipoprotein(a)",
   "gene": "LPA",
   "disease_as_written": "AF",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1158,
    "end": 1268
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2001,
    "end": 2186
   }
  }
 },
 {
  "pmid": "38854583",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins linked to sepsis outcomes are given only as counts; none is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1380,
   "end": 1568
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38858729",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL proteome-wide MR of plasma proteins on pancreatic cancer; no direction stated for PC pairs; CHST11 named with colocalisation (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 280,
   "end": 486
  },
  "claim": {
   "protein_as_written": "carbohydrate sulfotransferase 11",
   "gene": "CHST11",
   "disease_as_written": "PC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1631,
    "end": 1890
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1631,
    "end": 1890
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38865108",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma TGFBR3 on hypertension and CVD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1386,
   "end": 1577
  },
  "claim": {
   "protein_as_written": "TGFBR3",
   "gene": "TGFBR3",
   "disease_as_written": "hypertension",
   "direction": "lowers",
   "estimate": {
    "or": 0.99,
    "low": 0.98,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2857,
    "end": 3267
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38867170",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are brain and blood eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 420,
   "end": 734
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38869147",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Instruments are human brain pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 399,
   "end": 686
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38871465",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2,769 plasma proteins on IPF; no direction is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 371,
   "end": 511
  },
  "claim": {
   "protein_as_written": "FUT3",
   "gene": "FUT3",
   "disease_as_written": "IPF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 371,
    "end": 511
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 371,
    "end": 511
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38872630",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of cathepsin levels (GWAS from IEU OpenGWAS) on Parkinson's disease; conclusions state higher CTSB lowers PD risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1488,
   "end": 1796
  },
  "claim": {
   "protein_as_written": "CTSB",
   "gene": "CTSB",
   "disease_as_written": "PD",
   "direction": "lowers",
   "estimate": {
    "or": 0.898,
    "low": 0.834,
    "high": 0.966,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2323,
    "end": 2511
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38874077",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38874503",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with variants associated with circulating inflammatory proteins on urological cancers; kidney/bladder pairs and protective prostate pairs failed FDR, but the prostate risk-factor pairs are not said to have failed.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 663,
   "end": 847
  },
  "claim": {
   "protein_as_written": "Glial cell line-derived neurotrophic factor",
   "gene": "GDNF",
   "disease_as_written": "prostate cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1312,
    "end": 1541
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38874858",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs for Runx2 expression from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 465,
   "end": 621
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38876042",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR includes plasma proteins; TIE1 in CSF and plasma raised ADHD risk after Bonferroni correction, and the conclusions name TIE1 (GMPPB is a brain protein).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1290,
   "end": 1449
  },
  "claim": {
   "protein_as_written": "TIE1",
   "gene": "TIE1",
   "disease_as_written": "ADHD",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1290,
    "end": 1449
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1450,
    "end": 1573
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2074,
    "end": 2160
   }
  }
 },
 {
  "pmid": "38878676",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of circulating proteins on prostate cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 335,
   "end": 568
  },
  "claim": {
   "protein_as_written": "PPA2",
   "gene": "PPA2",
   "disease_as_written": "aggressive disease",
   "direction": "raises",
   "estimate": {
    "or": 2.13,
    "low": 1.54,
    "high": 2.93,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1295,
    "end": 1685
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 569,
    "end": 771
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38883777",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Observational proteomics; the only MR is reverse MR from dementia to proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1038,
   "end": 1156
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38887235",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of pQTLs for 2,004 circulating proteins on breast cancer; targets named without direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 513,
   "end": 723
  },
  "claim": {
   "protein_as_written": "TLR1",
   "gene": "TLR1",
   "disease_as_written": "BC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1303,
    "end": 1482
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1554,
    "end": 1662
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1303,
    "end": 1482
   }
  }
 },
 {
  "pmid": "38888899",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The only protein MR uses brain proteins (on smoking behavior); the main MR exposures are psychiatric liabilities and substance use.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2406,
   "end": 2699
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38892221",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR links inflammatory proteins such as FGF5 to CKD; no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1089,
   "end": 1309
  },
  "claim": {
   "protein_as_written": "FGF5",
   "gene": "FGF5",
   "disease_as_written": "CKD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1089,
    "end": 1309
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1089,
    "end": 1309
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38895109",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR with cis variants associated with circulating ANGPTL3/4 and APOC3 levels on CAD and T2D.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 515,
   "end": 712
  },
  "claim": {
   "protein_as_written": "ANGPTL4",
   "gene": "ANGPTL4",
   "disease_as_written": "coronary artery disease",
   "direction": "raises",
   "estimate": {
    "or": 0.57,
    "low": 0.47,
    "high": 0.7,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1094,
    "end": 1328
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 167,
    "end": 358
   }
  }
 },
 {
  "pmid": "38896366",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR, but the results tie the pairs to circulating protein levels; conclusions name SDCCAG8 without a direction, results give OR 0.46.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 945,
   "end": 1387
  },
  "claim": {
   "protein_as_written": "SDCCAG8",
   "gene": "SDCCAG8",
   "disease_as_written": "thyroid cancer",
   "direction": "lowers",
   "estimate": {
    "or": 0.46,
    "low": 0.34,
    "high": 0.64,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 945,
    "end": 1387
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38898508",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma protein pQTLs on CKD; conclusions name no protein, the first result with a direction is GCKR (OR 1.17).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1018,
   "end": 1273
  },
  "claim": {
   "protein_as_written": "GCKR",
   "gene": "GCKR",
   "disease_as_written": "CKD",
   "direction": "raises",
   "estimate": {
    "or": 1.17,
    "low": 1.1,
    "high": 1.24,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1846,
    "end": 2102
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1846,
    "end": 2102
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38898596",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTLs of plasma proteins used in MR on migraine.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 437,
   "end": 601
  },
  "claim": {
   "protein_as_written": "LRP11",
   "gene": "LRP11",
   "disease_as_written": "any migraine",
   "direction": "lowers",
   "estimate": {
    "or": 0.968,
    "low": 0.955,
    "high": 0.981,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1191,
    "end": 1414
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 719,
    "end": 1020
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38901247",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of serum interleukin levels from serum proteome studies on cancers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 353,
   "end": 548
  },
  "claim": {
   "protein_as_written": "IL-1α",
   "gene": "IL1A",
   "disease_as_written": "Hodgkin lymphoma",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 832,
    "end": 1178
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38903171",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL (35,559 and 54,219 samples) proteome-wide SMR on AMD; the abstract ties the identified proteins to the proteome-wide MR, and WARS1 is named as associated without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 483,
   "end": 669
  },
  "claim": {
   "protein_as_written": "WARS1",
   "gene": "WARS1",
   "disease_as_written": "AMD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1480,
    "end": 1819
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1480,
    "end": 1819
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 987,
    "end": 1114
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38903760",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "HMGCR 'inhibition' in drug-target MR; instruments not named in the abstract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1285,
   "end": 1414
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "rotator cuff disease",
   "direction": "raises",
   "estimate": {
    "or": 0.68,
    "low": 0.56,
    "high": 0.83,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1787,
    "end": 1970
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2324,
    "end": 2425
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38903813",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug targets proxied through LDL and triglyceride GWAS from GLGC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 678,
   "end": 926
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38904434",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Methods paper on caffeine as exposure for BMI; no protein exposure or disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1319,
   "end": 1522
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38906890",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "CETP drug-target MR scaled to HDL cholesterol, a downstream biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 496,
   "end": 695
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38908058",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR gives plasma proteins' own effects on stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 886,
   "end": 1070
  },
  "claim": {
   "protein_as_written": "FAM134B",
   "gene": "RETREG1",
   "disease_as_written": "stroke",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 886,
    "end": 1070
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38909219",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants were derived from the GLGC lipid GWAS, so lipid levels weight them; the other exposures are lipid traits and SMR of expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 622,
   "end": 802
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38909833",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Exposures are dorsolateral prefrontal cortex protein abundances.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 393,
   "end": 660
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38911899",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "A protocol; the abstract states no results and no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1072,
   "end": 1285
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38915894",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 587,
   "end": 803
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38918852",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are drug classes proxied by SNPs associated with the drugs, not a circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 977,
   "end": 1330
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38927385",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are serum and CSF metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 320,
   "end": 487
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38927411",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE druggable proteins on aortic dissection.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 686,
   "end": 777
  },
  "claim": {
   "protein_as_written": "ASPN",
   "gene": "ASPN",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "frame": "per higher protein",
    "high": 1.54,
    "low": 1.2,
    "unit": "not stated",
    "or": 1.36
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1393,
    "end": 1562
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1323,
    "end": 1392
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1393,
    "end": 1562
   }
  }
 },
 {
  "pmid": "38931433",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of genetically predicted plasma protein levels (deCODE, UKB-PPP) on T1D.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 968,
   "end": 1163
  },
  "claim": {
   "protein_as_written": "MANSC4",
   "gene": "MANSC4",
   "disease_as_written": "T1D",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1870,
    "end": 2049
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1870,
    "end": 2049
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2281,
    "end": 2532
   }
  }
 },
 {
  "pmid": "38933282",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Protein-level pairs come from SMR pooling mQTL, eQTL and pQTL, with the protein instruments' tissue not stated; conclusions name no protein, and the first directed protein-level pair in the results is PLAU's promotional effect on SS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 351,
   "end": 594
  },
  "claim": {
   "protein_as_written": "PLAU",
   "gene": "PLAU",
   "disease_as_written": "SS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1729,
    "end": 1860
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38933427",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma levels of coagulation proteins (deCODE, Fenland, ARIC) on VTE.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 686,
   "end": 1254
  },
  "claim": {
   "protein_as_written": "F2",
   "gene": "F2",
   "disease_as_written": "VTE",
   "direction": "raises",
   "estimate": {
    "or": 0.44,
    "low": 0.38,
    "high": 0.51,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1255,
    "end": 1573
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1831,
    "end": 2007
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2008,
    "end": 2225
   }
  }
 },
 {
  "pmid": "38933947",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MYBL1's causal effect from MR integrated from public databases; instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 446,
   "end": 669
  },
  "claim": {
   "protein_as_written": "MYBL1",
   "gene": "MYBL1",
   "disease_as_written": "CD",
   "direction": "raises",
   "estimate": {
    "unit": "not stated",
    "frame": "per higher protein",
    "low": 1.05,
    "high": 1.45,
    "or": 1.23
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1022,
    "end": 1164
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1466,
    "end": 1575
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38947379",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are immune cell traits, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 625,
   "end": 895
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38947504",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on thyroid cancer; NANS passed multiple-testing correction, with no direction given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 538,
   "end": 725
  },
  "claim": {
   "protein_as_written": "NANS",
   "gene": "NANS",
   "disease_as_written": "TCs",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 538,
    "end": 725
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "38947510",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is renal function, a quantitative measure. CKD treatment is named only as what restoring renal function might lead to.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 453,
   "end": 602
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38951247",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract names no protein for its protein-disease associations.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 620,
   "end": 802
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38958042",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of genetically predicted plasma proteins on IPF and COPD; the conclusions name SCARF2 for COPD, and the results give its direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 953,
   "end": 1095
  },
  "claim": {
   "protein_as_written": "SCARF2",
   "gene": "SCARF2",
   "disease_as_written": "COPD",
   "direction": "lowers",
   "estimate": {
    "or": 0.7431,
    "low": 0.6253,
    "high": 0.8831,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1096,
    "end": 1317
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1318,
    "end": 1389
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1804,
    "end": 1853
   }
  }
 },
 {
  "pmid": "38961500",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants weighted by LDL-C and triglyceride levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 859,
   "end": 975
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38961868",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The MR's proteins are brain and CSF proteins, and the outcome is a cognitive score.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2140,
   "end": 2396
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38964432",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of ARIC plasma proteins on multiple sclerosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1261,
   "end": 1489
  },
  "claim": {
   "protein_as_written": "PLEK",
   "gene": "PLEK",
   "disease_as_written": "MS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1261,
    "end": 1489
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1490,
    "end": 1572
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1772,
    "end": 1873
   }
  }
 },
 {
  "pmid": "38971663",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by LDL-C-associated variants and eQTLs; outcomes are gut microbiota.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 505,
   "end": 724
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38974243",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets are proxied by gene variants weighted by LDL cholesterol.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 558,
   "end": 726
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38975226",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The main exposures are lipids and amino acids; the only protein MR, a drug-target MR of CEPT1, CPT1, and EPT1, is reported null, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1272,
   "end": 1377
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38976909",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteomics MR on cholelithiasis; conclusions name FUT3 first without direction, results give OR 0.87.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1816,
   "end": 1954
  },
  "claim": {
   "protein_as_written": "FUT3",
   "gene": "FUT3",
   "disease_as_written": "cholelithiasis",
   "direction": "lowers",
   "estimate": {
    "or": 0.87,
    "low": 0.84,
    "high": 0.89,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 981,
    "end": 1431
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1487,
    "end": 1606
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 981,
    "end": 1431
   }
  }
 },
 {
  "pmid": "38977137",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR outcome is amyloid-beta PET level, an imaging measure, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 866,
   "end": 1074
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38977622",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR and two-sample MR of druggable genes, instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 525,
   "end": 742
  },
  "claim": {
   "protein_as_written": "TNFSF12",
   "gene": "TNFSF12",
   "disease_as_written": "hemorrhagic strokes",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1632,
    "end": 1818
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1193,
    "end": 1276
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "38985358",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 1478 blood proteins on head and neck cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 437,
   "end": 661
  },
  "claim": {
   "protein_as_written": "ADAM23",
   "gene": "ADAM23",
   "disease_as_written": "head and neck cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1488,
    "end": 1614
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1615,
    "end": 1798
   }
  }
 },
 {
  "pmid": "38987357",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "MR exposures are cerebrospinal fluid proteins, not circulating ones.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1000,
   "end": 1097
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38990854",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR between GERD and migraine, with no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1072,
   "end": 1204
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38995687",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "38996988",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Targets come from analyses pooling expression, methylation, and pQTL data from blood and brain.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 382,
   "end": 658
  },
  "claim": {
   "protein_as_written": "STX6",
   "gene": "STX6",
   "disease_as_written": "sCJD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 926,
    "end": 1102
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 926,
    "end": 1102
   }
  }
 },
 {
  "pmid": "38997544",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Whole-blood cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 336,
   "end": 574
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39000484",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating biomarkers including the protein cystatin C on diseases; conclusions name no protein, and the first protein pair with a direction in the results is cystatin C with bipolar disorder (negative effect).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1085,
   "end": 1311
  },
  "claim": {
   "protein_as_written": "cystatin C",
   "gene": "CST3",
   "disease_as_written": "bipolar disorder",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1085,
    "end": 1311
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39003418",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-MR of plasma proteins on skin cancers including basal cell carcinoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 399,
   "end": 556
  },
  "claim": {
   "protein_as_written": "ASIP",
   "gene": "ASIP",
   "disease_as_written": "BCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1128,
    "end": 1221
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1299,
    "end": 1434
   }
  }
 },
 {
  "pmid": "39006413",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating biomarkers, including proteins such as cystatin C, on diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 768,
   "end": 1085
  },
  "claim": {
   "protein_as_written": "cystatin C",
   "gene": "CST3",
   "disease_as_written": "bipolar disorder",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1095,
    "end": 1318
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39006495",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on acne vulgaris; plasma TIMP4 raised risk at a Bonferroni threshold.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 553,
   "end": 646
  },
  "claim": {
   "protein_as_written": "TIMP4",
   "gene": "TIMP4",
   "disease_as_written": "acne vulgaris",
   "direction": "raises",
   "estimate": {
    "or": 1.15,
    "low": 1.09,
    "high": 1.21,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1370,
    "end": 1480
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.93,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1549,
    "end": 1660
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2040,
    "end": 2167
   }
  }
 },
 {
  "pmid": "39009607",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The MR's causal genes are named without the disease each was tested on and without their instruments, so E2 can't be settled from the abstract, but no protein-disease pair from MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 663,
   "end": 788
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39009667",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "PWAS and MR of ARIC plasma proteome on IBD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 626,
   "end": 829
  },
  "claim": {
   "protein_as_written": "ERAP2",
   "gene": "ERAP2",
   "disease_as_written": "IBD",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1000,
    "end": 1253
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39009924",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of PCSK9 inhibition and apoB targeting is weighted by LDL cholesterol reduction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1023,
   "end": 1364
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39010704",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "SNPs near SLC5A1 and SLC5A2 proxy inhibition; instruments not named as protein-level variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 383,
   "end": 794
  },
  "claim": {
   "protein_as_written": "SGLT1",
   "gene": "SLC5A1",
   "disease_as_written": "ALS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1222,
    "end": 1351
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1222,
    "end": 1351
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39010723",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins includes MICB with CKD, without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1136,
   "end": 1260
  },
  "claim": {
   "protein_as_written": "MICB",
   "gene": "MICB",
   "disease_as_written": "CKD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1136,
    "end": 1260
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39011113",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTLs are used, but the outcomes are MRI markers of cerebral small vessel disease (white matter hyperintensities, perivascular spaces), imaging measures, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 241,
   "end": 459
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39011643",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on lung cancer subtypes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 462,
   "end": 608
  },
  "claim": {
   "protein_as_written": "SFTPB",
   "gene": "SFTPB",
   "disease_as_written": "lung adenocarcinoma",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 609,
    "end": 925
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 609,
    "end": 925
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39012516",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted protein levels (pQTLs) on AML.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1038,
   "end": 1244
  },
  "claim": {
   "protein_as_written": "REC8",
   "gene": "REC8",
   "disease_as_written": "AML",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1038,
    "end": 1244
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39014047",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 485,
   "end": 586
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39017955",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR on CRC, but no protein is named with the disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 919,
   "end": 1086
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39018378",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets are proxied by variants weighted by systolic blood pressure, not by protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 872,
   "end": 1070
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39021342",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are plasma protein-to-protein ratios.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 713,
   "end": 974
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39025441",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR uses blood eQTLs (eQTLGen) only, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 870,
   "end": 1202
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39025905",
  "eligibility": "E5",
  "e2_kind": null,
  "eligibility_reason": "A methods paper proposing cisMR-cML, with a proteome-wide CAD application as illustration.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 529,
   "end": 674
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39026678",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on PsA; conclusions name IL-10 first without direction, results give OR 0.45.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 571,
   "end": 768
  },
  "claim": {
   "protein_as_written": "Interleukin-10 (IL-10)",
   "gene": "IL10",
   "disease_as_written": "PsA",
   "direction": "lowers",
   "estimate": {
    "or": 0.45,
    "low": 0.28,
    "high": 0.7,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1239,
    "end": 1395
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.834,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1514,
    "end": 1676
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39027515",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR exposures are not named; genes identified from multi-omics integration.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 347,
   "end": 436
  },
  "claim": {
   "protein_as_written": "cathepsin S (CTSS)",
   "gene": "CTSS",
   "disease_as_written": "pSS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 716,
    "end": 879
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 716,
    "end": 879
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39029667",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Proteins tested by 'drug-target MR' whose instruments the abstract doesn't name as circulating-level pQTLs; CD40 is the first protein named in the conclusions whose direction the results give (OR 0.71).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 913,
   "end": 1075
  },
  "claim": {
   "protein_as_written": "CD40",
   "gene": "CD40",
   "disease_as_written": "MS",
   "direction": "lowers",
   "estimate": {
    "or": 0.71,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1698,
    "end": 2005
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.976,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1698,
    "end": 2005
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2140,
    "end": 2363
   }
  }
 },
 {
  "pmid": "39033731",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on AAA; conclusions name TGFB1 without direction, results give OR 1.21.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 473,
   "end": 642
  },
  "claim": {
   "protein_as_written": "TGFB1",
   "gene": "TGFB1",
   "disease_as_written": "AAA",
   "direction": "raises",
   "estimate": {
    "or": 1.21,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 957,
    "end": 1205
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1397,
    "end": 1487
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1501,
    "end": 1682
   }
  }
 },
 {
  "pmid": "39034037",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "PPARG is instrumented by gene expression (SMR) and by LDL-weighted variants, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 981,
   "end": 1150
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39035989",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide cis-pQTL MR (UKB-PPP, deCODE) on basal cell carcinoma; PTGES2 and RNASET2 named without direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1681,
   "end": 1986
  },
  "claim": {
   "protein_as_written": "PTGES2",
   "gene": "PTGES2",
   "disease_as_written": "BCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2499,
    "end": 2689
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.92,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 2052,
    "end": 2169
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2499,
    "end": 2689
   }
  }
 },
 {
  "pmid": "39036049",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UKB-PPP plasma protein MR on endometriosis; conclusions name FSHB first without direction, results give OR 3.91.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1097,
   "end": 1186
  },
  "claim": {
   "protein_as_written": "FSHB",
   "gene": "FSHB",
   "disease_as_written": "EM",
   "direction": "raises",
   "estimate": {
    "or": 3.91,
    "low": 3.13,
    "high": 4.87,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1187,
    "end": 1519
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1704,
    "end": 1779
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2055,
    "end": 2229
   }
  }
 },
 {
  "pmid": "39038097",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 1463 plasma protein abundances with pQTL instruments on subsequent MACE after stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 747,
   "end": 943
  },
  "claim": {
   "protein_as_written": "CCL27",
   "gene": "CCL27",
   "disease_as_written": "subsequent MACE",
   "direction": "lowers",
   "estimate": {
    "or": 0.77,
    "low": 0.66,
    "high": 0.88,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1244,
    "end": 1578
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39038939",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are GTEx eQTLs and brain (ROSMAP) pQTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 364,
   "end": 600
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39039470",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Protein-level MR with UKB-PPP plasma pQTLs on migraine; conclusions name GSTM4 without direction, the protein-level results give it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 695,
   "end": 823
  },
  "claim": {
   "protein_as_written": "GSTM4",
   "gene": "GSTM4",
   "disease_as_written": "migraine",
   "direction": "lowers",
   "estimate": {
    "or": 0.91,
    "low": 0.87,
    "high": 0.95,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1832,
    "end": 2242
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.86,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1832,
    "end": 2242
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2364,
    "end": 2468
   }
  }
 },
 {
  "pmid": "39040085",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are blood eQTLs of druggable genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 387,
   "end": 505
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39040677",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating inflammatory proteins (pQTLs) on diabetic renal complications from FinnGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 518,
   "end": 689
  },
  "claim": {
   "protein_as_written": "interleukin 12B (IL-12B)",
   "gene": "IL12B",
   "disease_as_written": "type 1 diabetes (T1D) with renal complications",
   "direction": "raises",
   "estimate": {
    "or": 1.691,
    "low": 1.179,
    "high": 2.427,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 898,
    "end": 1599
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1600,
    "end": 1771
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39043809",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Primary analysis is LDL-weighted, but secondary MR uses plasma cis-pQTLs of HMGCR, which the abstract says confirmed the DN and DR associations.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 948,
   "end": 1246
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "DN",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1433,
    "end": 1484
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 305,
    "end": 541
   }
  }
 },
 {
  "pmid": "39051921",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools eQTL and deCODE pQTL evidence, and the pairs aren't tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1508,
   "end": 2198
  },
  "claim": {
   "protein_as_written": "RELT",
   "gene": "RELT",
   "disease_as_written": "IAs",
   "direction": "lowers",
   "estimate": {
    "or": 0.14,
    "low": 0.04,
    "high": 0.5,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1508,
    "end": 2198
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 702,
    "end": 1110
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2949,
    "end": 3101
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39055828",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of drug target genes and variants weighted by LDL-C and triglycerides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 496,
   "end": 820
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39059088",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is between vascular diseases; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1050,
   "end": 1206
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39059473",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins (pQTLs, SCALLOP-like) on atrial fibrillation; FGF5-AF pair stated without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 503,
   "end": 654
  },
  "claim": {
   "protein_as_written": "FGF5",
   "gene": "FGF5",
   "disease_as_written": "AF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1665,
    "end": 1740
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1258,
    "end": 1394
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1665,
    "end": 1740
   }
  }
 },
 {
  "pmid": "39072584",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is platelet count, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 661,
   "end": 724
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39076342",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins from proteome GWAS on myocardial infarction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 92,
   "end": 395
  },
  "claim": {
   "protein_as_written": "KIR2DS2",
   "gene": "KIR2DS2",
   "disease_as_written": "MI",
   "direction": "lowers",
   "estimate": {
    "or": 0.93,
    "low": 0.9,
    "high": 0.96,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1709,
    "end": 1874
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1964,
    "end": 2100
   }
  }
 },
 {
  "pmid": "39076991",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of proteins (deCODE pQTLs) on multiple sclerosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 659,
   "end": 996
  },
  "claim": {
   "protein_as_written": "FCRL3",
   "gene": "FCRL3",
   "disease_as_written": "multiple sclerosis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 0,
    "end": 135
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1531,
    "end": 1614
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1744,
    "end": 1852
   }
  }
 },
 {
  "pmid": "39081035",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of HMGCR, ANGPTL3, CETP 'targets' with instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1174,
   "end": 1430
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "IA",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1586,
    "end": 1849
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1174,
    "end": 1430
   }
  }
 },
 {
  "pmid": "39083861",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is low hand grip strength, a trait, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 334,
   "end": 516
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39084678",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The plasma protein analysis found no significant protein; the stated pairs are brain protein abundances, so no circulating protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 988,
   "end": 1087
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39085621",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating C4A levels, instrumented by phosSNPs that are pQTLs, on JDM.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1207,
   "end": 1438
  },
  "claim": {
   "protein_as_written": "C4A",
   "gene": "C4A",
   "disease_as_written": "JDM",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1207,
    "end": 1438
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39087774",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 681,
   "end": 907
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39090671",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "The apolipoprotein A and B MR gives only a null result, and the paper's pairs come from drug-target MR of genetically mimicked inhibition of PCSK9 and other targets, whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1668,
   "end": 2057
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "IPF",
   "direction": "lowers",
   "estimate": {
    "or": 1.36,
    "low": 1.02,
    "high": 1.82,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2372,
    "end": 2603
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2372,
    "end": 2603
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39091241",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma APOB levels on liver cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 826,
   "end": 1141
  },
  "claim": {
   "protein_as_written": "apolipoprotein B (APOB)",
   "gene": "APOB",
   "disease_as_written": "liver cancer",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 703,
    "end": 825
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 826,
    "end": 1141
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39094357",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is of pulmonary fibrosis on lung cancer subtypes; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 797,
   "end": 958
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39098392",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins were tested, but the findings stated are for metabolites only; no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1016,
   "end": 1140
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39103489",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug targets (including PCSK9) instrumented by variants from the Global Lipid Genetics Consortium, i.e. weighted by serum lipids.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 471,
   "end": 615
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39103761",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are gut microbiota taxa.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 360,
   "end": 462
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39108314",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with plasma protein levels as exposures and clinically diagnosed LOAD as outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2198,
   "end": 2357
  },
  "claim": {
   "protein_as_written": "HGF",
   "gene": "HGF",
   "disease_as_written": "LOAD",
   "direction": "lowers",
   "estimate": {
    "or": 0.945,
    "low": 0.906,
    "high": 0.984,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2186,
    "end": 2357
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39109334",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The abstract doesn't say the C1QB exposure is its circulating level or name its instruments (OpenGWAS holds both eQTL and pQTL GWASs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 502,
   "end": 601
  },
  "claim": {
   "protein_as_written": "C1QB",
   "gene": "C1QB",
   "disease_as_written": "CRC",
   "direction": "raises",
   "estimate": {
    "or": 1.104,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1015,
    "end": 1123
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 339,
    "end": 492
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39110588",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are druggable genes in blood and retina, supported by blood eQTL data, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 945,
   "end": 1160
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39110833",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of unnamed hypnotic targets; no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1396,
   "end": 1522
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39112975",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR of circulating cytokine levels on sepsis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1360,
   "end": 1642
  },
  "claim": {
   "protein_as_written": "MIP1α",
   "gene": "CCL3",
   "disease_as_written": "sepsis",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1360,
    "end": 1642
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2114,
    "end": 2362
   }
  }
 },
 {
  "pmid": "39113615",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is cis-eQTL gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 383,
   "end": 568
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39114294",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The MR of circulating Apo-A1 and Apo-B (proteins) meets E2, but both are reported only as null; the drug-target pairs are lipid-weighted or expression-based and don't count, so no counting protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2671,
   "end": 2784
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39114924",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcomes are CSVD magnetic resonance imaging markers, imaging measures rather than a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 409,
   "end": 732
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39115672",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (INTERVAL and others) on stroke subtypes; conclusions name CXCL8 and TNFRSF11b, and the results give CXCL8's direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1460,
   "end": 1566
  },
  "claim": {
   "protein_as_written": "CXCL8",
   "gene": "CXCL8",
   "disease_as_written": "large-artery atherosclerotic (LAA) stroke",
   "direction": "raises",
   "estimate": {
    "or": 1.005,
    "low": 1.001,
    "high": 1.01,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1014,
    "end": 1344
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39116956",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR pools brain and plasma protein instruments, and the abstract doesn't tie ANO5's pair to the plasma analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 341,
   "end": 578
  },
  "claim": {
   "protein_as_written": "ANO5",
   "gene": "ANO5",
   "disease_as_written": "amyotrophic lateral sclerosis",
   "direction": "raises",
   "estimate": {
    "or": 1.3,
    "low": 1.14,
    "high": 1.49,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1616,
    "end": 1801
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.848,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1231,
    "end": 1493
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1616,
    "end": 1801
   }
  }
 },
 {
  "pmid": "39117060",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable-gene MR framed on gene expression; no circulating protein instruments named (outcomes are also muscle traits).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1412,
   "end": 1595
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39119575",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE circulating protein levels on osteonecrosis from FinnGen; conclusions name HEBP1 first, the results give it raising risk after FDR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 383,
   "end": 573
  },
  "claim": {
   "protein_as_written": "Heme-binding protein 1 (HEBP1)",
   "gene": "HEBP1",
   "disease_as_written": "osteonecrosis",
   "direction": "raises",
   "estimate": {
    "or": 1.4,
    "low": 1.19,
    "high": 1.65,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1119,
    "end": 1310
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39119976",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UK Biobank plasma proteins on stroke in South Asians; conclusions give GP6 no direction, results give OR 2.53 at FDR 0.059 (threshold FDR < 0.1).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1096,
   "end": 1299
  },
  "claim": {
   "protein_as_written": "GP6",
   "gene": "GP6",
   "disease_as_written": "cardioembolic stroke",
   "direction": "raises",
   "estimate": {
    "or": 2.53,
    "low": 1.59,
    "high": 4.03,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1096,
    "end": 1299
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.914,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1613,
    "end": 1737
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 166
   }
  }
 },
 {
  "pmid": "39119979",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 396,
   "end": 496
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39120624",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is bone mineral density, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 936,
   "end": 1044
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39121604",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of ferroptosis genes, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 310,
   "end": 503
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39121606",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants weighted by serum CRP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 765,
   "end": 904
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39127978",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Insulin targets proxied by blood glucose-lowering variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 641,
   "end": 728
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39129354",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The plasma proteins' MR outcome is brain structure, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 905,
   "end": 1106
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39130432",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is genetic variation in drug target genes; instruments not named as the protein's circulating level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 739,
   "end": 895
  },
  "claim": {
   "protein_as_written": "ESR1",
   "gene": "ESR1",
   "disease_as_written": "ankylosing spondylitis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 905,
    "end": 1229
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 905,
    "end": 1229
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39130628",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 544,
   "end": 734
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39136778",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of 2,940 plasma proteins (UK Biobank) on atopic dermatitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 418,
   "end": 626
  },
  "claim": {
   "protein_as_written": "PVALB",
   "gene": "PVALB",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1029,
    "end": 1260
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1733,
    "end": 1823
   }
  }
 },
 {
  "pmid": "39144148",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on IBD and its subtypes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 332,
   "end": 542
  },
  "claim": {
   "protein_as_written": "DAG1",
   "gene": "DAG1",
   "disease_as_written": "IBD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1078,
    "end": 1226
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39145416",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 inflammatory proteins with pQTL instruments on heart failure (HERMES).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 414,
   "end": 649
  },
  "claim": {
   "protein_as_written": "leukaemia inhibitory factor receptor",
   "gene": "LIFR",
   "disease_as_written": "HF",
   "direction": "lowers",
   "estimate": {
    "or": 0.841,
    "low": 0.789,
    "high": 0.897,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1804,
    "end": 2262
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39148824",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Protein MR outcome is cardiac age acceleration, a quantitative trait, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1884,
   "end": 2152
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39148858",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with UK Biobank plasma pQTLs on type 1 diabetes; HLA-DRA named first among risk-increasing proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 575,
   "end": 743
  },
  "claim": {
   "protein_as_written": "HLA-DRA",
   "gene": "HLA-DRA",
   "disease_as_written": "T1D",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 744,
    "end": 979
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39153411",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR with 'genetic proxies for antidiabetic drug targets' whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 372,
   "end": 665
  },
  "claim": {
   "protein_as_written": "ABCC8",
   "gene": "ABCC8",
   "disease_as_written": "osteoarthritis",
   "direction": "raises",
   "estimate": {
    "or": 2.07,
    "low": 1.5,
    "high": 2.84,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 974,
    "end": 1414
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 974,
    "end": 1414
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39156738",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma levels of senescence-related proteins using plasma-proteome GWAS instruments on AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1586,
   "end": 1848
  },
  "claim": {
   "protein_as_written": "PLAUR",
   "gene": "PLAUR",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "or": 1.15,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1861,
    "end": 2186
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1586,
    "end": 1848
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39158561",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of apolipoprotein A-I level (a circulating protein) on small vessel stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 755,
   "end": 1064
  },
  "claim": {
   "protein_as_written": "apolipoprotein A-I",
   "gene": "APOA1",
   "disease_as_written": "SVS",
   "direction": "lowers",
   "estimate": {
    "or": 0.83,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 755,
    "end": 1064
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39163931",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins associated with GI diseases are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1794,
   "end": 1907
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39165753",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR findings are for genes (eQTL/scRNA); the pQTL analysis was inconclusive, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1138,
   "end": 1241
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39166104",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "SGLT2 inhibition proxied by SLC5A2 variants weighted by HbA1c; mediators are metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 648,
   "end": 770
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39167160",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 plasma inflammatory proteins on hypertrophic scar.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 659,
   "end": 769
  },
  "claim": {
   "protein_as_written": "OPG",
   "gene": "TNFRSF11B",
   "disease_as_written": "hypertrophic scar",
   "direction": "lowers",
   "estimate": {
    "or": 0.59,
    "low": 0.41,
    "high": 0.85,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1952,
    "end": 2121
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39170695",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug target genes analysed through expression in blood and atrial appendage.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1095,
   "end": 1275
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39175755",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR of druggable genes on LSCC without naming the instruments (expression or protein).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 390,
   "end": 680
  },
  "claim": {
   "protein_as_written": "COPA",
   "gene": "COPA",
   "disease_as_written": "LSCC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1278,
    "end": 1417
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1746,
    "end": 1884
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39181687",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Primary MR uses blood cis-eQTLs; the circulating-protein result comes from an unspecified proteomic validation whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1745,
   "end": 1813
  },
  "claim": {
   "protein_as_written": "PRCP",
   "gene": "PRCP",
   "disease_as_written": "SAH",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1745,
    "end": 1813
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1639,
    "end": 1744
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 101
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39184138",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are antihypertensive drug classes proxied by SNPs for their several targets, not one protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 836,
   "end": 1013
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39185418",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "CXCL10 is named only as a mediator of hypothyroidism's effect; its own effect on IPF isn't given, and the abstract has no results.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1053,
   "end": 1201
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39185422",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma proteins on ankylosing spondylitis; conclusions name IL23R first without direction, results say elevated IL23R increases risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 726,
   "end": 833
  },
  "claim": {
   "protein_as_written": "IL23R",
   "gene": "IL23R",
   "disease_as_written": "AS",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1338,
    "end": 1479
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1480,
    "end": 1578
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1677,
    "end": 1831
   }
  }
 },
 {
  "pmid": "39190027",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcomes for serum CD300LG are glycaemic traits (fasting glucose, 2 h glucose, HbA1c), not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1983,
   "end": 2171
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39190310",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Antihypertensive drug-target variants weighted by systolic blood pressure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1178,
   "end": 1355
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39191171",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR whose instruments include blood pQTLs, so it meets E2, but the only disease pair stated (PPARG, bipolar II) is HbA1c-weighted and no counting protein-disease pair is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1588,
   "end": 1692
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39191728",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR including plasma proteins; the conclusions name plasma FLRT3 (the only circulating one) without direction, and results say higher plasma FLRT3 lowers BD risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 799,
   "end": 1015
  },
  "claim": {
   "protein_as_written": "FLRT3",
   "gene": "FLRT3",
   "disease_as_written": "BD_ALL",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 799,
    "end": 1015
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39192889",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are paired only with 'organ-related diseases', a class with no member disease paired.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1142,
   "end": 1363
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39193372",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of lipid-lowering targets, which the abstract says it assesses through their effect on lower lipids (lipid-mediated effects), so APOB's variants are weighted by lipids rather than by its circulating level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 502,
   "end": 586
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39194222",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteome on sepsis; ICAM5 pair stated with OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 972,
   "end": 1202
  },
  "claim": {
   "protein_as_written": "ICAM5",
   "gene": "ICAM5",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": {
    "or": 1.1,
    "low": 1.05,
    "high": 1.15,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 972,
    "end": 1202
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39198854",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "GLP1R agonism instrumented by cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 656,
   "end": 765
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39199149",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pooling QTL kinds, but the ICAM1-diabetic retinopathy pair is tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2009,
   "end": 2176
  },
  "claim": {
   "protein_as_written": "ICAM-1",
   "gene": "ICAM1",
   "disease_as_written": "DR",
   "direction": "raises",
   "estimate": {
    "or": 1.05,
    "low": 1.03,
    "high": 1.08,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2384,
    "end": 2472
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39202419",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "ACLY inhibition is proxied by eQTL variants weighted by LDL cholesterol, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 785,
   "end": 1072
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39206334",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "IL-6 signalling proxied by CRP-lowering variants near IL6R.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 475,
   "end": 666
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39210598",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A methods benchmark that estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 788,
   "end": 1070
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39211870",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from social contact to protein levels; no protein is an exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1010,
   "end": 1246
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39214372",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma proteins on stroke; conclusions name APRT without direction, results give APRT lowering cardioembolic stroke (PFDR < 0.05).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1670,
   "end": 1779
  },
  "claim": {
   "protein_as_written": "APRT",
   "gene": "APRT",
   "disease_as_written": "cardioembolic stroke",
   "direction": "lowers",
   "estimate": {
    "or": 0.641,
    "low": 0.517,
    "high": 0.795,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1780,
    "end": 2036
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2849,
    "end": 2975
   }
  }
 },
 {
  "pmid": "39215079",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The only protein pair is LAYN with 'different cancer types', a class with no member disease named, so no pair counts.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1128,
   "end": 1318
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39216017",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "SGLT2 inhibition is proxied by variants for urinary sodium, a downstream biomarker, not a circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 479,
   "end": 546
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39216403",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable genes are instrumented by cis-eQTLs from eQTLGen, and telomere length is the other exposure; no protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 272,
   "end": 547
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39217396",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 inflammatory proteins (pQTL) on aortic stenosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 609,
   "end": 865
  },
  "claim": {
   "protein_as_written": "fibroblast growth factor 19 (FGF19)",
   "gene": "FGF19",
   "disease_as_written": "AS",
   "direction": "lowers",
   "estimate": {
    "or": 0.83,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1453,
    "end": 1658
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39221148",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTLs (deCODE, UKB-PPP) with POAG.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 383,
   "end": 566
  },
  "claim": {
   "protein_as_written": "ROBO1",
   "gene": "ROBO1",
   "disease_as_written": "POAG",
   "direction": "raises",
   "estimate": {
    "or": 1.38,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1369,
    "end": 1614
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.865,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1369,
    "end": 1614
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1369,
    "end": 1614
   }
  }
 },
 {
  "pmid": "39222420",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with pQTL instruments for circulating IL-12/IL-23 pathway proteins on primary Sjogren's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 479,
   "end": 705
  },
  "claim": {
   "protein_as_written": "IL-12p40",
   "gene": "IL12B",
   "disease_as_written": "primary Sjögren's disease",
   "direction": "raises",
   "estimate": {
    "or": 0.79,
    "low": 0.68,
    "high": 0.93,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1188,
    "end": 1387
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1810,
    "end": 1882
   }
  }
 },
 {
  "pmid": "39227185",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "PCSK9 inhibition proxied by drug-target genetics; instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 647,
   "end": 837
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "psoriasis",
   "direction": "raises",
   "estimate": {
    "or": 0.6,
    "low": 0.474,
    "high": 0.761,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1018,
    "end": 1244
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1841,
    "end": 2004
   }
  }
 },
 {
  "pmid": "39228495",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by LDL-C-associated variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 895,
   "end": 1097
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39229261",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Beside the CRP-weighted IL-6R analysis, the abstract reports MR of soluble IL-6R, the receptor's circulating form, on the same diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1928,
   "end": 2000
  },
  "claim": {
   "protein_as_written": "sIL-6R",
   "gene": "IL6R",
   "disease_as_written": "idiopathic pulmonary fibrosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1928,
    "end": 2000
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 244,
    "end": 343
   }
  }
 },
 {
  "pmid": "39230170",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR covers protein levels (pQTLs) as well as expression, so E2 isn't plainly failed, but every pair the abstract states comes from gene expression, with no protein-disease pair from protein MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 534,
   "end": 680
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39236454",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR was used to identify pathways associated with cognitive impairment; no protein-level exposure on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 982,
   "end": 1172
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39237840",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on kidney stone disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1115,
   "end": 1292
  },
  "claim": {
   "protein_as_written": "FKBPL",
   "gene": "FKBPL",
   "disease_as_written": "KSD",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1115,
    "end": 1292
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H3 + PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1440,
    "end": 1582
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39239107",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid drug targets (including APOB) are instrumented by gene variants associated with lipid traits from GLGC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1674,
   "end": 1879
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39239555",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating GP73 on CAD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1045,
   "end": 1281
  },
  "claim": {
   "protein_as_written": "GP73",
   "gene": "GOLM1",
   "disease_as_written": "CAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1763,
    "end": 1825
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39241967",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Genetically predicted plasma MERTK (pQTS) on infection mortality, a binary outcome of death from diagnosed infection.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 718,
   "end": 872
  },
  "claim": {
   "protein_as_written": "plasma MERTK protein",
   "gene": "MERTK",
   "disease_as_written": "infection mortality",
   "direction": "raises",
   "estimate": {
    "or": 1.46,
    "low": 1.15,
    "high": 1.85,
    "unit": "per unit",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1473,
    "end": 1628
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1641,
    "end": 1761
   }
  }
 },
 {
  "pmid": "39245738",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma protein levels on oral cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 972,
   "end": 1097
  },
  "claim": {
   "protein_as_written": "NDRG4",
   "gene": "NDRG4",
   "disease_as_written": "oral cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 972,
    "end": 1097
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39247875",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "A blood pQTL MR was run, but the abstract names no protein-disease pair from it; EGFR and the other named genes come from brain eQTL datasets (GTEx, PsychENCODE, BrainMeta).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1327,
   "end": 1422
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39253091",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract names no protein-disease pair from the MR, only counts of genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1006,
   "end": 1150
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39253131",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 492,
   "end": 812
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39254080",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Circulating PCSK9 levels are tested on appendicular lean mass, a measurement, not on sarcopenia as a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1538,
   "end": 1831
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39254691",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins (35,559-person pQTL study) on ankylosing spondylitis; HERC5 raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1817,
   "end": 2034
  },
  "claim": {
   "protein_as_written": "HERC5",
   "gene": "HERC5",
   "disease_as_written": "AS",
   "direction": "raises",
   "estimate": {
    "or": 2.11,
    "low": 1.44,
    "high": 3.09,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1817,
    "end": 2034
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2035,
    "end": 2100
   }
  }
 },
 {
  "pmid": "39257479",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are plasma metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 398,
   "end": 556
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39259428",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Only gene-expression pairs are reported; the abstract states no pair from the pQTL analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1459,
   "end": 1580
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39261750",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins instrumented by pQTLs on migraine, a disease; named protein targets are given without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 463,
   "end": 608
  },
  "claim": {
   "protein_as_written": "FCAR",
   "gene": "FCAR",
   "disease_as_written": "migraine",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1150,
    "end": 1341
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1150,
    "end": 1341
   }
  }
 },
 {
  "pmid": "39261869",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR on osteoarthritis; first directed pair ECM1 with OA, supported by colocalization.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 750,
   "end": 841
  },
  "claim": {
   "protein_as_written": "ECM1",
   "gene": "ECM1",
   "disease_as_written": "OA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1046,
    "end": 1172
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1046,
    "end": 1172
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39263038",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The candidate genes come from one MR screen pooling eQTLs and pQTLs, and the abstract doesn't tie the pair to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1251,
   "end": 1420
  },
  "claim": {
   "protein_as_written": "CD33",
   "gene": "CD33",
   "disease_as_written": "lung adenocarcinoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1421,
    "end": 1593
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1421,
    "end": 1593
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39264754",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Cytokines are tested as mediators on cortical surface area and thickness, imaging measures.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 624,
   "end": 715
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39267096",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE cis-pQTLs for circulating plasma proteins on NISCM; conclusions name LILRA5 first, its direction protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 519,
   "end": 664
  },
  "claim": {
   "protein_as_written": "LILRA5",
   "gene": "LILRA5",
   "disease_as_written": "NISCM",
   "direction": "lowers",
   "estimate": {
    "or": 0.758,
    "low": 0.67,
    "high": 0.857,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1406,
    "end": 1551
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1311,
    "end": 1405
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2268,
    "end": 2469
   }
  }
 },
 {
  "pmid": "39268072",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (deCODE) on peripheral neuropathies from FinnGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 657,
   "end": 815
  },
  "claim": {
   "protein_as_written": "UBC12",
   "gene": "UBE2M",
   "disease_as_written": "DP",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1630,
    "end": 1735
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39268232",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "SGLT2 inhibition is proxied by SLC5A2 variants weighted by HbA1c.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 885,
   "end": 1178
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39268462",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 750,
   "end": 863
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39268473",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Antihypertensive drug targets are proxied by variants associated with systolic blood pressure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 642,
   "end": 821
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39270733",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "SGLT2 inhibition proxied by SLC5A2 expression variants weighted by HbA1c, not circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 554,
   "end": 811
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39271518",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Serum protein level GWAS are among the drug-target proxies, so E2 is met, but every pair stated comes from gene expression or missense variants, none from serum protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1348,
   "end": 1547
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39273172",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Analyses pool plasma and brain proteins; the protein-disease pairs are not tied to the plasma analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 386,
   "end": 875
  },
  "claim": {
   "protein_as_written": "TMEM106B",
   "gene": "TMEM106B",
   "disease_as_written": "Alzheimer's disease (AD)",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1428,
    "end": 1997
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39278107",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma protein levels on endometrial cancer; conclusions name IL-6 without a direction, MR gives OR 1.19.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1382,
   "end": 1556
  },
  "claim": {
   "protein_as_written": "IL-6",
   "gene": "IL6",
   "disease_as_written": "endometrial cancer",
   "direction": "raises",
   "estimate": {
    "or": 1.19,
    "low": 1.04,
    "high": 1.36,
    "unit": "other",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1382,
    "end": 1556
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39278398",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR is at the gene level; no circulating protein exposure is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 812,
   "end": 956
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39279974",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of pQTLs for 4,907 plasma proteins on gastric cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 468,
   "end": 668
  },
  "claim": {
   "protein_as_written": "motilin (MLN)",
   "gene": "MLN",
   "disease_as_written": "gastric cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 971,
    "end": 1152
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39280009",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR pools methylation, RNA, and protein QTLs; genes not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 510,
   "end": 637
  },
  "claim": {
   "protein_as_written": "TUFM",
   "gene": "TUFM",
   "disease_as_written": "T2DM",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1703,
    "end": 1825
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1443,
    "end": 1702
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2399,
    "end": 2493
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39283655",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating INHBC on cardiometabolic diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 739,
   "end": 916
  },
  "claim": {
   "protein_as_written": "INHBC",
   "gene": "INHBC",
   "disease_as_written": "coronary artery disease (CAD)",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 739,
    "end": 916
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1522,
    "end": 1684
   }
  }
 },
 {
  "pmid": "39284832",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is telomere length, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 993,
   "end": 1100
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39284843",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Pools eQTL, mQTL and pQTL analyses; the protein-level GATM result is not stated to be from circulating protein; full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 661,
   "end": 863
  },
  "claim": {
   "protein_as_written": "glycine amidinotransferase (GATM)",
   "gene": "GATM",
   "disease_as_written": "CKD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1745,
    "end": 1909
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2078,
    "end": 2206
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39286458",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "LPL 'enhancement' is a drug-target exposure whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1168,
   "end": 1276
  },
  "claim": {
   "protein_as_written": "Lipoprotein lipase (LPL)",
   "gene": "LPL",
   "disease_as_written": "LE",
   "direction": "lowers",
   "estimate": {
    "or": 0.76,
    "low": 0.65,
    "high": 0.9,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1473,
    "end": 1610
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.862,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1611,
    "end": 1830
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1914,
    "end": 1984
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39287922",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma-protein MR results are unnamed; named proteins come from SMR of gene expression or lifestyle-to-protein MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1090,
   "end": 1292
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39287993",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposure is leukocyte telomere length, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 414,
   "end": 586
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39297226",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 4709 circulating proteins (deCODE) on acne.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 394,
   "end": 525
  },
  "claim": {
   "protein_as_written": "fatty acid synthase (FASN)",
   "gene": "FASN",
   "disease_as_written": "acne",
   "direction": "lowers",
   "estimate": {
    "or": 0.768,
    "low": 0.676,
    "high": 0.872,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1308,
    "end": 1505
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1506,
    "end": 1682
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1819,
    "end": 1973
   }
  }
 },
 {
  "pmid": "39302116",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants selected by association with systolic blood pressure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 530,
   "end": 732
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39307953",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Methods paper; applied exposure is smoking, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1346,
   "end": 1590
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39314522",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "deCODE pQTL MR on PCOS; conclusions say CDCP1, GLRX2, KIRREL2 relate to higher risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 619,
   "end": 938
  },
  "claim": {
   "protein_as_written": "CUB domain-containing protein 1 (CDCP1)",
   "gene": "CDCP1",
   "disease_as_written": "PCOS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2054,
    "end": 2304
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1644,
    "end": 1836
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39314935",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR found proteins causal for T2DM but the abstract names none.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2506,
   "end": 2652
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39314942",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR found 11 proteins causal for ASCVD but names none.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2431,
   "end": 2499
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39314945",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with cis-pQTLs of plasma proteins on incident ADRD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 832,
   "end": 1047
  },
  "claim": {
   "protein_as_written": "apolipoprotein E",
   "gene": "APOE",
   "disease_as_written": "ADRD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 832,
    "end": 1047
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39315093",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory proteins on Guillain-Barre syndrome; IFN-gamma OR 1.96.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 608,
   "end": 771
  },
  "claim": {
   "protein_as_written": "IFN-γ",
   "gene": "IFNG",
   "disease_as_written": "GBS",
   "direction": "raises",
   "estimate": {
    "or": 1.96,
    "low": 1.02,
    "high": 3.78,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1239,
    "end": 1552
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1992,
    "end": 2176
   }
  }
 },
 {
  "pmid": "39318474",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is SGLT2 inhibition with instruments not named in the abstract; the proteomic MR names no protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 411,
   "end": 596
  },
  "claim": {
   "protein_as_written": "SGLT2",
   "gene": "SLC5A2",
   "disease_as_written": "interstitial lung disease",
   "direction": "raises",
   "estimate": {
    "or": 0.054,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2039,
    "end": 2221
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 98
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39322770",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR pairs named only with the class 'CVDs', no member disease paired with a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 756,
   "end": 949
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39325747",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "PCSK9 pQTL MR found no association with mood disorders; no protein-disease pair is claimed.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 894,
   "end": 1001
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39329105",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Proteins mediate selenium's effect on eGFR, a quantitative trait, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1010,
   "end": 1126
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39333727",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "ARIC plasma pQTL MR on CKD; first directional pair is TCEA2, inverse.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 457,
   "end": 587
  },
  "claim": {
   "protein_as_written": "Transcription elongation factor A protein 2 (TCEA2)",
   "gene": "TCEA2",
   "disease_as_written": "CKD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1568,
    "end": 1815
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1475,
    "end": 1567
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39336801",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "NR0B2 proxied by cis SNPs associated with triglyceride homeostasis (biomarker-weighted drug-target MR).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 811,
   "end": 1142
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39342991",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins with plasma pQTL instruments on glaucoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 330,
   "end": 596
  },
  "claim": {
   "protein_as_written": "ENPP5",
   "gene": "ENPP5",
   "disease_as_written": "Glaucoma",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1024,
    "end": 1163
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1406,
    "end": 1513
   }
  }
 },
 {
  "pmid": "39343514",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The MR exposure is the Rarres2 gene, its instruments unnamed (could be expression or protein QTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1571,
   "end": 1687
  },
  "claim": {
   "protein_as_written": "Rarres2",
   "gene": "RARRES2",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1813,
    "end": 1905
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1906,
    "end": 2048
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39351539",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma pQTLs on breast cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 669,
   "end": 789
  },
  "claim": {
   "protein_as_written": "CASP8",
   "gene": "CASP8",
   "disease_as_written": "breast cancer",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1447,
    "end": 1625
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1860,
    "end": 2028
   }
  }
 },
 {
  "pmid": "39351893",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "A database of MR results; the abstract states no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1268,
   "end": 1376
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39354406",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTLs used as exposures for atrioventricular block; the proteins are reported apart from the eQTL genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 744,
   "end": 957
  },
  "claim": {
   "protein_as_written": "cadherin-5",
   "gene": "CDH5",
   "disease_as_written": "AVB",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1720,
    "end": 1842
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39355774",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Six SNPs proxy SGLT2 inhibition; the abstract does not say what they are associated with.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 643,
   "end": 732
  },
  "claim": {
   "protein_as_written": "SGLT2",
   "gene": "SLC5A2",
   "disease_as_written": "PAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1147,
    "end": 1296
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 376,
    "end": 520
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39355913",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (UKB-PPP, cis-pQTL instruments) on incident atrial fibrillation; abstract states protein-AF pairs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 967,
   "end": 1139
  },
  "claim": {
   "protein_as_written": "COL4A1",
   "gene": "COL4A1",
   "disease_as_written": "AF",
   "direction": "raises",
   "estimate": {
    "or": 1.11,
    "low": 1.04,
    "high": 1.19,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1643,
    "end": 1935
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39357883",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are aging-related genes from expression analysis, not circulating protein levels, and the outcome is aging.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1088,
   "end": 1225
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39358768",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with pQTLs gives MST1 levels inversely associated with IVDD (lipid drug-target analyses are biomarker-weighted and don't count).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1117,
   "end": 1299
  },
  "claim": {
   "protein_as_written": "MST1 (macrophage stimulating 1)",
   "gene": "MST1",
   "disease_as_written": "IVDD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2454,
    "end": 2553
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1300,
    "end": 1445
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 3092,
    "end": 3160
   }
  }
 },
 {
  "pmid": "39358799",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are GTEx and eQTLGen cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 435,
   "end": 594
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39359474",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR includes pQTL MR of circulating protein levels on AF; conclusions' TTN comes from mQTL/eQTL, so the headline is the first circulating-protein pair with a direction in the results.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1898,
   "end": 2128
  },
  "claim": {
   "protein_as_written": "ALAD",
   "gene": "ALAD",
   "disease_as_written": "AF",
   "direction": "lowers",
   "estimate": {
    "or": 0.898,
    "low": 0.845,
    "high": 0.954,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1898,
    "end": 2128
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.67,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1898,
    "end": 2128
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39367121",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The only MR of a circulating protein (IL-17 on BPH) has PFDR = 0.12, failing correction; the other pairs come from transcriptomic SMR/TWAS of genes, immune cells, and metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1827,
   "end": 2037
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39368924",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory cytokines (SCALLOP, deCODE pQTLs) on dentofacial anomalies (FinnGen).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 498,
   "end": 712
  },
  "claim": {
   "protein_as_written": "chemokine ligand 25",
   "gene": "CCL25",
   "disease_as_written": "DA",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 998,
    "end": 1172
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39370703",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Discovery used eQTL exposures with circulating pQTLs as replication; the stated pairs are not tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1034,
   "end": 1168
  },
  "claim": {
   "protein_as_written": "IL12RB1",
   "gene": "IL12RB1",
   "disease_as_written": "oral ulcers",
   "direction": "raises",
   "estimate": {
    "or": 1.01,
    "low": 1.01,
    "high": 1.01,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1411,
    "end": 1657
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1411,
    "end": 1657
   }
  }
 },
 {
  "pmid": "39375737",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 4907 circulating deCODE proteins on IPF.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 453,
   "end": 681
  },
  "claim": {
   "protein_as_written": "Prothrombin",
   "gene": "F2",
   "disease_as_written": "IPF",
   "direction": "raises",
   "estimate": {
    "or": 3.26,
    "low": 1.75,
    "high": 6.07,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1262,
    "end": 1442
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1262,
    "end": 1442
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 682,
    "end": 820
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 106
   }
  }
 },
 {
  "pmid": "39377966",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating cytokine levels on achalasia; pairs named as circulating cytokines.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1060,
   "end": 1259
  },
  "claim": {
   "protein_as_written": "Eotaxin",
   "gene": "CCL11",
   "disease_as_written": "achalasia",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1060,
    "end": 1259
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1823,
    "end": 1926
   }
  }
 },
 {
  "pmid": "39379957",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs of drug target genes and LDL-weighted variants near target genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 735,
   "end": 1013
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39380626",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug targets are instrumented with cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 606,
   "end": 753
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39381207",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are gut microbiota and mapped genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 813,
   "end": 894
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39381438",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR uses target genes' expression in tissues.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1276,
   "end": 1683
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39383931",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on major depressive disorder.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 472,
   "end": 634
  },
  "claim": {
   "protein_as_written": "CASP-8",
   "gene": "CASP8",
   "disease_as_written": "MDD",
   "direction": "lowers",
   "estimate": {
    "or": 0.97,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1196,
    "end": 1407
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39386869",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Probabilistic MR of plasma protein abundance on CAD, Bonferroni-corrected; no direction is stated for any protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1119,
   "end": 1293
  },
  "claim": {
   "protein_as_written": "PLG",
   "gene": "PLG",
   "disease_as_written": "CAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1119,
    "end": 1293
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39387050",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR on sepsis names no protein in the abstract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1296,
   "end": 1418
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39388897",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR relates kaempferol's target genes to immune cells; no circulating protein's effect on a disease is estimated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1224,
   "end": 1418
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39390078",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on BPH and prostatitis; first directed pair is IL-17C with BPH (OR 0.92), called suggestive.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 718,
   "end": 1201
  },
  "claim": {
   "protein_as_written": "interleukin-17 C (IL-17 C)",
   "gene": "IL17C",
   "disease_as_written": "BPH",
   "direction": "lowers",
   "estimate": {
    "frame": "per higher protein",
    "high": 0.99,
    "low": 0.85,
    "unit": "not stated",
    "or": 0.92
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 718,
    "end": 1201
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39391881",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MEGF9 exposure from the IEU GWAS database without saying whether its instruments are pQTLs or other QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1656,
   "end": 1821
  },
  "claim": {
   "protein_as_written": "MEGF9",
   "gene": "MEGF9",
   "disease_as_written": "MI",
   "direction": "raises",
   "estimate": {
    "or": 1.35,
    "low": 1.069,
    "high": 1.705,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1822,
    "end": 1914
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2503,
    "end": 2613
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39397091",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs from eQTLGen only.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 415,
   "end": 517
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39397782",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with cis variants for circulating proteins on myocardial infarction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 858,
   "end": 970
  },
  "claim": {
   "protein_as_written": "renin",
   "gene": "REN",
   "disease_as_written": "MI",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1378,
    "end": 1539
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39398994",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR (deCODE, UKB-PPP) on AAA; PCSK9 OR 1.3 at FDR<0.05 with colocalization.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 822,
   "end": 979
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "AAA",
   "direction": "raises",
   "estimate": {
    "or": 1.3,
    "low": 1.2,
    "high": 1.4,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1381,
    "end": 1613
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1381,
    "end": 1613
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39400547",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on gastrointestinal diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 918,
   "end": 1080
  },
  "claim": {
   "protein_as_written": "NOV",
   "gene": "CCN3",
   "disease_as_written": "diverticulosis disease",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 918,
    "end": 1080
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 918,
    "end": 1080
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39402528",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug targets proxied by eQTLs and by LDL-C-associated variants, not circulating protein pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 512,
   "end": 716
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39406990",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The protein MR outcomes are BMI and waist circumference, quantitative traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 960,
   "end": 1517
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39407121",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "MR exposures are prefrontal cortex brain proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 390,
   "end": 526
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39408566",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (pQTL) on ocular diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 450,
   "end": 706
  },
  "claim": {
   "protein_as_written": "ECI1",
   "gene": "ECI1",
   "disease_as_written": "glaucoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 707,
    "end": 900
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 450,
    "end": 706
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39409102",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are skeletal muscle cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 877,
   "end": 1200
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39414629",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on IBD with Bonferroni correction; no direction is given for any protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 900,
   "end": 985
  },
  "claim": {
   "protein_as_written": "FCGR2A",
   "gene": "FCGR2A",
   "disease_as_written": "IBD",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1627,
    "end": 1774
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 986,
    "end": 1131
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1627,
    "end": 1774
   }
  }
 },
 {
  "pmid": "39415269",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of CETP concentration (μg/mL), a circulating protein level, on dementia outcomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 588,
   "end": 841
  },
  "claim": {
   "protein_as_written": "CETP",
   "gene": "CETP",
   "disease_as_written": "LBD",
   "direction": "raises",
   "estimate": {
    "or": 0.81,
    "low": 0.74,
    "high": 0.89,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1219,
    "end": 1496
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1718,
    "end": 1867
   }
  }
 },
 {
  "pmid": "39417098",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is WMH volume, an imaging measure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1654,
   "end": 1963
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39417126",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is tau PET deposition, an imaging measure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1106,
   "end": 1213
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39418314",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are glycemic traits, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 257,
   "end": 538
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39418486",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PCSK9 and HMGCR inhibition proxied by LDL cholesterol lowering, i.e. biomarker-weighted.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 236,
   "end": 444
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39420052",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target exposures are LDL-c or TG levels mediated by PCSK9/LPL variants, i.e. biomarker-weighted.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1009,
   "end": 1178
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39421691",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are plasma metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 687,
   "end": 832
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39422242",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with protein QTLs for plasma RAC1 levels on steroid-sensitive nephrotic syndrome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 667,
   "end": 849
  },
  "claim": {
   "protein_as_written": "RAC1",
   "gene": "RAC1",
   "disease_as_written": "SSNS",
   "direction": "raises",
   "estimate": {
    "or": 1.82,
    "low": 1.05,
    "high": 3.17,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1311,
    "end": 1514
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1894,
    "end": 2052
   }
  }
 },
 {
  "pmid": "39422802",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma proteins on gastric cancer; pairs named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 486,
   "end": 611
  },
  "claim": {
   "protein_as_written": "LY6D",
   "gene": "LY6D",
   "disease_as_written": "GC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 917,
    "end": 1059
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1060,
    "end": 1265
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1266,
    "end": 1397
   }
  }
 },
 {
  "pmid": "39424455",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "BTN3A2, a plasma protein, named causal for depression by MR, with no direction; unsigned claim.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1551,
   "end": 1689
  },
  "claim": {
   "protein_as_written": "BTN3A2",
   "gene": "BTN3A2",
   "disease_as_written": "depression",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1551,
    "end": 1689
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39424597",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "PDE levels are proxied by eQTLs of the encoding genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 557,
   "end": 780
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39425105",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR pools QTLs for genes, methylation, and proteins in plasma; the abstract doesn't say which kind gave the gene results.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 382,
   "end": 518
  },
  "claim": {
   "protein_as_written": "BTRC",
   "gene": "BTRC",
   "disease_as_written": "IPF",
   "direction": "lowers",
   "estimate": {
    "or": 0.3,
    "low": 0.17,
    "high": 0.54,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1176,
    "end": 1424
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 995,
    "end": 1175
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39426230",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of 'targets' with instruments not named (could be eQTL or pQTL); GFPT1-OA from MR without direction (direction in conclusions is experimental).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 742,
   "end": 824
  },
  "claim": {
   "protein_as_written": "GFPT1",
   "gene": "GFPT1",
   "disease_as_written": "OA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 742,
    "end": 824
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 742,
    "end": 824
   }
  }
 },
 {
  "pmid": "39426521",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma FGF21 MR outcomes are macronutrient intake, a behaviour, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 871,
   "end": 994
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39426575",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "LRG1 and PSMA4 are 'genes' from MR whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1379,
   "end": 1516
  },
  "claim": {
   "protein_as_written": "LRG1",
   "gene": "LRG1",
   "disease_as_written": "influenza and pneumonia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2531,
    "end": 2708
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 2531,
    "end": 2708
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2531,
    "end": 2708
   }
  }
 },
 {
  "pmid": "39427525",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of the plasma protein signatures (NRCAM among them) on Alzheimer disease; the exposure is named as a plasma protein feature.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2573,
   "end": 2661
  },
  "claim": {
   "protein_as_written": "NRCAM",
   "gene": "NRCAM",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2573,
    "end": 2661
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39434152",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is facial aging, a trait, not a disease; a pQTL analysis of MED1 means 'no protein exposure' isn't shown.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1510,
   "end": 1690
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39434187",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis MR of 1567 plasma proteins on cardiac diseases; first directed protein pair is higher RET decreasing AF.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 565,
   "end": 730
  },
  "claim": {
   "protein_as_written": "RET",
   "gene": "RET",
   "disease_as_written": "AF",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1483,
    "end": 1625
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1626,
    "end": 1712
   }
  }
 },
 {
  "pmid": "39435355",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Antihypertensive drug targets are proxied by variants weighted by systolic blood pressure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 570,
   "end": 746
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39437618",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The GNLY finding pools cis-eQTL and cis-pQTL analyses and the abstract does not tie it to the circulating protein's analysis or say the pQTLs are plasma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1700,
   "end": 2024
  },
  "claim": {
   "protein_as_written": "GNLY",
   "gene": "GNLY",
   "disease_as_written": "prostatitis",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1700,
    "end": 2024
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1700,
    "end": 2024
   }
  }
 },
 {
  "pmid": "39445158",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "ISG15 is a 'gene' from MR whose instruments the abstract doesn't name ('variations in the ISG15 gene').",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2050,
   "end": 2214
  },
  "claim": {
   "protein_as_written": "ISG15",
   "gene": "ISG15",
   "disease_as_written": "SLE",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1500,
    "end": 1657
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2560,
    "end": 2789
   }
  }
 },
 {
  "pmid": "39448886",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of VAT on PCOS and of key DEPs on PCOS, with the DEPs' instruments unnamed, but no named protein is paired with PCOS from MR (PKM2, HK1, NDUFS3, UQCR10 come from dot blots).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2403,
   "end": 2529
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39449751",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants weighted by HbA1c.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 590,
   "end": 752
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39455528",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR with immune-cell eQTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 603,
   "end": 849
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39455620",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The only MR exposures are 91 inflammatory cytokines whose data come from a pQTL study; the outcome is diabetic nephropathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 660,
   "end": 773
  },
  "claim": {
   "protein_as_written": "tumor necrosis factor ligand superfamily member 14 (TNFSF14)",
   "gene": "TNFSF14",
   "disease_as_written": "DN",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1112,
    "end": 1368
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39463412",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein (deCODE) MR on NAFLD; KNG1 first with a stated sign.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 685,
   "end": 748
  },
  "claim": {
   "protein_as_written": "KNG1",
   "gene": "KNG1",
   "disease_as_written": "NAFLD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1103,
    "end": 1320
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39467906",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 351,
   "end": 490
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39468075",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Transcriptome-wide MR of gene expression in CD4+ T cells.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 294,
   "end": 509
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39468243",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR and SMR use eQTL data (gene expression).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 535,
   "end": 744
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39470521",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR of HMGCR/PCSK9/LPL inhibition; instruments not named in the abstract. Conclusions: HMGCR inhibitors (statins) protective against sleep apnea syndrome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1265,
   "end": 1514
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "sleep apnea syndrome",
   "direction": "raises",
   "estimate": {
    "or": 0.627,
    "low": 0.511,
    "high": 0.767,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1836,
    "end": 1997
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1836,
    "end": 1997
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39471697",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory regulators (proteome and cytokine GWAS) on PHN and TN.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 765,
   "end": 922
  },
  "claim": {
   "protein_as_written": "MCP3",
   "gene": "CCL7",
   "disease_as_written": "PHN",
   "direction": "lowers",
   "estimate": {
    "or": 0.52,
    "low": 0.35,
    "high": 0.77,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1096,
    "end": 1498
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39472987",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2940 UK Biobank plasma proteins on asthma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 504,
   "end": 694
  },
  "claim": {
   "protein_as_written": "IL1RAP",
   "gene": "IL1RAP",
   "disease_as_written": "asthma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1400,
    "end": 1521
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39474612",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein levels from seven pQTL studies on hyperlipidemia; first directed pair APOB.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1127,
   "end": 1594
  },
  "claim": {
   "protein_as_written": "apolipoprotein B (APOB)",
   "gene": "APOB",
   "disease_as_written": "hyperlipidemia",
   "direction": "raises",
   "estimate": {
    "or": 9.37,
    "low": 5.12,
    "high": 17.12,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1127,
    "end": 1594
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.997,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1127,
    "end": 1594
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 689,
    "end": 995
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1595,
    "end": 1754
   }
  }
 },
 {
  "pmid": "39474649",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are frailty index and low grip strength, traits rather than diagnosed diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 396,
   "end": 625
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39477889",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteomic GWAS on hepatocellular carcinoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 402,
   "end": 601
  },
  "claim": {
   "protein_as_written": "TFPI2",
   "gene": "TFPI2",
   "disease_as_written": "HCC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1138,
    "end": 1303
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 402,
    "end": 601
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1656,
    "end": 1778
   }
  }
 },
 {
  "pmid": "39478651",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Protein-level SMR whose tissue is not stated circulating, pooled with expression and methylation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 467,
   "end": 641
  },
  "claim": {
   "protein_as_written": "FIS1 protein",
   "gene": "FIS1",
   "disease_as_written": "ED",
   "direction": "lowers",
   "estimate": {
    "or": 0.71,
    "low": 0.55,
    "high": 0.92,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1599,
    "end": 1737
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1738,
    "end": 1881
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39484277",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "GLP1R variants are weighted by glycated hemoglobin to proxy GLP-1RAs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 663,
   "end": 891
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39486179",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are ECG traits, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 493,
   "end": 713
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39487684",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Conventional MR of circulating GLP-1 and GIP concentrations on MASLD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 492,
   "end": 662
  },
  "claim": {
   "protein_as_written": "GLP-1",
   "gene": "GCG",
   "disease_as_written": "MASLD",
   "direction": "lowers",
   "estimate": {
    "frame": "per higher protein",
    "high": 0.839,
    "low": 0.033,
    "unit": "not stated",
    "or": 0.168
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 968,
    "end": 1209
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39487866",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The exposure is CD20, which the abstract names as a B-cell surface marker proxied through MS4A1 variants, so it is not a circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 119,
   "end": 302
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39489338",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of drug classes (e.g. PCSK9 inhibitors) whose instruments the abstract does not name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 464,
   "end": 613
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "PCOS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1701,
    "end": 1883
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1701,
    "end": 1883
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39489852",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2133,
   "end": 2230
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39490725",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omic SMR, but the abstract ties the HSPA1A, HSPA1B and NFKB1 pairs to MR of circulating protein levels on AMD; conclusions name no protein, so the first directed pair in the results is used.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1540,
   "end": 1827
  },
  "claim": {
   "protein_as_written": "HSPA1A",
   "gene": "HSPA1A",
   "disease_as_written": "AMD",
   "direction": "lowers",
   "estimate": {
    "or": 0.28,
    "low": 0.19,
    "high": 0.41,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1540,
    "end": 1827
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1828,
    "end": 1896
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 545,
    "end": 737
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39490735",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on osteoporosis is reported only as a count; the named proteins come from Cox regression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1295,
   "end": 1402
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39491680",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR of psychiatric disorders, but the abstract names no specific protein with a specific disorder.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1443,
   "end": 1572
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39491682",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood cis-eQTLs (gene expression).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 284,
   "end": 510
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39492919",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of protein levels on AD, but the abstract doesn't say whether the proteins are circulating or which instruments were used.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 404,
   "end": 587
  },
  "claim": {
   "protein_as_written": "GAL3ST2",
   "gene": "GAL3ST2",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1030,
    "end": 1191
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1030,
    "end": 1191
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1653,
    "end": 1781
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39493760",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of UKB-PPP serum proteins on acne.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 559,
   "end": 781
  },
  "claim": {
   "protein_as_written": "FSTL1",
   "gene": "FSTL1",
   "disease_as_written": "acne",
   "direction": "raises",
   "estimate": {
    "or": 1.24,
    "low": null,
    "high": null,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1322,
    "end": 1478
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39495227",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma and CSF protein MR on intelligence and cognitive performance, which are traits, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 407,
   "end": 597
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39497977",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of eQTLs and pQTLs in which CTSS is named, with an OR, as a risk protein, tying it to the pQTL analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1197,
   "end": 1366
  },
  "claim": {
   "protein_as_written": "CTSS",
   "gene": "CTSS",
   "disease_as_written": "pSS",
   "direction": "raises",
   "estimate": {
    "or": 1.384,
    "low": 1.147,
    "high": 1.669,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1197,
    "end": 1366
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39500755",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 plasma proteins on intervertebral disc degeneration from FinnGen, with proteins surviving multiple-testing correction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 117
  },
  "claim": {
   "protein_as_written": "myoneurin",
   "gene": "MYNN",
   "disease_as_written": "IVDD",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1159,
    "end": 1437
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39503011",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of circulating inflammatory proteins on endometriosis; CXCL5 lowers risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 502,
   "end": 793
  },
  "claim": {
   "protein_as_written": "CXCL5",
   "gene": "CXCL5",
   "disease_as_written": "endometriosis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1539,
    "end": 1706
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 972,
    "end": 1114
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39506937",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR of circulating proteins is on kidney function (eGFR decline), a quantitative trait, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1034,
   "end": 1205
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39507894",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on PCOS names KRT19 as significant, without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 751,
   "end": 928
  },
  "claim": {
   "protein_as_written": "Keratin 19",
   "gene": "KRT19",
   "disease_as_written": "PCOS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 929,
    "end": 1131
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1543,
    "end": 1746
   }
  }
 },
 {
  "pmid": "39511635",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR uses the expression of drug target genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 973,
   "end": 1166
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39512814",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR pools cis-eQTL, cis-mQTL and cis-pQTL, and the abstract doesn't say which instruments gave the CDKN1A-HF estimate.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 783,
   "end": 983
  },
  "claim": {
   "protein_as_written": "CDKN1A",
   "gene": "CDKN1A",
   "disease_as_written": "HF",
   "direction": "raises",
   "estimate": {
    "or": 1.09,
    "low": 1.02,
    "high": 1.15,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1313,
    "end": 1576
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1741,
    "end": 1840
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 84
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39512998",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 301,
   "end": 446
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39516845",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein cis-pQTL MR on membranous and IgA nephropathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1244,
   "end": 1535
  },
  "claim": {
   "protein_as_written": "PLA2R1",
   "gene": "PLA2R1",
   "disease_as_written": "MN",
   "direction": "raises",
   "estimate": {
    "or": 2.01,
    "low": 1.83,
    "high": 2.21,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1244,
    "end": 1535
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.695,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1801,
    "end": 2027
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2183,
    "end": 2413
   }
  }
 },
 {
  "pmid": "39524758",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The MR's instruments aren't named (so E2 is at most unsettled), and the MR sentence says only that genes are involved in PMG-related processes, stating no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2126,
   "end": 2273
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39526184",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome, coronary artery calcification, is an imaging measure, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 745,
   "end": 836
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39526243",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is heel bone mineral density, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 498,
   "end": 643
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39528761",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Exposures are cortical (brain) proteins and brain cell-type genes, not circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 330,
   "end": 691
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39528825",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The pQTLs are from cerebrospinal fluid.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 837,
   "end": 1066
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39529882",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR instruments are cis-eQTLs of druggable genes from blood, not pQTLs of circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 431,
   "end": 650
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39530187",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 4548 circulating proteins on kidney stones; results give directed pairs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 467,
   "end": 634
  },
  "claim": {
   "protein_as_written": "COLGALT1",
   "gene": "COLGALT1",
   "disease_as_written": "kidney stone",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1180,
    "end": 1496
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39532570",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 374,
   "end": 690
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39533579",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are CSF metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 151,
   "end": 367
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39533633",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with cis-pQTLs of plasma proteins on diverticular disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 689,
   "end": 892
  },
  "claim": {
   "protein_as_written": "CCN3/NOV",
   "gene": "CCN3",
   "disease_as_written": "DD",
   "direction": "lowers",
   "estimate": {
    "or": 0.98,
    "low": 0.97,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1629,
    "end": 1784
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1147,
    "end": 1393
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 115
   }
  }
 },
 {
  "pmid": "39534640",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are pulse pressure and large artery stiffness, quantitative traits, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 489,
   "end": 739
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39536725",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 circulating plasma proteins on atopic dermatitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 560,
   "end": 773
  },
  "claim": {
   "protein_as_written": "IFNA16",
   "gene": "IFNA16",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1387,
    "end": 1584
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39539729",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "CD36 comes from integrated proteome-wide and transcriptome-wide MR; instruments and tissue not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 633,
   "end": 763
  },
  "claim": {
   "protein_as_written": "CD36",
   "gene": "CD36",
   "disease_as_written": "IA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1881,
    "end": 1983
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39541108",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 734 plasma proteins on diabetic retinopathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 101,
   "end": 266
  },
  "claim": {
   "protein_as_written": "CCL3L1",
   "gene": "CCL3L1",
   "disease_as_written": "DR",
   "direction": "lowers",
   "estimate": {
    "or": 0.582,
    "low": 0.343,
    "high": 0.986,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 696,
    "end": 1124
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1589,
    "end": 1753
   }
  }
 },
 {
  "pmid": "39541744",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Antihypertensive drug targets proxied by blood-pressure-weighted SNPs and eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1072,
   "end": 1340
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39541979",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating proteins (plasma cis-pQTLs) on PCOS; EGLN1 is named without an MR direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 328,
   "end": 471
  },
  "claim": {
   "protein_as_written": "EGLN1",
   "gene": "EGLN1",
   "disease_as_written": "PCOS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1864,
    "end": 2013
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1681,
    "end": 1863
   }
  }
 },
 {
  "pmid": "39542148",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins enter only as mediators of SGLT2 inhibition, with no own effect on ischemic stroke stated; the SGLT2 pair is not MR of a circulating level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1836,
   "end": 1931
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39544374",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 plasma inflammatory proteins (Olink Target) on schizophrenia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 648,
   "end": 828
  },
  "claim": {
   "protein_as_written": "IL1A",
   "gene": "IL1A",
   "disease_as_written": "SZ",
   "direction": "lowers",
   "estimate": {
    "or": 0.93,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1050,
    "end": 1186
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1425,
    "end": 1515
   }
  }
 },
 {
  "pmid": "39548148",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE plasma proteins on endometrial cancer; conclusions name IGF2R and CST3 without direction, and the results give IGF2R an OR above 1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 269,
   "end": 483
  },
  "claim": {
   "protein_as_written": "IGF2R",
   "gene": "IGF2R",
   "disease_as_written": "EC",
   "direction": "raises",
   "estimate": {
    "or": 1.165,
    "low": 1.067,
    "high": 1.272,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1207,
    "end": 1446
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1447,
    "end": 1639
   }
  }
 },
 {
  "pmid": "39554199",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from TET2 CHIP to proteins; no protein exposure on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 942,
   "end": 1110
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39554251",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on JIA; conclusions name GP1BA first without direction, results say higher GP1BA raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 463,
   "end": 584
  },
  "claim": {
   "protein_as_written": "GP1BA",
   "gene": "GP1BA",
   "disease_as_written": "JIA",
   "direction": "raises",
   "estimate": {
    "or": 9.26,
    "low": 2.3,
    "high": 37.2,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 877,
    "end": 1071
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1072,
    "end": 1213
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1446,
    "end": 1666
   }
  }
 },
 {
  "pmid": "39555095",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with instruments for circulating inflammatory proteins on erectile dysfunction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 466,
   "end": 632
  },
  "claim": {
   "protein_as_written": "macrophage inflammatory protein-1 alpha (MIP-1α)",
   "gene": "CCL3",
   "disease_as_written": "ED",
   "direction": "raises",
   "estimate": {
    "or": 1.19,
    "low": 1.02,
    "high": 1.39,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1241,
    "end": 1435
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1854,
    "end": 2084
   }
  }
 },
 {
  "pmid": "39557714",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of 'AGT inhibitors' with instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1551,
   "end": 1662
  },
  "claim": {
   "protein_as_written": "AGT",
   "gene": "AGT",
   "disease_as_written": "colorectal cancer",
   "direction": "raises",
   "estimate": {
    "or": 0.874,
    "low": 0.792,
    "high": 0.964,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 3082,
    "end": 3249
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1551,
    "end": 1662
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39562718",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with blood pQTLs on Alzheimer's disease; the pair has no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 613,
   "end": 740
  },
  "claim": {
   "protein_as_written": "CEND1",
   "gene": "CEND1",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1526,
    "end": 1621
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39563941",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "LPL agonism is proxied by variants in drug-target genes whose instruments (or weighting biomarker) the abstract doesn't name; FGF5 is only a mediator with no own effect given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 422,
   "end": 642
  },
  "claim": {
   "protein_as_written": "LPL",
   "gene": "LPL",
   "disease_as_written": "AF",
   "direction": "lowers",
   "estimate": {
    "or": 0.854,
    "low": 0.816,
    "high": 0.894,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1041,
    "end": 1169
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1778,
    "end": 2023
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39565569",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure instruments are cis-eQTLs from eQTLGen (gene expression).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 876,
   "end": 1026
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39572673",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Genetic (MR) analysis of serum circulating proteins on cirrhosis names six proteins without a direction for cirrhosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 200,
   "end": 417
  },
  "claim": {
   "protein_as_written": "SERPINA1",
   "gene": "SERPINA1",
   "disease_as_written": "cirrhosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 200,
    "end": 417
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1146,
    "end": 1343
   }
  }
 },
 {
  "pmid": "39572695",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-MR of circulating proteins on cardiac diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 619,
   "end": 935
  },
  "claim": {
   "protein_as_written": "spondin-1",
   "gene": "SPON1",
   "disease_as_written": "atrial fibrillation",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 619,
    "end": 935
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 619,
    "end": 935
   }
  }
 },
 {
  "pmid": "39574905",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Circulating inflammatory cytokines instrumented by pQTL GWAS, outcomes T2D and diabetic nephropathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 509,
   "end": 625
  },
  "claim": {
   "protein_as_written": "fibroblast growth factor 19",
   "gene": "FGF19",
   "disease_as_written": "type 2 diabetes mellitus",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 930,
    "end": 1348
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39578729",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTLs from deCODE as instruments for plasma proteins on migraine.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 542,
   "end": 727
  },
  "claim": {
   "protein_as_written": "PNKP",
   "gene": "PNKP",
   "disease_as_written": "migraine",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1207,
    "end": 1364
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 542,
    "end": 727
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1847,
    "end": 1961
   }
  }
 },
 {
  "pmid": "39579543",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on 17 oral phenotypes, one of which, stomatitis, is a diagnosed disease paired with CCL4.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 501,
   "end": 689
  },
  "claim": {
   "protein_as_written": "CCL4",
   "gene": "CCL4",
   "disease_as_written": "stomatitis",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1119,
    "end": 1253
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39580111",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on spirometry measures and an obstructive spirometry pattern, which are measurements, not diagnosed diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1660,
   "end": 1793
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39580580",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Main exposures are lipids; drug-target (HMGCR, NPC1L1, PCSK9) analyses found no association, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1415,
   "end": 1519
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39582067",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The only MR exposure is folate intake.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1332,
   "end": 1442
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39582071",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Discovery MR uses cis-eQTLs; DLK1 pair rests on validations pooling GTEx eQTLs and pQTL datasets.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1098,
   "end": 1316
  },
  "claim": {
   "protein_as_written": "DLK1",
   "gene": "DLK1",
   "disease_as_written": "spinal stenosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2114,
    "end": 2295
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1484,
    "end": 1704
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2114,
    "end": 2295
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39585470",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UKB-PPP plasma proteins on kidney stone disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 447,
   "end": 532
  },
  "claim": {
   "protein_as_written": "ITIH4",
   "gene": "ITIH4",
   "disease_as_written": "KSD",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 855,
    "end": 992
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39586554",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from social contact to protein levels; no protein exposure on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1042,
   "end": 1278
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39588545",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs between psychiatric disorders and hemorrhoidal disease; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 727,
   "end": 834
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39589413",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "IL-6R blockade was proxied by variants weighted by serum CRP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 353,
   "end": 624
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39589539",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are circulating plasma lipids.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 273,
   "end": 387
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39591827",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR outcomes are sarcopenia-related traits (appendicular lean mass, grip strength), not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1953,
   "end": 2140
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39592890",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTLs (deCODE) as mediators, with the proteins' own effects on GI diseases given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1434,
   "end": 1624
  },
  "claim": {
   "protein_as_written": "SULT2A1",
   "gene": "SULT2A1",
   "disease_as_written": "cholelithiasis",
   "direction": "raises",
   "estimate": {
    "or": 1.98,
    "low": 1.8,
    "high": 2.18,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1434,
    "end": 1624
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.996,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1625,
    "end": 1850
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39596173",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma protein pQTLs on hypertension; glucosamine 6-phosphate N-acetyltransferase protective with OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 233,
   "end": 544
  },
  "claim": {
   "protein_as_written": "glucosamine 6-phosphate N-acetyltransferase",
   "gene": "GNPNAT1",
   "disease_as_written": "hypertension",
   "direction": "lowers",
   "estimate": {
    "or": 0.995,
    "low": 0.992,
    "high": 0.998,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 830,
    "end": 1050
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39604029",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of deCODE and UKB-PPP plasma proteins on hypertension; conclusion gives IFNLR1 a direction (agonist treats hypertension).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 600,
   "end": 713
  },
  "claim": {
   "protein_as_written": "IFNLR1",
   "gene": "IFNLR1",
   "disease_as_written": "hypertension",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1789,
    "end": 1884
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.913,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1537,
    "end": 1662
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1789,
    "end": 1884
   }
  }
 },
 {
  "pmid": "39605940",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Genetically proxied GLP-1RAs (GLP1R agonism) whose instruments the abstract doesn't name; agonism lowers ED risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 365,
   "end": 483
  },
  "claim": {
   "protein_as_written": "GLP-1RAs",
   "gene": "GLP1R",
   "disease_as_written": "ED",
   "direction": "lowers",
   "estimate": {
    "or": 0.493,
    "low": 0.43,
    "high": 0.565,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 717,
    "end": 880
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 137,
    "end": 260
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39606095",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Directed pairs are drug-target 'inhibition' exposures whose instruments the abstract doesn't name; circulating ApoB itself showed no causality.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1005,
   "end": 1201
  },
  "claim": {
   "protein_as_written": "ApoB",
   "gene": "APOB",
   "disease_as_written": "autoimmune thyroiditis",
   "direction": "raises",
   "estimate": {
    "or": 0.462,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1005,
    "end": 1201
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 554,
    "end": 818
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39606342",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcome is insulin sensitivity, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2089,
   "end": 2254
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39609799",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted serum HGFA levels on PAH.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1550,
   "end": 1701
  },
  "claim": {
   "protein_as_written": "HGFA",
   "gene": "HGFAC",
   "disease_as_written": "PAH",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1550,
    "end": 1701
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39611306",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets are proxied by variants near target genes selected and weighted by LDL-c (or TG).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 862,
   "end": 1144
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39614330",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR uses immune-cell eQTLs, gene expression rather than circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 554,
   "end": 848
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39614878",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of pQTL-instrumented proteins on kidney stones, with named key proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 510,
   "end": 694
  },
  "claim": {
   "protein_as_written": "CD27",
   "gene": "CD27",
   "disease_as_written": "kidney stones",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1097,
    "end": 1288
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39615872",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR pools CSF and plasma protein instruments; NMB's tissue isn't stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 309,
   "end": 509
  },
  "claim": {
   "protein_as_written": "neuromedin B (NMB)",
   "gene": "NMB",
   "disease_as_written": "SCZ",
   "direction": "raises",
   "estimate": {
    "unit": "not stated",
    "frame": "per higher protein",
    "low": 1.27,
    "high": 1.58,
    "or": 1.41
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 991,
    "end": 1172
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1173,
    "end": 1251
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1252,
    "end": 1353
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1719,
    "end": 1822
   }
  }
 },
 {
  "pmid": "39616386",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is 25-hydroxyvitamin D, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1632,
   "end": 1768
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39619395",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "APOC3 inhibition is proxied per 1 mmol/L reduction in triglycerides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1600,
   "end": 1775
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39622444",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Gene-level drug-target MR whose instruments (expression or protein QTLs) the abstract does not name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 225,
   "end": 432
  },
  "claim": {
   "protein_as_written": "OPRL1",
   "gene": "OPRL1",
   "disease_as_written": "breast cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1205,
    "end": 1310
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 750,
    "end": 869
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1205,
    "end": 1310
   }
  }
 },
 {
  "pmid": "39624895",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcomes are blood pressure traits, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 457,
   "end": 703
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39627291",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "PWAS and MR of plasma pQTLs on atopic dermatitis, but no protein is named with the disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1349,
   "end": 1445
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39631652",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 508,
   "end": 643
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39633845",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of 'HMGCR inhibition' etc.; instruments not named in the abstract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 344,
   "end": 537
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "breast cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1120,
    "end": 1488
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1120,
    "end": 1488
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39637861",
  "eligibility": "E5",
  "e2_kind": null,
  "eligibility_reason": "A methods paper proposing a new MR method (MR-SPI), applied as a demonstration.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 462,
   "end": 641
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39639394",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating plasma proteins (pQTLs) on DPN; conclusions name proteins without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 219,
   "end": 344
  },
  "claim": {
   "protein_as_written": "ITM2B",
   "gene": "ITM2B",
   "disease_as_written": "DPN",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1314,
    "end": 1545
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1314,
    "end": 1545
   }
  }
 },
 {
  "pmid": "39640975",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Antidiabetic drug targets are proxied by variants weighted by HbA1c (a downstream biomarker), and other exposures are HbA1c, T2D, and gene expression; no circulating protein level is instrumented.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1552,
   "end": 1830
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39644392",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on knee and hip osteoarthritis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 360,
   "end": 571
  },
  "claim": {
   "protein_as_written": "CXCL9",
   "gene": "CXCL9",
   "disease_as_written": "KOA",
   "direction": "raises",
   "estimate": {
    "frame": "per higher protein",
    "high": 1.492,
    "low": 1.046,
    "unit": "not stated",
    "or": 1.249
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 913,
    "end": 1081
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39649642",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are GTEx cis-eQTLs; outcome is height.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 713,
   "end": 925
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39653801",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is brain age gap, a trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 794,
   "end": 872
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39661645",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants proxy blood pressure, HDL, triglyceride, and weight lowering.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1850,
   "end": 2240
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39662658",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target instruments are variants tied to target genes' expression and weighted by HbA1c.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 264,
   "end": 464
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39669686",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "TSMR of UKB-PPP serum proteins on psoriasis; MMP12 passed SMR and colocalization filters; no direction for the MR pairs (only the observational score), so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1453,
   "end": 1615
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "psoriasis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1453,
    "end": 1615
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1453,
    "end": 1615
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39671389",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pooling mQTL, eQTL and pQTL; the key genes come from the multi-omics analysis, not tied to a circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 535,
   "end": 779
  },
  "claim": {
   "protein_as_written": "SUOX",
   "gene": "SUOX",
   "disease_as_written": "GERD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1330,
    "end": 1501
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1330,
    "end": 1501
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39677447",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based MR of plasma protein levels on venous thrombosis recurrence; factor XI a risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 965,
   "end": 1142
  },
  "claim": {
   "protein_as_written": "coagulation factor XI",
   "gene": "F11",
   "disease_as_written": "VT recurrence",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 965,
    "end": 1231
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39678043",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR 'of genetic variants' for cytokines; instruments not named as circulating levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1309,
   "end": 1496
  },
  "claim": {
   "protein_as_written": "CCL2",
   "gene": "CCL2",
   "disease_as_written": "CHOL",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1309,
    "end": 1496
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39680155",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pooling eQTL, mQTL and pQTL; the LMAN2 pair rests on expression with support from protein-level analyses whose tissue is not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1087,
   "end": 1324
  },
  "claim": {
   "protein_as_written": "LMAN2",
   "gene": "LMAN2",
   "disease_as_written": "urolithiasis",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1087,
    "end": 1324
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2009,
    "end": 2238
   }
  }
 },
 {
  "pmid": "39691718",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are mediators of trace elements' effects; no protein's own effect on a disease is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1388,
   "end": 1564
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39701775",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Loci were screened by integrating proteome-wide MR with transcriptomic, methylation and splicing analyses; the abstract doesn't tie the named loci to the circulating protein's MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1189,
   "end": 1340
  },
  "claim": {
   "protein_as_written": "COL15A1",
   "gene": "COL15A1",
   "disease_as_written": "influenza",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1712,
    "end": 1806
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2401,
    "end": 2521
   }
  }
 },
 {
  "pmid": "39702585",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma pQTLs on skin cancers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 360,
   "end": 572
  },
  "claim": {
   "protein_as_written": "ASIP",
   "gene": "ASIP",
   "disease_as_written": "basal cell carcinoma (BCC)",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 573,
    "end": 726
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 828,
    "end": 1031
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 828,
    "end": 1031
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39703113",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "VDBP concentration was tested against epilepsy but the abstract states no causal relationship, so no protein-disease pair is claimed.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 922,
   "end": 1007
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39703124",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR between metabolic and neurodegenerative diseases; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 372,
   "end": 577
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39704160",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins (pQTL) on HS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 838,
   "end": 992
  },
  "claim": {
   "protein_as_written": "T-cell surface glycoprotein CD5",
   "gene": "CD5",
   "disease_as_written": "HS",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1314,
    "end": 1458
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39705479",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by variants associated with LDL and triglycerides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1105,
   "end": 1267
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39707285",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on bladder cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 248,
   "end": 367
  },
  "claim": {
   "protein_as_written": "SLURP1",
   "gene": "SLURP1",
   "disease_as_written": "BCa",
   "direction": "raises",
   "estimate": {
    "or": 1.5,
    "low": 1.3,
    "high": 1.74,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1291,
    "end": 1420
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 722,
    "end": 932
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1481,
    "end": 1704
   }
  }
 },
 {
  "pmid": "39707330",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The SMR includes pQTLs, and the abstract attributes the protein-level pairs with AS to them explicitly ('At the protein level').",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1280,
   "end": 1497
  },
  "claim": {
   "protein_as_written": "AIF1",
   "gene": "AIF1",
   "disease_as_written": "AS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1280,
    "end": 1497
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 518,
    "end": 753
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39710002",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR only between diabetes, frailty, and muscle phenotypes; proteins/genes come from TWAS, not MR of a protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1647,
   "end": 1836
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39715222",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma cis-pQTLs on myocardial infarction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 691,
   "end": 807
  },
  "claim": {
   "protein_as_written": "CD8A",
   "gene": "CD8A",
   "disease_as_written": "MI",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 905,
    "end": 1022
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1072,
    "end": 1141
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39716054",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on frailty, a clinical syndrome analysed as risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 309,
   "end": 453
  },
  "claim": {
   "protein_as_written": "BIRC2",
   "gene": "BIRC2",
   "disease_as_written": "frailty",
   "direction": "lowers",
   "estimate": {
    "or": 0.978,
    "low": 0.967,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 808,
    "end": 1160
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1161,
    "end": 1247
   }
  }
 },
 {
  "pmid": "39716115",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 844,
   "end": 1005
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39718588",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Genetically proxied PCSK9 inhibition and other drug targets, instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 400,
   "end": 685
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1321,
    "end": 1539
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1321,
    "end": 1539
   }
  }
 },
 {
  "pmid": "39719581",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR used cis-eQTLs of druggable genes (eQTLGen, PsychENCODE), not protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 911,
   "end": 1070
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39720696",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is mentioned among methods to find burn-linked genes, but the abstract states no protein-disease pair from MR; the CYP19A1 finding is observational expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 485,
   "end": 827
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39720783",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are gene expression and DNA methylation in blood.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 569,
   "end": 787
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39721116",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating plasma proteins on intracranial aneurysm.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 389,
   "end": 559
  },
  "claim": {
   "protein_as_written": "FGF5",
   "gene": "FGF5",
   "disease_as_written": "IAs",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1348,
    "end": 1418
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.993,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 947,
    "end": 1190
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 947,
    "end": 1190
   }
  }
 },
 {
  "pmid": "39721452",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses eQTL data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 775,
   "end": 870
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39723341",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins among other exposures on atopic dermatitis; first protein pair IL-18R1 with OR 1.12 at FDR < 0.01.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 418,
   "end": 623
  },
  "claim": {
   "protein_as_written": "IL-18R1",
   "gene": "IL18R1",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "frame": "per higher protein",
    "high": 1.17,
    "low": 1.08,
    "unit": "not stated",
    "or": 1.12
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1217,
    "end": 1276
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39726690",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins (pQTLs) on epithelial ovarian cancer subtypes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 436,
   "end": 644
  },
  "claim": {
   "protein_as_written": "A1BG",
   "gene": "A1BG",
   "disease_as_written": "EOC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1532,
    "end": 1649
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1532,
    "end": 1649
   }
  }
 },
 {
  "pmid": "39734218",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides eQTL MR, a separate protein-level SMR gives NRBP1 and SUMF1 as risk genes for gout, an MR on the protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 512,
   "end": 719
  },
  "claim": {
   "protein_as_written": "NRBP1",
   "gene": "NRBP1",
   "disease_as_written": "gout",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1418,
    "end": 1534
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 876,
    "end": 1039
   }
  }
 },
 {
  "pmid": "39734575",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 plasma proteins on AMD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 365,
   "end": 562
  },
  "claim": {
   "protein_as_written": "fibroblast growth factor 19",
   "gene": "FGF19",
   "disease_as_written": "AMD",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 831,
    "end": 1156
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39734669",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is between 25-hydroxyvitamin D and schizophrenia; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 801,
   "end": 994
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39736250",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposures are hub genes whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1562,
   "end": 1827
  },
  "claim": {
   "protein_as_written": "CASP8",
   "gene": "CASP8",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 3080,
    "end": 3237
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 3080,
    "end": 3237
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 3385,
    "end": 3574
   }
  }
 },
 {
  "pmid": "39736334",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of signature proteins from UK Biobank's plasma proteomics on incident diabetes. The exposure is named as the proteins and not as expression, signalling or gene variants, and the MR gives no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 749,
   "end": 956
  },
  "claim": {
   "protein_as_written": "AGR2",
   "gene": "AGR2",
   "disease_as_written": "diabetes",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1498,
    "end": 1652
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39738466",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Risk genes come from pooled eQTL analysis and plasma protein profiling; the abstract does not name circulating-protein instruments for the pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 443,
   "end": 696
  },
  "claim": {
   "protein_as_written": "CCN3",
   "gene": "CCN3",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 443,
    "end": 696
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39743746",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR on neurodegenerative diseases, but the abstract names no protein, giving only counts.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 971,
   "end": 1085
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39747467",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma proteins on IBD-related arthritis; associations given without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1992,
   "end": 2198
  },
  "claim": {
   "protein_as_written": "pterin-4-alpha-carbinolamine dehydratase",
   "gene": "PCBD1",
   "disease_as_written": "Crohn's disease-related arthritis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2408,
    "end": 2841
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39751938",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on CLL risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 325,
   "end": 451
  },
  "claim": {
   "protein_as_written": "Peptidyl-prolyl cis-trans isomerase E (PPIE)",
   "gene": "PPIE",
   "disease_as_written": "CLL",
   "direction": "raises",
   "estimate": {
    "or": 1.66,
    "low": 1.22,
    "high": 2.27,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 841,
    "end": 1221
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.758,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1222,
    "end": 1321
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39753750",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from loneliness to proteins, not from proteins to a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 723,
   "end": 906
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39753851",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLGen expression QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 311,
   "end": 507
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39754686",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are ratios of circulating protein levels, not one gene's product.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 501,
   "end": 579
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39755304",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma (and CSF) proteins on Alzheimer's disease; plasma CTSH is the first directed pair in the conclusions, Bonferroni-significant.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2441,
   "end": 2712
  },
  "claim": {
   "protein_as_written": "CTSH",
   "gene": "CTSH",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "or": 1.06,
    "low": 1.03,
    "high": 1.08,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2441,
    "end": 2712
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 2330,
    "end": 2428
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 621,
    "end": 771
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39755897",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets (HMGCR, NPC1L1, PCSK9) weighted by LDL as a biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 452,
   "end": 821
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39756125",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating cytokine levels on Behcet's syndrome, a disease; pairs are stated without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 539,
   "end": 709
  },
  "claim": {
   "protein_as_written": "Interleukin 12 subunit beta(IL-12B)",
   "gene": "IL12B",
   "disease_as_written": "Behcet's syndrome",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1087,
    "end": 1345
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39762453",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins was performed but no protein-disease pair from it is stated; DDIT4/ARHGAP15 come from eQTL MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 717,
   "end": 820
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39762845",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug target genes are proxied by eQTLGen cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 661,
   "end": 788
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39763263",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "No abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39763524",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins; univariate MR of lipid-associated proteins on CVDs gives a protein-CAD pair (CELSR2), stated without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 753,
   "end": 818
  },
  "claim": {
   "protein_as_written": "CELSR2",
   "gene": "CELSR2",
   "disease_as_written": "CAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1620,
    "end": 1696
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39767639",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of genetic variation in antidiabetic drug targets; instruments only 'from previous published articles', not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 837,
   "end": 917
  },
  "claim": {
   "protein_as_written": "SGLT2",
   "gene": "SLC5A2",
   "disease_as_written": "ALS",
   "direction": "raises",
   "estimate": {
    "or": 0.32,
    "low": 0.14,
    "high": 0.74,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 927,
    "end": 1067
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 927,
    "end": 1067
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39770468",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with cis-pQTLs on RLS; MAN1A2 named without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1108,
   "end": 1246
  },
  "claim": {
   "protein_as_written": "MAN1A2",
   "gene": "MAN1A2",
   "disease_as_written": "RLS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1456,
    "end": 1702
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1108,
    "end": 1246
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1456,
    "end": 1702
   }
  }
 },
 {
  "pmid": "39778021",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides protein ratios, the paper reports MR of single circulating proteins (UKB-PPP) on HCC; TDRKH is the one protein causally associated, with an OR below 1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1273,
   "end": 1433
  },
  "claim": {
   "protein_as_written": "TDRKH",
   "gene": "TDRKH",
   "disease_as_written": "HCC",
   "direction": "lowers",
   "estimate": {
    "or": 0.5964,
    "low": 0.4196,
    "high": 0.8476,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1273,
    "end": 1433
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39778696",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 571,
   "end": 840
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39787209",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is rate of cognitive decline in AD patients, a quantitative trait, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1111,
   "end": 1282
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39790564",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on erectile dysfunction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 357,
   "end": 457
  },
  "claim": {
   "protein_as_written": "TMEM9",
   "gene": "TMEM9",
   "disease_as_written": "ED",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1284,
    "end": 1459
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39793738",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are CSF metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 276,
   "end": 422
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39793886",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Methods paper on phosphosite-protein causal links in tumour samples; no MR of a circulating protein on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 573,
   "end": 744
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39794838",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides eQTL MR, it estimates plasma ACE protein levels' effect on AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1538,
   "end": 1866
  },
  "claim": {
   "protein_as_written": "ACE",
   "gene": "ACE",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": {
    "or": 1.13,
    "low": 1.09,
    "high": 1.17,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2073,
    "end": 2234
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1867,
    "end": 1905
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2235,
    "end": 2441
   }
  }
 },
 {
  "pmid": "39796139",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The exposures are circulating microRNAs instrumented by miR-eQTLs, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 277,
   "end": 601
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39799159",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Genes (including lncRNAs) prioritised by TWAS and SMR of expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 557,
   "end": 1045
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39802509",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The SMR integrates gene expression and blood protein concentrations, and the abstract doesn't say which QTLs instrumented the SMR that named GNLY, so pooled kinds of QTL leave E2 unsettled.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 710,
   "end": 857
  },
  "claim": {
   "protein_as_written": "GNLY",
   "gene": "GNLY",
   "disease_as_written": "primary open-angle glaucoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1473,
    "end": 1584
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1473,
    "end": 1584
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39803274",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 448,
   "end": 695
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39805382",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of adaptive immune response-related genes on DR; the abstract names neither the instruments nor a circulating level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 523,
   "end": 628
  },
  "claim": {
   "protein_as_written": "TRAV23DV6",
   "gene": "TRAV23DV6",
   "disease_as_written": "DR",
   "direction": "raises",
   "estimate": {
    "or": 1.367,
    "low": 1.005,
    "high": 1.859,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 831,
    "end": 962
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 963,
    "end": 1040
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1506,
    "end": 1646
   }
  }
 },
 {
  "pmid": "39806139",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR whose only exposures are differentially expressed plasma proteins, on lung adenocarcinoma; IL20RB OR 1.600.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 560,
   "end": 760
  },
  "claim": {
   "protein_as_written": "IL20RB",
   "gene": "IL20RB",
   "disease_as_written": "LUAD",
   "direction": "raises",
   "estimate": {
    "or": 1.6,
    "low": 1.098,
    "high": 2.331,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 929,
    "end": 1128
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39806364",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins were exposures, but none is named, they failed FDR correction, and CD40L receptor appears only as a mediator without its own effect on SS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1425,
   "end": 1597
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39806440",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (and CSF proteins separately) on asthma; conclusions name IL1R1 first, results give its plasma direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 705,
   "end": 828
  },
  "claim": {
   "protein_as_written": "IL1R1",
   "gene": "IL1R1",
   "disease_as_written": "asthma",
   "direction": "raises",
   "estimate": {
    "or": 1.3,
    "low": 1.2,
    "high": 1.42,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1331,
    "end": 1662
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39809087",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR finding is stated only for unnamed 'plasma proteins inhibited by mTOR'; no named protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 890,
   "end": 1356
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39818967",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating abundance of 996 proteins on lacunar stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 380,
   "end": 573
  },
  "claim": {
   "protein_as_written": "COL2A1 (collagen type II α-1 chain)",
   "gene": "COL2A1",
   "disease_as_written": "lacunar stroke",
   "direction": "lowers",
   "estimate": {
    "or": 0.89,
    "low": 0.86,
    "high": 0.91,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1480,
    "end": 1622
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39821175",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of ESR2 on Parkinson's disease without naming its instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1179,
   "end": 1304
  },
  "claim": {
   "protein_as_written": "ESR2",
   "gene": "ESR2",
   "disease_as_written": "PD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1179,
    "end": 1304
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1179,
    "end": 1304
   }
  }
 },
 {
  "pmid": "39821516",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood eQTLs for antihypertensive drug target gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 515,
   "end": 727
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39823480",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "The headline protein the conclusions name, circulating PPP3CA; PPP3R1 (calcineurin), is a complex of two genes' products.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2509,
   "end": 2659
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39824883",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is pubertal timing, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 934,
   "end": 1160
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39824903",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (antibody-based pQTLs) on ILD from FinnGen; no direction stated for any pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 439,
   "end": 677
  },
  "claim": {
   "protein_as_written": "CDH15",
   "gene": "CDH15",
   "disease_as_written": "ILD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1276,
    "end": 1663
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1276,
    "end": 1663
   }
  }
 },
 {
  "pmid": "39825753",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are gene-expression eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 637,
   "end": 753
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39826584",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood eQTLs for drug target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 420,
   "end": 638
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39827250",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Instruments are brain pQTLs (and eQTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 301,
   "end": 715
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39828257",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "ANGPTL3 inhibition is proxied by variants weighted by triglycerides and LDL-C.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1328,
   "end": 1666
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39828767",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are lipid species.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 307,
   "end": 574
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39830273",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR with brain cell type-specific eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 653,
   "end": 801
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39835424",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The plasma protein MR's outcome is visceral obesity, an adiposity trait the paper treats as a risk factor for diseases, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1068,
   "end": 1288
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39837327",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are serum metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 633,
   "end": 882
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39838927",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are mitochondria-related gene expression levels (eQTL), not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1370,
   "end": 1475
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39841246",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable-gene MR uses eQTLs from blood and brain.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 601,
   "end": 790
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39842668",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are smoking behaviors and MDD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 576,
   "end": 693
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39842943",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on type 2 diabetes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1533,
   "end": 1731
  },
  "claim": {
   "protein_as_written": "GSTA1",
   "gene": "GSTA1",
   "disease_as_written": "T2D",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1533,
    "end": 1731
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1533,
    "end": 1731
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39844246",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "One SMR pools mQTL, eQTL and pQTL data, with skin and lymphocyte data in validation, and the abstract never says APOF's pQTLs are of plasma or serum, so the pair isn't tied to a circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 395,
   "end": 629
  },
  "claim": {
   "protein_as_written": "APOF",
   "gene": "APOF",
   "disease_as_written": "psoriasis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1376,
    "end": 1515
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1747,
    "end": 1831
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39844355",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-MR of ARIC plasma proteins on hypertension (FinnGen); ERAP1 named with a negative correlation with risk after colocalisation and replication.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 768,
   "end": 880
  },
  "claim": {
   "protein_as_written": "ERAP1",
   "gene": "ERAP1",
   "disease_as_written": "HT",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1480,
    "end": 1627
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1641,
    "end": 1888
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1641,
    "end": 1888
   }
  }
 },
 {
  "pmid": "39844969",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "CETP 'inhibition' instrumented by variants in drug-target genes; abstract doesn't say whether by pQTLs or lipid-weighted.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 442,
   "end": 646
  },
  "claim": {
   "protein_as_written": "CETP",
   "gene": "CETP",
   "disease_as_written": "UF",
   "direction": "raises",
   "estimate": {
    "or": 0.95,
    "low": 0.92,
    "high": 0.98,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1503,
    "end": 1617
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1008,
    "end": 1397
   }
  }
 },
 {
  "pmid": "39846783",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UVMR of adiposity-associated circulating proteins on CRC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 762,
   "end": 823
  },
  "claim": {
   "protein_as_written": "GREM1",
   "gene": "GREM1",
   "disease_as_written": "CRC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1260,
    "end": 1449
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1784,
    "end": 1982
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39849060",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Protein exposures are protein-to-protein ratios; other exposures are gut microbiota.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1190,
   "end": 1302
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39850014",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets are proxied by variants at LDL-C loci weighted by LDL cholesterol.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 713,
   "end": 855
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39856218",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step proteome-wide MR of circulating proteins mediating obesity's effect; COL6A3's own effect on CAD is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 462,
   "end": 659
  },
  "claim": {
   "protein_as_written": "COL6A3",
   "gene": "COL6A3",
   "disease_as_written": "coronary artery disease",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 660,
    "end": 760
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1072,
    "end": 1265
   }
  }
 },
 {
  "pmid": "39857769",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Candidate genes were screened by MR pooling eQTL and pQTL data, without tying the pair to the protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 473,
   "end": 617
  },
  "claim": {
   "protein_as_written": "MTHFD1",
   "gene": "MTHFD1",
   "disease_as_written": "PRAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1814,
    "end": 1907
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1281,
    "end": 1412
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39857814",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR pooling eQTL, mQTL and pQTL; pQTL tissue not named as circulating.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 603,
   "end": 755
  },
  "claim": {
   "protein_as_written": "CD274",
   "gene": "CD274",
   "disease_as_written": "IBD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1381,
    "end": 1611
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39863625",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 66 mitochondria-associated protein GWAS on schizophrenia; first results pair with a direction is ETHE1 (OR 1.06).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 359,
   "end": 603
  },
  "claim": {
   "protein_as_written": "ETHE1",
   "gene": "ETHE1",
   "disease_as_written": "SCZ",
   "direction": "raises",
   "estimate": {
    "or": 1.06,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1065,
    "end": 1230
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39863728",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug targets proxied by variants associated with lipid traits from GLGC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 519,
   "end": 719
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39867359",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR runs from physical activity to protein levels; proteins appear only as mediators of physical activity's effect, not as MR exposures for dementia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 710,
   "end": 851
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39868518",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets are proxied by lipid-associated variants (GLGC) and expression QTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 374,
   "end": 508
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39870808",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR in a plasma-proteomics framework gives an OR per SD of BDH1, an exposure named as the protein's level. That meets E2, as 'per SD of kit ligand' does in the codebook.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1004,
   "end": 1195
  },
  "claim": {
   "protein_as_written": "BDH1",
   "gene": "BDH1",
   "disease_as_written": "type 2 diabetes",
   "direction": "lowers",
   "estimate": {
    "or": 0.97,
    "low": 0.95,
    "high": 0.99,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1004,
    "end": 1195
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39871287",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 'HMOX1 exposure' from a gene-expression screen on airway diseases; the abstract doesn't name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 576,
   "end": 795
  },
  "claim": {
   "protein_as_written": "HMOX1",
   "gene": "HMOX1",
   "disease_as_written": "CRSwNP",
   "direction": "lowers",
   "estimate": {
    "or": 0.945,
    "low": 0.893,
    "high": 0.999,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1600,
    "end": 1740
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 105
   }
  }
 },
 {
  "pmid": "39871959",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of proteins on diabetic kidney disease; five proteins named causal without direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 485,
   "end": 783
  },
  "claim": {
   "protein_as_written": "AKT2",
   "gene": "AKT2",
   "disease_as_written": "DKD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1087,
    "end": 1328
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 485,
    "end": 783
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39874030",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "CD209 is named only as a mediator between COVID-19 and T2D; its own effect on T2D is not stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 471,
   "end": 577
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39875498",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 plasma proteins (deCODE) on gastric cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 110,
   "end": 287
  },
  "claim": {
   "protein_as_written": "CHST15",
   "gene": "CHST15",
   "disease_as_written": "GASTRIC CANCER",
   "direction": "lowers",
   "estimate": {
    "or": 0.7553,
    "low": 0.6346,
    "high": 0.8988,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1007,
    "end": 1311
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39880326",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "The MR's drug targets are thyroid hormone receptors, not one gene's product, with no instruments named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1199,
   "end": 1274
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39883516",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of blood cis-pQTLs on psoriasis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 584,
   "end": 735
  },
  "claim": {
   "protein_as_written": "AIF1",
   "gene": "AIF1",
   "disease_as_written": "psoriasis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1556,
    "end": 1793
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 989,
    "end": 1273
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1274,
    "end": 1477
   }
  }
 },
 {
  "pmid": "39885106",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of dementia-associated plasma proteins on Alzheimer's disease; causal relationships named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1126,
   "end": 1373
  },
  "claim": {
   "protein_as_written": "GDF15",
   "gene": "GDF15",
   "disease_as_written": "Alzheimer's disease",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1126,
    "end": 1373
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39885253",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTLs of plasma proteins (deCODE, UKB) instrument circulating proteins against multiple myeloma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 918,
   "end": 1003
  },
  "claim": {
   "protein_as_written": "dermatopontin (DPT)",
   "gene": "DPT",
   "disease_as_written": "MM",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1412,
    "end": 1926
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39887658",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The MR rests on genome-wide aggregated trans-effect scores pooling transcript expression in whole blood with circulating protein levels; the abstract does not tie the pairs to the protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 399,
   "end": 676
  },
  "claim": {
   "protein_as_written": "TP53BP1",
   "gene": "TP53BP1",
   "disease_as_written": "rheumatoid arthritis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 842,
    "end": 1144
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39890696",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The exposures are the expression of differentially expressed T cell genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1363,
   "end": 1484
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39892755",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein pQTLs (n = 54,219) on major depressive disorder.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 254,
   "end": 550
  },
  "claim": {
   "protein_as_written": "BTN2A1",
   "gene": "BTN2A1",
   "disease_as_written": "MDD",
   "direction": "lowers",
   "estimate": {
    "or": 0.86,
    "low": 0.825,
    "high": 0.895,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 893,
    "end": 1240
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.62,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1296,
    "end": 1497
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1498,
    "end": 1592
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39893413",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The drug-target MR of ANGPTL3 and APOC3 inhibitors has bone mineral density, a quantitative trait, as its only outcome; the OP framing in the conclusions rests on BMD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 574,
   "end": 736
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39893495",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Mediation and drug-targeted MR of plasma proteins on allergic asthma; the drug-target MR gives TPST1's own MR on the disease, named in the conclusions without a direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2568,
   "end": 2723
  },
  "claim": {
   "protein_as_written": "TPST1",
   "gene": "TPST1",
   "disease_as_written": "allergic asthma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2568,
    "end": 2723
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2568,
    "end": 2723
   }
  }
 },
 {
  "pmid": "39895541",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTLs of UK Biobank and deCODE plasma proteins used as instruments for AAA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 558,
   "end": 657
  },
  "claim": {
   "protein_as_written": "COL6A3",
   "gene": "COL6A3",
   "disease_as_written": "AAA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1415,
    "end": 1642
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1415,
    "end": 1642
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39900481",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is PPARG enhancement/activation by drug-target MR; the abstract doesn't say the PPARG variants are weighted by a named biomarker or name their instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 691,
   "end": 873
  },
  "claim": {
   "protein_as_written": "PPARG",
   "gene": "PPARG",
   "disease_as_written": "full-course DR",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1501,
    "end": 1599
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1425,
    "end": 1500
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39902581",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets are proxied by variants associated with LDL-C.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 624,
   "end": 875
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39907620",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is inhibition of genes; the abstract does not name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 517,
   "end": 778
  },
  "claim": {
   "protein_as_written": "sodium/glucose cotransporter 2 (SLC5A2)",
   "gene": "SLC5A2",
   "disease_as_written": "HNC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 517,
    "end": 778
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 910,
    "end": 1127
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39911230",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein pQTLs (plasma RSPO3) on endometriosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1158,
   "end": 1408
  },
  "claim": {
   "protein_as_written": "R-Spondin 3 (RSPO3)",
   "gene": "RSPO3",
   "disease_as_written": "EM",
   "direction": "lowers",
   "estimate": {
    "or": 1.0029,
    "low": 1.0015,
    "high": 1.0043,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1158,
    "end": 1408
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.874,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1409,
    "end": 1504
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2016,
    "end": 2174
   }
  }
 },
 {
  "pmid": "39911358",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-modifying drug targets instrumented with lipid-trait variants from GLGC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 446,
   "end": 578
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39913044",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR uses expression of drug target genes (eQTLs), not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1142,
   "end": 1258
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39915329",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of the proteome and transcriptome together; the targets named are not tied to the circulating-protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 398,
   "end": 606
  },
  "claim": {
   "protein_as_written": "IL6R",
   "gene": "IL6R",
   "disease_as_written": "HFrEF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1208,
    "end": 1343
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1208,
    "end": 1343
   }
  }
 },
 {
  "pmid": "39915571",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposure is serum uric acid (a metabolite) and urate-lowering drug targets, no protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 126,
   "end": 368
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39918451",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposures are drug targets' 'inhibition' instrumented by variants in or near the genes; instruments not named as pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 580,
   "end": 837
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "T2D",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1133,
    "end": 1303
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 580,
    "end": 837
   }
  }
 },
 {
  "pmid": "39918628",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs of druggable genes in blood.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 406,
   "end": 580
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39919333",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma protein levels on hip fracture; the only directed protein MR pairs are for falls, grip strength, and BMD, which are not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1696,
   "end": 2001
  },
  "claim": {
   "protein_as_written": "SOST",
   "gene": "SOST",
   "disease_as_written": "hip fracture",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1696,
    "end": 2001
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39921581",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating GCKR levels on gestational diabetes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 950,
   "end": 1038
  },
  "claim": {
   "protein_as_written": "GCKR",
   "gene": "GCKR",
   "disease_as_written": "GDM",
   "direction": "raises",
   "estimate": {
    "or": 3.466,
    "low": 2.401,
    "high": 5.002,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1201,
    "end": 1392
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.997,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1201,
    "end": 1392
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1918,
    "end": 2099
   }
  }
 },
 {
  "pmid": "39922081",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE and UKB-PPP plasma pQTLs on CAVD; conclusions name ANGPTL4 as a target without a direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1579,
   "end": 1754
  },
  "claim": {
   "protein_as_written": "ANGPTL4",
   "gene": "ANGPTL4",
   "disease_as_written": "CAVD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1579,
    "end": 1754
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1579,
    "end": 1754
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 638,
    "end": 794
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1579,
    "end": 1754
   }
  }
 },
 {
  "pmid": "39926273",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "An introductory methods paper that estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 41,
   "end": 215
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39926389",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target genes proxied by eQTLs and by LDL-C-associated variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 531,
   "end": 857
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39929371",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of 'genetically proxied inhibition' with instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1029,
   "end": 1169
  },
  "claim": {
   "protein_as_written": "ANGPTL3",
   "gene": "ANGPTL3",
   "disease_as_written": "LBD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1274,
    "end": 1409
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1274,
    "end": 1409
   }
  }
 },
 {
  "pmid": "39930075",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The plasma protein analysis is a PWAS; the MR (SMR) is on eQTLs and mQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1527,
   "end": 1624
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39932908",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 1553 circulating proteins on OA traits; DNAJB12 with knee OA, Bonferroni corrected.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 208,
   "end": 414
  },
  "claim": {
   "protein_as_written": "DNAJB12",
   "gene": "DNAJB12",
   "disease_as_written": "knee OA",
   "direction": "raises",
   "estimate": {
    "or": 1.51,
    "low": 1.26,
    "high": 1.81,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1454,
    "end": 1704
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1705,
    "end": 1856
   }
  }
 },
 {
  "pmid": "39933264",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are single-cell eQTL-proxied gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 302,
   "end": 643
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39933395",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 4853 plasma proteins on four cancers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 410,
   "end": 529
  },
  "claim": {
   "protein_as_written": "CD36",
   "gene": "CD36",
   "disease_as_written": "breast cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1269,
    "end": 1443
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1269,
    "end": 1443
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1269,
    "end": 1443
   }
  }
 },
 {
  "pmid": "39934551",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR uses eQTLGen expression data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 817,
   "end": 892
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39934773",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug targets whose instruments the abstract does not name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 624,
   "end": 781
  },
  "claim": {
   "protein_as_written": "APOB",
   "gene": "APOB",
   "disease_as_written": "asthma",
   "direction": "raises",
   "estimate": {
    "or": 0.86,
    "low": 0.77,
    "high": 0.97,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 892,
    "end": 1138
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 892,
    "end": 1138
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39935908",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with UKB-PPP cis-pQTLs on Graves' disease; proteins named without a direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 521,
   "end": 650
  },
  "claim": {
   "protein_as_written": "CD40",
   "gene": "CD40",
   "disease_as_written": "GD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1155,
    "end": 1274
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1155,
    "end": 1274
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39949133",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are sarcopenia-related traits, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 625,
   "end": 853
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39950180",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "A separate two-sample MR with pQTL instruments on bipolar disorder; pairs without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1804,
   "end": 1974
  },
  "claim": {
   "protein_as_written": "BMP1",
   "gene": "BMP1",
   "disease_as_written": "BD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2884,
    "end": 3025
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39950870",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "The exposure is hemoglobin level, a multi-subunit protein not encoded by one gene.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 839,
   "end": 984
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39951190",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "One instrument is circulating PDE5A levels, so E2 is met, but the AD and Lewy body results are per lower diastolic pressure (biomarker-weighted) and the vascular dementia finding, the only one across all instruments, is reported as a trend after correction for multiple comparisons, leaving no counting pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 928,
   "end": 1264
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39953202",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins appear only as unnamed mediators; no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1552,
   "end": 1715
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39953207",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR on genetic variation in calcium channel subunit genes; instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 832,
   "end": 1123
  },
  "claim": {
   "protein_as_written": "α1-C",
   "gene": "CACNA1C",
   "disease_as_written": "ADHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 832,
    "end": 1123
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 832,
    "end": 1123
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39953266",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on PsA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 491,
   "end": 618
  },
  "claim": {
   "protein_as_written": "IL23R",
   "gene": "IL23R",
   "disease_as_written": "PsA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 619,
    "end": 848
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39956371",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug targets proxied by eQTLs (eQTLGen, GTEx) and deCODE pQTLs pooled; the PEAR1 result rests on \"genetic expression\" not tied to the circulating protein; full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 533,
   "end": 790
  },
  "claim": {
   "protein_as_written": "platelet endothelial aggregation receptor 1",
   "gene": "PEAR1",
   "disease_as_written": "aSAH",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1799,
    "end": 1953
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1799,
    "end": 1953
   }
  }
 },
 {
  "pmid": "39957148",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposure is a drug class (erythropoiesis-stimulating agents); no protein is named as the MR exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 329,
   "end": 497
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39960916",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR uses plasma and CSF protein summary statistics together; the headline proteins are not tied to the plasma analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 386,
   "end": 650
  },
  "claim": {
   "protein_as_written": "ICAM-1",
   "gene": "ICAM1",
   "disease_as_written": "SLE",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1439,
    "end": 1553
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1554,
    "end": 1653
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39961865",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 4,907 plasma proteins on urticaria risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 712,
   "end": 871
  },
  "claim": {
   "protein_as_written": "GZMB",
   "gene": "GZMB",
   "disease_as_written": "urticaria",
   "direction": "lowers",
   "estimate": {
    "or": 0.76,
    "low": 0.65,
    "high": 0.88,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1607,
    "end": 1871
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39962118",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating SERPING1 level on lung cancer; higher level lowers risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 271,
   "end": 460
  },
  "claim": {
   "protein_as_written": "serpin peptidase inhibitor family G1 (SERPING1)",
   "gene": "SERPING1",
   "disease_as_written": "LC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 271,
    "end": 460
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1491,
    "end": 1632
   }
  }
 },
 {
  "pmid": "39964572",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is Crohn's disease, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 683,
   "end": 853
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39965006",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposure is amlodipine use, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1186,
   "end": 1357
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39969766",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins tested on HNC, but no protein is named with its own effect on HNC; PSMA1 and FAM107B appear only as mediators without their own effect's sign.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1397,
   "end": 1509
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39972214",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR outcomes are cardiometabolic traits, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 964,
   "end": 1180
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39972314",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTLs for 734 plasma proteins on ovarian cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 368,
   "end": 505
  },
  "claim": {
   "protein_as_written": "CLEC11A",
   "gene": "CLEC11A",
   "disease_as_written": "OC",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1148,
    "end": 1599
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39974404",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with deCODE plasma protein instruments on CRC; CHDRL2 named as drug target without a direction, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 428,
   "end": 584
  },
  "claim": {
   "protein_as_written": "CHDRL2",
   "gene": "CHRDL2",
   "disease_as_written": "CRC",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1734,
    "end": 1842
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1310,
    "end": 1465
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 722,
    "end": 841
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1734,
    "end": 1842
   }
  }
 },
 {
  "pmid": "39975574",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of lipid metabolism genes on CVD names no protein-disease pair in the abstract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1284,
   "end": 1346
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39978332",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are whole-blood cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 684,
   "end": 848
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39978659",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Druggable-gene MR with instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 250,
   "end": 399
  },
  "claim": {
   "protein_as_written": "IFN-γ",
   "gene": "IFNG",
   "disease_as_written": "active UC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 858,
    "end": 1038
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 858,
    "end": 1038
   }
  }
 },
 {
  "pmid": "39979134",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides LDL-weighted drug-target MR, protein MR (TSMR and SMR) tested PCSK9 at the protein (translational) level on intracranial aneurysm, so its 'expression' is named as the protein's.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1415,
   "end": 1585
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "IA",
   "direction": "lowers",
   "estimate": {
    "or": 0.896,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1742,
    "end": 1959
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1742,
    "end": 1959
   }
  }
 },
 {
  "pmid": "39979251",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTLs with depression GWAS; MR confirms causal proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 644,
   "end": 818
  },
  "claim": {
   "protein_as_written": "BTN3A3",
   "gene": "BTN3A3",
   "disease_as_written": "depression",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1031,
    "end": 1182
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1031,
    "end": 1182
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39979637",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on PD; the MR finding gives no direction (hazard ratios are observational), so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 817,
   "end": 892
  },
  "claim": {
   "protein_as_written": "ITGAM",
   "gene": "ITGAM",
   "disease_as_written": "PD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 817,
    "end": 892
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39980825",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The SMR pairs are tied to genetically predicted levels of circulating proteins; NFKB1 lowers OU risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 827,
   "end": 917
  },
  "claim": {
   "protein_as_written": "NFKB1",
   "gene": "NFKB1",
   "disease_as_written": "OU",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 918,
    "end": 1062
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 704,
    "end": 826
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1500,
    "end": 1624
   }
  }
 },
 {
  "pmid": "39985383",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "PSRC1's support pools genetic, transcriptomic, and proteomic layers, and the abstract doesn't name its instruments; the full text decides E2.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 613,
   "end": 776
  },
  "claim": {
   "protein_as_written": "PSRC1",
   "gene": "PSRC1",
   "disease_as_written": "CAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 778,
    "end": 1200
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1201,
    "end": 1307
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "39985880",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Lp(a) and apoB are circulating proteins, but the outcomes are calcification severity measures, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1013,
   "end": 1271
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39988236",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Blood eQTL MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 780,
   "end": 919
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39991825",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma protein levels on HCC; seven proteins named with no direction, so the first (ASS1) is an unsigned claim.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1111,
   "end": 1241
  },
  "claim": {
   "protein_as_written": "ASS1",
   "gene": "ASS1",
   "disease_as_written": "HCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1111,
    "end": 1241
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1242,
    "end": 1347
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1603,
    "end": 1796
   }
  }
 },
 {
  "pmid": "39992613",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with UKB-PPP pQTLs on HSV infection; the conclusions name HLA-E without a direction, and the results say higher HLA-E raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 334,
   "end": 526
  },
  "claim": {
   "protein_as_written": "HLA-E",
   "gene": "HLA-E",
   "disease_as_written": "HSV infection",
   "direction": "raises",
   "estimate": {
    "or": 1.39,
    "low": 1.17,
    "high": 1.65,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1076,
    "end": 1370
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "39993089",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on coronary atherosclerosis; the abstract names fibronectin 1 without a direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 677,
   "end": 846
  },
  "claim": {
   "protein_as_written": "fibronectin 1",
   "gene": "FN1",
   "disease_as_written": "coronary AS",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1395,
    "end": 1576
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1395,
    "end": 1576
   }
  }
 },
 {
  "pmid": "39993665",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Multisite chronic pain from UK Biobank is the count of body sites with chronic pain, a quantitative score rather than a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 527,
   "end": 588
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "39994764",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma proteins on prostate cancer; conclusions name SMAD2 first without direction, and results say higher SMAD2 lowers risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 697,
   "end": 1071
  },
  "claim": {
   "protein_as_written": "SMAD2",
   "gene": "SMAD2",
   "disease_as_written": "prostate cancer",
   "direction": "lowers",
   "estimate": {
    "or": 0.71,
    "low": 0.578,
    "high": 0.873,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 697,
    "end": 1071
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1072,
    "end": 1647
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40001646",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL from UKB-PPP, SNHL from FinnGen; four proteins named with no direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 560,
   "end": 776
  },
  "claim": {
   "protein_as_written": "LATS1",
   "gene": "LATS1",
   "disease_as_written": "sensorineural hearing loss",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1306,
    "end": 1489
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1129,
    "end": 1305
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1306,
    "end": 1360
   }
  }
 },
 {
  "pmid": "40001968",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Forward MR of deCODE plasma proteins reports only 64 unnamed loci; named proteins come from reverse MR or PPI analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1084,
   "end": 1176
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40002719",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma protein pQTLs on ankylosing spondylitis; no direction stated (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 273,
   "end": 445
  },
  "claim": {
   "protein_as_written": "Interleukin-6 receptor alpha (IL-6Rα)",
   "gene": "IL6R",
   "disease_as_written": "AS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1138,
    "end": 1380
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1138,
    "end": 1380
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1513,
    "end": 1589
   }
  }
 },
 {
  "pmid": "40008429",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "deCODE plasma pQTL PWAS validated by SMR on PD onset; GPNMB is named for PD onset without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 347,
   "end": 550
  },
  "claim": {
   "protein_as_written": "GPNMB",
   "gene": "GPNMB",
   "disease_as_written": "PD",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1892,
    "end": 1968
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40008515",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR finding is on CT-quantified aortic valve calcification, an imaging measure, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1536,
   "end": 1705
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40008516",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on AAA; conclusions name proteins without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 467,
   "end": 655
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "AAA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1833,
    "end": 2054
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1215,
    "end": 1310
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1833,
    "end": 2054
   }
  }
 },
 {
  "pmid": "40009978",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR, but outcomes are handgrip strength, lean mass, and walking pace, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 554,
   "end": 660
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40013238",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of core plasma proteins on AMI risk; its only MR exposures are proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1231,
   "end": 1475
  },
  "claim": {
   "protein_as_written": "FCN2",
   "gene": "FCN2",
   "disease_as_written": "AMI",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1930,
    "end": 2067
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2225,
    "end": 2387
   }
  }
 },
 {
  "pmid": "40014632",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from kidney function to plasma proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 434,
   "end": 794
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40016789",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are RA and RA drugs targeting NSCLC differentially expressed genes; no circulating protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 990,
   "end": 1154
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40017018",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on obesity, naming AFM, CRP and CFH as causal.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 929,
   "end": 1009
  },
  "claim": {
   "protein_as_written": "AFM",
   "gene": "AFM",
   "disease_as_written": "obesity",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1582,
    "end": 1668
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40023096",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating cytokine levels (proteome/cytokine GWAS) on male reproductive diseases; first directed pair IL-22 with abnormal spermatozoa.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 378,
   "end": 553
  },
  "claim": {
   "protein_as_written": "interleukin-22 (IL-22)",
   "gene": "IL22",
   "disease_as_written": "AS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 952,
    "end": 1156
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40023257",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses cis-eQTL data only.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 392,
   "end": 669
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40023359",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR uses LDL-C predicted by variants near HMGCR, PCSK9 and others.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1306,
   "end": 1479
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40025292",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Brain proteome and transcriptome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 292,
   "end": 428
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40026415",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of deCODE plasma proteins on cardiovascular diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 678,
   "end": 841
  },
  "claim": {
   "protein_as_written": "A4GNT",
   "gene": "A4GNT",
   "disease_as_written": "coronary artery disease",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1461,
    "end": 1623
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40027362",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of 4,719 plasma proteins on myocardial infarction and atrial fibrillation; PLG is protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 480,
   "end": 678
  },
  "claim": {
   "protein_as_written": "plasminogen (PLG)",
   "gene": "PLG",
   "disease_as_written": "MI",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 480,
    "end": 678
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1083,
    "end": 1305
   }
  }
 },
 {
  "pmid": "40028697",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted circulating levels of 734 plasma proteins on pre-eclampsia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 861,
   "end": 991
  },
  "claim": {
   "protein_as_written": "CRELD1",
   "gene": "CRELD1",
   "disease_as_written": "PE",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 992,
    "end": 1392
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40031975",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on ccRCC; conclusions name TP53 without a direction, results give OR 3.325.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 718,
   "end": 996
  },
  "claim": {
   "protein_as_written": "TP53",
   "gene": "TP53",
   "disease_as_written": "ccRCC",
   "direction": "raises",
   "estimate": {
    "or": 3.325,
    "low": 1.805,
    "high": 6.124,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 718,
    "end": 996
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1572,
    "end": 1739
   }
  }
 },
 {
  "pmid": "40033250",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteome MR with deCODE pQTLs on ALS; conclusions name no proteins, results give C1QC first with a positive direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 868,
   "end": 1021
  },
  "claim": {
   "protein_as_written": "C1QC",
   "gene": "C1QC",
   "disease_as_written": "ALS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1592,
    "end": 1837
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40034783",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Targets rest on genetically predicted gene expression; no circulating protein level is instrumented.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 650,
   "end": 877
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40037332",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-MR of plasma protein abundance (UK Biobank, deCODE) on neurodegenerative diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 452,
   "end": 689
  },
  "claim": {
   "protein_as_written": "C1S",
   "gene": "C1S",
   "disease_as_written": "Alzheimer's disease",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1904,
    "end": 2449
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1063,
    "end": 1267
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40038097",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR pools eQTL and pQTL data; targets not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 349,
   "end": 658
  },
  "claim": {
   "protein_as_written": "CDKN1A",
   "gene": "CDKN1A",
   "disease_as_written": "breast cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 925,
    "end": 1090
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 925,
    "end": 1090
   }
  }
 },
 {
  "pmid": "40038197",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposure is 'C5orf24 levels' with instruments not named and not stated to be circulating; could be expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 887,
   "end": 1050
  },
  "claim": {
   "protein_as_written": "C5orf24",
   "gene": "C5orf24",
   "disease_as_written": "stroke",
   "direction": "lowers",
   "estimate": {
    "or": 0.68,
    "low": 0.48,
    "high": 0.98,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 887,
    "end": 1050
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1620,
    "end": 1701
   }
  }
 },
 {
  "pmid": "40041284",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein instruments analysed for causal effects on osteoporosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 628,
   "end": 897
  },
  "claim": {
   "protein_as_written": "ANKED46",
   "gene": "ANKRD46",
   "disease_as_written": "osteoporosis",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1373,
    "end": 1721
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40042804",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on inflammatory skin diseases; pairs named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 532,
   "end": 670
  },
  "claim": {
   "protein_as_written": "RARRES2",
   "gene": "RARRES2",
   "disease_as_written": "atopic dermatitis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1083,
    "end": 1238
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1083,
    "end": 1238
   }
  }
 },
 {
  "pmid": "40044659",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are birth weight and cortical structural phenotypes, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1352,
   "end": 1520
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40045304",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with blood protein-abundance pQTLs, run apart from the eQTL arm, gives MAPK3 protein's protective effect on rheumatoid arthritis; the other findings are methylation and expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 467,
   "end": 629
  },
  "claim": {
   "protein_as_written": "MAPK3",
   "gene": "MAPK3",
   "disease_as_written": "RA",
   "direction": "lowers",
   "estimate": {
    "or": 0.89,
    "low": 0.84,
    "high": 0.94,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2205,
    "end": 2335
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40046022",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTLs of UKB-PPP circulating proteins on PAH; conclusion states higher circulating S100A3 lowers PAH risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1113,
   "end": 1333
  },
  "claim": {
   "protein_as_written": "S100A3",
   "gene": "S100A3",
   "disease_as_written": "PAH",
   "direction": "lowers",
   "estimate": {
    "or": 0.073,
    "low": 0.02,
    "high": 0.267,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2266,
    "end": 2420
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.999,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1946,
    "end": 2062
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40046334",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR and MR of 'genes'; the abstract doesn't name their instruments (the RNA-seq it names validates expression in tissue).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 410,
   "end": 582
  },
  "claim": {
   "protein_as_written": "XBP1",
   "gene": "XBP1",
   "disease_as_written": "meningioma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 583,
    "end": 836
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 410,
    "end": 582
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40048323",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is chronic pain at a body site (head, neck or shoulder, back, abdomen, hip, knee) in UK Biobank participants, a symptom rather than a diagnosed condition.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 229,
   "end": 496
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40049431",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL-MR, of unnamed tissue, is one of several pooled methods; the candidate genes come from all of them together and single-cell analysis, and no protein-disease pair is attributed to the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1231,
   "end": 1382
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40050982",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTLs for 1,916 plasma proteins on Alzheimer's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 451,
   "end": 777
  },
  "claim": {
   "protein_as_written": "GRN",
   "gene": "GRN",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1359,
    "end": 1450
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40052268",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "LPL-pathway targets are proxied by triglyceride-lowering variants in their genes, weighted by a biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 735,
   "end": 1156
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40052612",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 4,907 plasma proteins on gastric cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 877,
   "end": 992
  },
  "claim": {
   "protein_as_written": "DNAJB9",
   "gene": "DNAJB9",
   "disease_as_written": "GC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 993,
    "end": 1248
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40052860",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The MR pools pQTL sources (deCODE, ARIC, UKB) with eQTLGen expression QTLs, and the abstract doesn't tie the SVEP1 pair to the circulating protein's instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 361,
   "end": 591
  },
  "claim": {
   "protein_as_written": "SVEP1",
   "gene": "SVEP1",
   "disease_as_written": "exfoliation glaucoma",
   "direction": "raises",
   "estimate": {
    "or": 1.2,
    "low": 1.1,
    "high": 1.31,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 971,
    "end": 1193
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40059241",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 734 plasma proteins (cis-pQTLs) on esophageal cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 429,
   "end": 629
  },
  "claim": {
   "protein_as_written": "HPSE",
   "gene": "HPSE",
   "disease_as_written": "EC",
   "direction": "lowers",
   "estimate": {
    "or": 0.8,
    "low": 0.7,
    "high": 0.92,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1185,
    "end": 1340
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.637,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1534,
    "end": 1668
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40060891",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (proteome-wide) on pancreatic cancer risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 356,
   "end": 505
  },
  "claim": {
   "protein_as_written": "FN1",
   "gene": "FN1",
   "disease_as_written": "PC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1043,
    "end": 1179
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 506,
    "end": 675
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 969,
    "end": 1042
   }
  }
 },
 {
  "pmid": "40061319",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins associated with AAA are not named; named proteins are mediators of smoking's effect without their own effect stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1881,
   "end": 2060
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40062439",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "A protein-level SMR analysis, reported separately from methylation and expression, pairs proteins with psoriatic arthritis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1529,
   "end": 1629
  },
  "claim": {
   "protein_as_written": "GCKR",
   "gene": "GCKR",
   "disease_as_written": "PsA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1886,
    "end": 2092
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 912,
    "end": 1044
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40063313",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "TWAS and SMR of gene expression; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 663,
   "end": 815
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40064973",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of proteins on pelvic organ prolapse; conclusions give no direction, results say EFEMP1 protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 443,
   "end": 673
  },
  "claim": {
   "protein_as_written": "EFEMP1",
   "gene": "EFEMP1",
   "disease_as_written": "POP",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 443,
    "end": 673
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 443,
    "end": 673
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 443,
    "end": 673
   }
  }
 },
 {
  "pmid": "40068040",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug targets proxied by SNPs near genes and eQTLs; outcomes are cytokine levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 314,
   "end": 433
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40070583",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory proteins on infertility.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 375,
   "end": 567
  },
  "claim": {
   "protein_as_written": "C-X-C motif chemokine 6 (CXCL6)",
   "gene": "CXCL6",
   "disease_as_written": "male infertility",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 791,
    "end": 977
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 791,
    "end": 977
   }
  }
 },
 {
  "pmid": "40072421",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract reports counts of associations and protein classes but names no specific protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1827,
   "end": 1951
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40073132",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is brain age gap, an imaging measure, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 106,
   "end": 230
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40074652",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR estimates for LIMK2 are on CSF biomarkers and hippocampal size, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1903,
   "end": 2133
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40075078",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted circulating biomarkers including interleukin-23 receptor on sarcoidosis; association without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 993,
   "end": 1147
  },
  "claim": {
   "protein_as_written": "interleukin-23 receptor",
   "gene": "IL23R",
   "disease_as_written": "sarcoidosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 993,
    "end": 1147
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40077914",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses blood eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1051,
   "end": 1181
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40078362",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is genetically proxied inhibition of ibrutinib targets, instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 424,
   "end": 736
  },
  "claim": {
   "protein_as_written": "CSK",
   "gene": "CSK",
   "disease_as_written": "conduction blocks",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1737,
    "end": 1929
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 424,
    "end": 736
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40082904",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target genes' variants are weighted by LDL cholesterol, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 911,
   "end": 1081
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40087334",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on glaucoma and its subtypes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1714,
   "end": 1839
  },
  "claim": {
   "protein_as_written": "CD5",
   "gene": "CD5",
   "disease_as_written": "POAG",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1714,
    "end": 1839
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1840,
    "end": 1912
   }
  }
 },
 {
  "pmid": "40087642",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The abstract reports causal protein-CHD associations without naming MR or its instruments, so the full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 623,
   "end": 747
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "CHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 623,
    "end": 747
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40091050",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR rests on plasma eQTL (gene expression) via TWAS, not pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 384,
   "end": 740
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40092126",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments for the druggable genes came from eQTLGen (gene expression), though the result is restated as plasma levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 317,
   "end": 451
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40092369",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR findings are reverse direction (proteins as markers, not causes); no forward protein-disease MR pair stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2682,
   "end": 2864
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40093223",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is coronary artery calcium, an imaging measure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 537,
   "end": 955
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40095250",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "HMGCR inhibition is genetically modelled from gene variants taken from a lipid consortium; the abstract doesn't name a weighting biomarker or the instruments as protein-level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1443,
   "end": 1682
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "breast cancer",
   "direction": "raises",
   "estimate": {
    "or": 0.833,
    "low": 0.752,
    "high": 0.923,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2342,
    "end": 2613
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2342,
    "end": 2613
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40102747",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on gastric cancer; the only named protein, PPCDC, is given no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1746,
   "end": 1921
  },
  "claim": {
   "protein_as_written": "PPCDC",
   "gene": "PPCDC",
   "disease_as_written": "GC",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1922,
    "end": 2117
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1922,
    "end": 2117
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1922,
    "end": 2117
   }
  }
 },
 {
  "pmid": "40102900",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of PCSK9 inhibition without naming its instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1127,
   "end": 1250
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "PCa",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1673,
    "end": 1727
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1127,
    "end": 1250
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40107973",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma pQTLs (deCODE, UKB-PPP) on LUAD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 607,
   "end": 898
  },
  "claim": {
   "protein_as_written": "BCHE",
   "gene": "BCHE",
   "disease_as_written": "LUAD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1412,
    "end": 1560
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1890,
    "end": 2035
   }
  }
 },
 {
  "pmid": "40108295",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with plasma pQTLs (deCODE, UKB) on MS; proteins named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 745,
   "end": 898
  },
  "claim": {
   "protein_as_written": "EVI5",
   "gene": "EVI5",
   "disease_as_written": "MS",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2907,
    "end": 2990
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.98,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 2720,
    "end": 2906
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2907,
    "end": 2990
   }
  }
 },
 {
  "pmid": "40108736",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of GSTO1 'levels' in a gene-expression study; the abstract doesn't say whether these are circulating protein levels or expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1150,
   "end": 1280
  },
  "claim": {
   "protein_as_written": "GSTO1",
   "gene": "GSTO1",
   "disease_as_written": "sepsis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1686,
    "end": 1852
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40109242",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 427,
   "end": 524
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40114078",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma pQTLs on cluster headache.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 624,
   "end": 767
  },
  "claim": {
   "protein_as_written": "PXDNL",
   "gene": "PXDNL",
   "disease_as_written": "CH",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1155,
    "end": 1344
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1155,
    "end": 1344
   }
  }
 },
 {
  "pmid": "40116326",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTL genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 926,
   "end": 996
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40118817",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma protein cis-pQTLs on IBD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 493,
   "end": 769
  },
  "claim": {
   "protein_as_written": "IL12B",
   "gene": "IL12B",
   "disease_as_written": "IBD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1002,
    "end": 1174
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1002,
    "end": 1174
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40119457",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of metformin targets; outcome also sarcopenia traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 541,
   "end": 923
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40124114",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR on GBM gives RPN1 (plasma) decreased risk; conclusions name RPN1 without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 508,
   "end": 717
  },
  "claim": {
   "protein_as_written": "RPN1",
   "gene": "RPN1",
   "disease_as_written": "GBM",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1057,
    "end": 1166
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.1035,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1251,
    "end": 1353
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1650,
    "end": 1716
   }
  }
 },
 {
  "pmid": "40125968",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcomes are kidney function traits (eGFR, urinary albumin, serum creatinine), not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 588,
   "end": 767
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40128146",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target genetic tools not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 679,
   "end": 896
  },
  "claim": {
   "protein_as_written": "TNF",
   "gene": "TNF",
   "disease_as_written": "sinusitis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1294,
    "end": 1397
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1294,
    "end": 1397
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1410,
    "end": 1633
   }
  }
 },
 {
  "pmid": "40128726",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract names no protein-disease pair, only counts of genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1508,
   "end": 1605
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40129067",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The only MR result the abstract states, RCC2 with BCC, rests on methylation QTLs (CpG sites), and no circulating protein level is named as an exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1155,
   "end": 1280
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40131661",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are tested for ovarian cancer but no protein is named in a pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 716,
   "end": 884
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40135285",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating inflammatory proteins are tested against autoimmune diseases, but no named protein is paired with a named disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1554,
   "end": 1641
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40136421",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma-protein MR on lung function indices, plus a mediation analysis of proteins' effects on COPD and asthma that names no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1649,
   "end": 1761
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40148470",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR on immune-related bone diseases; the conclusions name HDGF first for RA without direction, and the results give its OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 885,
   "end": 1123
  },
  "claim": {
   "protein_as_written": "HDGF",
   "gene": "HDGF",
   "disease_as_written": "RA",
   "direction": "raises",
   "estimate": {
    "or": 1.0373,
    "low": 1.0028,
    "high": 1.073,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2891,
    "end": 3764
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.8426,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 3765,
    "end": 4240
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40148878",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Pooled MR of druggable proteins and gene expression; the prioritized targets mix proteins and genes without saying which analysis gave each.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 368,
   "end": 500
  },
  "claim": {
   "protein_as_written": "NCF1",
   "gene": "NCF1",
   "disease_as_written": "AKI",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1110,
    "end": 1370
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1614,
    "end": 1754
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40149558",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are gene expression (eQTLGen cis-eQTL) and DNA methylation QTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 336,
   "end": 609
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40149599",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating SHBG level (deCODE proteomics) on ALS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 424,
   "end": 704
  },
  "claim": {
   "protein_as_written": "SHBG",
   "gene": "SHBG",
   "disease_as_written": "ALS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1036,
    "end": 1128
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40149725",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The MR pools eQTL, mQTL and pQTL of mitochondrial genes, and the pair is not tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 563,
   "end": 854
  },
  "claim": {
   "protein_as_written": "ACSF3",
   "gene": "ACSF3",
   "disease_as_written": "TB",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 949,
    "end": 1089
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40155631",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are druggable genes instrumented by cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 424,
   "end": 582
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40155688",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The 12 plasma proteins associated with ALS are not named; no protein-disease pair is stated (SHBG is named as an exposure but no result for it is given).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 975,
   "end": 1077
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40156905",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR on key genes whose instruments the abstract doesn't name (could be eQTLs); the pair ITGA2B-PH is stated without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1569,
   "end": 1683
  },
  "claim": {
   "protein_as_written": "ITGA2B",
   "gene": "ITGA2B",
   "disease_as_written": "PH",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1569,
    "end": 1683
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1398,
    "end": 1486
   }
  }
 },
 {
  "pmid": "40159335",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Bibliometric analysis; no protein MR estimate.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 517,
   "end": 711
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40161303",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-MR with APOC3 gene-region variants associated with plasma APOC3 levels, outcome CAD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 383,
   "end": 571
  },
  "claim": {
   "protein_as_written": "APOC3",
   "gene": "APOC3",
   "disease_as_written": "CAD",
   "direction": "raises",
   "estimate": {
    "frame": "per lower protein",
    "high": 0.92,
    "low": 0.75,
    "unit": "not stated",
    "or": 0.83
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1757,
    "end": 1854
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 155,
    "end": 234
   }
  }
 },
 {
  "pmid": "40161480",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on autoimmune liver diseases; conclusions name no protein, so the first results pair with a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 511,
   "end": 823
  },
  "claim": {
   "protein_as_written": "CDCP1",
   "gene": "CDCP1",
   "disease_as_written": "autoimmune hepatitis (AIH)",
   "direction": "raises",
   "estimate": {
    "or": 1.363,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 881,
    "end": 1042
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40164335",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are lipid traits (HDL-TG) and drug targets acting on HDL-TG, not a circulating protein on disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1119,
   "end": 1371
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40167410",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on CKD names no protein except ENPP5 as a mediator, without its own effect on CKD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1367,
   "end": 1468
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40180044",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pools methylation, expression, and protein QTLs; the headline 'level of RMDN1' is not tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 263,
   "end": 506
  },
  "claim": {
   "protein_as_written": "RMDN1",
   "gene": "RMDN1",
   "disease_as_written": "ADHD",
   "direction": "lowers",
   "estimate": {
    "or": 0.88,
    "low": 0.83,
    "high": 0.94,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1323,
    "end": 1490
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40181221",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are protein ratios.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 348,
   "end": 500
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40181376",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma cytokine levels (deCODE, Fenland) on PCOS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1921,
   "end": 2068
  },
  "claim": {
   "protein_as_written": "IL6R",
   "gene": "IL6R",
   "disease_as_written": "PCOS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2069,
    "end": 2211
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40184136",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on heart failure subtypes; no protein named in the closing sentences, so the first results pair with a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 128
  },
  "claim": {
   "protein_as_written": "natural killer cell receptor 2B4",
   "gene": "CD244",
   "disease_as_written": "ICM",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 808,
    "end": 1778
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40186323",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on Alzheimer's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 537,
   "end": 680
  },
  "claim": {
   "protein_as_written": "GSTP1",
   "gene": "GSTP1",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1015,
    "end": 1217
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1218,
    "end": 1345
   }
  }
 },
 {
  "pmid": "40187354",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted UKB-PPP plasma protein levels on asthma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 604,
   "end": 835
  },
  "claim": {
   "protein_as_written": "GCHFR",
   "gene": "GCHFR",
   "disease_as_written": "asthma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 604,
    "end": 835
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40188416",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically proxied circulating coagulation protein levels (deCODE, UK Biobank) on ischemic stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 363,
   "end": 638
  },
  "claim": {
   "protein_as_written": "factor XI",
   "gene": "F11",
   "disease_as_written": "cardioembolic stroke",
   "direction": "raises",
   "estimate": {
    "or": 1.31,
    "low": 1.19,
    "high": 1.44,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1173,
    "end": 1842
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1173,
    "end": 1842
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40190471",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma inflammatory protein levels (pQTLs) on basal cell carcinoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 485,
   "end": 717
  },
  "claim": {
   "protein_as_written": "CCL4",
   "gene": "CCL4",
   "disease_as_written": "BCC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1103,
    "end": 1266
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1712,
    "end": 1848
   }
  }
 },
 {
  "pmid": "40191191",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is MI; gene analyses use eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 660,
   "end": 789
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40193678",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 4907 plasma proteins on childhood asthma; conclusions give ITIH4 raising risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 485,
   "end": 615
  },
  "claim": {
   "protein_as_written": "ITIH4",
   "gene": "ITIH4",
   "disease_as_written": "childhood asthma",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1527,
    "end": 1759
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40199857",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are immune cell traits, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 286,
   "end": 708
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40204939",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen, not protein QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 215,
   "end": 524
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40210889",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma proteins on MAPK-activated colorectal cancer; MICB stated as raising risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 569,
   "end": 760
  },
  "claim": {
   "protein_as_written": "MHC class I polypeptide-related sequence B (MICB)",
   "gene": "MICB",
   "disease_as_written": "MAPK-activated CRCs",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 761,
    "end": 967
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40211130",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-MR with deCODE plasma protein data on glioblastoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 546,
   "end": 689
  },
  "claim": {
   "protein_as_written": "GPX7",
   "gene": "GPX7",
   "disease_as_written": "GBM",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 965,
    "end": 1105
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 965,
    "end": 1105
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 965,
    "end": 1105
   }
  }
 },
 {
  "pmid": "40211681",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Serum protein MR, but outcomes are longevity measures, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 431,
   "end": 803
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40212190",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40214710",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Targets come from eQTL MR in peripheral and central tissues, with pQTL SMR as validation; the pairs are not tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 604,
   "end": 785
  },
  "claim": {
   "protein_as_written": "VAMP8",
   "gene": "VAMP8",
   "disease_as_written": "CA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1588,
    "end": 1866
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1588,
    "end": 1866
   }
  }
 },
 {
  "pmid": "40221021",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR outcome is insulin sensitivity, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 984,
   "end": 1202
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40221544",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses blood eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 268,
   "end": 421
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40222168",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is used to find 'risk genes' with unnamed instruments, and the abstract names no protein paired with IBS-D from MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1832,
   "end": 1972
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40225015",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "HMGCR, PCSK9 and NPC1L1 drug targets proxied by LDL-C-weighted variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 883,
   "end": 1094
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40225784",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (FGF21, HAVCR1) on type 2 diabetes risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1046,
   "end": 1224
  },
  "claim": {
   "protein_as_written": "FGF21",
   "gene": "FGF21",
   "disease_as_written": "type 2 diabetes",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1046,
    "end": 1224
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40226474",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide pQTL MR of plasma proteins on bladder cancer; GSTM4 OR 0.81.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 640,
   "end": 761
  },
  "claim": {
   "protein_as_written": "GSTM4",
   "gene": "GSTM4",
   "disease_as_written": "BCa",
   "direction": "lowers",
   "estimate": {
    "or": 0.81,
    "low": 0.74,
    "high": 0.89,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 640,
    "end": 761
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.89,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 640,
    "end": 761
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 640,
    "end": 761
   }
  }
 },
 {
  "pmid": "40229234",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma ST2 protein on asthma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 954,
   "end": 1107
  },
  "claim": {
   "protein_as_written": "ST2 (also known as IL1RL1)",
   "gene": "IL1RL1",
   "disease_as_written": "asthma",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 954,
    "end": 1107
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40229327",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Pools gene and protein QTL analyses, and the protein QTLs' tissue isn't named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 267,
   "end": 397
  },
  "claim": {
   "protein_as_written": "EGFL9 [DLK2]",
   "gene": "DLK2",
   "disease_as_written": "GC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 489,
    "end": 706
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 707,
    "end": 818
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40229388",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "HMGCR inhibition instrumented by eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 525,
   "end": 703
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40229705",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 66 mitochondrial plasma proteins (Human Plasma Proteome Atlas) on congenital defects; conclusions name none, first result with direction is PDK1 inverse with heart malformation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1112,
   "end": 1263
  },
  "claim": {
   "protein_as_written": "pyruvate dehydrogenase kinase isozyme 1",
   "gene": "PDK1",
   "disease_as_written": "congenital heart malformation",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1603,
    "end": 1774
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40231531",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammation-related proteins on sepsis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 349,
   "end": 518
  },
  "claim": {
   "protein_as_written": "fractalkine",
   "gene": "CX3CL1",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": {
    "or": 2.383,
    "low": 1.38,
    "high": 4.113,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 956,
    "end": 1143
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1249,
    "end": 1403
   }
  }
 },
 {
  "pmid": "40240578",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Main MR exposures are pain phenotypes; SLIT39A8 drug-target MR names the gene only as a mediator with no own effect stated, so no protein-disease pair is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1596,
   "end": 1750
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40240670",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with deCODE plasma pQTLs on intrahepatic cholangiocarcinoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 380,
   "end": 536
  },
  "claim": {
   "protein_as_written": "STX12",
   "gene": "STX12",
   "disease_as_written": "ICC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 905,
    "end": 1026
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40243942",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "UHRF1 MR exposure is a gene whose instruments the abstract does not name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 540,
   "end": 771
  },
  "claim": {
   "protein_as_written": "UHRF1",
   "gene": "UHRF1",
   "disease_as_written": "MAFLD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 540,
    "end": 771
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 540,
    "end": 771
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1346,
    "end": 1525
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40245661",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating inflammatory proteins are tested on MS, but the abstract names no protein, so it states no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1345,
   "end": 1426
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40247738",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Protein exposures are brain proteomes, not circulating.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 916,
   "end": 1021
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40249358",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40252200",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on HCC names no protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 818,
   "end": 881
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40257326",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The exposure is 'genetic variants in' the target genes; instruments are not named as protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 547,
   "end": 629
  },
  "claim": {
   "protein_as_written": "GSK3B",
   "gene": "GSK3B",
   "disease_as_written": "MS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 547,
    "end": 629
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40263141",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with plasma proteins as exposures on SQCLC; SSR1's causal association with SQCLC is named without its own direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1172,
   "end": 1262
  },
  "claim": {
   "protein_as_written": "SSR1",
   "gene": "SSR1",
   "disease_as_written": "SQCLC",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1660,
    "end": 1802
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40263317",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTLs of circulating proteins used in MR on type 1 diabetes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 681,
   "end": 903
  },
  "claim": {
   "protein_as_written": "CTRB1",
   "gene": "CTRB1",
   "disease_as_written": "Type 1 diabetes",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 681,
    "end": 903
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 681,
    "end": 903
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40263428",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "SGLT2 inhibition is proxied by gene expression and HbA1c-weighted variants, not circulating protein pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 304,
   "end": 484
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40266545",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating (plasma) protein levels on dementia types; conclusions name C1R without direction, results give it raising AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1033,
   "end": 1424
  },
  "claim": {
   "protein_as_written": "C1R",
   "gene": "C1R",
   "disease_as_written": "Alzheimer's disease (AD)",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1033,
    "end": 1424
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40267292",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "eQTLGen expression MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 645,
   "end": 802
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40269081",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omic SMR including pQTLs, with the ENG protein named, apart from the genes and CpG sites, as a risk factor for endometriosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1117,
   "end": 1201
  },
  "claim": {
   "protein_as_written": "ENG",
   "gene": "ENG",
   "disease_as_written": "endometriosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1117,
    "end": 1201
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 599,
    "end": 669
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40274105",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is said to identify 'a few proteins' as causal, none named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1189,
   "end": 1266
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40280189",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR pools eQTL, mQTL and pQTL from blood and brain, and the pair isn't tied to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 418,
   "end": 682
  },
  "claim": {
   "protein_as_written": "BACH2",
   "gene": "BACH2",
   "disease_as_written": "MS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1059,
    "end": 1279
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 798,
    "end": 885
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40281223",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Abstract (pooling protein and gene expression across blood and brain) names biomarkers and conditions but states no specific protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 857,
   "end": 939
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40282409",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "ABCG2 drug-target MR proxied by urate, a downstream biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 802,
   "end": 1019
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40283935",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR based on plasma proteomics identified GBS susceptibility proteins; TNF is negatively and PDCD1LG2 positively associated with GBS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 783,
   "end": 1020
  },
  "claim": {
   "protein_as_written": "TNF",
   "gene": "TNF",
   "disease_as_written": "GBS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1536,
    "end": 1638
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40285860",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on PDAC; KRT5 and VCAN are the MR-identified biomarkers validated afterwards, and the seven MR proteins all raise risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 520,
   "end": 645
  },
  "claim": {
   "protein_as_written": "KRT5",
   "gene": "KRT5",
   "disease_as_written": "PDAC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 930,
    "end": 1044
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40285955",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTLs were used, but the abstract states only methylation and expression pairs with MS, no protein-MS pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 859,
   "end": 1028
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40286918",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The SMR includes a pQTL analysis, so E2 isn't plainly failed, but its one pQTL association is unnamed and the named genes come from methylation and expression SMR, so the abstract states no protein-disease pair from protein MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1033,
   "end": 1138
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40287056",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with plasma pQTLs on MASLD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 481,
   "end": 724
  },
  "claim": {
   "protein_as_written": "IL-6",
   "gene": "IL6",
   "disease_as_written": "MASLD",
   "direction": "raises",
   "estimate": {
    "or": 2.02,
    "low": 1.54,
    "high": 2.64,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1451,
    "end": 1736
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1289,
    "end": 1450
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1737,
    "end": 1798
   }
  }
 },
 {
  "pmid": "40287427",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are BMI and type 2 diabetes, outcome proteomic age acceleration; no protein is an exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1144,
   "end": 1270
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40287778",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins named only as mediators, without their own effects on DR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 806,
   "end": 994
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40289090",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets' variants weighted by lipid phenotypes (lipid-lowering drug-target MR).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 302,
   "end": 615
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40289841",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are metformin use and eQTL-based SMR of genes; no circulating protein level is instrumented.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 292,
   "end": 452
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40292753",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A review of biobank genetics; it estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1114,
   "end": 1187
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40294019",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma (and CSF) protein levels on NMOSD, a disease, with stated pairs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 998,
   "end": 1084
  },
  "claim": {
   "protein_as_written": "CLEC11A",
   "gene": "CLEC11A",
   "disease_as_written": "NMOSD",
   "direction": "raises",
   "estimate": {
    "unit": "not stated",
    "frame": "per higher protein",
    "low": 1.29,
    "high": 4.04,
    "or": 13.45
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2287,
    "end": 2482
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1899,
    "end": 2012
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40294794",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on intracranial aneurysm.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 551,
   "end": 709
  },
  "claim": {
   "protein_as_written": "BTD",
   "gene": "BTD",
   "disease_as_written": "IA",
   "direction": "lowers",
   "estimate": {
    "or": 0.6489,
    "low": 0.552,
    "high": 0.7628,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2172,
    "end": 2281
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2172,
    "end": 2281
   }
  }
 },
 {
  "pmid": "40295454",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins associated with lung cancer are counted but none is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1391,
   "end": 1585
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40296043",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "GLP-1RA exposure is proxied by HbA1c-weighted variants in target genes and by eQTLs, never protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 764,
   "end": 1037
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40296064",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target instruments weighted by HbA1c or taken from gene expression, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 756,
   "end": 849
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40297438",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are circulating metabolites; the drug-target cis-MR acts through BCAA levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 900,
   "end": 1046
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40299486",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of druggable genes on MM with instruments not named (supported by TWAS and expression colocalisation); ORM1 named without MR direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 411,
   "end": 520
  },
  "claim": {
   "protein_as_written": "Orosomucoid 1 (ORM1)",
   "gene": "ORM1",
   "disease_as_written": "MM",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1446,
    "end": 1531
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 948,
    "end": 1159
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1446,
    "end": 1531
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40299563",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR of blood proteins on diabetic kidney disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 629,
   "end": 845
  },
  "claim": {
   "protein_as_written": "UMOD",
   "gene": "UMOD",
   "disease_as_written": "DKD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1156,
    "end": 1317
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1318,
    "end": 1397
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1480,
    "end": 1664
   }
  }
 },
 {
  "pmid": "40299566",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma and inflammatory proteins on Bell's palsy; BLVRB is the first protein named after validation, with no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 608,
   "end": 775
  },
  "claim": {
   "protein_as_written": "BLVRB",
   "gene": "BLVRB",
   "disease_as_written": "Bell's palsy",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1359,
    "end": 1490
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 776,
    "end": 890
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40301247",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The two-sample MR uses 'genetic proxies for antidiabetic drug targets' whose instruments the abstract doesn't name, beside an mRNA SMR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 390,
   "end": 700
  },
  "claim": {
   "protein_as_written": "KCNJ11",
   "gene": "KCNJ11",
   "disease_as_written": "stroke",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 819,
    "end": 986
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 819,
    "end": 986
   }
  }
 },
 {
  "pmid": "40301928",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Blood eQTL MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 450,
   "end": 725
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40303168",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis- or pan-pQTLs as instruments for plasma proteins on COVID-19 stages.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 784,
   "end": 892
  },
  "claim": {
   "protein_as_written": "BGAT",
   "gene": "ABO",
   "disease_as_written": "COVID-19",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1173,
    "end": 1328
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40304040",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR of plasma proteins on ischemic stroke; conclusions name no protein, results give FGF5 first with a positive association.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1029,
   "end": 1711
  },
  "claim": {
   "protein_as_written": "FGF5 [fibroblast growth factor 5]",
   "gene": "FGF5",
   "disease_as_written": "IS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1029,
    "end": 1711
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1712,
    "end": 1887
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40304996",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 499,
   "end": 640
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40307879",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 'identified proteins levels' (proteins found in carotid plaques) on ischemic stroke; the abstract does not say the levels are circulating or name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1043,
   "end": 1191
  },
  "claim": {
   "protein_as_written": "IL6R",
   "gene": "IL6R",
   "disease_as_written": "ischemic stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1758,
    "end": 1854
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40311696",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "A separate pQTL-based MR validation gives NMB protein's effect on mitral valve prolapse; no non-circulating tissue is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2040,
   "end": 2139
  },
  "claim": {
   "protein_as_written": "NMB",
   "gene": "NMB",
   "disease_as_written": "MVP",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2040,
    "end": 2139
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40312834",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target instruments (NPC1L1, PPARA) come from lipid-trait GWAS variants, i.e. weighted by lipids.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 327,
   "end": 454
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40313062",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The EGFR-AD pair comes from analyses pooling eQTL, mQTL, and pQTL in blood and brain, not tied to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 686,
   "end": 819
  },
  "claim": {
   "protein_as_written": "EGFR",
   "gene": "EGFR",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1137,
    "end": 1399
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40314374",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on abdominal aortic aneurysm.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 444,
   "end": 634
  },
  "claim": {
   "protein_as_written": "CALB2",
   "gene": "CALB2",
   "disease_as_written": "AAA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1722,
    "end": 1891
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 140
   }
  }
 },
 {
  "pmid": "40314641",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating mTORC1-downstream proteins (INTERVAL) on diabetic retinopathy (FinnGen).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 493,
   "end": 654
  },
  "claim": {
   "protein_as_written": "eIF4E",
   "gene": "EIF4E",
   "disease_as_written": "DR",
   "direction": "raises",
   "estimate": {
    "or": 1.057,
    "low": 1.008,
    "high": 1.109,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1180,
    "end": 1345
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1180,
    "end": 1345
   }
  }
 },
 {
  "pmid": "40315629",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "CETP is weighted by HDL-C (biomarker-weighted), but APOA4, a circulating protein, is instrumented from 'GWAS and eQTL' data, pooled kinds not tied to its circulating level and framed as 'activation'.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 666,
   "end": 755
  },
  "claim": {
   "protein_as_written": "APOA4",
   "gene": "APOA4",
   "disease_as_written": "SLE",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1387,
    "end": 1471
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40316856",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on bladder cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 460,
   "end": 741
  },
  "claim": {
   "protein_as_written": "ANKRD27",
   "gene": "ANKRD27",
   "disease_as_written": "BC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 742,
    "end": 1022
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 460,
    "end": 741
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40320164",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by cis variants linked to HbA1c or BMI.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 438,
   "end": 659
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40320523",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR uses eQTLGen expression data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 923,
   "end": 1170
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40325173",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR instruments come from the eQTLGen Consortium (gene expression).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 617,
   "end": 704
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40327005",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE and UKB pQTLs on AMD; conclusions name WARS1 without direction, results give it a higher risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 428,
   "end": 542
  },
  "claim": {
   "protein_as_written": "cytoplasmic tryptophanyl-tRNA synthetase 1 (WARS1)",
   "gene": "WARS1",
   "disease_as_written": "AMD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 672,
    "end": 820
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40327989",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory proteins (n = 14,824) on myopia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 403,
   "end": 634
  },
  "claim": {
   "protein_as_written": "CXCL9",
   "gene": "CXCL9",
   "disease_as_written": "myopia",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 919,
    "end": 1157
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40328427",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins whose outcome is aging phenotypes, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1484,
   "end": 1688
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40329273",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from ADHD to OSA; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1495,
   "end": 1689
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40330585",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR and SMR use eQTL instruments for drug target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 725,
   "end": 928
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40332106",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR outcome is an rs-fMRI phenotype (pheno12), an imaging measure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 859,
   "end": 1033
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40332653",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR is between circulating inflammatory factors and CD13 levels, a biomarker, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 728,
   "end": 889
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40334965",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on psychiatric disorders; BTN2A1 with MDD named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 388,
   "end": 649
  },
  "claim": {
   "protein_as_written": "BTN2A1",
   "gene": "BTN2A1",
   "disease_as_written": "major depressive disorder",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1160,
    "end": 1524
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40338406",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteomic MR with deCODE and UKB-PPP pQTLs on PTC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 435,
   "end": 605
  },
  "claim": {
   "protein_as_written": "LY75",
   "gene": "LY75",
   "disease_as_written": "PTC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 870,
    "end": 980
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 870,
    "end": 980
   }
  }
 },
 {
  "pmid": "40342965",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on type 1 diabetes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 952,
   "end": 1150
  },
  "claim": {
   "protein_as_written": "RBP2",
   "gene": "RBP2",
   "disease_as_written": "type 1 diabetes",
   "direction": "lowers",
   "estimate": {
    "or": 0.05,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1151,
    "end": 1247
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40343008",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of the IL1R1 \"gene\" on depression; instruments not named as circulating-level pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 849,
   "end": 981
  },
  "claim": {
   "protein_as_written": "IL1R1",
   "gene": "IL1R1",
   "disease_as_written": "depression",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1903,
    "end": 1998
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2265,
    "end": 2426
   }
  }
 },
 {
  "pmid": "40343466",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome, frailty-related skeletal muscle aging, is an aging process rather than a diagnosed disease; the SMR's instruments are unnamed, so E2 is at most unstated and E3 is the first criterion failed.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 820,
   "end": 1073
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40346920",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma cis-pQTLs validated PRCP's protein level against IA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1353,
   "end": 1491
  },
  "claim": {
   "protein_as_written": "PRCP",
   "gene": "PRCP",
   "disease_as_written": "IA",
   "direction": "lowers",
   "estimate": {
    "or": 0.734,
    "low": 0.561,
    "high": 0.959,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1353,
    "end": 1491
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1052,
    "end": 1120
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1742,
    "end": 1865
   }
  }
 },
 {
  "pmid": "40347490",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PCSK9 variants (a liver eQTL and the R46L function variant) are scaled per SD of apoB, not instrumented on circulating PCSK9 level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 962,
   "end": 1066
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40348582",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with UK Biobank plasma pQTLs on HCM; conclusions name CA3 first without direction, results say it raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 676,
   "end": 774
  },
  "claim": {
   "protein_as_written": "carbonic anhydrase 3 (CA3)",
   "gene": "CA3",
   "disease_as_written": "HCM",
   "direction": "raises",
   "estimate": {
    "or": 1.292,
    "low": 1.021,
    "high": 1.636,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1398,
    "end": 1697
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1860,
    "end": 2001
   }
  }
 },
 {
  "pmid": "40349828",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on ankylosing spondylitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1117,
   "end": 1401
  },
  "claim": {
   "protein_as_written": "ERAP1",
   "gene": "ERAP1",
   "disease_as_written": "AS",
   "direction": "raises",
   "estimate": {
    "or": 1.3,
    "low": 1.21,
    "high": 1.39,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1117,
    "end": 1401
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1635,
    "end": 1701
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 113
   }
  }
 },
 {
  "pmid": "40349847",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Druggable genes analysed at both transcriptional and protein levels; pairs are not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 302,
   "end": 523
  },
  "claim": {
   "protein_as_written": "PSORS1C3",
   "gene": "PSORS1C3",
   "disease_as_written": "diabetic microangiopathy",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 870,
    "end": 1088
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 870,
    "end": 1088
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 870,
    "end": 1088
   }
  }
 },
 {
  "pmid": "40351396",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The drug-target MR is weighted by SBP, but the SMR of the drugs' target genes, which gives the pairs, doesn't say whether its instruments are expression or protein QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 841,
   "end": 1019
  },
  "claim": {
   "protein_as_written": "AGTR1",
   "gene": "AGTR1",
   "disease_as_written": "CAVS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1845,
    "end": 1929
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1845,
    "end": 1929
   }
  }
 },
 {
  "pmid": "40355193",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UKB-PPP plasma proteins on COPD; results give directed pairs (MICB_MICA is not one gene's product, so the first single-gene pair, TIE-1, is taken).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 511,
   "end": 705
  },
  "claim": {
   "protein_as_written": "tyrosine-protein kinase receptor tie-1 (TIE-1)",
   "gene": "TIE1",
   "disease_as_written": "COPD",
   "direction": "raises",
   "estimate": {
    "or": 1.27,
    "low": 1.13,
    "high": 1.43,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1303,
    "end": 1571
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40355913",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The MR yields 'genes' whose instruments the abstract doesn't name (only the title says plasma circulating protein-centered); USP8 passes the DEG filter on the MR genes and is paired with PDD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 469,
   "end": 572
  },
  "claim": {
   "protein_as_written": "USP8",
   "gene": "USP8",
   "disease_as_written": "PDD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1217,
    "end": 1341
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40355922",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins enter only as mediators of cardiometabolic diseases on HFpEF; no protein's own effect on HFpEF is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1378,
   "end": 1492
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40358432",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The record is a retraction notice for another article; it reports no MR estimate of a protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 797,
   "end": 838
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40360159",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "ACE inhibition is proxied by variants weighted by blood pressure (per 10-mmHg decrement); no circulating protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 899,
   "end": 1255
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40369022",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 plasma circulating proteins on RA; KCNIP3 protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 457,
   "end": 644
  },
  "claim": {
   "protein_as_written": "KCNIP3",
   "gene": "KCNIP3",
   "disease_as_written": "RA",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1498,
    "end": 1652
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1947,
    "end": 2131
   }
  }
 },
 {
  "pmid": "40369498",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "GLP-1R instruments are cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 641,
   "end": 761
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40369625",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is BMI; the SMR genes are not circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1003,
   "end": 1151
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40372036",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on obesity risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 349,
   "end": 600
  },
  "claim": {
   "protein_as_written": "Fms-related receptor tyrosine kinase 1 (FLT1)",
   "gene": "FLT1",
   "disease_as_written": "obesity",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1372,
    "end": 1561
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40372791",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR proxies CASR, DGKD, CYP24A1, SLC34A1 by serum calcium or phosphate.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1247,
   "end": 1442
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40374125",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "GCK variants are weighted by HbA1c to proxy glucokinase activation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 290,
   "end": 514
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40378846",
  "eligibility": "E5",
  "e2_kind": null,
  "eligibility_reason": "A methods paper presenting a new MR estimator, with sclerostin as an application.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 365,
   "end": 539
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40380075",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2923 UK Biobank plasma proteins on PD; pairs given without direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 462,
   "end": 660
  },
  "claim": {
   "protein_as_written": "CTF1",
   "gene": "CTF1",
   "disease_as_written": "PD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 661,
    "end": 778
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1333,
    "end": 1525
   }
  }
 },
 {
  "pmid": "40381082",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The pair rests on a pQTL MR whose tissue isn't named, run beside eQTL MR, so the abstract doesn't say the instruments are circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 603,
   "end": 741
  },
  "claim": {
   "protein_as_written": "CTSF",
   "gene": "CTSF",
   "disease_as_written": "colorectal cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1281,
    "end": 1463
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1281,
    "end": 1463
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40383946",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of circulating CDKN1A on heart failure; higher circulating level associated with lower HF risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1196,
   "end": 1341
  },
  "claim": {
   "protein_as_written": "CDKN1A",
   "gene": "CDKN1A",
   "disease_as_written": "HF",
   "direction": "lowers",
   "estimate": {
    "frame": "per higher protein",
    "high": 0.99,
    "low": 0.69,
    "unit": "not stated",
    "or": 0.82
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1196,
    "end": 1341
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40383956",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with cis-pQTLs of 90 cardiovascular proteins on diabetic nephropathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 371,
   "end": 596
  },
  "claim": {
   "protein_as_written": "CX3CL1",
   "gene": "CX3CL1",
   "disease_as_written": "DN",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 597,
    "end": 714
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1021,
    "end": 1108
   }
  }
 },
 {
  "pmid": "40388730",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The three plasma proteins causal for GC are unnamed, and CCDC80 is named only as a mediator; the abstract never gives its own MR effect on GC (its sign is stated only inside contradictory mediation wording).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 979,
   "end": 1094
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40388790",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 490,
   "end": 746
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40393368",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on OHSS; proteins named as contributors without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 452,
   "end": 691
  },
  "claim": {
   "protein_as_written": "SBSN",
   "gene": "SBSN",
   "disease_as_written": "OHSS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1755,
    "end": 1926
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1755,
    "end": 1926
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40394429",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 462,
   "end": 566
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40394637",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma proteins on peripheral artery disease with directional pairs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1058,
   "end": 1219
  },
  "claim": {
   "protein_as_written": "MMP1",
   "gene": "MMP1",
   "disease_as_written": "PAD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1058,
    "end": 1219
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1220,
    "end": 1344
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1750,
    "end": 1912
   }
  }
 },
 {
  "pmid": "40397384",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on AD names none of the 25 proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 972,
   "end": 1110
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40398594",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Protein-level SMR with plasma pQTLs on acne.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1027,
   "end": 1233
  },
  "claim": {
   "protein_as_written": "CRELD2",
   "gene": "CRELD2",
   "disease_as_written": "acne",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1587,
    "end": 1766
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1587,
    "end": 1766
   }
  }
 },
 {
  "pmid": "40399559",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 1517 plasma proteins (deCODE) on melanoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1037,
   "end": 1215
  },
  "claim": {
   "protein_as_written": "PARP1",
   "gene": "PARP1",
   "disease_as_written": "melanoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1037,
    "end": 1215
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1037,
    "end": 1215
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40400956",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma pQTLs on sepsis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 527,
   "end": 685
  },
  "claim": {
   "protein_as_written": "CD33",
   "gene": "CD33",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": {
    "or": 1.04,
    "low": 1.02,
    "high": 1.05,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1118,
    "end": 1352
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1667,
    "end": 1905
   }
  }
 },
 {
  "pmid": "40405979",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR exposures are obesity and depression; SMR pools QTL kinds and the proteins SCG3 and FLRT2 come from BLISS (a PWAS), so no protein-disease pair from MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1532,
   "end": 1611
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40406288",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "CETP inhibition is genetically proxied without the abstract naming its instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 904,
   "end": 1131
  },
  "claim": {
   "protein_as_written": "CETP",
   "gene": "CETP",
   "disease_as_written": "sepsis-related critical care admission",
   "direction": "raises",
   "estimate": {
    "or": 0.84,
    "low": 0.74,
    "high": 0.95,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1981,
    "end": 2129
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1981,
    "end": 2129
   }
  }
 },
 {
  "pmid": "40408000",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Metformin is proxied by SNPs related to AMPK, a multi-subunit kinase, not one circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 757,
   "end": 965
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40409638",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins (deCODE, UKB-PPP) on aortic aneurysm; drugs targeting IL6R such as tocilizumab are said to benefit AA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 857,
   "end": 1057
  },
  "claim": {
   "protein_as_written": "IL6R",
   "gene": "IL6R",
   "disease_as_written": "AA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1058,
    "end": 1253
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 857,
    "end": 1057
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1058,
    "end": 1253
   }
  }
 },
 {
  "pmid": "40411576",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR integrating protein QTL data with osteoporosis GWAS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 681,
   "end": 869
  },
  "claim": {
   "protein_as_written": "CXCL1",
   "gene": "CXCL1",
   "disease_as_written": "osteoporosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1842,
    "end": 2032
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40415139",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug targets proxied by eQTLs and LDL-associated variants, not pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 995,
   "end": 1241
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40420090",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins (UKB-PPP, deCODE) on VTE.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1031,
   "end": 1138
  },
  "claim": {
   "protein_as_written": "PLEK",
   "gene": "PLEK",
   "disease_as_written": "VTE",
   "direction": "lowers",
   "estimate": {
    "or": 0.98,
    "low": 0.98,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1139,
    "end": 1235
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40421300",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on COPD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 481,
   "end": 631
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "COPD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1254,
    "end": 1385
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1254,
    "end": 1385
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40426228",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "The exposure is genetically proxied GIPR agonism, whose instruments the abstract doesn't name; the mediator Flt3L's own MR effect on disease is not given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 519,
   "end": 811
  },
  "claim": {
   "protein_as_written": "GIPR",
   "gene": "GIPR",
   "disease_as_written": "angina",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1393,
    "end": 1457
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1393,
    "end": 1457
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40426853",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable genes instrumented by blood, kidney and intestinal eQTLs only.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 459,
   "end": 731
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40426943",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR and SMR pool eQTL and pQTL instruments, and the abstract doesn't tie the gene-CRC pairs to circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 139
  },
  "claim": {
   "protein_as_written": "DBI",
   "gene": "DBI",
   "disease_as_written": "CRC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1175,
    "end": 1413
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 139
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40427057",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Cross-tissue TWAS with GTEx eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 412,
   "end": 634
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40429780",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR runs from Sjögren's disease to other diseases; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1195,
   "end": 1317
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40430440",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of 'candidate targets' on gout without naming their instruments (could be expression or protein).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 657,
   "end": 795
  },
  "claim": {
   "protein_as_written": "KCNA5",
   "gene": "KCNA5",
   "disease_as_written": "gout",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1059,
    "end": 1253
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1059,
    "end": 1253
   }
  }
 },
 {
  "pmid": "40433361",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR instruments for drug targets not named in the abstract; unsigned pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 992,
   "end": 1112
  },
  "claim": {
   "protein_as_written": "TNNC1",
   "gene": "TNNC1",
   "disease_as_written": "LUAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1429,
    "end": 1511
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1429,
    "end": 1511
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40435780",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR exposures are metabolites and transcripts; no circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1524,
   "end": 1783
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40438617",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE plasma protein pQTLs on postherpetic neuralgia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 538,
   "end": 705
  },
  "claim": {
   "protein_as_written": "NMRAL1",
   "gene": "NMRAL1",
   "disease_as_written": "PHN",
   "direction": "lowers",
   "estimate": {
    "or": 0.553,
    "low": 0.405,
    "high": 0.755,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1407,
    "end": 1535
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1407,
    "end": 1535
   }
  }
 },
 {
  "pmid": "40439986",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on psoriatic arthritis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 539,
   "end": 902
  },
  "claim": {
   "protein_as_written": "APOF",
   "gene": "APOF",
   "disease_as_written": "PsA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1218,
    "end": 1330
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1218,
    "end": 1330
   }
  }
 },
 {
  "pmid": "40441009",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR on gene-expression QTLs in blood and brain.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 445,
   "end": 700
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40441203",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is PCSK9/HMGCR inhibition by drug-target MR; instruments not named in the abstract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 665,
   "end": 875
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "polycystic ovary syndrome",
   "direction": "raises",
   "estimate": {
    "or": 0.321,
    "low": 0.136,
    "high": 0.757,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1039,
    "end": 1190
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1039,
    "end": 1190
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40442619",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of proteins on alopecia areata; the abstract does not say what instrumented them.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 306,
   "end": 444
  },
  "claim": {
   "protein_as_written": "DEFB1",
   "gene": "DEFB1",
   "disease_as_written": "AA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1103,
    "end": 1209
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1375,
    "end": 1496
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40442727",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step proteome-wide MR with UKB-PPP circulating proteins as mediators, giving proteins' own effects on CAD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 635,
   "end": 757
  },
  "claim": {
   "protein_as_written": "PLA2G7",
   "gene": "PLA2G7",
   "disease_as_written": "CAD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1407,
    "end": 1524
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 915,
    "end": 1123
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40442813",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "GLP1R cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 798,
   "end": 961
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40443776",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets are proxied by LDL-weighted variants and eQTLs; no circulating protein level is instrumented.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 367,
   "end": 715
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40444654",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Protein-level MR of circulating STAT3 (and others) on multiple sclerosis, tied explicitly to circulating levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1305,
   "end": 1428
  },
  "claim": {
   "protein_as_written": "STAT3",
   "gene": "STAT3",
   "disease_as_written": "MS",
   "direction": "lowers",
   "estimate": {
    "or": 0.43,
    "low": 0.33,
    "high": 0.54,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1305,
    "end": 1428
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 491,
    "end": 680
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40450010",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR concerns eosinophil count and asthma; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 498,
   "end": 696
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40450254",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 384,
   "end": 558
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40450304",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of plasma proteins (deCODE, UKB-PPP) on endometriosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 382,
   "end": 564
  },
  "claim": {
   "protein_as_written": "EPHB4",
   "gene": "EPHB4",
   "disease_as_written": "endometriosis",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1003,
    "end": 1248
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.99,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1003,
    "end": 1248
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1907,
    "end": 2098
   }
  }
 },
 {
  "pmid": "40451486",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma-protein pQTL MR on delirium; abstract names proteins causally associated with delirium but gives no direction, so the claim is unsigned (first protein the conclusions name).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 376,
   "end": 525
  },
  "claim": {
   "protein_as_written": "HIBCH",
   "gene": "HIBCH",
   "disease_as_written": "delirium",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1851,
    "end": 1957
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1576,
    "end": 1664
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1665,
    "end": 1838
   }
  }
 },
 {
  "pmid": "40451550",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides eQTL MR, a pQTL MR of CXCL10 on atrial fibrillation is reported.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1175,
   "end": 1301
  },
  "claim": {
   "protein_as_written": "CXCL10",
   "gene": "CXCL10",
   "disease_as_written": "AF",
   "direction": "lowers",
   "estimate": {
    "or": 0.59,
    "low": 0.43,
    "high": 0.82,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1175,
    "end": 1301
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 816,
    "end": 975
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1434,
    "end": 1503
   }
  }
 },
 {
  "pmid": "40452211",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "The exposures are antidiabetic drug targets (genes) and inhibitors, and their instruments are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 345,
   "end": 612
  },
  "claim": {
   "protein_as_written": "sodium-glucose cotransporter 2 (SGLT2)",
   "gene": "SLC5A2",
   "disease_as_written": "preterm birth",
   "direction": "raises",
   "estimate": {
    "or": 0.084,
    "low": 0.009,
    "high": 0.834,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 791,
    "end": 997
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 791,
    "end": 997
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40452368",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins from UKB-PPP and deCODE on AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 595,
   "end": 754
  },
  "claim": {
   "protein_as_written": "GRN",
   "gene": "GRN",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1674,
    "end": 1748
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1336,
    "end": 1437
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1674,
    "end": 1748
   }
  }
 },
 {
  "pmid": "40452777",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of over 2,000 plasma proteins on generalized vitiligo.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 355,
   "end": 504
  },
  "claim": {
   "protein_as_written": "GZMB",
   "gene": "GZMB",
   "disease_as_written": "vitiligo",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1232,
    "end": 1441
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1524,
    "end": 1722
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1232,
    "end": 1441
   }
  }
 },
 {
  "pmid": "40453312",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 1001 plasma proteins on five metabolism-related diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 626,
   "end": 764
  },
  "claim": {
   "protein_as_written": "FGR proto-oncogene, Src family tyrosine kinase (FGR)",
   "gene": "FGR",
   "disease_as_written": "coronary artery disease",
   "direction": "lowers",
   "estimate": {
    "or": 0.82,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1193,
    "end": 1572
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40453984",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR between COPD, sepsis and immune cells; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 570,
   "end": 690
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40455174",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating cholesterol-metabolism proteins on HCC and MASLD; conclusions name APOE without direction (pathogenic), so its results direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 790,
   "end": 984
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "HCC",
   "direction": "raises",
   "estimate": {
    "or": 1.71,
    "low": 1.22,
    "high": 2.4,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1469,
    "end": 1663
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40456753",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR links unnamed proteins to brain disorders; no pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 681,
   "end": 903
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40459852",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins (UKB-PPP, deCODE) on sepsis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 220,
   "end": 412
  },
  "claim": {
   "protein_as_written": "DUSP13",
   "gene": "DUSP13",
   "disease_as_written": "sepsis",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1366,
    "end": 1519
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 822,
    "end": 999
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 413,
    "end": 581
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1366,
    "end": 1519
   }
  }
 },
 {
  "pmid": "40462010",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on CRC; conclusions name proteins without direction, results give GREM1 positively associated (FDR).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1508,
   "end": 1727
  },
  "claim": {
   "protein_as_written": "GREM1",
   "gene": "GREM1",
   "disease_as_written": "CRC",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1508,
    "end": 1727
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H3 + PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1728,
    "end": 1924
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2058,
    "end": 2238
   }
  }
 },
 {
  "pmid": "40462713",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins (deCODE pQTLs) on lower-extremity DVT; the results give directions.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 451,
   "end": 534
  },
  "claim": {
   "protein_as_written": "MAP1LC3A",
   "gene": "MAP1LC3A",
   "disease_as_written": "DVT",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1031,
    "end": 1287
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40463815",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins mediating T2DM's effect on ED, with the sign of each named protein's own effect on ED stated (127 proteins linked to ED by MR).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1167,
   "end": 1251
  },
  "claim": {
   "protein_as_written": "SERPINA10",
   "gene": "SERPINA10",
   "disease_as_written": "ED",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1252,
    "end": 1490
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40463816",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are gut microbial taxa.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1399,
   "end": 1564
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40468462",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on rheumatoid arthritis; conclusions name SPAG11B without direction, results give it lowering risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 426,
   "end": 577
  },
  "claim": {
   "protein_as_written": "SPAG11B",
   "gene": "SPAG11B",
   "disease_as_written": "RA",
   "direction": "lowers",
   "estimate": {
    "or": 0.49,
    "low": 0.4,
    "high": 0.61,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 838,
    "end": 1156
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40469443",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins mediate urate's effect on AF, and the abstract gives HNF4α's own effect on AF ('drive AF') but no sign.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 559,
   "end": 694
  },
  "claim": {
   "protein_as_written": "HNF4α",
   "gene": "HNF4A",
   "disease_as_written": "AF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1226,
    "end": 1329
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40469476",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of CSNK2A1 'expression' without naming whether instruments are eQTLs or pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1590,
   "end": 1785
  },
  "claim": {
   "protein_as_written": "CSNK2A1",
   "gene": "CSNK2A1",
   "disease_as_written": "HZ",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1590,
    "end": 1785
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40474819",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract (a commentary).",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40476595",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses cis-eQTLs of drug targets (outcome BMD).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 893,
   "end": 1032
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40480287",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTL-instrumented gene expression, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 410,
   "end": 475
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40480837",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of UK Biobank plasma proteins on NSCLC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1575,
   "end": 1644
  },
  "claim": {
   "protein_as_written": "CXCL17",
   "gene": "CXCL17",
   "disease_as_written": "NSCLC",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1575,
    "end": 1644
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40481092",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UKB-PPP and deCODE plasma proteins on AITD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1119,
   "end": 1220
  },
  "claim": {
   "protein_as_written": "LIF",
   "gene": "LIF",
   "disease_as_written": "AITD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1509,
    "end": 1670
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1221,
    "end": 1508
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1763,
    "end": 1982
   }
  }
 },
 {
  "pmid": "40481979",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of UKB-PPP and Fenland plasma pQTLs on LUAD; conclusions name ICAM5 without a direction, results give OR 0.88.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 363,
   "end": 611
  },
  "claim": {
   "protein_as_written": "ICAM5",
   "gene": "ICAM5",
   "disease_as_written": "LUAD",
   "direction": "lowers",
   "estimate": {
    "or": 0.88,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1402,
    "end": 1582
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1207,
    "end": 1401
   }
  }
 },
 {
  "pmid": "40490792",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs of druggable genes from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 437,
   "end": 761
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40495162",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR (deCODE, UKB-PPP) on sleep apnea; TIMP4 called causal and pathogenic, which gives no direction, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 714,
   "end": 900
  },
  "claim": {
   "protein_as_written": "TIMP4",
   "gene": "TIMP4",
   "disease_as_written": "SA",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1541,
    "end": 1676
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.961,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1541,
    "end": 1676
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1867,
    "end": 2024
   }
  }
 },
 {
  "pmid": "40495196",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating plasma proteins on POI (FinnGen); FGF23 is the first protein paired with POI, with no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 492,
   "end": 679
  },
  "claim": {
   "protein_as_written": "fibroblast growth factor 23",
   "gene": "FGF23",
   "disease_as_written": "POI",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1055,
    "end": 1715
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40495522",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR on GGE, but no protein is named in an MR pair (named genes come from TWAS).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1359,
   "end": 1501
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40496862",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable genes instrumented with eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 374,
   "end": 618
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40498118",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins and circulating inflammatory proteins on kidney stone disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 307,
   "end": 445
  },
  "claim": {
   "protein_as_written": "CCL19",
   "gene": "CCL19",
   "disease_as_written": "KSD",
   "direction": "raises",
   "estimate": {
    "or": 1.084,
    "low": 1.006,
    "high": 1.167,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1120,
    "end": 1368
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40499826",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are plasma protein level ratios.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 381,
   "end": 545
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40500572",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory cytokines on EGPA subtypes; the conclusion's key points name leukemia inhibitory factor without a direction, and the results give its direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1497,
   "end": 1668
  },
  "claim": {
   "protein_as_written": "leukemia inhibitory factor",
   "gene": "LIF",
   "disease_as_written": "ANCA/MPO ( +) EGPA",
   "direction": "lowers",
   "estimate": {
    "or": 0.963,
    "low": 0.942,
    "high": 0.985,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1879,
    "end": 2071
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40502026",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "An eQTL resource paper; no MR of a circulating protein on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2164,
   "end": 2268
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40502600",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is used only to orient effects between metabolic traits; the abstract states no MR with a protein as the exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1068,
   "end": 1241
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40502751",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from MDD to proteomic aging; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1013,
   "end": 1138
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40511612",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-MR of circulating ANGPTL4 (per SD decrease) on colorectal cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1007,
   "end": 1269
  },
  "claim": {
   "protein_as_written": "ANGPTL4",
   "gene": "ANGPTL4",
   "disease_as_written": "colorectal cancer",
   "direction": "raises",
   "estimate": {
    "or": 0.76,
    "low": 0.66,
    "high": 0.89,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1007,
    "end": 1269
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.83,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1007,
    "end": 1269
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2206,
    "end": 2316
   }
  }
 },
 {
  "pmid": "40513936",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 490,
   "end": 731
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40514687",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Main MR uses cis-eQTLs; a pQTL validation of STX4 is named but its tissue isn't said to be circulating.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1064,
   "end": 1169
  },
  "claim": {
   "protein_as_written": "STX4",
   "gene": "STX4",
   "disease_as_written": "childhood asthma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1834,
    "end": 1948
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1649,
    "end": 1833
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2636,
    "end": 2816
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40517355",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR pools eQTL and pQTL exposure data and states the pair as CD14 'expression', not named as a gene's, an mRNA's, or a protein's, nor tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 749,
   "end": 917
  },
  "claim": {
   "protein_as_written": "CD14",
   "gene": "CD14",
   "disease_as_written": "ovarian cancer",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1224,
    "end": 1336
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40518741",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 478,
   "end": 590
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40522254",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets (HMGCR, PCSK9) are proxied by gene variants associated with lipids from the Global Lipid Genetics Consortium, not by protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 621,
   "end": 758
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40524645",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is genetically proxied inhibition of drug targets; instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 489,
   "end": 602
  },
  "claim": {
   "protein_as_written": "VEGFA",
   "gene": "VEGFA",
   "disease_as_written": "T2D",
   "direction": "lowers",
   "estimate": {
    "or": 2.66,
    "low": 1.34,
    "high": 3.78,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1164,
    "end": 1373
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1164,
    "end": 1373
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40527012",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from smoking intensity to protein levels and adiposity; no protein exposure on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 745,
   "end": 1009
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40527765",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are 731 immune cell characteristics, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 515,
   "end": 701
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40527798",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target gene variants selected from hemoglobin GWAS (downstream biomarker).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 498,
   "end": 689
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40527822",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with deCODE cis-pQTLs of plasma proteins on cardiomyopathies.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1052,
   "end": 1153
  },
  "claim": {
   "protein_as_written": "CCL17",
   "gene": "CCL17",
   "disease_as_written": "HCM",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1687,
    "end": 1959
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40528431",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of GGT1, which the abstract names as one of 2923 plasma proteins, on cirrhosis; no direction is stated for the MR pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1162,
   "end": 1260
  },
  "claim": {
   "protein_as_written": "GGT1",
   "gene": "GGT1",
   "disease_as_written": "cirrhosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1162,
    "end": 1260
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40529500",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating proteins on ED. No direction is given, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 115,
   "end": 270
  },
  "claim": {
   "protein_as_written": "AMN",
   "gene": "AMN",
   "disease_as_written": "ED",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1024,
    "end": 1213
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1024,
    "end": 1213
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1442,
    "end": 1623
   }
  }
 },
 {
  "pmid": "40533710",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteomic MR of UKB-PPP plasma proteins on prostate cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 478,
   "end": 609
  },
  "claim": {
   "protein_as_written": "C5",
   "gene": "C5",
   "disease_as_written": "PCa",
   "direction": "raises",
   "estimate": {
    "or": 1.23,
    "low": 1.1,
    "high": 1.37,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1330,
    "end": 1485
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1330,
    "end": 1485
   }
  }
 },
 {
  "pmid": "40533815",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "PWAS risk genes are named, but no protein-disease pair is attributed to MR of a protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2084,
   "end": 2154
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40535814",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug targets proxied by GWAS SNPs and cis-eQTLs; no circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 910,
   "end": 1010
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40536728",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with pQTLs of genetically predicted protein levels on vitiligo.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 398,
   "end": 795
  },
  "claim": {
   "protein_as_written": "KLF4",
   "gene": "KLF4",
   "disease_as_written": "vitiligo",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1056,
    "end": 1232
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 398,
    "end": 795
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1779,
    "end": 1912
   }
  }
 },
 {
  "pmid": "40536885",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is cis-eQTLs (and methylation QTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 238,
   "end": 374
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40537683",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 358,
   "end": 545
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40544884",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL SMR found three proteins linked to depression but names none; the named genes come from methylation and expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1324,
   "end": 1461
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40546783",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR of celecoxib's target carbonic anhydrase 2 on deep vein thrombosis; instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1481,
   "end": 1736
  },
  "claim": {
   "protein_as_written": "carbonic anhydrase 2",
   "gene": "CA2",
   "disease_as_written": "deep vein thrombosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1481,
    "end": 1736
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1481,
    "end": 1736
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40553479",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB and deCODE plasma proteins on endometrial cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 448,
   "end": 824
  },
  "claim": {
   "protein_as_written": "GSTO1-1",
   "gene": "GSTO1",
   "disease_as_written": "endometrial cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1214,
    "end": 1617
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1118,
    "end": 1213
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40555237",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are single-cell eQTL-proxied gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 848,
   "end": 1052
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40557537",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Instruments pool eQTL and pQTL datasets; the pair is not tied to a circulating-protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 568,
   "end": 800
  },
  "claim": {
   "protein_as_written": "LGALS9",
   "gene": "LGALS9",
   "disease_as_written": "GBM",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1284,
    "end": 1365
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40558823",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A methods tutorial that estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 736,
   "end": 1021
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40562111",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with deCODE blood-derived pQTLs (35,559 Icelanders) on postpartum depression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 421,
   "end": 646
  },
  "claim": {
   "protein_as_written": "BRPF1",
   "gene": "BRPF1",
   "disease_as_written": "PPD",
   "direction": "lowers",
   "estimate": {
    "or": 0.797,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 981,
    "end": 1121
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1880,
    "end": 2044
   }
  }
 },
 {
  "pmid": "40562807",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood and brain cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 347,
   "end": 577
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40564071",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with blood pQTLs of drug-targeted proteins on pancreatic cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 440,
   "end": 661
  },
  "claim": {
   "protein_as_written": "AGT",
   "gene": "AGT",
   "disease_as_written": "PC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1219,
    "end": 1346
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1549,
    "end": 1749
   }
  }
 },
 {
  "pmid": "40564099",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UKB-PPP plasma proteins on psoriasis; conclusions name IFNLR1, whose direction the results state.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 507,
   "end": 758
  },
  "claim": {
   "protein_as_written": "IFNLR1",
   "gene": "IFNLR1",
   "disease_as_written": "PsO",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1387,
    "end": 1609
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1610,
    "end": 1706
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 759,
    "end": 902
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1893,
    "end": 1959
   }
  }
 },
 {
  "pmid": "40569533",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-MR of 91 circulating inflammatory proteins proxied by pQTLs on myasthenia gravis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 452,
   "end": 648
  },
  "claim": {
   "protein_as_written": "TNFSF12",
   "gene": "TNFSF12",
   "disease_as_written": "MG",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1011,
    "end": 1107
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40573242",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "ICS target genes are instrumented with whole-blood cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 489,
   "end": 642
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40573254",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR on genes of sphingolipid metabolism; instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 523,
   "end": 714
  },
  "claim": {
   "protein_as_written": "SPHK1",
   "gene": "SPHK1",
   "disease_as_written": "IPF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 899,
    "end": 966
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1301,
    "end": 1474
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40575595",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of serum lipid traits including apolipoprotein B and A1 levels on cardiac arrest.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1250,
   "end": 1469
  },
  "claim": {
   "protein_as_written": "apolipoprotein B (ApoB)",
   "gene": "APOB",
   "disease_as_written": "CA",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1250,
    "end": 1469
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40575858",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is GPX1 gene expression in whole blood.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 798,
   "end": 1098
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40577066",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (UMOD, SSC4D) on kidney stones.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 908,
   "end": 981
  },
  "claim": {
   "protein_as_written": "plasma UMOD",
   "gene": "UMOD",
   "disease_as_written": "kidney stone",
   "direction": "lowers",
   "estimate": {
    "frame": "per higher protein",
    "high": 0.97,
    "low": 0.9,
    "unit": "not stated",
    "or": 0.93
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1665,
    "end": 1837
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1838,
    "end": 2058
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40577117",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma and brain protein SMR; the abstract names no causal protein for MS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1076,
   "end": 1199
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40578264",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on heart failure; GOLM1 named causal without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1594,
   "end": 1697
  },
  "claim": {
   "protein_as_written": "Golgi membrane protein 1",
   "gene": "GOLM1",
   "disease_as_written": "HF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1594,
    "end": 1697
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40581728",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The MR outcomes include obesity-associated illnesses, so E3 is not plainly failed, but the abstract names no protein-disease pair from the MR, only a count of proteins causal for obesity or related illnesses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1446,
   "end": 1565
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40584268",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on thoracic rib fractures; HAMP named without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 828,
   "end": 1052
  },
  "claim": {
   "protein_as_written": "HAMP",
   "gene": "HAMP",
   "disease_as_written": "thoracic rib fractures",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1562,
    "end": 1637
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40587063",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs between stroke and CAD; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 883,
   "end": 976
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40588408",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The pQTL MR outcome is facial aging, a trait rather than a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 4468,
   "end": 4696
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40592408",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins associated with BD are only counted; named mediators (EFCAB14, CDHR1) are given no own effect on BD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1152,
   "end": 1271
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40592928",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools eQTL, mQTL, and pQTL data with the pQTL tissue unstated; FOXO1, named in the conclusions, rests on mQTL-eQTL-pQTL integration; no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 249,
   "end": 413
  },
  "claim": {
   "protein_as_written": "FOXO1",
   "gene": "FOXO1",
   "disease_as_written": "IPF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1075,
    "end": 1255
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 739,
    "end": 871
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40593373",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Analyses pool eQTLs (eQTLGen) and pQTLs (deCODE) in one drug target MR; pair not tied to circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 417,
   "end": 601
  },
  "claim": {
   "protein_as_written": "PPP1R14A",
   "gene": "PPP1R14A",
   "disease_as_written": "OCCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 947,
    "end": 1004
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 947,
    "end": 1004
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1187,
    "end": 1245
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40594157",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR of genes found as differentially expressed; the abstract doesn't name the instruments (expression or protein).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 774,
   "end": 891
  },
  "claim": {
   "protein_as_written": "CDKN2A",
   "gene": "CDKN2A",
   "disease_as_written": "early-stage EC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1784,
    "end": 1925
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1784,
    "end": 1925
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40595969",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Exposures are brain protein abundance and brain gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 829,
   "end": 971
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40596422",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug target genes instrumented by LDL-c GWAS variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 553,
   "end": 747
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40596960",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 448,
   "end": 686
  },
  "claim": {
   "protein_as_written": "FURIN",
   "gene": "FURIN",
   "disease_as_written": "stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1852,
    "end": 2129
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1127,
    "end": 1409
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1127,
    "end": 1409
   }
  }
 },
 {
  "pmid": "40597402",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are coffee and caffeine intake; serum ALP is an outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1819,
   "end": 1995
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40597970",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Antihypertensive drug targets proxied by variants weighted by blood pressure as a biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 822,
   "end": 1214
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40607238",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with deCODE and UKB-PPP plasma pQTLs on AAA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 828,
   "end": 1011
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "AAAs",
   "direction": "raises",
   "estimate": {
    "or": 1.3,
    "low": 1.2,
    "high": 1.4,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1307,
    "end": 1554
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1307,
    "end": 1554
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40617003",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating plasma proteins on rheumatoid arthritis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 379,
   "end": 588
  },
  "claim": {
   "protein_as_written": "BRD2",
   "gene": "BRD2",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1183,
    "end": 1368
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1584,
    "end": 1703
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40618325",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are blood eQTLs and methylation of druggable genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 363,
   "end": 526
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40618921",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR instruments are unnamed and pooled across skeletal muscle and blood, so circulating protein instruments are not stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 523,
   "end": 650
  },
  "claim": {
   "protein_as_written": "AEBP1",
   "gene": "AEBP1",
   "disease_as_written": "T2DM",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1057,
    "end": 1243
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1244,
    "end": 1338
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1844,
    "end": 1946
   }
  }
 },
 {
  "pmid": "40622200",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of deCODE plasma protein pQTLs on allergic conjunctivitis; conclusions name CD36 without direction, results give CD36 lowering risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 336,
   "end": 526
  },
  "claim": {
   "protein_as_written": "CD36",
   "gene": "CD36",
   "disease_as_written": "AC",
   "direction": "lowers",
   "estimate": {
    "or": 0.78,
    "low": 0.7,
    "high": 0.88,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1244,
    "end": 1463
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.974,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1570,
    "end": 1676
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1051,
    "end": 1243
   }
  }
 },
 {
  "pmid": "40622612",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "deCODE plasma pQTLs with FinnGen vascular dementia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 672,
   "end": 833
  },
  "claim": {
   "protein_as_written": "MED4",
   "gene": "MED4",
   "disease_as_written": "VaD",
   "direction": "raises",
   "estimate": {
    "or": 1.819,
    "low": 1.493,
    "high": 2.217,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1810,
    "end": 2289
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2689,
    "end": 2860
   }
  }
 },
 {
  "pmid": "40624693",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR pairs are between m6A sites, gene expression and disease; pQTLs feed only the FUSION association analysis, and no protein's level is the exposure of a stated MR pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 601,
   "end": 776
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40627109",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Candidate proteins come from analyses pooling eQTL and pQTL (two-sample MR and SMR).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 485,
   "end": 586
  },
  "claim": {
   "protein_as_written": "STX10",
   "gene": "STX10",
   "disease_as_written": "CRC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 913,
    "end": 1016
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40629029",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 plasma proteins on CRC; TIMP1 named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 651,
   "end": 866
  },
  "claim": {
   "protein_as_written": "TIMP1",
   "gene": "TIMP1",
   "disease_as_written": "CRC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1774,
    "end": 2019
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1609,
    "end": 1773
   }
  }
 },
 {
  "pmid": "40629568",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "HMGCR proxied by LDL cholesterol-associated variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1022,
   "end": 1265
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40629581",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 circulating proteins on heart failure and atrial fibrillation; DEFB135 protective, FDR-corrected.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1104,
   "end": 1318
  },
  "claim": {
   "protein_as_written": "defensin beta 135 (DEFB135)",
   "gene": "DEFB135",
   "disease_as_written": "heart failure",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1104,
    "end": 1318
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40634593",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR pools eQTLs and pQTLs; the GSN pair rests on 'expression'.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 952,
   "end": 1022
  },
  "claim": {
   "protein_as_written": "GSN",
   "gene": "GSN",
   "disease_as_written": "ER + breast cancer",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1023,
    "end": 1167
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.0101,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1023,
    "end": 1167
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40635100",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome MR of genetically predicted protein levels on glaucoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 976,
   "end": 1390
  },
  "claim": {
   "protein_as_written": "CPXM1",
   "gene": "CPXM1",
   "disease_as_written": "glaucoma",
   "direction": "lowers",
   "estimate": {
    "or": 0.86,
    "low": 0.81,
    "high": 0.91,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 976,
    "end": 1390
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.94,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1391,
    "end": 1677
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 876,
    "end": 975
   }
  }
 },
 {
  "pmid": "40635520",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable genes are instrumented by cis-eQTLs from blood and skin.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 361,
   "end": 735
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40635764",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL data; the abstract does not tie the pairs to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 320,
   "end": 498
  },
  "claim": {
   "protein_as_written": "S100A6",
   "gene": "S100A6",
   "disease_as_written": "NAFLD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1783,
    "end": 1941
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 499,
    "end": 691
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40638267",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "pQTLs are from brain (dorsolateral prefrontal cortex) proteomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 547,
   "end": 767
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40639752",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "WIPF1 comes from SMR pooling GTEx eQTLs and deCODE pQTLs, not tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 281,
   "end": 478
  },
  "claim": {
   "protein_as_written": "WIPF1",
   "gene": "WIPF1",
   "disease_as_written": "AF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1047,
    "end": 1161
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1047,
    "end": 1161
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1394,
    "end": 1648
   }
  }
 },
 {
  "pmid": "40640432",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Primary SMR uses gene expression; the protein-level MR's instruments and whether the protein is circulating aren't stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1151,
   "end": 1244
  },
  "claim": {
   "protein_as_written": "IQGAP2",
   "gene": "IQGAP2",
   "disease_as_written": "PC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1151,
    "end": 1244
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.79,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 934,
    "end": 1150
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1427,
    "end": 1599
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40646181",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Genes identified by MR with Cox analysis; abstract does not name the MR exposure or instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 264,
   "end": 388
  },
  "claim": {
   "protein_as_written": "MMRN1",
   "gene": "MMRN1",
   "disease_as_written": "CRC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 761,
    "end": 827
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1971,
    "end": 2133
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40649979",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UKB-PPP and deCODE plasma proteins on coronary atherosclerosis; no direction is given for any protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1185,
   "end": 1333
  },
  "claim": {
   "protein_as_written": "CELSR2",
   "gene": "CELSR2",
   "disease_as_written": "CAS",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1705,
    "end": 1883
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1334,
    "end": 1632
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1705,
    "end": 1883
   }
  }
 },
 {
  "pmid": "40651217",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory proteins (pQTLs) on tinnitus.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 584,
   "end": 686
  },
  "claim": {
   "protein_as_written": "CCL19",
   "gene": "CCL19",
   "disease_as_written": "tinnitus",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 687,
    "end": 852
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40652422",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The only MR (SMR) uses cis-eQTLs; PWAS is not MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 790,
   "end": 903
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40653474",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 655,
   "end": 1086
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40653482",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR with brain cell-type and bulk eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 640,
   "end": 768
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40657364",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of pQTLs among pooled multi-omics QTLs; the pQTLs' tissue is not named as plasma or serum.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 440,
   "end": 654
  },
  "claim": {
   "protein_as_written": "PARK7",
   "gene": "PARK7",
   "disease_as_written": "BC",
   "direction": "lowers",
   "estimate": {
    "or": 0.83,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1747,
    "end": 1909
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 2746,
    "end": 2814
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 655,
    "end": 851
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40657554",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on cardiovascular diseases; no pair is given a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 257,
   "end": 377
  },
  "claim": {
   "protein_as_written": "BTN3A2",
   "gene": "BTN3A2",
   "disease_as_written": "ischemic stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 749,
    "end": 892
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40658235",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 circulating plasma proteins (deCODE) on osteomyelitis, a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 521,
   "end": 657
  },
  "claim": {
   "protein_as_written": "SYTL1",
   "gene": "SYTL1",
   "disease_as_written": "osteomyelitis",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1297,
    "end": 1502
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40659289",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are single-cell gene expression (sc-eQTL), not circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 297,
   "end": 533
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40665092",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR confirms the plasma HGF-breast cancer association; the stated OR is observational, so the MR's direction is not given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 841,
   "end": 966
  },
  "claim": {
   "protein_as_written": "HGF",
   "gene": "HGF",
   "disease_as_written": "breast cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 841,
    "end": 966
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1082,
    "end": 1227
   }
  }
 },
 {
  "pmid": "40666678",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SHBG cis-pQTLs instrument SHBG levels for obstetric disorders.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 554,
   "end": 728
  },
  "claim": {
   "protein_as_written": "SHBG",
   "gene": "SHBG",
   "disease_as_written": "gestational diabetes",
   "direction": "lowers",
   "estimate": {
    "or": 0.835,
    "low": 0.785,
    "high": 0.889,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1432,
    "end": 1613
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1262,
    "end": 1419
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 554,
    "end": 728
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40669587",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (UKB-PPP) on RA; no direction given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 867,
   "end": 1082
  },
  "claim": {
   "protein_as_written": "ICAM3",
   "gene": "ICAM3",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 867,
    "end": 1082
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 867,
    "end": 1082
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40669713",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR instrumented by eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 510,
   "end": 571
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40671149",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with pQTLs; OLFML3 raises narcolepsy and hypertension risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1464,
   "end": 1684
  },
  "claim": {
   "protein_as_written": "OLFML3",
   "gene": "OLFML3",
   "disease_as_written": "narcolepsy",
   "direction": "raises",
   "estimate": {
    "or": 2.412,
    "low": 1.07,
    "high": 5.436,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1464,
    "end": 1684
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40671653",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The 22 proteins whose genetically proxied levels were associated with AAA are unnamed, and the named proteins appear only as mediators of smoking's effect, with no protein's own effect on AAA stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1814,
   "end": 1913
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40672508",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR links MRI-based aging clocks with other clocks and disease endpoints; no single circulating protein is an MR exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1016,
   "end": 1255
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40673098",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pooling methylation, expression and protein QTLs; the KLC1 pair is stated across transcription and protein abundance, not tied to a circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 384,
   "end": 779
  },
  "claim": {
   "protein_as_written": "KLC1",
   "gene": "KLC1",
   "disease_as_written": "lung cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1267,
    "end": 1387
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40673688",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins and laboratory indicators including apolipoprotein A on kidney stones; the only named protein pair is APOA with kidney stones, with no direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1034,
   "end": 1296
  },
  "claim": {
   "protein_as_written": "APOA",
   "gene": "APOA1",
   "disease_as_written": "kidney stones",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1034,
    "end": 1296
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40674570",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis- and trans-pQTLs of circulating proteins on spontaneous abortion.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 393,
   "end": 590
  },
  "claim": {
   "protein_as_written": "MMP9",
   "gene": "MMP9",
   "disease_as_written": "spontaneous abortion",
   "direction": "raises",
   "estimate": {
    "or": 1.11,
    "low": 1.03,
    "high": 1.19,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 937,
    "end": 1189
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40675462",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on UC (FinnGen).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 588,
   "end": 729
  },
  "claim": {
   "protein_as_written": "UBC",
   "gene": "UBC",
   "disease_as_written": "UC",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1648,
    "end": 1832
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2020,
    "end": 2158
   }
  }
 },
 {
  "pmid": "40677778",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable-genome drug-target MR on osteoporosis with instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 285,
   "end": 432
  },
  "claim": {
   "protein_as_written": "TAS1R3",
   "gene": "TAS1R3",
   "disease_as_written": "OP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1722,
    "end": 1810
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1722,
    "end": 1810
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40679760",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on ischemic stroke; plasma FLT1 inversely associated in discovery and FinnGen validation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 904,
   "end": 1051
  },
  "claim": {
   "protein_as_written": "plasma FLT1",
   "gene": "FLT1",
   "disease_as_written": "ischemic stroke",
   "direction": "lowers",
   "estimate": {
    "or": 0.864,
    "low": 0.774,
    "high": 0.965,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1304,
    "end": 1524
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 904,
    "end": 1051
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1199,
    "end": 1303
   }
  }
 },
 {
  "pmid": "40680977",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "A methods paper on SLC5A2 instrumented by expression and HbA1c-weighted variants, with no circulating protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 530,
   "end": 745
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40684330",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs from blood and brain.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 427,
   "end": 686
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40685484",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of druggable genes from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 406,
   "end": 606
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40687641",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on BPH with colocalization.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1141,
   "end": 1402
  },
  "claim": {
   "protein_as_written": "AIF1",
   "gene": "AIF1",
   "disease_as_written": "BPH",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1503,
    "end": 1754
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.999,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1141,
    "end": 1402
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1503,
    "end": 1754
   }
  }
 },
 {
  "pmid": "40689090",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on lipids and, for lipid-associated proteins, on CVDs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 844,
   "end": 909
  },
  "claim": {
   "protein_as_written": "CELSR2",
   "gene": "CELSR2",
   "disease_as_written": "coronary artery disease",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1794,
    "end": 1890
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1907,
    "end": 2112
   }
  }
 },
 {
  "pmid": "40694910",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The exposure is BPS-targeted proteins (AZU1, CTSD), whose instruments the abstract doesn't name; the plasma pQTL datasets it names serve the mediation analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 458,
   "end": 581
  },
  "claim": {
   "protein_as_written": "AZU1",
   "gene": "AZU1",
   "disease_as_written": "depression",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2066,
    "end": 2275
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40695397",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTLs from UKBPPP and deCODE as instruments for plasma proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 400,
   "end": 508
  },
  "claim": {
   "protein_as_written": "CASP9",
   "gene": "CASP9",
   "disease_as_written": "atrioventricular block",
   "direction": "raises",
   "estimate": {
    "frame": "per higher protein",
    "high": 4.26,
    "low": 1.65,
    "unit": "not stated",
    "or": 2.65
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 953,
    "end": 1311
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40695668",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "HMGCR inhibition is the exposure, its instruments named only as variants from lipid GWAS datasets.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 684,
   "end": 801
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "small vessel ischemic stroke",
   "direction": "raises",
   "estimate": {
    "or": 0.5,
    "low": 0.36,
    "high": 0.7,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1602,
    "end": 1745
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1842,
    "end": 1950
   }
  }
 },
 {
  "pmid": "40696067",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Instruments are variants associated with circulating PDE5A protein (UKB-PPP); lower PDE5A lowers colorectal cancer risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 453,
   "end": 724
  },
  "claim": {
   "protein_as_written": "PDE5A protein",
   "gene": "PDE5A",
   "disease_as_written": "colorectal cancer",
   "direction": "raises",
   "estimate": {
    "or": 0.8,
    "low": 0.75,
    "high": 0.86,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 999,
    "end": 1265
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 725,
    "end": 919
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1621,
    "end": 1810
   }
  }
 },
 {
  "pmid": "40696520",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR of genes whose QTL kind the abstract does not name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 545,
   "end": 737
  },
  "claim": {
   "protein_as_written": "NCF2",
   "gene": "NCF2",
   "disease_as_written": "OP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1346,
    "end": 1504
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1638,
    "end": 1764
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40696606",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR and SMR of serum/plasma proteins on atopic dermatitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 553,
   "end": 716
  },
  "claim": {
   "protein_as_written": "CACYBP",
   "gene": "CACYBP",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 885,
    "end": 1109
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 885,
    "end": 1109
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40697080",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pooling methylation, expression and pQTLs; the pQTLs' tissue is not stated as circulating.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 363,
   "end": 578
  },
  "claim": {
   "protein_as_written": "NUDT2",
   "gene": "NUDT2",
   "disease_as_written": "HUA",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1036,
    "end": 1177
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40697193",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of drug-target genes and HbA1c-associated variants near them, not circulating-protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1043,
   "end": 1315
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40702285",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The only proteins are cerebrospinal fluid proteins, as mediators.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1594,
   "end": 1743
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40706753",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The MR is set up on thyroid diseases, but the only MR result the abstract states is on free thyroxine levels, so no protein-disease pair is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 981,
   "end": 1141
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40708517",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Pairs come from analyses pooling deCODE protein, eQTLGen mRNA, tissue and single-cell QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 404,
   "end": 612
  },
  "claim": {
   "protein_as_written": "NUDT2",
   "gene": "NUDT2",
   "disease_as_written": "keloids",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1358,
    "end": 1549
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2284,
    "end": 2428
   }
  }
 },
 {
  "pmid": "40709250",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR analyses take non-secretor status and telomere length as exposures; the IL-6/IL-12 statement compares genetically determined levels in cases, not MR of a protein on AS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 565,
   "end": 727
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40713851",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposures are genetic liability to psychiatric disorders, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 973,
   "end": 1132
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40715499",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are druggable genes instrumented by blood cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 371,
   "end": 547
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40716783",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR between MDD and waist-hip ratio; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 320,
   "end": 575
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40722198",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "GLP1RAs proxied by cis-eQTLs, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 576,
   "end": 694
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40722787",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma proteins on immune-related adverse events; pairs named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 518,
   "end": 745
  },
  "claim": {
   "protein_as_written": "CCL20",
   "gene": "CCL20",
   "disease_as_written": "all-grade irAEs",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1144,
    "end": 1366
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40727246",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs between diseases (PBC and hypothyroidism); the genes named are not instrumented as circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 710,
   "end": 860
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40731231",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs of genes, and metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 642,
   "end": 753
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40735247",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma GDF15 on AD and related dementias; no direction attributed to the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 581,
   "end": 883
  },
  "claim": {
   "protein_as_written": "plasma GDF15",
   "gene": "GDF15",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 581,
    "end": 883
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40739745",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins paired only with the class 'hematologic malignancies', no member disease named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1358,
   "end": 1536
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40740240",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (UKB-PPP, deCODE) on bladder cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 471,
   "end": 656
  },
  "claim": {
   "protein_as_written": "SLURP1",
   "gene": "SLURP1",
   "disease_as_written": "bladder cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 861,
    "end": 1058
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 861,
    "end": 1058
   }
  }
 },
 {
  "pmid": "40740773",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR names the SYK gene; its instruments are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1381,
   "end": 1531
  },
  "claim": {
   "protein_as_written": "spleen tyrosine kinase (SYK)",
   "gene": "SYK",
   "disease_as_written": "sarcopenia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1381,
    "end": 1531
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40745068",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on IVDD; proteins named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 567,
   "end": 754
  },
  "claim": {
   "protein_as_written": "COPS2",
   "gene": "COPS2",
   "disease_as_written": "IVDD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1545,
    "end": 1723
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2181,
    "end": 2338
   }
  }
 },
 {
  "pmid": "40747309",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR (UKB-PPP) of plasma proteins on diabetic retinopathy; conclusions call LAT2 protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1682,
   "end": 1838
  },
  "claim": {
   "protein_as_written": "LAT2",
   "gene": "LAT2",
   "disease_as_written": "diabetic retinopathy",
   "direction": "lowers",
   "estimate": {
    "or": 0.358,
    "low": 0.215,
    "high": 0.597,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1682,
    "end": 1838
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.8546,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1228,
    "end": 1350
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40748365",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Besides the glucose-weighted GCK/GCKR exposures, the MR includes inflammatory proteins instrumented by pQTLs as mediators, but the abstract gives no protein's own effect on a GI disease, so no counting pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1399,
   "end": 1534
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40751156",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UKB-PPP plasma protein PWAS and MR on 26 CVDs; PROC and venous thromboembolism are named without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1112,
   "end": 1264
  },
  "claim": {
   "protein_as_written": "PROC",
   "gene": "PROC",
   "disease_as_written": "venous thromboembolism",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1402,
    "end": 1493
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40751857",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Multi-omics MR whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 447,
   "end": 676
  },
  "claim": {
   "protein_as_written": "BET1L",
   "gene": "BET1L",
   "disease_as_written": "meningiomas",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 918,
    "end": 1211
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 918,
    "end": 1211
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40751895",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 plasma proteins on rheumatoid arthritis with EPHA3 as a risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 357,
   "end": 529
  },
  "claim": {
   "protein_as_written": "EPHA3",
   "gene": "EPHA3",
   "disease_as_written": "RA",
   "direction": "raises",
   "estimate": {
    "or": 1.312,
    "low": 1.102,
    "high": 1.562,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1404,
    "end": 1587
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40752706",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The druggable MR screen is said to identify FYN as glyphosate's target; no protein-disease pair from MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 228,
   "end": 381
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40754897",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR includes circulating protein levels on prostate cancer; SCP2 at the circulating protein level raises risk, matching the conclusion's directed pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1778,
   "end": 1882
  },
  "claim": {
   "protein_as_written": "SCP2",
   "gene": "SCP2",
   "disease_as_written": "PCa",
   "direction": "raises",
   "estimate": {
    "or": 2.1,
    "low": 1.34,
    "high": 3.29,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1778,
    "end": 1882
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40756183",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A GWAS of plasma HRG; no MR of a protein on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1694,
   "end": 1965
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40758327",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are gut microbiome traits; plasma proteins are outcomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 305,
   "end": 684
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40760551",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on osteonecrosis; conclusions name CDCP1 first without direction, results give OR 1.23.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 501,
   "end": 658
  },
  "claim": {
   "protein_as_written": "CDCP1",
   "gene": "CDCP1",
   "disease_as_written": "osteonecrosis",
   "direction": "raises",
   "estimate": {
    "or": 1.23,
    "low": 1.01,
    "high": 1.5,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1018,
    "end": 1154
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40760855",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UKB-PPP plasma GFAP instruments; higher GFAP raises encephalitis risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1562,
   "end": 1812
  },
  "claim": {
   "protein_as_written": "GFAP",
   "gene": "GFAP",
   "disease_as_written": "encephalitis",
   "direction": "raises",
   "estimate": {
    "or": 2.52,
    "low": 1.67,
    "high": 3.47,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1562,
    "end": 1812
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40761792",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "No MR of a circulating protein on sepsis; metabolite-protein interaction mapping.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 414,
   "end": 748
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40762097",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins were exposures, but no named protein is paired with AAA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1134,
   "end": 1348
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40763690",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The genes come from overlapping SMR of mQTL, eQTL, and pQTL, and the abstract doesn't tie them to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1080,
   "end": 1368
  },
  "claim": {
   "protein_as_written": "TIE1",
   "gene": "TIE1",
   "disease_as_written": "TMD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1759,
    "end": 1965
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1080,
    "end": 1368
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1759,
    "end": 1965
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40764749",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of druggable genes on osteoporosis without naming the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 299,
   "end": 448
  },
  "claim": {
   "protein_as_written": "FMO4",
   "gene": "FMO4",
   "disease_as_written": "osteoporosis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 822,
    "end": 975
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40765098",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by variants weighted by LDL cholesterol.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 739,
   "end": 849
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40768106",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Pooled eQTL/pQTL analyses, but results give each target's blood pQTL estimate separately.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1426,
   "end": 2073
  },
  "claim": {
   "protein_as_written": "ULK3",
   "gene": "ULK3",
   "disease_as_written": "CPPD disease",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1426,
    "end": 2073
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1350,
    "end": 1425
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2463,
    "end": 2560
   }
  }
 },
 {
  "pmid": "40769382",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants taken from the Global Lipids Genetics Consortium, i.e. weighted by lipid levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 433,
   "end": 717
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40770693",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pooling mQTL, eQTL and pQTL; the pair is not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1031,
   "end": 1208
  },
  "claim": {
   "protein_as_written": "ATAD3A",
   "gene": "ATAD3A",
   "disease_as_written": "multiple myositis",
   "direction": "raises",
   "estimate": {
    "or": 1.41,
    "low": 1.13,
    "high": 1.76,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1291,
    "end": 1539
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40775174",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Genes identified from pooled eQTL and pQTL databases; the CANT1-scoliosis pair is not tied to a circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 698,
   "end": 819
  },
  "claim": {
   "protein_as_written": "CANT1",
   "gene": "CANT1",
   "disease_as_written": "scoliosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1968,
    "end": 2089
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1501,
    "end": 1577
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1968,
    "end": 2089
   }
  }
 },
 {
  "pmid": "40775364",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "TRP channel exposures are eQTLGen expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 420,
   "end": 520
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40777745",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR and colocalization highlight seven unnamed genes; no protein-disease pair from protein MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 881,
   "end": 999
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40778120",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from CKD to protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1888,
   "end": 2032
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40780050",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Targets assessed through genetically predicted gene expression, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 727,
   "end": 958
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40784413",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The proteins' MR estimates are reported for the three disorders jointly, with no protein paired with a named disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1009,
   "end": 1227
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40788656",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The named protein-T1D associations come from GATE scores; MR support is given only as a count, with no named pair attributed to MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 884,
   "end": 1054
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40789551",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The MR exposure is \"genetic predisposition toward S100B\"; its instruments are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 990,
   "end": 1088
  },
  "claim": {
   "protein_as_written": "S100B",
   "gene": "S100B",
   "disease_as_written": "HF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 990,
    "end": 1088
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1434,
    "end": 1493
   }
  }
 },
 {
  "pmid": "40789559",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is abdominal aortic calcification from a UK Biobank GWAS, an imaging finding rather than a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 446,
   "end": 727
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40789825",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of proteins from a proteomic study; abstract names neither circulating level nor instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1111,
   "end": 1248
  },
  "claim": {
   "protein_as_written": "STX7",
   "gene": "STX7",
   "disease_as_written": "E-PDAC",
   "direction": "raises",
   "estimate": {
    "or": 1.26,
    "low": 1.03,
    "high": 1.54,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1249,
    "end": 1468
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40792569",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is pulse pressure, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 712,
   "end": 914
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40793967",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are lipid traits, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 273,
   "end": 594
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40796333",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "PWAS and MR of UKB-PPP plasma pQTLs on T2DM; no direction is given, so the first protein named, HYOU1, is the unsigned claim.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 295,
   "end": 551
  },
  "claim": {
   "protein_as_written": "HYOU1",
   "gene": "HYOU1",
   "disease_as_written": "T2DM",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 671,
    "end": 836
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 552,
    "end": 670
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40796935",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Instruments are kidney tissue pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 565,
   "end": 759
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40797068",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Among its analyses, MR of circulating plasma PCSK9 protein levels on CAVS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 852,
   "end": 999
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "CAVS",
   "direction": "raises",
   "estimate": {
    "or": 0.86,
    "low": 0.83,
    "high": 0.88,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1501,
    "end": 1781
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1314,
    "end": 1500
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1314,
    "end": 1500
   }
  }
 },
 {
  "pmid": "40808423",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets (ACLY, PCSK9) proxied through LDL cholesterol lowering.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1340,
   "end": 1605
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40808471",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SGLT2 inhibition instrumented by SNPs near SLC5A2 ('variants in the gene'), instruments not named as protein-level ones.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 502,
   "end": 706
  },
  "claim": {
   "protein_as_written": "SGLT2i",
   "gene": "SLC5A2",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "or": 0.77,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1070,
    "end": 1342
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1343,
    "end": 1388
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 143,
    "end": 257
   }
  }
 },
 {
  "pmid": "40809993",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Among its MR exposures is C-reactive protein, a circulating protein, with a causal effect on peripheral artery disease stated without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1017,
   "end": 1209
  },
  "claim": {
   "protein_as_written": "C-reactive protein",
   "gene": "CRP",
   "disease_as_written": "peripheral artery disease",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1017,
    "end": 1209
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40810909",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on ITP from FinnGen; conclusions name DNAJC21 and NOTCH3 without direction, results give DNAJC21 as a risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 328,
   "end": 496
  },
  "claim": {
   "protein_as_written": "DNAJC21",
   "gene": "DNAJC21",
   "disease_as_written": "ITP",
   "direction": "raises",
   "estimate": {
    "or": 2.417,
    "low": 1.391,
    "high": 4.2,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1145,
    "end": 1352
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1665,
    "end": 1770
   }
  }
 },
 {
  "pmid": "40813130",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP circulating proteins on MS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 398,
   "end": 709
  },
  "claim": {
   "protein_as_written": "CD8A",
   "gene": "CD8A",
   "disease_as_written": "MS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1306,
    "end": 1520
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40818497",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by variants associated with lipid levels (GLGC), i.e. biomarker-weighted.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 547,
   "end": 676
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40820167",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Protein-level SMR uses pQTLs pooled across blood, cerebrospinal fluid and brain without saying which tissue gave each protein's estimate.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 343,
   "end": 480
  },
  "claim": {
   "protein_as_written": "TMEM106B",
   "gene": "TMEM106B",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "or": 1.44,
    "low": 1.24,
    "high": 1.68,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1492,
    "end": 1817
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.96,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1343,
    "end": 1491
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40820226",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Druggable-genome MR pools eQTL and pQTL.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 254,
   "end": 469
  },
  "claim": {
   "protein_as_written": "CPA4",
   "gene": "CPA4",
   "disease_as_written": "bladder cancer",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1121,
    "end": 1225
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40820458",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR instruments are drug target gene expression in blood and brain, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 790,
   "end": 942
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40823340",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of APOE and IL10RB, which the conclusion ties to plasma proteins causally linked to ADRD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1058,
   "end": 1212
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "ADRD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 727,
    "end": 865
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40823507",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with pQTL data identifies ICAM1 as a causal protein for psoriasis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 531,
   "end": 707
  },
  "claim": {
   "protein_as_written": "ICAM1",
   "gene": "ICAM1",
   "disease_as_written": "psoriasis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1623,
    "end": 1756
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40826785",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The named proteins come from enrichment and network analysis, and the abstract never states them as MR results on SLE, so no counting pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 405,
   "end": 708
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40827246",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are ubiquitin-related genes, and the abstract doesn't name their instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 434,
   "end": 611
  },
  "claim": {
   "protein_as_written": "IFNGR1",
   "gene": "IFNGR1",
   "disease_as_written": "keloid",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1239,
    "end": 1308
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 114
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40827287",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of deCODE plasma pQTLs on POAG.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 490,
   "end": 662
  },
  "claim": {
   "protein_as_written": "SVEP1",
   "gene": "SVEP1",
   "disease_as_written": "POAG",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1512,
    "end": 1646
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1846,
    "end": 1934
   }
  }
 },
 {
  "pmid": "40830297",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins enter only as mediators of zinc's effect on DKD; no protein's own effect on DKD is stated, so no counting pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1514,
   "end": 1672
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40831791",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are druggable genes instrumented by blood eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 473,
   "end": 585
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40832429",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR concerns sleep and disease; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1182,
   "end": 1406
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40832708",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40833086",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The one pQTL associated with CAD is not named; the named genes come from mQTL and eQTL analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1015,
   "end": 1110
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40834945",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of 'TEK' on GBM risk without naming the instruments (expression or protein).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 647,
   "end": 835
  },
  "claim": {
   "protein_as_written": "TEK",
   "gene": "TEK",
   "disease_as_written": "GBM",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 647,
    "end": 835
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1358,
    "end": 1566
   }
  }
 },
 {
  "pmid": "40835971",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are unnamed 'baseline molecules' and outcomes are immune responses; no circulating protein's effect on a disease is estimated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 696,
   "end": 879
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40841572",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs of anti-allergic drug targets.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 334,
   "end": 583
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40842128",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The ZDHHC20 pair rests on 'expression' from MR that pools eQTL, pQTL, and mQTL, without saying which kind of QTL gave it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 605,
   "end": 783
  },
  "claim": {
   "protein_as_written": "ZDHHC20",
   "gene": "ZDHHC20",
   "disease_as_written": "schizophrenia",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1241,
    "end": 1406
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1849,
    "end": 2070
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40848829",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR on delirium, but no protein is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 873,
   "end": 962
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40849109",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Blood pQTL SMR ties ACADVL's protein level to schizophrenia, apart from its methylation and expression; higher protein levels are protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 993,
   "end": 1128
  },
  "claim": {
   "protein_as_written": "ACADVL",
   "gene": "ACADVL",
   "disease_as_written": "schizophrenia",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 993,
    "end": 1128
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1548,
    "end": 1608
   }
  }
 },
 {
  "pmid": "40849856",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug target MR based on eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 801,
   "end": 966
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40853154",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "No abstract in the record (a commentary).",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40853405",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR uses eQTL (gene expression) instruments only.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 598,
   "end": 730
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40853611",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Targets come from eQTL MR validated by SMR and pQTL analysis; the pair is not tied to a circulating protein's MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 757,
   "end": 924
  },
  "claim": {
   "protein_as_written": "CYTL1",
   "gene": "CYTL1",
   "disease_as_written": "mesothelioma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2026,
    "end": 2117
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2118,
    "end": 2270
   }
  }
 },
 {
  "pmid": "40854907",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are brain-tissue eQTLs and pQTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 352,
   "end": 581
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40855041",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory proteins on ICH.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 610,
   "end": 724
  },
  "claim": {
   "protein_as_written": "Axin1",
   "gene": "AXIN1",
   "disease_as_written": "ICH",
   "direction": "lowers",
   "estimate": {
    "or": 0.77,
    "low": 0.61,
    "high": 0.96,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1270,
    "end": 1680
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2821,
    "end": 3010
   }
  }
 },
 {
  "pmid": "40855105",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR integrated cis-pQTL and cis-eQTL data; the CTSS pair is not tied to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 219,
   "end": 419
  },
  "claim": {
   "protein_as_written": "CTSS",
   "gene": "CTSS",
   "disease_as_written": "postoperative abdominal wall hernia",
   "direction": "raises",
   "estimate": {
    "frame": "per higher protein",
    "high": 1.2,
    "low": 1.06,
    "unit": "not stated",
    "or": 1.13
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1390,
    "end": 1534
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1126,
    "end": 1220
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1390,
    "end": 1534
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40855239",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The TREM1 finding comes from analyses pooling mQTLs, cis-eQTLs, and pQTLs and rests on 'TREM1 expression', not tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 421,
   "end": 976
  },
  "claim": {
   "protein_as_written": "TREM1",
   "gene": "TREM1",
   "disease_as_written": "CrNEN",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1078,
    "end": 1218
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2192,
    "end": 2324
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40855282",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with pQTLs identified proteins associated with CRC; the abstract ties CCM2 to protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1137,
   "end": 1270
  },
  "claim": {
   "protein_as_written": "CCM2",
   "gene": "CCM2",
   "disease_as_written": "CRC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1377,
    "end": 1479
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.857,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1480,
    "end": 1596
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40856249",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma protein levels (deCODE) on vitiligo.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 845,
   "end": 1062
  },
  "claim": {
   "protein_as_written": "HERC4",
   "gene": "HERC4",
   "disease_as_written": "vitiligo",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1750,
    "end": 1891
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1750,
    "end": 1891
   }
  }
 },
 {
  "pmid": "40858495",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 252,
   "end": 425
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40859530",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of protein levels from pQTL data on KOA, the plasma biomarker ECM1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 715,
   "end": 931
  },
  "claim": {
   "protein_as_written": "ECM1",
   "gene": "ECM1",
   "disease_as_written": "KOA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1506,
    "end": 1637
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1182,
    "end": 1294
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1182,
    "end": 1294
   }
  }
 },
 {
  "pmid": "40859556",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are skimmed milk and serum metabolites; drug targets come from SMR of genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 202,
   "end": 370
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40859561",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools eQTL, pQTL and mQTL, and the abstract doesn't tie the OA genes to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 422,
   "end": 749
  },
  "claim": {
   "protein_as_written": "USP8",
   "gene": "USP8",
   "disease_as_written": "OA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1064,
    "end": 1166
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1911,
    "end": 1975
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40859573",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Pairs come from MR of differentially expressed genes validated across eQTL MR, eQTL SMR, and pQTL MR, pooling kinds of QTL; instruments for the claim are not tied to circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 631,
   "end": 839
  },
  "claim": {
   "protein_as_written": "CPPED1",
   "gene": "CPPED1",
   "disease_as_written": "squamous carcinoma",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 840,
    "end": 1029
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40860620",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are named only as mediators of obesity's effects, without their own effect on the disease; the direct protein-disease associations name no protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1887,
   "end": 2024
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40864544",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on Alzheimer's disease; the conclusions name five proteins without a direction, so the first of them (TSLP) takes its direction from the results.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1893,
   "end": 2050
  },
  "claim": {
   "protein_as_written": "TSLP",
   "gene": "TSLP",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "or": 1.1,
    "low": 1.01,
    "high": 1.19,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 952,
    "end": 1317
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2051,
    "end": 2248
   }
  }
 },
 {
  "pmid": "40865676",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL genes reported only as a count; no protein-disease pair named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 648,
   "end": 939
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40865775",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 66 mitochondria-associated proteins (GWAS of 3301 Europeans) on MDD; first pair with a direction is TruA, OR 0.98.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1153,
   "end": 1324
  },
  "claim": {
   "protein_as_written": "TruA",
   "gene": "PUS1",
   "disease_as_written": "MDD",
   "direction": "lowers",
   "estimate": {
    "or": 0.98,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1153,
    "end": 1324
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40866154",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with UKB-PPP and deCODE plasma pQTLs on chronic pancreatitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 387,
   "end": 532
  },
  "claim": {
   "protein_as_written": "CST3",
   "gene": "CST3",
   "disease_as_written": "CP",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1202,
    "end": 1420
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1202,
    "end": 1420
   }
  }
 },
 {
  "pmid": "40868097",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR on RA, but no protein is named in a protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1307,
   "end": 1378
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40873177",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools eQTL and pQTL data, and the shared signals are not tied to the circulating protein analysis; no direction is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 645,
   "end": 782
  },
  "claim": {
   "protein_as_written": "ADAMTS4",
   "gene": "ADAMTS4",
   "disease_as_written": "T2DM",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1356,
    "end": 1467
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40873285",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "GCHFR comes from SMR across TWAS weights pooling plasma protein with tissue and single-cell expression; the abstract does not tie it to the plasma protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 748,
   "end": 914
  },
  "claim": {
   "protein_as_written": "GCHFR",
   "gene": "GCHFR",
   "disease_as_written": "IPF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1981,
    "end": 2053
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1535,
    "end": 1621
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40874865",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of 'genetically proxied GLP-1RAs' (receptor agonism) without naming the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 382,
   "end": 526
  },
  "claim": {
   "protein_as_written": "GLP-1RAs",
   "gene": "GLP1R",
   "disease_as_written": "acute pancreatitis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 382,
    "end": 526
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 382,
    "end": 526
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40877285",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Sex-stratified MR with plasma SD-pQTLs on dementia; NCAM1 named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1725,
   "end": 1900
  },
  "claim": {
   "protein_as_written": "NCAM1",
   "gene": "NCAM1",
   "disease_as_written": "dementia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1725,
    "end": 1900
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40877637",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on ovarian cancer and subtypes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 285,
   "end": 563
  },
  "claim": {
   "protein_as_written": "follitropin subunit beta (FSHB)",
   "gene": "FSHB",
   "disease_as_written": "endometrioid OC",
   "direction": "raises",
   "estimate": {
    "or": 2.41,
    "low": 1.56,
    "high": 3.71,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 867,
    "end": 987
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40878475",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The pQTL SMR found three pQTLs associated with T2DM but names no protein; the named findings (HSF1 expression, methylation) aren't protein MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1054,
   "end": 1246
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40881439",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pooling eQTLs, pQTLs, sQTLs and m6A-QTLs, tissue of pQTLs not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 502,
   "end": 803
  },
  "claim": {
   "protein_as_written": "METTL3",
   "gene": "METTL3",
   "disease_as_written": "AMD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1481,
    "end": 1607
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40881642",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PNPLA3 inhibition proxied by PNPLA3-region variants weighted by hepatic fat percentage.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 477,
   "end": 721
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40883583",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based MR and colocalisation of plasma proteins against complex traits, including type 2 diabetes; links stated without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 738,
   "end": 901
  },
  "claim": {
   "protein_as_written": "leukocyte receptor tyrosine kinase (LTK)",
   "gene": "LTK",
   "disease_as_written": "type-2 diabetes",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1088,
    "end": 1272
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 902,
    "end": 1087
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40883588",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UK Biobank plasma proteomics pQTLs on premature ovarian failure (FinnGen).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 699,
   "end": 869
  },
  "claim": {
   "protein_as_written": "TNXB",
   "gene": "TNXB",
   "disease_as_written": "POF",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1827,
    "end": 1880
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1708,
    "end": 1826
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40888248",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating proteins on diabetes subtypes; colocalised pairs named without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1325,
   "end": 1463
  },
  "claim": {
   "protein_as_written": "GRN",
   "gene": "GRN",
   "disease_as_written": "MARD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1464,
    "end": 1615
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1464,
    "end": 1615
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40888559",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The analysis integrates eQTL and pQTL data, and the DKK3-ED pair is not tied to a circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 385,
   "end": 619
  },
  "claim": {
   "protein_as_written": "DKK3",
   "gene": "DKK3",
   "disease_as_written": "ED",
   "direction": "lowers",
   "estimate": {
    "or": 0.8555,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 912,
    "end": 1069
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1509,
    "end": 1747
   }
  }
 },
 {
  "pmid": "40890957",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "TSMR and SMR of serum proteins on rosacea.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 535,
   "end": 729
  },
  "claim": {
   "protein_as_written": "ABHD14B",
   "gene": "ABHD14B",
   "disease_as_written": "rosacea",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 861,
    "end": 1071
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40891821",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcomes are LVEF and volume, quantitative traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1753,
   "end": 1869
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40892678",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma protein levels on SLE.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 359,
   "end": 602
  },
  "claim": {
   "protein_as_written": "ATG4B",
   "gene": "ATG4B",
   "disease_as_written": "SLE",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1593,
    "end": 1779
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 914,
    "end": 1170
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 603,
    "end": 904
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1593,
    "end": 1779
   }
  }
 },
 {
  "pmid": "40893937",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on endometriosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 270,
   "end": 500
  },
  "claim": {
   "protein_as_written": "RSPO3",
   "gene": "RSPO3",
   "disease_as_written": "endometriosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 968,
    "end": 1107
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 744,
    "end": 847
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 968,
    "end": 1107
   }
  }
 },
 {
  "pmid": "40897285",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating FCRL3 protein on multiple sclerosis (OR 0.912), concluded protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1123,
   "end": 1432
  },
  "claim": {
   "protein_as_written": "Fc receptor-like 3 (FCRL3)",
   "gene": "FCRL3",
   "disease_as_written": "MS",
   "direction": "lowers",
   "estimate": {
    "or": 0.912,
    "low": 0.882,
    "high": 0.942,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1123,
    "end": 1432
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.915,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1433,
    "end": 1550
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1819,
    "end": 1968
   }
  }
 },
 {
  "pmid": "40898345",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "ERAP2 comes from an integrative omics pipeline whose only MR step described is an SMR of the ERAP2 gene's expression; the instruments for circulating ERAP2 are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1147,
   "end": 1383
  },
  "claim": {
   "protein_as_written": "ERAP2",
   "gene": "ERAP2",
   "disease_as_written": "JIA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1951,
    "end": 2169
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1951,
    "end": 2169
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40898453",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is bone mineral density, a measurement.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 277,
   "end": 480
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40898542",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "ApoA-I and apoB levels were exposures but the abstract states only a lumped null for lipid levels; gene pairs are LDL/TG-weighted drug-target proxies.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1220,
   "end": 1302
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40898824",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on IgA nephropathy; SNAP29 is a plasma risk factor (ETFDH is proxied by metformin target genes, not a circulating level).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 478,
   "end": 616
  },
  "claim": {
   "protein_as_written": "Synaptosome-associated protein 29",
   "gene": "SNAP29",
   "disease_as_written": "IgAN",
   "direction": "raises",
   "estimate": {
    "or": 1.118,
    "low": 1.025,
    "high": 1.218,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1269,
    "end": 1492
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40906170",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins, including NT5E, on myocarditis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1343,
   "end": 1467
  },
  "claim": {
   "protein_as_written": "NT5E",
   "gene": "NT5E",
   "disease_as_written": "myocarditis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1343,
    "end": 1467
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 570,
    "end": 701
   }
  }
 },
 {
  "pmid": "40908527",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are bone mineral density sites, a measurement, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 430,
   "end": 619
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40909825",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract reports only the share of protein-disease pairs with MR support and names no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 450,
   "end": 779
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40910294",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable genes are instrumented with eQTLGen expression QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 309,
   "end": 429
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40913361",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "deCODE circulating protein MR on periodontitis; conclusions name FGF2, AZGP1, BTC without direction, so the first with a direction in the results, FGF2 (OR 1.06), is the claim.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1404,
   "end": 1568
  },
  "claim": {
   "protein_as_written": "FGF2 (fibroblast growth factor 2)",
   "gene": "FGF2",
   "disease_as_written": "periodontitis",
   "direction": "raises",
   "estimate": {
    "or": 1.06,
    "low": 1.032,
    "high": 1.082,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 771,
    "end": 1097
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 493,
    "end": 602
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1404,
    "end": 1568
   }
  }
 },
 {
  "pmid": "40916281",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of 'core genes' on atherosclerosis; the abstract does not name the MR's instruments (deCODE pQTLs are mentioned only for identifying proteins).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1969,
   "end": 2303
  },
  "claim": {
   "protein_as_written": "CSF1R",
   "gene": "CSF1R",
   "disease_as_written": "AS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 3759,
    "end": 3837
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 4875,
    "end": 5126
   }
  }
 },
 {
  "pmid": "40919881",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of UK Biobank plasma proteins on myasthenia gravis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 925,
   "end": 1364
  },
  "claim": {
   "protein_as_written": "CEACAM8",
   "gene": "CEACAM8",
   "disease_as_written": "MG",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 925,
    "end": 1364
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40921788",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Instruments are brain pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 136,
   "end": 410
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40922238",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 inflammatory proteins from a pQTL study on prostate cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 559,
   "end": 812
  },
  "claim": {
   "protein_as_written": "Flt3L",
   "gene": "FLT3LG",
   "disease_as_written": "PCa",
   "direction": "raises",
   "estimate": {
    "or": 1.0016,
    "low": 1,
    "high": 1.0032,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2093,
    "end": 2225
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40922322",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets (including PCSK9) are proxied by variants associated with LDL cholesterol or triglycerides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 800,
   "end": 1070
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40923186",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Druggable-genome MR includes blood pQTLs; MMP12 from the blood pQTL analysis colocalised with IS; no direction given, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1113,
   "end": 1343
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "IS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1521,
    "end": 1648
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1113,
    "end": 1343
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1521,
    "end": 1648
   }
  }
 },
 {
  "pmid": "40927812",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Variants in and around target genes proxy inhibition; the abstract does not say they were weighted by a biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 784,
   "end": 927
  },
  "claim": {
   "protein_as_written": "Niemann-Pick C1-like 1",
   "gene": "NPC1L1",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": {
    "frame": "per lower protein",
    "high": 6.75,
    "low": 1.36,
    "unit": "not stated",
    "or": 3.03
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1009,
    "end": 1268
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1269,
    "end": 1368
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1009,
    "end": 1268
   }
  }
 },
 {
  "pmid": "40927895",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on CVDs; the only named MR pair is LPA with coronary artery disease, OR above 1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1064,
   "end": 1153
  },
  "claim": {
   "protein_as_written": "LPA",
   "gene": "LPA",
   "disease_as_written": "coronary artery disease",
   "direction": "raises",
   "estimate": {
    "or": 1.13,
    "low": 1.1,
    "high": 1.17,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1064,
    "end": 1347
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40930268",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 734 circulating plasma proteins on NMDAR encephalitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 418,
   "end": 634
  },
  "claim": {
   "protein_as_written": "SIRPA",
   "gene": "SIRPA",
   "disease_as_written": "NMDAR-E",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1638,
    "end": 1797
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2212,
    "end": 2412
   }
  }
 },
 {
  "pmid": "40931165",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "GIPR/GLP1R variants weighted by BMI or HbA1c lowering.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 985,
   "end": 1314
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40934270",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted circulating apolipoprotein A-1 level on sepsis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1967,
   "end": 2090
  },
  "claim": {
   "protein_as_written": "ApoA-1",
   "gene": "APOA1",
   "disease_as_written": "sepsis",
   "direction": "lowers",
   "estimate": {
    "or": 0.927,
    "low": 0.861,
    "high": 0.999,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1979,
    "end": 2090
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40934790",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "HMGCR proxied by a variant weighted by LDL cholesterol.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 731,
   "end": 874
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40934961",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "One-sample MR with UKB-PPP pQTLs and two-sample MR with deCODE pQTLs on CKD; ENPP6 protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2027,
   "end": 2308
  },
  "claim": {
   "protein_as_written": "ENPP6",
   "gene": "ENPP6",
   "disease_as_written": "CKD",
   "direction": "lowers",
   "estimate": {
    "or": 0.32,
    "low": 0.14,
    "high": 0.73,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2521,
    "end": 2779
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2780,
    "end": 2912
   }
  }
 },
 {
  "pmid": "40935427",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 4489 plasma proteins on VTDR; MMP8 named in conclusions without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 658,
   "end": 765
  },
  "claim": {
   "protein_as_written": "MMP8",
   "gene": "MMP8",
   "disease_as_written": "VTDR",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1586,
    "end": 1788
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1510,
    "end": 1585
   }
  }
 },
 {
  "pmid": "40938633",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR identified 20 causal biomarkers pooled across CpGs, proteins, and metabolites with instruments unnamed, and COLEC11 is attributed to cross-omics integration, not to MR, so no protein-diabetes pair from the protein's MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 911,
   "end": 1058
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40946247",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is mentioned only as validating unnamed core regulators. MMP3's prominence comes from network analyses, and the abstract states no protein-disease pair from MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 645,
   "end": 814
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40947455",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are gene expression of blood proteins via eQTLGen cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 672,
   "end": 789
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40949582",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 346,
   "end": 493
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40950430",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is said to support 84 proteins but no protein-disease pair from MR is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 974,
   "end": 1090
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40951528",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2,925 proteomic molecular biomarkers on MASLD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 428,
   "end": 603
  },
  "claim": {
   "protein_as_written": "CNPY4",
   "gene": "CNPY4",
   "disease_as_written": "MASLD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1878,
    "end": 2014
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40956419",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are ratios of protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 469,
   "end": 619
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40957584",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR using cis-pQTLs from UKB-PPP and deCODE on periodontitis; VEGFA's OR above 1 gives raises.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 738,
   "end": 859
  },
  "claim": {
   "protein_as_written": "VEGFA",
   "gene": "VEGFA",
   "disease_as_written": "periodontitis",
   "direction": "raises",
   "estimate": {
    "or": 1.043,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1205,
    "end": 1310
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40958290",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are immune cell signatures.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 507,
   "end": 702
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40958295",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are six liver biomarkers, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 404,
   "end": 737
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40958296",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Lactylation-related genes instrumented by eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 870,
   "end": 1031
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40958306",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL; the gene-cholelithiasis pairs rest on integrated omics not tied to circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 637,
   "end": 836
  },
  "claim": {
   "protein_as_written": "LIAS",
   "gene": "LIAS",
   "disease_as_written": "cholelithiasis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1214,
    "end": 1474
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1214,
    "end": 1474
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1910,
    "end": 2031
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "40966854",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract reports only counts of genes and proteins from pooled brain and blood MR, naming no protein paired with PAU.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 839,
   "end": 975
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40974265",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteomic MR with pQTLs on AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1162,
   "end": 1270
  },
  "claim": {
   "protein_as_written": "LILRB1",
   "gene": "LILRB1",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1393,
    "end": 1536
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1271,
    "end": 1392
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2125,
    "end": 2322
   }
  }
 },
 {
  "pmid": "40981245",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of PCSK9 inhibition (instruments not named, so E2 is unsettled rather than failed) on memory loss, a reported adverse event or symptom, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 725,
   "end": 853
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40988181",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating plasma proteins on cerebral palsy; CD5 named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1099,
   "end": 1218
  },
  "claim": {
   "protein_as_written": "CD5",
   "gene": "CD5",
   "disease_as_written": "CP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1382,
    "end": 1669
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 0,
    "end": 130
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1382,
    "end": 1669
   }
  }
 },
 {
  "pmid": "40988203",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins (UKB-PPP) MR on cutaneous melanoma; DPEP1 inverse with CM in results (conclusions name no protein).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 961,
   "end": 1119
  },
  "claim": {
   "protein_as_written": "dipeptidase 1",
   "gene": "DPEP1",
   "disease_as_written": "CM",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1120,
    "end": 1240
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1120,
    "end": 1240
   }
  }
 },
 {
  "pmid": "40988230",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR on functional dyspepsia, but the abstract names no protein in any MR pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1078,
   "end": 1137
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40988251",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins appear only as mediators with no own effect on the disease stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1265,
   "end": 1383
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40988970",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on allergic rhinitis; no direction given (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 469,
   "end": 616
  },
  "claim": {
   "protein_as_written": "IL-4",
   "gene": "IL4",
   "disease_as_written": "AR",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1734,
    "end": 1883
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1884,
    "end": 2082
   }
  }
 },
 {
  "pmid": "40991151",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma proteins on preeclampsia and other outcomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 642,
   "end": 722
  },
  "claim": {
   "protein_as_written": "SERPINE2",
   "gene": "SERPINE2",
   "disease_as_written": "preeclampsia",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1231,
    "end": 1331
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40992936",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UK Biobank plasma proteins on COPD; ADM named protective first.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1532,
   "end": 1627
  },
  "claim": {
   "protein_as_written": "ADM",
   "gene": "ADM",
   "disease_as_written": "COPD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1532,
    "end": 1627
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "40994391",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are plasma protein ratios.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 342,
   "end": 413
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40994653",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 542,
   "end": 946
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40994779",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with plasma cis-pQTLs on PCOS; conclusions name FGF23 first, results give its positive direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1138,
   "end": 1320
  },
  "claim": {
   "protein_as_written": "FGF23",
   "gene": "FGF23",
   "disease_as_written": "PCOS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1138,
    "end": 1320
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1007,
    "end": 1137
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1334,
    "end": 1498
   }
  }
 },
 {
  "pmid": "40996707",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A database resource; it estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 547,
   "end": 691
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "40996951",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on RA; six proteins pass colocalization and SMR, without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1170,
   "end": 1245
  },
  "claim": {
   "protein_as_written": "FCRL3",
   "gene": "FCRL3",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1246,
    "end": 1445
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1246,
    "end": 1445
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1246,
    "end": 1445
   }
  }
 },
 {
  "pmid": "41001433",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposure is LPL 'activation' as a lipid-modifying drug target, instruments not named in the abstract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1162,
   "end": 1409
  },
  "claim": {
   "protein_as_written": "LPL",
   "gene": "LPL",
   "disease_as_written": "gout",
   "direction": "lowers",
   "estimate": {
    "or": 0.84,
    "low": 0.76,
    "high": 0.93,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1609,
    "end": 1768
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1410,
    "end": 1469
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1609,
    "end": 1768
   }
  }
 },
 {
  "pmid": "41004220",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of drug target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 566,
   "end": 912
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41005615",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Multiomics MR on quantitative trait loci for druggable genes, not naming which kind of QTL gave CTSS; full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 498,
   "end": 703
  },
  "claim": {
   "protein_as_written": "CTSS",
   "gene": "CTSS",
   "disease_as_written": "vitiligo",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1677,
    "end": 1751
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1677,
    "end": 1751
   }
  }
 },
 {
  "pmid": "41006511",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with pQTLs of plasma proteins (and ratios) on nephrolithiasis; BTN3A2 is a single protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 345,
   "end": 580
  },
  "claim": {
   "protein_as_written": "BTN3A2",
   "gene": "BTN3A2",
   "disease_as_written": "nephrolithiasis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1444,
    "end": 1607
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1444,
    "end": 1607
   }
  }
 },
 {
  "pmid": "41011137",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from Meniere's disease to metabolic, immune and inflammatory traits; no protein is an exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2049,
   "end": 2290
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41016013",
  "eligibility": "E5",
  "e2_kind": null,
  "eligibility_reason": "A methods paper proposing a new MR method, with plasma proteins on stroke as an application.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 713,
   "end": 849
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41020923",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is PUFA metabolism, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 699,
   "end": 796
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41021077",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR is run separately on methylation, expression and protein QTLs, and the abstract ties POGLUT3 to the protein-level analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1677,
   "end": 1831
  },
  "claim": {
   "protein_as_written": "POGLUT3",
   "gene": "POGLUT3",
   "disease_as_written": "LUAD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2145,
    "end": 2327
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41021153",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 831,
   "end": 1075
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41023518",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug target genes are instrumented with eQTLs; other exposures are drug use, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1065,
   "end": 1309
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41025730",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on chronic widespread pain; pairs given without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 997,
   "end": 1268
  },
  "claim": {
   "protein_as_written": "CA14",
   "gene": "CA14",
   "disease_as_written": "CWP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 997,
    "end": 1268
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 997,
    "end": 1268
   }
  }
 },
 {
  "pmid": "41027922",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR validates SH2B3, but the abstract names no disease paired with it from that MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 966,
   "end": 1099
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41029098",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs of druggable genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 599,
   "end": 797
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41029138",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are gut microbiota with metabolite mediators; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 655,
   "end": 878
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41029142",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically elevated plasma complement protein levels on IgAN; conclusions give no direction, the first directed result is CFHR1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 950,
   "end": 1231
  },
  "claim": {
   "protein_as_written": "complement factor H-related protein 1 (CFHR1)",
   "gene": "CFHR1",
   "disease_as_written": "IgAN",
   "direction": "raises",
   "estimate": {
    "or": 1.239,
    "low": 1.084,
    "high": 1.417,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 950,
    "end": 1231
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1768,
    "end": 1877
   }
  }
 },
 {
  "pmid": "41029154",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are blood eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 500,
   "end": 744
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41029162",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating apolipoproteins and inflammatory proteins on gallstone disease; first protein pair with direction in results is ApoA1 lowering GSD risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1086,
   "end": 1337
  },
  "claim": {
   "protein_as_written": "apolipoprotein A1",
   "gene": "APOA1",
   "disease_as_written": "GSD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1086,
    "end": 1337
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41029168",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of genes on HCC that doesn't say whether the instruments are eQTLs or pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 297,
   "end": 396
  },
  "claim": {
   "protein_as_written": "HLA-DPA1",
   "gene": "HLA-DPA1",
   "disease_as_written": "HCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 695,
    "end": 983
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 695,
    "end": 983
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 695,
    "end": 983
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41029193",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are single-cell eQTLs of immune cell genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 514,
   "end": 735
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41029778",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The MR pools RNA-seq, eQTL, and pQTL data, and the abstract doesn't tie CPXM1's result to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 440,
   "end": 680
  },
  "claim": {
   "protein_as_written": "CPXM1 (Carboxypeptidase X, M14 family member 1)",
   "gene": "CPXM1",
   "disease_as_written": "osteoporosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 681,
    "end": 856
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1602,
    "end": 1728
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41030199",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (Fenland pQTLs) on inflammatory bowel disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 307,
   "end": 462
  },
  "claim": {
   "protein_as_written": "glucokinase regulatory protein (GCKR)",
   "gene": "GCKR",
   "disease_as_written": "IBD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1257,
    "end": 1460
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1257,
    "end": 1460
   }
  }
 },
 {
  "pmid": "41036470",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR (UKB-PPP, deCODE) with two-step MR; the mediation result states that lower KIAA0319 raises AD risk through PMM2.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 517,
   "end": 743
  },
  "claim": {
   "protein_as_written": "KIAA0319",
   "gene": "KIAA0319",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1555,
    "end": 1777
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1896,
    "end": 1978
   }
  }
 },
 {
  "pmid": "41039543",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures on colorectal cancer are plasma miRNAs; proteins are only outcomes of miRNAs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 406,
   "end": 640
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41047677",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins (Olink) on DLBCL; IL-10 first risk-increasing pair with OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 600,
   "end": 688
  },
  "claim": {
   "protein_as_written": "IL-10",
   "gene": "IL10",
   "disease_as_written": "DLBCL",
   "direction": "raises",
   "estimate": {
    "or": 1.46,
    "low": 1.05,
    "high": 2.03,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 938,
    "end": 1126
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41048997",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are paired only with the class 'hematological tumors', with no member disease named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 963,
   "end": 1147
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41049004",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Genes tested by drug target MR and SMR whose instruments the abstract does not name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1149,
   "end": 1350
  },
  "claim": {
   "protein_as_written": "FAM120A",
   "gene": "FAM120A",
   "disease_as_written": "CRC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1149,
    "end": 1350
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41049388",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins run on asthma (5 FinnGen R12 asthma cohorts) names seven causal plasma proteins, an unsigned pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1070,
   "end": 1253
  },
  "claim": {
   "protein_as_written": "GRAMD1C",
   "gene": "GRAMD1C",
   "disease_as_written": "asthma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1070,
    "end": 1253
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41050057",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is between FN-BMD and hip osteoarthritis; proteomic analyses are PWAS/BLISS, not MR of protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 375,
   "end": 503
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41053817",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR pooled eQTL, pQTL and mQTL; the pair isn't tied to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 566,
   "end": 839
  },
  "claim": {
   "protein_as_written": "C4BPA",
   "gene": "C4BPA",
   "disease_as_written": "NSCLC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1150,
    "end": 1346
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1600,
    "end": 1724
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41054850",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating ACE2 (UKB-PPP plasma protein) on disease; conclusions state ACE2 causally protective for hypertension.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1938,
   "end": 2051
  },
  "claim": {
   "protein_as_written": "ACE2",
   "gene": "ACE2",
   "disease_as_written": "hypertension",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2065,
    "end": 2225
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2226,
    "end": 2329
   }
  }
 },
 {
  "pmid": "41056018",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is muscle fatty infiltration measured on MRI, an imaging trait, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 497,
   "end": 623
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41060444",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with instruments for 734 plasma proteins on intracranial aneurysms; RELT is a plasma protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 516,
   "end": 660
  },
  "claim": {
   "protein_as_written": "RELT",
   "gene": "RELT",
   "disease_as_written": "unruptured intracranial aneurysms",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 958,
    "end": 1109
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 820,
    "end": 957
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41063246",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of circulating proteins on T2D; PAM named in the interpretation with no MR direction anywhere, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 395,
   "end": 576
  },
  "claim": {
   "protein_as_written": "PAM",
   "gene": "PAM",
   "disease_as_written": "T2D",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1998,
    "end": 2174
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 910,
    "end": 1081
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1998,
    "end": 2174
   }
  }
 },
 {
  "pmid": "41063934",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug classes proxied by systolic blood pressure variants near target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 787,
   "end": 913
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41064534",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UKB-PPP plasma proteins on dry AMD; no direction given for any protein, first named prioritized protein is C3.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 433,
   "end": 638
  },
  "claim": {
   "protein_as_written": "C3",
   "gene": "C3",
   "disease_as_written": "dry AMD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1396,
    "end": 1552
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 639,
    "end": 825
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1396,
    "end": 1552
   }
  }
 },
 {
  "pmid": "41065563",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2007 plasma proteins on CAD and stroke; FURIN-stroke is the first definite pair, given no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 499,
   "end": 689
  },
  "claim": {
   "protein_as_written": "FURIN",
   "gene": "FURIN",
   "disease_as_written": "stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1459,
    "end": 1616
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1242,
    "end": 1458
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41065954",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "deCODE blood pQTL MR on osteoporosis, but no protein is named with its own effect on OP; MDM4 appears only as a mediator without its own effect stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1299,
   "end": 1405
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41067469",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4185 plasma proteins (pQTL) on Brugada syndrome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 715,
   "end": 841
  },
  "claim": {
   "protein_as_written": "HSPB1",
   "gene": "HSPB1",
   "disease_as_written": "BrS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1476,
    "end": 1607
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41071635",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Targets validated across eQTLgen, deCODE and Fenland pool expression and protein QTLs; not tied to the protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1085,
   "end": 1198
  },
  "claim": {
   "protein_as_written": "ART4",
   "gene": "ART4",
   "disease_as_written": "osteosarcopenia",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1614,
    "end": 1759
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41072314",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The abstract gives protein-level SMR results apart from the expression and methylation ones, and gives CD14's protein-level OR on T2DM separately.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1225,
   "end": 1336
  },
  "claim": {
   "protein_as_written": "CD14",
   "gene": "CD14",
   "disease_as_written": "T2DM",
   "direction": "raises",
   "estimate": {
    "or": 1.04,
    "low": 1.01,
    "high": 1.08,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1337,
    "end": 1532
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41076317",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "SMR uses deCODE plasma pQTLs, but the outcome, salt sensitivity of blood pressure, is a phenotype (a measured response), not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 219,
   "end": 360
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41077041",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MVMR and SMR identify SLC7A5 for arterial embolism and thrombosis, and the abstract doesn't name the instruments; cis-pQTL mapping is mentioned only as validation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 683,
   "end": 949
  },
  "claim": {
   "protein_as_written": "solute carrier family 7 member 5 (SLC7A5)",
   "gene": "SLC7A5",
   "disease_as_written": "arterial embolism and thrombosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1700,
    "end": 1870
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.91,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 950,
    "end": 1182
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1700,
    "end": 1870
   }
  }
 },
 {
  "pmid": "41078897",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug targets instrumented by lipid-associated variants from the Global Lipid Consortium.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 517,
   "end": 688
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41079190",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of druggable proteins on diabetic retinopathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2389,
   "end": 2518
  },
  "claim": {
   "protein_as_written": "NOG protein",
   "gene": "NOG",
   "disease_as_written": "DR",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2389,
    "end": 2518
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1892,
    "end": 2084
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2389,
    "end": 2518
   }
  }
 },
 {
  "pmid": "41080564",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR's exposures are eQTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 899,
   "end": 1022
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41082153",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The only disease pair stated is from GSTM1 gene expression; no protein-disease pair from protein MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 957,
   "end": 1096
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41085561",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Instruments include GWAS of circulating levels of protein drug targets (plasma ACE); the outcome is colorectal cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 704,
   "end": 946
  },
  "claim": {
   "protein_as_written": "plasma angiotensin-converting enzyme (ACE)",
   "gene": "ACE",
   "disease_as_written": "colorectal cancer",
   "direction": "lowers",
   "estimate": {
    "or": 1.08,
    "low": 1.03,
    "high": 1.13,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1553,
    "end": 1636
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1637,
    "end": 1806
   }
  }
 },
 {
  "pmid": "41085868",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR pools mQTL, eQTL, and pQTL data; PNKD not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 502,
   "end": 660
  },
  "claim": {
   "protein_as_written": "PNKD",
   "gene": "PNKD",
   "disease_as_written": "CRC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1041,
    "end": 1128
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41086986",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is PRISm; plasma proteins enter only as observational mediators.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 928,
   "end": 1040
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41088581",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on IBD; conclusions name proteins without direction, the first in results is erythrocyte band 7 (OR 0.84).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 728,
   "end": 1043
  },
  "claim": {
   "protein_as_written": "erythrocyte band 7 integral membrane protein",
   "gene": "STOM",
   "disease_as_written": "IBD",
   "direction": "lowers",
   "estimate": {
    "or": 0.84,
    "low": 0.77,
    "high": 0.9,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 728,
    "end": 1043
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41088586",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating IL-6 (pQTL instruments) on tenosynovitis from FinnGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 531,
   "end": 709
  },
  "claim": {
   "protein_as_written": "IL-6",
   "gene": "IL6",
   "disease_as_written": "tenosynovitis",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1371,
    "end": 1541
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2023,
    "end": 2207
   }
  }
 },
 {
  "pmid": "41088644",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of UKB-PPP plasma protein pQTLs on autoimmune hepatitis; the abstract gives no direction for any protein, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 462,
   "end": 584
  },
  "claim": {
   "protein_as_written": "advanced glycosylation end product-specific receptor",
   "gene": "AGER",
   "disease_as_written": "AIH",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1315,
    "end": 1671
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1315,
    "end": 1671
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 585,
    "end": 873
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1924,
    "end": 2083
   }
  }
 },
 {
  "pmid": "41088671",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of circulating proteins on COPD; MMP12 named without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 342,
   "end": 488
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "COPD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1067,
    "end": 1202
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1067,
    "end": 1202
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41089176",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 421,
   "end": 674
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41089402",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 Olink inflammation proteins on primary ovarian insufficiency.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1297,
   "end": 1510
  },
  "claim": {
   "protein_as_written": "CXCL10",
   "gene": "CXCL10",
   "disease_as_written": "POI",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1297,
    "end": 1510
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41089542",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "eQTL and deCODE pQTL exposures; the named protective factors aren't tied to the protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 357,
   "end": 485
  },
  "claim": {
   "protein_as_written": "HDC",
   "gene": "HDC",
   "disease_as_written": "sepsis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1064,
    "end": 1220
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41094299",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins (deCODE) on ankylosing spondylitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 752,
   "end": 1004
  },
  "claim": {
   "protein_as_written": "complement factor B (CFB)",
   "gene": "CFB",
   "disease_as_written": "AS",
   "direction": "raises",
   "estimate": {
    "frame": "per higher protein",
    "high": 4.73,
    "low": 1.89,
    "unit": "not stated",
    "or": 2.99
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1168,
    "end": 1598
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.869,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1750,
    "end": 1845
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1846,
    "end": 1951
   }
  }
 },
 {
  "pmid": "41097341",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses multi-tissue eQTLs, gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 265,
   "end": 403
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41098849",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UKB-PPP blood proteins on psoriasis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 524,
   "end": 679
  },
  "claim": {
   "protein_as_written": "TNF",
   "gene": "TNF",
   "disease_as_written": "psoriasis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 870,
    "end": 1027
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H3 + PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1028,
    "end": 1110
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1556,
    "end": 1622
   }
  }
 },
 {
  "pmid": "41099890",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma protein cis instruments on peripheral facial paralysis; SLIT2 named without an MR direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 629,
   "end": 722
  },
  "claim": {
   "protein_as_written": "SLIT2",
   "gene": "SLIT2",
   "disease_as_written": "PFP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2990,
    "end": 3264
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1797,
    "end": 2045
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2990,
    "end": 3264
   }
  }
 },
 {
  "pmid": "41100431",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are lipid metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 272,
   "end": 396
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41101252",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 1562 plasma proteins on CHD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 483,
   "end": 735
  },
  "claim": {
   "protein_as_written": "IL6R",
   "gene": "IL6R",
   "disease_as_written": "CHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1440,
    "end": 1662
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1440,
    "end": 1662
   }
  }
 },
 {
  "pmid": "41102548",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are CSF and blood metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 654,
   "end": 820
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41102562",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR concerns MRI-based organ age gaps and diseases, not protein exposures.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 645,
   "end": 829
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41102784",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR pools eQTL and pQTL data from heart and blood tissues; the abstract does not tie the pair to the circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 712,
   "end": 870
  },
  "claim": {
   "protein_as_written": "IMPA1",
   "gene": "IMPA1",
   "disease_as_written": "DCM",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1024,
    "end": 1189
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1024,
    "end": 1189
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41105381",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma methyltransferase protein concentrations on digestive system cancers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 180,
   "end": 318
  },
  "claim": {
   "protein_as_written": "HEMK2",
   "gene": "N6AMT1",
   "disease_as_written": "colorectal cancer",
   "direction": "raises",
   "estimate": {
    "or": 1.28,
    "low": 1.06,
    "high": 1.55,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 874,
    "end": 1172
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 874,
    "end": 1172
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41106624",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Pools mQTL, eQTL and pQTL layers; pair not tied to the circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 639,
   "end": 750
  },
  "claim": {
   "protein_as_written": "CRAT",
   "gene": "CRAT",
   "disease_as_written": "ASD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1147,
    "end": 1264
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 832,
    "end": 904
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41107716",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with UKB-PPP and deCODE plasma pQTLs on osteoporosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1167,
   "end": 1514
  },
  "claim": {
   "protein_as_written": "GALNT3",
   "gene": "GALNT3",
   "disease_as_written": "osteoporosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1847,
    "end": 2031
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41107957",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are aging phenotypes (biological age acceleration, frailty index, telomere length, healthspan), not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 528,
   "end": 727
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41108338",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma inflammatory proteins are the exposures, but the outcomes are longitudinal brain structure measures (imaging traits), not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 198,
   "end": 317
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41112270",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (UKB-PPP, deCODE) on recurrent spontaneous abortion; elevated plasma IL6R raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 724,
   "end": 820
  },
  "claim": {
   "protein_as_written": "interleukin 6 receptor (IL6R)",
   "gene": "IL6R",
   "disease_as_written": "RSA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1133,
    "end": 1284
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1510,
    "end": 1694
   }
  }
 },
 {
  "pmid": "41112282",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR exposure is CARD gene expression, not circulating protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2005,
   "end": 2208
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41114479",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins MR on epilepsy, but no protein is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 862,
   "end": 953
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41114911",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcomes are immune cell traits (CD40+ monocytes), not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1400,
   "end": 1621
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41116632",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on Parkinson's disease; conclusions name no protein, so the first directed result pair (TNFRSF9, protective) is the claim.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1005,
   "end": 1260
  },
  "claim": {
   "protein_as_written": "TNFRSF9",
   "gene": "TNFRSF9",
   "disease_as_written": "PD",
   "direction": "lowers",
   "estimate": {
    "or": 0.83,
    "low": 0.74,
    "high": 0.92,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1005,
    "end": 1260
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41117279",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by HMGCR-region alleles weighted by LDL-C, and SMR of expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1127,
   "end": 1398
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41118010",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein pQTL MR on lung cancer; MMP8 protective with OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1002,
   "end": 1113
  },
  "claim": {
   "protein_as_written": "MMP8",
   "gene": "MMP8",
   "disease_as_written": "LC",
   "direction": "lowers",
   "estimate": {
    "or": 0.87,
    "low": 0.78,
    "high": 0.97,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1565,
    "end": 1664
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41118084",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The two-sample MR's instruments are SNPs of antipsychotic drug-target genes ('variants in the gene'), not named as protein QTLs; the DRD4 SMR uses eQTLs and doesn't count.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 337,
   "end": 536
  },
  "claim": {
   "protein_as_written": "KCNH2",
   "gene": "KCNH2",
   "disease_as_written": "lung cancer",
   "direction": "lowers",
   "estimate": {
    "or": 0.91,
    "low": 0.83,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 848,
    "end": 1022
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 337,
    "end": 536
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41127252",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2172 UK Biobank plasma proteins on dementia subtypes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 330,
   "end": 807
  },
  "claim": {
   "protein_as_written": "Apolipoprotein E",
   "gene": "APOE",
   "disease_as_written": "Alzheimer's disease",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1610,
    "end": 1757
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41129298",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are the frailty index and sarcopenia-related traits, continuous measures.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 432,
   "end": 595
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41129479",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "TSMR with plasma proteome pQTLs (Zheng 2020, deCODE) on PanNENs; PDIA5 and ARFIP1 associated without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 641,
   "end": 773
  },
  "claim": {
   "protein_as_written": "PDIA5",
   "gene": "PDIA5",
   "disease_as_written": "PanNEN",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2045,
    "end": 2122
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2045,
    "end": 2122
   }
  }
 },
 {
  "pmid": "41134489",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of CSF-1 levels on osteoarthritis; high levels raise knee OA risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 506,
   "end": 628
  },
  "claim": {
   "protein_as_written": "macrophage colony-stimulating factor",
   "gene": "CSF1",
   "disease_as_written": "knee osteoarthritis",
   "direction": "raises",
   "estimate": {
    "or": 1.08,
    "low": 1.02,
    "high": 1.15,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1480,
    "end": 1717
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41134885",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Protein MR outcome is retinal vascular fractal dimension, a trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 766,
   "end": 1125
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41135742",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins and genes, with TEF coming from cross-validation across multi-omics datasets, so the pair isn't tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 662,
   "end": 783
  },
  "claim": {
   "protein_as_written": "transcriptional enhancer factor (TEF)",
   "gene": "TEF",
   "disease_as_written": "PD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 662,
    "end": 867
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1332,
    "end": 1548
   }
  }
 },
 {
  "pmid": "41137216",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma protein pQTLs on essential tremor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 434,
   "end": 575
  },
  "claim": {
   "protein_as_written": "ATOX1",
   "gene": "ATOX1",
   "disease_as_written": "ET",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1276,
    "end": 1419
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1085,
    "end": 1180
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1420,
    "end": 1507
   }
  }
 },
 {
  "pmid": "41137358",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "CSF3R instrumented by eQTLGen expression QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 493,
   "end": 634
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41138838",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (with CSF proteins separately) on AD; plasma CTSH pair is tied to plasma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 900,
   "end": 1057
  },
  "claim": {
   "protein_as_written": "cathepsin H (CTSH)",
   "gene": "CTSH",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1527,
    "end": 1913
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41139274",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR prioritizing plasma proteins by causal effects on rosacea.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 254,
   "end": 396
  },
  "claim": {
   "protein_as_written": "Granzyme K (GZMK)",
   "gene": "GZMK",
   "disease_as_written": "rosacea",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 644,
    "end": 764
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 644,
    "end": 764
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 644,
    "end": 764
   }
  }
 },
 {
  "pmid": "41142054",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR whose instruments the abstract doesn't name; JAK2 is a causal gene for allergic asthma without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1012,
   "end": 1265
  },
  "claim": {
   "protein_as_written": "Janus kinase 2 (JAK2)",
   "gene": "JAK2",
   "disease_as_written": "AA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1012,
    "end": 1265
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.95,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1012,
    "end": 1265
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1511,
    "end": 1724
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41142151",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE plasma protein GWAS on postherpetic neuralgia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 394,
   "end": 639
  },
  "claim": {
   "protein_as_written": "ATRN",
   "gene": "ATRN",
   "disease_as_written": "PHN",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1132,
    "end": 1303
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41142241",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs of druggable genes in blood and liver.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 540,
   "end": 727
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41144107",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract names no protein paired with DLBCL; inflammatory factors are reported only as a count.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1371,
   "end": 1519
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41145761",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is a metabolite, isovalerylcarnitine, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 959,
   "end": 1060
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41146943",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with deCODE pQTLs on T2D; TPST2 and CHRDL1, confirmed after the FDR step, are named as targets with no direction, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 355,
   "end": 527
  },
  "claim": {
   "protein_as_written": "TPST2",
   "gene": "TPST2",
   "disease_as_written": "T2D",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 977,
    "end": 1151
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 977,
    "end": 1151
   }
  }
 },
 {
  "pmid": "41148479",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Mediation MR through plasma proteins: the abstract gives the 32 mediating proteins' own association with colon adenocarcinoma (the mediator's step), STAT1 named first, with no sign.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 161
  },
  "claim": {
   "protein_as_written": "signal transducer and activator of transcription 1 (STAT1)",
   "gene": "STAT1",
   "disease_as_written": "colon adenocarcinoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 826,
    "end": 1062
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41153716",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are metabolic traits and plasma metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 759,
   "end": 897
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41154186",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on intracranial aneurysm.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 680,
   "end": 961
  },
  "claim": {
   "protein_as_written": "F2R",
   "gene": "F2R",
   "disease_as_written": "IA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1757,
    "end": 1938
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41158172",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of plasma protein levels on retinal neurodegenerative diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 339,
   "end": 528
  },
  "claim": {
   "protein_as_written": "ICAM1",
   "gene": "ICAM1",
   "disease_as_written": "diabetic retinopathy",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 882,
    "end": 1094
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 529,
    "end": 669
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 785,
    "end": 881
   }
  }
 },
 {
  "pmid": "41158706",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of predicted protein levels on bladder cancer, with a single kind of QTL and no tissues pooled.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 134
  },
  "claim": {
   "protein_as_written": "ATRAID",
   "gene": "ATRAID",
   "disease_as_written": "bladder cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2090,
    "end": 2201
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1366,
    "end": 1594
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41161126",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is bioavailable testosterone, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 859,
   "end": 923
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41162548",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with blood pQTLs among other QTLs on Graves' disease; FGFRL1 is identified in both the eQTL and the pQTL analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 240,
   "end": 485
  },
  "claim": {
   "protein_as_written": "FGFRL1",
   "gene": "FGFRL1",
   "disease_as_written": "GD",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1482,
    "end": 1664
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41162682",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is monocyte count.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1447,
   "end": 1538
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41163282",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with circulating cytokines from pQTL data as mediators; CD5 stated as related to migraine (the mediator's step), with no sign for its own effect.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 955,
   "end": 1058
  },
  "claim": {
   "protein_as_written": "CD5",
   "gene": "CD5",
   "disease_as_written": "migraine",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1642,
    "end": 1703
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41163284",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs of druggable genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 436,
   "end": 601
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41165052",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of 4907 plasma proteins on epilepsy; candidates named without direction at nominal significance.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 548,
   "end": 640
  },
  "claim": {
   "protein_as_written": "CRABP2",
   "gene": "CRABP2",
   "disease_as_written": "epilepsy",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1283,
    "end": 1430
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41165397",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood and single-cell eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 431,
   "end": 639
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41168076",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A transcriptomic and machine-learning analysis of PTM genes; the abstract describes no MR of a circulating protein's level on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 735,
   "end": 874
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41169458",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR within a PWAS/TWAS framework; the abstract names neither the instruments nor that the protein is circulating.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 579,
   "end": 718
  },
  "claim": {
   "protein_as_written": "TIMP4",
   "gene": "TIMP4",
   "disease_as_written": "MN",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1198,
    "end": 1451
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.801,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1198,
    "end": 1451
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1816,
    "end": 1926
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41169663",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically determined circulating cathepsin levels (INTERVAL pQTLs) on atrial fibrillation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 665,
   "end": 877
  },
  "claim": {
   "protein_as_written": "cathepsin O",
   "gene": "CTSO",
   "disease_as_written": "AF",
   "direction": "raises",
   "estimate": {
    "or": 1.06,
    "low": 1.02,
    "high": 1.1,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1302,
    "end": 1562
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41170417",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins associated with hyperlipidemia are only counted, none named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 810,
   "end": 949
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41175382",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Protein and gene levels come from proteome-wide and transcriptome-wide analyses, the protein is never named as circulating, and the conclusions' DNAJC21 pair rests on both levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 490,
   "end": 887
  },
  "claim": {
   "protein_as_written": "DNAJC21",
   "gene": "DNAJC21",
   "disease_as_written": "ITP",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1743,
    "end": 1872
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1873,
    "end": 1994
   }
  }
 },
 {
  "pmid": "41177795",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pooled mQTL, eQTL and pQTL without saying the pQTLs are circulating.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 299,
   "end": 546
  },
  "claim": {
   "protein_as_written": "CASP3",
   "gene": "CASP3",
   "disease_as_written": "IBS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 941,
    "end": 1242
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41180196",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma pQTLs on MASLD. NCAN is named causal without a direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 547,
   "end": 828
  },
  "claim": {
   "protein_as_written": "NCAN",
   "gene": "NCAN",
   "disease_as_written": "MASLD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1358,
    "end": 1499
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1358,
    "end": 1499
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1725,
    "end": 1898
   }
  }
 },
 {
  "pmid": "41182006",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "IL-6 signalling is proxied by IL6R variants weighted by C-reactive protein, plus a missense variant; no circulating protein level is the exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 688,
   "end": 958
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41183724",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of maternal serum protein concentrations on gestational hypertension.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1505,
   "end": 1730
  },
  "claim": {
   "protein_as_written": "a disintegrin and metalloproteinase domain-containing protein 12",
   "gene": "ADAM12",
   "disease_as_written": "gestational hypertension",
   "direction": "lowers",
   "estimate": {
    "or": 0.78,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2190,
    "end": 2410
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41186605",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR of drug-target genes, instruments not named (likely expression).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1159,
   "end": 1251
  },
  "claim": {
   "protein_as_written": "TNNT3",
   "gene": "TNNT3",
   "disease_as_written": "TNBC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1674,
    "end": 1867
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1390,
    "end": 1536
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1537,
    "end": 1673
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41186856",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma PLCG1 on papillary thyroid carcinoma; conclusions give no direction, SMPD3 has no stated MR direction, PLCG1 does.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1438,
   "end": 1677
  },
  "claim": {
   "protein_as_written": "phospholipase C gamma 1 (PLCG1)",
   "gene": "PLCG1",
   "disease_as_written": "PTC",
   "direction": "lowers",
   "estimate": {
    "or": 0.679,
    "low": 0.52,
    "high": 0.887,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1438,
    "end": 1677
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41189191",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug target genes proxied by SBP-associated variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 508,
   "end": 668
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41189271",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR pools eQTLs and pQTLs as exposures for lactylation genes, and the EP300 pair is not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 312,
   "end": 635
  },
  "claim": {
   "protein_as_written": "EP300",
   "gene": "EP300",
   "disease_as_written": "UC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1433,
    "end": 1533
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1105,
    "end": 1183
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41191606",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-MR gives EGLN1 protein level's effect on CRC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2553,
   "end": 2817
  },
  "claim": {
   "protein_as_written": "EGLN1",
   "gene": "EGLN1",
   "disease_as_written": "high BMI-associated CRC",
   "direction": "lowers",
   "estimate": {
    "or": 0.832,
    "low": 0.753,
    "high": 0.918,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 3547,
    "end": 3699
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 3547,
    "end": 3699
   }
  }
 },
 {
  "pmid": "41192836",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 4,907 plasma proteins on keloid.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 439,
   "end": 637
  },
  "claim": {
   "protein_as_written": "R-spondin 3 (RSPO3)",
   "gene": "RSPO3",
   "disease_as_written": "KL",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 950,
    "end": 1056
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2070,
    "end": 2160
   }
  }
 },
 {
  "pmid": "41193035",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins with cis-pQTLs on T2D.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1482,
   "end": 1916
  },
  "claim": {
   "protein_as_written": "tyrosine-protein kinase receptor TYRO3",
   "gene": "TYRO3",
   "disease_as_written": "T2D",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1482,
    "end": 1916
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41196107",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Genes VIM, STX8, MIF come from QTL analyses pooling methylation, expression and protein data, not tied to the protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1486,
   "end": 1643
  },
  "claim": {
   "protein_as_written": "VIM",
   "gene": "VIM",
   "disease_as_written": "pneumoconiosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1657,
    "end": 1875
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41196451",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma proteins on lung cancer phenotypes; first result with a direction is GGT1 raising NSCLC risk at FDR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 521,
   "end": 665
  },
  "claim": {
   "protein_as_written": "GGT1",
   "gene": "GGT1",
   "disease_as_written": "non-small cell lung cancer",
   "direction": "raises",
   "estimate": {
    "or": 1.27,
    "low": 1.1,
    "high": 1.46,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 734,
    "end": 1193
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41199372",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteomic GWAS on ALS; proteins passing a DEG filter named, no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1231,
   "end": 1355
  },
  "claim": {
   "protein_as_written": "FCRL3",
   "gene": "FCRL3",
   "disease_as_written": "ALS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2552,
    "end": 2867
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2552,
    "end": 2867
   }
  }
 },
 {
  "pmid": "41200167",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with deCODE and UKB-PPP pQTLs on AML; conclusions name TNFAIP8 first without a direction, results call it a risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 447,
   "end": 740
  },
  "claim": {
   "protein_as_written": "TNFAIP8",
   "gene": "TNFAIP8",
   "disease_as_written": "AML",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1212,
    "end": 1355
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 447,
    "end": 740
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1802,
    "end": 1945
   }
  }
 },
 {
  "pmid": "41200820",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of UKB-PPP plasma proteins on CHD outcomes; follistatin-MI named without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1118,
   "end": 1337
  },
  "claim": {
   "protein_as_written": "follistatin",
   "gene": "FST",
   "disease_as_written": "myocardial infarction",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2071,
    "end": 2290
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41204712",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of clinical serum biomarkers, including GGT, a circulating protein measured as a biomarker, on benign prostatic hyperplasia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 776,
   "end": 906
  },
  "claim": {
   "protein_as_written": "GGT",
   "gene": "GGT1",
   "disease_as_written": "BPH",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 776,
    "end": 906
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41206518",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating GIP level on type 2 diabetes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 714,
   "end": 893
  },
  "claim": {
   "protein_as_written": "gastric inhibitory polypeptide (GIP)",
   "gene": "GIP",
   "disease_as_written": "T2D",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 714,
    "end": 893
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41207538",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of HMGCR, LDLR and LPL 'activation' without naming the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1612,
   "end": 1806
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "asthma",
   "direction": "lowers",
   "estimate": {
    "or": 0.846,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1612,
    "end": 1806
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2176,
    "end": 2334
   }
  }
 },
 {
  "pmid": "41207901",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug targets are proxied by gene expression data from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 924,
   "end": 1093
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41209747",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The targets come from analyses pooling eQTLs and pQTLs, not tied to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 418,
   "end": 581
  },
  "claim": {
   "protein_as_written": "P2RY13",
   "gene": "P2RY13",
   "disease_as_written": "LBP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1209,
    "end": 1495
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1209,
    "end": 1495
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1209,
    "end": 1495
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41210213",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "cis-eQTL MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 876,
   "end": 1041
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41210684",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR integrates eQTL and pQTL analyses, and ISOC1 is not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 587,
   "end": 797
  },
  "claim": {
   "protein_as_written": "ISOC1",
   "gene": "ISOC1",
   "disease_as_written": "RCC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1107,
    "end": 1260
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1579,
    "end": 1708
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41212276",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 750,
   "end": 908
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41212630",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with blood pQTLs among other QTLs; PARK7's protective association is tied to protein abundance.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1429,
   "end": 1636
  },
  "claim": {
   "protein_as_written": "PARK7",
   "gene": "PARK7",
   "disease_as_written": "VV",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1429,
    "end": 1636
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41212952",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Lipid-lowering drug target genes (HMGCR, PCSK9) with instruments not named; they could be LDL-weighted, so full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1094,
   "end": 1294
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "COPD",
   "direction": "raises",
   "estimate": {
    "or": 0.63,
    "low": 0.54,
    "high": 0.75,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1094,
    "end": 1294
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1748,
    "end": 1874
   }
  }
 },
 {
  "pmid": "41213089",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cross-tissue proteomic MR; APOE's association is stated for plasma as well as CSF; no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 924,
   "end": 1045
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "VD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 924,
    "end": 1045
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1451,
    "end": 1584
   }
  }
 },
 {
  "pmid": "41216123",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are named only as mediators of an immune phenotype's effect, without their own effect on AGA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1603,
   "end": 1732
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41216288",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The MR pools eQTLs and pQTLs; the pair is not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 327,
   "end": 523
  },
  "claim": {
   "protein_as_written": "EPS15L1",
   "gene": "EPS15L1",
   "disease_as_written": "CM",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 822,
    "end": 937
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1454,
    "end": 1560
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41216857",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are single-cell gene expression profiles (eQTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 509,
   "end": 691
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41217734",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating plasma protein traits on osteosarcoma; GLO1 pair with OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 404,
   "end": 574
  },
  "claim": {
   "protein_as_written": "Lactoylglutathione lyase, also known as Glyoxalase 1 (GLO1)",
   "gene": "GLO1",
   "disease_as_written": "OS",
   "direction": "lowers",
   "estimate": {
    "or": 0.2871,
    "low": 0.1602,
    "high": 0.5145,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 695,
    "end": 876
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41220142",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposures are described as gene 'expression' from deCODE and UKB-PPP 'genes data'; the abstract does not name the instruments as circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 553,
   "end": 794
  },
  "claim": {
   "protein_as_written": "TLR1",
   "gene": "TLR1",
   "disease_as_written": "RLS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1375,
    "end": 1597
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41220585",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Two pQTLs were prioritized but no protein-preeclampsia pair is named; named genes come from eQTL/mQTL analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1179,
   "end": 1309
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41221640",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with cis-pQTLs of circulating SLAMF1 on nontraumatic subarachnoid hemorrhage.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1618,
   "end": 1825
  },
  "claim": {
   "protein_as_written": "SLAMF1",
   "gene": "SLAMF1",
   "disease_as_written": "SAH",
   "direction": "raises",
   "estimate": {
    "or": 1.73,
    "low": 1.26,
    "high": 2.38,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1618,
    "end": 1825
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41222800",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of deCODE and Fenland blood proteins on lymphoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 310,
   "end": 459
  },
  "claim": {
   "protein_as_written": "FCRL3",
   "gene": "FCRL3",
   "disease_as_written": "lymphoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1802,
    "end": 1986
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1802,
    "end": 1986
   }
  }
 },
 {
  "pmid": "41225575",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with deCODE plasma pQTLs for FBP1 on DKD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 552,
   "end": 847
  },
  "claim": {
   "protein_as_written": "FBP1",
   "gene": "FBP1",
   "disease_as_written": "DKD",
   "direction": "lowers",
   "estimate": {
    "or": 0.57,
    "low": 0.33,
    "high": 0.98,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1133,
    "end": 1322
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41230735",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of Olink plasma proteins on osteoporotic fractures; KIR2DS4 associated with increased risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 883,
   "end": 1114
  },
  "claim": {
   "protein_as_written": "KIR2DS4",
   "gene": "KIR2DS4",
   "disease_as_written": "osteoporosis fractures",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1461,
    "end": 1647
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2016,
    "end": 2177
   }
  }
 },
 {
  "pmid": "41231246",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR of plasma proteins on major depressive disorder, a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 293,
   "end": 462
  },
  "claim": {
   "protein_as_written": "TRABD",
   "gene": "TRABD",
   "disease_as_written": "MDD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 463,
    "end": 672
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41232153",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma pQTLs from UKB-PPP and deCODE on ovarian endometriosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 598,
   "end": 756
  },
  "claim": {
   "protein_as_written": "HLA-DRA",
   "gene": "HLA-DRA",
   "disease_as_written": "ovarian endometriosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1228,
    "end": 1510
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41233666",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Gene exposures come from eQTL data; no protein-level instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 626,
   "end": 905
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41239018",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The abstract says the MR integrates genomic and eQTL data; gene 'levels' are never named as circulating protein, and no pQTL analysis is mentioned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1220,
   "end": 1420
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41239078",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of deCODE plasma pQTLs on dermatomyositis; MICA raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 562,
   "end": 757
  },
  "claim": {
   "protein_as_written": "MICA",
   "gene": "MICA",
   "disease_as_written": "DM",
   "direction": "raises",
   "estimate": {
    "or": 1.56,
    "low": 1.33,
    "high": 1.82,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1268,
    "end": 1426
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1427,
    "end": 1542
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41239582",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR, but the abstract ties the PROC-VTE pair to the pQTL (protein level) analysis, with OR 0.7.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1720,
   "end": 1857
  },
  "claim": {
   "protein_as_written": "PROC",
   "gene": "PROC",
   "disease_as_written": "VTE",
   "direction": "lowers",
   "estimate": {
    "or": 0.7,
    "low": 0.6,
    "high": 0.82,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1720,
    "end": 1857
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 776,
    "end": 938
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1858,
    "end": 1982
   }
  }
 },
 {
  "pmid": "41239706",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SCALLOP-sized pQTLs (14,824 Europeans) for 91 inflammatory proteins on endometriosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 415,
   "end": 609
  },
  "claim": {
   "protein_as_written": "Beta-nerve growth factor (β-NGF)",
   "gene": "NGF",
   "disease_as_written": "endometriosis",
   "direction": "raises",
   "estimate": {
    "or": 2.23,
    "low": 1.6,
    "high": 3.09,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 822,
    "end": 1016
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H3 + PP.H4",
   "coloc_value": 0.9722,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 822,
    "end": 1016
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1304,
    "end": 1370
   }
  }
 },
 {
  "pmid": "41239930",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are protein-to-protein ratios, not single gene products.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 148,
   "end": 269
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41248854",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL data of unnamed tissue; GCDH's protein levels positively associated with depression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 265,
   "end": 501
  },
  "claim": {
   "protein_as_written": "GCDH",
   "gene": "GCDH",
   "disease_as_written": "depression",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1099,
    "end": 1243
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 265,
    "end": 501
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41249132",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome for druggable genes is insulin resistance, a quantitative trait built from HOMA-IR and related measures, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 799,
   "end": 1136
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41249848",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTLs of ferroptosis-related genes are MR exposures for childhood obesity; first results pair with a direction is SMPD1 suppressing obesity.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 656,
   "end": 895
  },
  "claim": {
   "protein_as_written": "SMPD1",
   "gene": "SMPD1",
   "disease_as_written": "childhood obesity",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1214,
    "end": 1474
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41251751",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL drug-target MR of plasma and CSF proteins; the abstract ties the epilepsy pair to TMEM106B in plasma with a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1430,
   "end": 1512
  },
  "claim": {
   "protein_as_written": "TMEM106B",
   "gene": "TMEM106B",
   "disease_as_written": "EP",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1430,
    "end": 1512
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.796,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1002,
    "end": 1162
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1566,
    "end": 1665
   }
  }
 },
 {
  "pmid": "41252303",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with pQTLs; the conclusions name only MAPK1 expression, so the first protein-level results pair counts: CTSB lowers PD risk after FDR correction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 568,
   "end": 783
  },
  "claim": {
   "protein_as_written": "CTSB",
   "gene": "CTSB",
   "disease_as_written": "Parkinson's disease",
   "direction": "lowers",
   "estimate": {
    "or": 0.855,
    "low": 0.791,
    "high": 0.925,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1300,
    "end": 1486
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41254692",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Targets come from MR pooling cis-eQTLs and cis-pQTLs, tissue not stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 538,
   "end": 850
  },
  "claim": {
   "protein_as_written": "WWOX",
   "gene": "WWOX",
   "disease_as_written": "mature T/NK-cell lymphoma",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1272,
    "end": 1383
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1272,
    "end": 1383
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1817,
    "end": 1917
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41254735",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Abstract pools eQTL and pQTL instruments and does not say the pQTL is of the circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 516,
   "end": 619
  },
  "claim": {
   "protein_as_written": "HLA-A",
   "gene": "HLA-A",
   "disease_as_written": "DR",
   "direction": "raises",
   "estimate": {
    "or": 1.136,
    "low": 1.095,
    "high": 1.178,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 884,
    "end": 1159
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1267,
    "end": 1341
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1689,
    "end": 1914
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41254737",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with deCODE and UKB-PPP cis-pQTLs on atherosclerosis and CAD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 509,
   "end": 735
  },
  "claim": {
   "protein_as_written": "CALB2",
   "gene": "CALB2",
   "disease_as_written": "CAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1504,
    "end": 1636
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1967,
    "end": 2158
   }
  }
 },
 {
  "pmid": "41258297",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of CHRDL1 on NSCLC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 797,
   "end": 902
  },
  "claim": {
   "protein_as_written": "CHRDL1",
   "gene": "CHRDL1",
   "disease_as_written": "NSCLC",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1295,
    "end": 1428
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41258527",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable-gene MR on pancreatic cancer whose instruments the abstract doesn't name; the mediation's 'ADA expression' is not named as an mRNA's or a protein's, so the full text must settle E2.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 342,
   "end": 499
  },
  "claim": {
   "protein_as_written": "adenosine deaminase (ADA)",
   "gene": "ADA",
   "disease_as_written": "PC",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 881,
    "end": 999
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.7949,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1346,
    "end": 1569
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1346,
    "end": 1569
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41261583",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE plasma proteins on rheumatoid arthritis; C2 raised risk at an exploratory FDR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 659,
   "end": 787
  },
  "claim": {
   "protein_as_written": "C2",
   "gene": "C2",
   "disease_as_written": "RA",
   "direction": "raises",
   "estimate": {
    "or": 1.38,
    "low": 1.21,
    "high": 1.58,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1496,
    "end": 1755
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41261599",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteomic MR of plasma proteins on duodenal ulcer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 462,
   "end": 580
  },
  "claim": {
   "protein_as_written": "REG1B",
   "gene": "REG1B",
   "disease_as_written": "DU",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1556,
    "end": 1649
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1729,
    "end": 1879
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2188,
    "end": 2311
   }
  }
 },
 {
  "pmid": "41261617",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR uses pQTLs (Iceland, UK Biobank) but the outcome is HbA1c, a biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1187,
   "end": 1288
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41261618",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are circulating miRNAs instrumented by miR-eQTLs, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 565,
   "end": 841
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41261637",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 439,
   "end": 667
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41261649",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of circulating inflammatory proteins (UKB-PPP) on sepsis; APOE raises risk after adjustment.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1219,
   "end": 1408
  },
  "claim": {
   "protein_as_written": "APOE (apolipoprotein E)",
   "gene": "APOE",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": {
    "or": 1.07,
    "low": 1.04,
    "high": 1.11,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1219,
    "end": 1408
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.95,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1466,
    "end": 1612
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 685,
    "end": 862
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1754,
    "end": 1890
   }
  }
 },
 {
  "pmid": "41261695",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Phenome-wide MR including proteomic traits; galanin prepropeptide is paired with acne.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 899,
   "end": 1139
  },
  "claim": {
   "protein_as_written": "galanin and galanin message-associated peptide prepropeptide",
   "gene": "GAL",
   "disease_as_written": "acne",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1422,
    "end": 1653
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1306,
    "end": 1421
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41261704",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR includes plasma protein pQTLs of mitochondria-related genes on SLE, and SPATA20's pQTL is explicitly reported among the positive results; the protective direction comes from skin eQTLs, which don't count.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1341,
   "end": 1501
  },
  "claim": {
   "protein_as_written": "SPATA20",
   "gene": "SPATA20",
   "disease_as_written": "SLE",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1502,
    "end": 1637
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41263756",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41264079",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteome pQTLs instrument antidiabetic drug-target proteins, with lactase level on atrial fibrillation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 886,
   "end": 1042
  },
  "claim": {
   "protein_as_written": "lactase (LCT)",
   "gene": "LCT",
   "disease_as_written": "AF",
   "direction": "raises",
   "estimate": {
    "or": 1.013,
    "low": 1.007,
    "high": 1.018,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1597,
    "end": 1782
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2035,
    "end": 2149
   }
  }
 },
 {
  "pmid": "41265190",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Cytokines with effects on MM are not named; SLAM is named only as a mediator without its own effect on MM, and KIT comes from SMR of gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 832,
   "end": 922
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41266628",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma (and CSF) protein MR, but the outcomes are MRI markers of cerebral small vessel disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 281,
   "end": 556
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41268733",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma sICAM5 levels on critical COVID-19, an infection.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1306,
   "end": 1571
  },
  "claim": {
   "protein_as_written": "soluble ICAM5 (sICAM5)",
   "gene": "ICAM5",
   "disease_as_written": "critical COVID-19",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1306,
    "end": 1571
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41270069",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "PWAS, TWAS and MR are pooled, the 'protein abundance' isn't named as circulating, and the MR's instruments aren't named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 402,
   "end": 798
  },
  "claim": {
   "protein_as_written": "TAPBP",
   "gene": "TAPBP",
   "disease_as_written": "prostate cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1059,
    "end": 1241
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1059,
    "end": 1241
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41270966",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The proteins are said only to link the CKM/sarcopenia comorbidity, a grouping with no member disease paired with any protein, so no protein-disease pair is stated from MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2254,
   "end": 2398
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41272700",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR whose instruments the abstract doesn't name; FDPS is the first directed pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 776,
   "end": 925
  },
  "claim": {
   "protein_as_written": "FDPS",
   "gene": "FDPS",
   "disease_as_written": "breast cancer",
   "direction": "lowers",
   "estimate": {
    "or": 0.66,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1567,
    "end": 1752
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1567,
    "end": 1752
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41273989",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR using Icelandic and UK Biobank pQTL data for B2M on pancreatic cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 142,
   "end": 389
  },
  "claim": {
   "protein_as_written": "Beta-2-microglobulin (B2M)",
   "gene": "B2M",
   "disease_as_written": "pancreatic cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 390,
    "end": 671
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 967,
    "end": 1277
   }
  }
 },
 {
  "pmid": "41275212",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposures are plasma metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1007,
   "end": 1239
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41275282",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering gene targets (LPL, APOC3) are exposures whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1552,
   "end": 1692
  },
  "claim": {
   "protein_as_written": "LPL",
   "gene": "LPL",
   "disease_as_written": "chronic gastritis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2529,
    "end": 2657
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1552,
    "end": 1692
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41275639",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins appear only as a smoking-associated signature mediating smoking-OA; no protein-disease pair from protein MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1121,
   "end": 1318
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41277170",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR links genes with gene expression (SMR) and diseases with each other; no circulating protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 859,
   "end": 1081
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41282674",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide cis-pQTL MR on kidney outcomes, but the abstract names no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1029,
   "end": 1293
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41282774",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A GWAS of OCT-derived endophenotypes; no protein's circulating level is an MR exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1299,
   "end": 1550
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41282793",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Proteogenomic data are from neurological tissues, with multi-omics SMR; no circulating protein MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 240,
   "end": 490
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41283645",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on chronic ischemic heart disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 528,
   "end": 767
  },
  "claim": {
   "protein_as_written": "CXCL12",
   "gene": "CXCL12",
   "disease_as_written": "CIHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1448,
    "end": 1568
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1448,
    "end": 1568
   }
  }
 },
 {
  "pmid": "41283971",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR pools eQTL and pQTL genes, and the abstract doesn't tie the CXCL10 pair to the protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 581,
   "end": 771
  },
  "claim": {
   "protein_as_written": "CXCL10",
   "gene": "CXCL10",
   "disease_as_written": "NSCLC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1013,
    "end": 1132
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41287097",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Inflammatory proteins (LAP-TGF-beta1) appear only as mediators of gut microbiota's effect on urolithiasis, with no own effect stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1988,
   "end": 2279
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41288865",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with cis-pQTLs for plasma protein levels (deCODE, UKB-PPP, INTERVAL) on migraine.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 617,
   "end": 790
  },
  "claim": {
   "protein_as_written": "CALCB",
   "gene": "CALCB",
   "disease_as_written": "migraine",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2046,
    "end": 2166
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1540,
    "end": 1781
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1782,
    "end": 1944
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2321,
    "end": 2480
   }
  }
 },
 {
  "pmid": "41289788",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Genes from MR pooling eQTL and pQTL data, not tied to the protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 642,
   "end": 855
  },
  "claim": {
   "protein_as_written": "SARS2",
   "gene": "SARS2",
   "disease_as_written": "GC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1138,
    "end": 1254
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41291728",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of gene expression on survival.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 866,
   "end": 968
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41292233",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2943 plasma proteins on IS and VD; named proteins given without direction, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 297,
   "end": 423
  },
  "claim": {
   "protein_as_written": "CD40",
   "gene": "CD40",
   "disease_as_written": "IS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1066,
    "end": 1139
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41294017",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is genetic mimicry of HMGCR inhibition with instruments not named in the abstract; inhibition lowered osteonecrosis risk, so higher HMGCR raises it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1025,
   "end": 1152
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "osteonecrosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1025,
    "end": 1152
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1025,
    "end": 1152
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1540,
    "end": 1668
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41296236",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 365,
   "end": 541
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41298802",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of deCODE and UK Biobank plasma proteins on primary hepatic carcinoma; INHBC is called pathogenic, which gives no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 584,
   "end": 711
  },
  "claim": {
   "protein_as_written": "INHBC",
   "gene": "INHBC",
   "disease_as_written": "PHC",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1383,
    "end": 1606
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41298864",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR instrumented by cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 585,
   "end": 780
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41299274",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins from UKB-PPP and deCODE on AF/AFL.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 404,
   "end": 618
  },
  "claim": {
   "protein_as_written": "PCSK9",
   "gene": "PCSK9",
   "disease_as_written": "AF/AFL",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1691,
    "end": 1851
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1138,
    "end": 1301
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1691,
    "end": 1851
   }
  }
 },
 {
  "pmid": "41299773",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Blood pQTLs are used, but the four proteins found are not named; the named genes (BMP4, HSD17B13) come from methylation and expression analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1405,
   "end": 1543
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41300562",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are BMI, T2DM and glycemic traits; proteins come from PWAS, not MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1131,
   "end": 1273
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41307839",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR is of transcriptional regulation (expression), with no circulating protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1509,
   "end": 1643
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41309676",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from TET2 CHIP to proteins, not from a protein to a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 894,
   "end": 1061
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41313522",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from NLRC5 expression to proteins as outcomes; the MS association is from methylation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 614,
   "end": 764
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41314550",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "CHMP1A's association comes from SMR pooling blood mQTL, eQTL and pQTL layers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 504,
   "end": 760
  },
  "claim": {
   "protein_as_written": "CHMP1A",
   "gene": "CHMP1A",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1178,
    "end": 1397
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41318344",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on GCA; ULK3 given with OR and direction among FDR-significant proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1023,
   "end": 1169
  },
  "claim": {
   "protein_as_written": "Unc-51 like kinase 3 (ULK3)",
   "gene": "ULK3",
   "disease_as_written": "GCA",
   "direction": "lowers",
   "estimate": {
    "or": 0.47,
    "low": 0.37,
    "high": 0.71,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1380,
    "end": 1671
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41319014",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTLs from UKB-PPP and deCODE instrument proteins against Parkinson's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 317,
   "end": 547
  },
  "claim": {
   "protein_as_written": "CCNE1",
   "gene": "CCNE1",
   "disease_as_written": "PD",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1799,
    "end": 2010
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41321627",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR pools eQTL and pQTL, and the abstract doesn't tie the pair to a circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 250,
   "end": 415
  },
  "claim": {
   "protein_as_written": "CTSF",
   "gene": "CTSF",
   "disease_as_written": "breast cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 788,
    "end": 924
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 788,
    "end": 924
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41321787",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "The exposure is genetically predicted 'eNOS pathway activation', a protein's activity whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1339,
   "end": 1589
  },
  "claim": {
   "protein_as_written": "eNOS",
   "gene": "NOS3",
   "disease_as_written": "CKD",
   "direction": "lowers",
   "estimate": {
    "or": 0.47,
    "low": 0.34,
    "high": 0.64,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1339,
    "end": 1589
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41323472",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides disease-to-disease MR, a proteomic MR names proteins associated with anemia, a disease; no direction is given, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 752,
   "end": 855
  },
  "claim": {
   "protein_as_written": "MCCD1",
   "gene": "MCCD1",
   "disease_as_written": "anemia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1494,
    "end": 1697
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41323479",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Druggable-gene MR whose instruments the abstract does not name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 279,
   "end": 458
  },
  "claim": {
   "protein_as_written": "diazepam binding inhibitor (DBI)",
   "gene": "DBI",
   "disease_as_written": "AS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 859,
    "end": 959
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 859,
    "end": 959
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41324311",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins appear only as mediators of blood pressure's effect on RVAO; no protein's own effect given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1182,
   "end": 1379
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41324467",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma sclerostin pQTLs (UK Biobank Olink, Iceland SomaScan) meet E2, but the MR is null for CVDs; the only positive associations are observational correlations.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 807,
   "end": 989
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41327716",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug targets are proxied by variants weighted by lipid levels, and by eQTLs; no circulating protein level is instrumented.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 557,
   "end": 976
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41328997",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR between POAG and brain region volumes; SMR genes are not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 535,
   "end": 620
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41330563",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR uses blood cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 578,
   "end": 732
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41331564",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with plasma pQTLs on tension-type headache.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 360,
   "end": 549
  },
  "claim": {
   "protein_as_written": "NRXN3",
   "gene": "NRXN3",
   "disease_as_written": "TTH",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1543,
    "end": 1759
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1543,
    "end": 1759
   }
  }
 },
 {
  "pmid": "41332827",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "FGF21 agonism is instrumented by a missense variant, not by variants associated with circulating FGF21 level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 884,
   "end": 1117
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41333034",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Separate eQTL, mQTL and pQTL MR analyses; the abstract doesn't say which QTL kind gave the named genes' pairs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 485,
   "end": 753
  },
  "claim": {
   "protein_as_written": "NEU1",
   "gene": "NEU1",
   "disease_as_written": "SjD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1466,
    "end": 1721
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2000,
    "end": 2261
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41338326",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR estimated protein-protein relationships only; no disease outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 959,
   "end": 1068
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41340014",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based two-sample MR of blood proteins on lung cancer subtypes; no direction is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 727,
   "end": 877
  },
  "claim": {
   "protein_as_written": "GP1BA",
   "gene": "GP1BA",
   "disease_as_written": "squamous cell carcinoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1021,
    "end": 1137
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1449,
    "end": 1627
   }
  }
 },
 {
  "pmid": "41342072",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR runs from MDD to proteomic aging clocks, which are scores, not a protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1018,
   "end": 1152
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41345833",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are protein ratios (rQTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 610,
   "end": 774
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41346267",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of CD33 using plasma cis-pQTLs from deCODE on cutaneous melanoma, a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 593,
   "end": 1070
  },
  "claim": {
   "protein_as_written": "CD33",
   "gene": "CD33",
   "disease_as_written": "CM",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2331,
    "end": 2532
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1683,
    "end": 1846
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41346997",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma NMB on atopic dermatitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1164,
   "end": 1351
  },
  "claim": {
   "protein_as_written": "plasma NMB",
   "gene": "NMB",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "frame": "per higher protein",
    "high": null,
    "low": null,
    "unit": "not stated",
    "or": 1.18
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1164,
    "end": 1351
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1598,
    "end": 1717
   }
  }
 },
 {
  "pmid": "41348656",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Protocol whose main analysis runs from cancer liability to protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 535,
   "end": 666
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41350740",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The proteome-wide MR pools blood, CSF, and brain pQTLs; the pair is not tied to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 845,
   "end": 981
  },
  "claim": {
   "protein_as_written": "IDUA",
   "gene": "IDUA",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1872,
    "end": 2037
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41351645",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL, and the abstract doesn't say the pQTLs are of circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 305,
   "end": 581
  },
  "claim": {
   "protein_as_written": "PRDX3",
   "gene": "PRDX3",
   "disease_as_written": "stroke",
   "direction": "raises",
   "estimate": {
    "or": 1.472,
    "low": 1.076,
    "high": 2.014,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1087,
    "end": 1426
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41353125",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are whole-blood cis-eQTLs from GTEx.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 739,
   "end": 890
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41355166",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "EPAS1/EGLN1 instrumented by cis-eQTLs and by erythroid-trait-weighted gene variants; no circulating protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 486,
   "end": 718
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41357520",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "MR of the target gene XOR on erectile dysfunction without naming its instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 514,
   "end": 663
  },
  "claim": {
   "protein_as_written": "XOR",
   "gene": "XDH",
   "disease_as_written": "ED",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1089,
    "end": 1211
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 120
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41357784",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Antidiabetic drug targets proxied by HbA1c-associated variants (and eQTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 293,
   "end": 572
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41357840",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The genes' pairs come from multi-omics analyses pooling mQTLs, eQTLs and pQTLs, and the pQTLs' tissue is not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 476,
   "end": 652
  },
  "claim": {
   "protein_as_written": "HTATIP2",
   "gene": "HTATIP2",
   "disease_as_written": "HS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1509,
    "end": 1722
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1509,
    "end": 1722
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41358199",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with pQTL data identified plasma proteins causally associated with ulcerative colitis; hub genes are MR results passing further filters.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1197,
   "end": 1294
  },
  "claim": {
   "protein_as_written": "EIF5A2",
   "gene": "EIF5A2",
   "disease_as_written": "UC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1423,
    "end": 1526
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41358287",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on T2D names IGFBP3 as causal without a direction; unsigned claim.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2349,
   "end": 2444
  },
  "claim": {
   "protein_as_written": "IGFBP3",
   "gene": "IGFBP3",
   "disease_as_written": "T2D",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2349,
    "end": 2444
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41362644",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR includes plasma proteins (N = 3301) as exposures on preeclampsia; protein pairs named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 546,
   "end": 827
  },
  "claim": {
   "protein_as_written": "Astacin-like metalloendopeptidase (ASTL)",
   "gene": "ASTL",
   "disease_as_written": "preeclampsia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1074,
    "end": 1318
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1074,
    "end": 1318
   }
  }
 },
 {
  "pmid": "41366697",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are reported only as a count associated with heart failure-cancer comorbidity; no named protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2505,
   "end": 2615
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41366971",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (Ferkingstad deCODE pQTLs) on osteosarcoma (FinnGen); its only MR exposures are circulating proteins, and the core proteins named are among its 81 MR hits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 663,
   "end": 810
  },
  "claim": {
   "protein_as_written": "EGFR",
   "gene": "EGFR",
   "disease_as_written": "OS",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1492,
    "end": 1601
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41367007",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 396,
   "end": 603
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41368242",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL SMR of plasma proteins (UKB-PPP, deCODE, ARIC) on bladder cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 869,
   "end": 995
  },
  "claim": {
   "protein_as_written": "MFGE8",
   "gene": "MFGE8",
   "disease_as_written": "BC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1467,
    "end": 1597
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41369868",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "URAT1 inhibition proxied by drug-target variants whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1326,
   "end": 1575
  },
  "claim": {
   "protein_as_written": "URAT1",
   "gene": "SLC22A12",
   "disease_as_written": "AF",
   "direction": "raises",
   "estimate": {
    "or": 0.91,
    "low": 0.85,
    "high": 0.97,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1326,
    "end": 1575
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1762,
    "end": 2006
   }
  }
 },
 {
  "pmid": "41369912",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR instruments are cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 503,
   "end": 719
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41372382",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are physical health phenotypes (traits), not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1031,
   "end": 1211
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41372872",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma pQTLs on acute myeloid leukemia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 534,
   "end": 684
  },
  "claim": {
   "protein_as_written": "TCL1A",
   "gene": "TCL1A",
   "disease_as_written": "AML",
   "direction": "raises",
   "estimate": {
    "or": 1.66,
    "low": 1.46,
    "high": 1.88,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1178,
    "end": 1357
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1178,
    "end": 1357
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 974,
    "end": 1115
   }
  }
 },
 {
  "pmid": "41376171",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "A phenome-wide resource of gene-trait MR pairs; the abstract states no specific protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 656,
   "end": 739
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41376378",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Named pairs (PLAU, ALOX12, LGALS3) are expression-level; the 21 protein-level associations are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 906,
   "end": 1047
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41378496",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "IL-6 signaling inhibition is proxied by an IL6R variant scaled per CRP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1185,
   "end": 1326
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41380219",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2940 plasma proteins on hypertrophic scar, with BACH1 named protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 331,
   "end": 462
  },
  "claim": {
   "protein_as_written": "BACH1",
   "gene": "BACH1",
   "disease_as_written": "HS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1010,
    "end": 1182
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1010,
    "end": 1182
   }
  }
 },
 {
  "pmid": "41380876",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with 91 inflammatory factors (the protein levels of the standard 91-protein inflammatory panel) as exposures on chronic gastritis and GC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 586,
   "end": 803
  },
  "claim": {
   "protein_as_written": "LIFR",
   "gene": "LIFR",
   "disease_as_written": "GC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1787,
    "end": 1986
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1787,
    "end": 1986
   }
  }
 },
 {
  "pmid": "41381886",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR exposure is islet FXR and CASP6 expression, and outcomes are glycaemic traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2689,
   "end": 2931
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41382255",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma IDO1 (Olink, UK Biobank) on sarcopenia, a diagnosed condition; higher IDO1 raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 601,
   "end": 898
  },
  "claim": {
   "protein_as_written": "IDO1",
   "gene": "IDO1",
   "disease_as_written": "sarcopenia",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1397,
    "end": 1676
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41386309",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is disorders of iron metabolism, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1504,
   "end": 1635
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41386873",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are methylation and gene expression levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 940,
   "end": 1041
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41387240",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of proteins on multiple sclerosis risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 366,
   "end": 559
  },
  "claim": {
   "protein_as_written": "TNFAIP3",
   "gene": "TNFAIP3",
   "disease_as_written": "MS",
   "direction": "raises",
   "estimate": {
    "or": 2,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 638,
    "end": 760
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1545,
    "end": 1721
   }
  }
 },
 {
  "pmid": "41387722",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2,901 plasma proteins using pQTLs on 21 diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 736,
   "end": 995
  },
  "claim": {
   "protein_as_written": "angiotensin-converting enzyme",
   "gene": "ACE",
   "disease_as_written": "type 2 diabetes",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 736,
    "end": 995
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41388545",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of druggable genes on PCOS whose instruments the abstract doesn't name (eQTL and mQTL analyses beside).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 486,
   "end": 576
  },
  "claim": {
   "protein_as_written": "CBLN3",
   "gene": "CBLN3",
   "disease_as_written": "PCOS",
   "direction": "lowers",
   "estimate": {
    "or": 0.8605,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2784,
    "end": 3055
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.8665,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1729,
    "end": 1842
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2784,
    "end": 3055
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41389732",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are sarcopenia traits (muscle measures), not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 487,
   "end": 739
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41390018",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are gene expression (eQTLs), not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 326,
   "end": 558
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41392280",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are named only as mediators of MASLD's associations with ASCVD subtypes; no protein's own effect on a disease is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1885,
   "end": 2109
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41394328",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins enter only as mediators; the abstract gives no protein's own effect on primary aldosteronism.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1373,
   "end": 1575
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41398348",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is childhood BMI, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 555,
   "end": 726
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41398767",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTL-instrumented druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 436,
   "end": 613
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41398882",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma GABRA4/GABRB2 MR found no significant association with any height-related disease outcome (ISS, CTS); no protein-disease pair is stated as a finding.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2007,
   "end": 2150
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41399369",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Icelandic plasma proteome pQTLs with AD and SZ.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 466,
   "end": 536
  },
  "claim": {
   "protein_as_written": "DECR2",
   "gene": "DECR2",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1262,
    "end": 1405
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1262,
    "end": 1405
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1262,
    "end": 1405
   }
  }
 },
 {
  "pmid": "41399492",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR is run, but the abstract names no protein-disease pair from it; CXCL8 is tied to diagnostic, expression, and clinical data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1194,
   "end": 1317
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41401497",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs of druggable genes (and the outcome is post-stroke functional outcome).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 348,
   "end": 638
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41402213",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Genetically proxied inhibition of HMGCR, NPC1L1, PCSK9 with instruments not named; inhibition lowers CHD risk, so higher HMGCR raises it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 474,
   "end": 798
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "CHD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1422,
    "end": 1507
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 474,
    "end": 798
   }
  }
 },
 {
  "pmid": "41402890",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is of genetic liability to MPN on AML; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 643,
   "end": 717
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41403226",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with instruments for 4907 plasma proteins on Graves' disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 363,
   "end": 597
  },
  "claim": {
   "protein_as_written": "CTSS",
   "gene": "CTSS",
   "disease_as_written": "GD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1576,
    "end": 1752
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1576,
    "end": 1752
   }
  }
 },
 {
  "pmid": "41403607",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 plasma inflammatory proteins on sepsis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 592,
   "end": 691
  },
  "claim": {
   "protein_as_written": "TRAIL",
   "gene": "TNFSF10",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": {
    "or": 1.1,
    "low": 1.03,
    "high": 1.17,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1633,
    "end": 1771
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1633,
    "end": 1771
   }
  }
 },
 {
  "pmid": "41403635",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is gene expression (eQTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 745,
   "end": 866
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41404280",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Serum-protein MR (including protein to phenotype) whose outcomes are 25 cardiometabolic traits; no disease outcome named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 442,
   "end": 687
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41404285",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The protein MR results the abstract states are effects on blood pressure, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 941,
   "end": 1258
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41407005",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "OPERA pools kinds of QTL (expression, methylation, splicing, chromatin, protein) across blood and brain; pairs aren't tied to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 675,
   "end": 801
  },
  "claim": {
   "protein_as_written": "CDH13",
   "gene": "CDH13",
   "disease_as_written": "MD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1195,
    "end": 1363
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41407891",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Bidirectional two-sample MR of the plasma proteome on cataract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 312,
   "end": 554
  },
  "claim": {
   "protein_as_written": "ILF3",
   "gene": "ILF3",
   "disease_as_written": "cataract",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 697,
    "end": 850
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41415504",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Plasma and brain proteomics both analysed; the abstract doesn't say which protein data instrumented the MR. Pairs are causal links without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 287,
   "end": 499
  },
  "claim": {
   "protein_as_written": "SNAP25",
   "gene": "SNAP25",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 880,
    "end": 985
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 986,
    "end": 1142
   }
  }
 },
 {
  "pmid": "41417678",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR of 4,907 plasma proteins on rheumatoid arthritis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 737,
   "end": 964
  },
  "claim": {
   "protein_as_written": "thrombin/prothrombin (F2)",
   "gene": "F2",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1250,
    "end": 1472
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 737,
    "end": 964
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1620,
    "end": 1789
   }
  }
 },
 {
  "pmid": "41419940",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are obesity and autoimmune diseases, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1863,
   "end": 2075
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41422660",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics MR pools pQTL, eQTL and mQTL; GCHFR is not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 721,
   "end": 828
  },
  "claim": {
   "protein_as_written": "GCHFR",
   "gene": "GCHFR",
   "disease_as_written": "gout",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2243,
    "end": 2434
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1980,
    "end": 2229
   }
  }
 },
 {
  "pmid": "41424108",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Separate pQTL SMR analyses with deCODE and UKB-PPP pQTLs on Graves' disease; the AGER pair is tied to the pQTL analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 953,
   "end": 1025
  },
  "claim": {
   "protein_as_written": "AGER",
   "gene": "AGER",
   "disease_as_written": "Graves' disease",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1347,
    "end": 1433
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H3 + PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1347,
    "end": 1433
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1567,
    "end": 1671
   }
  }
 },
 {
  "pmid": "41427984",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of differentially expressed genes on breast and colorectal cancer; the abstract doesn't name the instruments (expression or protein QTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1050,
   "end": 1239
  },
  "claim": {
   "protein_as_written": "ZFP36L2",
   "gene": "ZFP36L2",
   "disease_as_written": "breast cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2158,
    "end": 2323
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41429525",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of proteins whose circulating levels are associated with gestational diabetes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1803,
   "end": 1976
  },
  "claim": {
   "protein_as_written": "GCKR",
   "gene": "GCKR",
   "disease_as_written": "GDM",
   "direction": "raises",
   "estimate": {
    "or": 3.55,
    "low": 2.6,
    "high": 4.84,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1040,
    "end": 1111
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41431733",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteome-wide two-sample MR on systemic sclerosis is the paper's only MR; CCL19, filtered from the MR's plasma proteins, is the first protein the conclusions name, with no MR direction (its elevation is transcriptomic).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 536,
   "end": 645
  },
  "claim": {
   "protein_as_written": "CCL19",
   "gene": "CCL19",
   "disease_as_written": "SSc",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2191,
    "end": 2369
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41431770",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is TYK2 gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 74,
   "end": 419
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41436647",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR uses both eQTLs and pQTLs (tissue unstated), and the key targets are not tied to the circulating protein analysis; no direction given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 310,
   "end": 506
  },
  "claim": {
   "protein_as_written": "SERPING1",
   "gene": "SERPING1",
   "disease_as_written": "LC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1187,
    "end": 1349
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1187,
    "end": 1349
   }
  }
 },
 {
  "pmid": "41437896",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma immune protein levels (cis-pQTLs) on neurodegenerative diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1244,
   "end": 1562
  },
  "claim": {
   "protein_as_written": "FCGR2A",
   "gene": "FCGR2A",
   "disease_as_written": "Parkinson's disease",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1939,
    "end": 2108
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41444882",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are metabolic and immune characteristics, not circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 430,
   "end": 555
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41454079",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins identifies RGMA and NPC2 as causal for pulmonary hypertension, without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 146,
   "end": 338
  },
  "claim": {
   "protein_as_written": "RGMA",
   "gene": "RGMA",
   "disease_as_written": "PH",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 806,
    "end": 922
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 806,
    "end": 922
   }
  }
 },
 {
  "pmid": "41456820",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The protein-CAD finding is attributed to liver (tissue) protein and gene expression, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1297,
   "end": 1450
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41457786",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "eQTL discovery across peripheral and central tissues, with validation on 'peripheral' pQTLs never named as plasma or serum.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 461,
   "end": 662
  },
  "claim": {
   "protein_as_written": "MAPK3",
   "gene": "MAPK3",
   "disease_as_written": "KOA",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1112,
    "end": 1312
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41457966",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is white matter hyperintensities, an imaging measure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 907,
   "end": 998
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41463415",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteomes (n = 54,219) on LUSC with Bonferroni correction; proteins named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 421,
   "end": 692
  },
  "claim": {
   "protein_as_written": "DOK2",
   "gene": "DOK2",
   "disease_as_written": "LUSC",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 873,
    "end": 975
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 873,
    "end": 975
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1543,
    "end": 1717
   }
  }
 },
 {
  "pmid": "41465952",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR uses variants in the target genes without naming what weighted them (inhibition).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 370,
   "end": 674
  },
  "claim": {
   "protein_as_written": "Asialoglycoprotein receptor 1",
   "gene": "ASGR1",
   "disease_as_written": "depression",
   "direction": "raises",
   "estimate": {
    "or": 0.28,
    "low": 0.11,
    "high": 0.72,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1186,
    "end": 1351
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 370,
    "end": 674
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41467369",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools cis-eQTL and cis-pQTL; the named genes are not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 981,
   "end": 1155
  },
  "claim": {
   "protein_as_written": "SEMA7A",
   "gene": "SEMA7A",
   "disease_as_written": "DCM",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1750,
    "end": 1854
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41469306",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides the eQTL analysis, the drug-target MR has its own analysis instrumented by protein QTLs from UK Biobank, with a separate OR for DPP-4.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 595,
   "end": 835
  },
  "claim": {
   "protein_as_written": "DPP-4",
   "gene": "DPP4",
   "disease_as_written": "PD",
   "direction": "raises",
   "estimate": {
    "or": 1.21,
    "low": 1.02,
    "high": 1.45,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1802,
    "end": 1956
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1802,
    "end": 1956
   }
  }
 },
 {
  "pmid": "41472731",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "Published erratum whose only abstract text is a correction notice, so no abstract is available.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 153,
   "end": 214
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41476995",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is diabetes, with OA as outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 472,
   "end": 576
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41477556",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR prioritised plasma proteins found by plasma proteomics, HP first, for tuberculosis; the exposure is the protein, and no direction is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 423,
   "end": 748
  },
  "claim": {
   "protein_as_written": "haptoglobin [HP]",
   "gene": "HP",
   "disease_as_written": "TB",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 423,
    "end": 748
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1489,
    "end": 1694
   }
  }
 },
 {
  "pmid": "41478252",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-MR of plasma proteins on abdominal aortic aneurysm, a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1549,
   "end": 1771
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "AAA",
   "direction": "raises",
   "estimate": {
    "or": 1.14,
    "low": 1.09,
    "high": 1.2,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1549,
    "end": 1771
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1772,
    "end": 1851
   }
  }
 },
 {
  "pmid": "41480591",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Methods simulation paper; estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 512,
   "end": 711
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41480606",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins instrumented by pQTLs on diabetic neuropathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 943,
   "end": 1082
  },
  "claim": {
   "protein_as_written": "MICB",
   "gene": "MICB",
   "disease_as_written": "DN",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1176,
    "end": 1317
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1083,
    "end": 1175
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1417,
    "end": 1467
   }
  }
 },
 {
  "pmid": "41482974",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is mental wellbeing; proteins only observational.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1802,
   "end": 1897
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41487509",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 605,
   "end": 843
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41487707",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "IVW MR with pQTL instruments for druggable proteins on Crohn's disease, separate from the eQTL analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1022,
   "end": 1194
  },
  "claim": {
   "protein_as_written": "HLA-A",
   "gene": "HLA-A",
   "disease_as_written": "CD",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1481,
    "end": 1585
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1195,
    "end": 1280
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1753,
    "end": 1885
   }
  }
 },
 {
  "pmid": "41488603",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein abundance on stroke; six proteins named as causally related to stroke without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1102,
   "end": 1382
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1102,
    "end": 1382
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41489590",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "HMGCR-region variants are used to instrument LDL-C and BMI, not the protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 838,
   "end": 1043
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41489638",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Multi-omics SMR pooling mQTL, eQTL and pQTL; the stated directional pairs are from expression, and the conclusions' genes come from the pooled analysis without being tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 780,
   "end": 1031
  },
  "claim": {
   "protein_as_written": "BLK",
   "gene": "BLK",
   "disease_as_written": "sleep disorders",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1934,
    "end": 2083
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41491993",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The MR result names only a class of diseases and no member disease paired with OMG.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1216,
   "end": 1464
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41493646",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with plasma pQTLs for MANBA on squamous cell carcinoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1042,
   "end": 1243
  },
  "claim": {
   "protein_as_written": "MANBA",
   "gene": "MANBA",
   "disease_as_written": "squamous cell carcinoma",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1042,
    "end": 1243
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41494198",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on sepsis; ApoE causal with no MR direction (the U-shape is observational).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 529,
   "end": 773
  },
  "claim": {
   "protein_as_written": "ApoE",
   "gene": "APOE",
   "disease_as_written": "sepsis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1146,
    "end": 1332
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1146,
    "end": 1332
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2258,
    "end": 2343
   }
  }
 },
 {
  "pmid": "41496079",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of candidate genes on coronary heart disease without the abstract naming the instruments (gene-level exposure).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1266,
   "end": 1490
  },
  "claim": {
   "protein_as_written": "STAT1",
   "gene": "STAT1",
   "disease_as_written": "CHD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1266,
    "end": 1490
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1491,
    "end": 1668
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1947,
    "end": 2106
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41496791",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR used eQTL data as exposures.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 575,
   "end": 733
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41497980",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on alcohol-associated liver disease, a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 739,
   "end": 909
  },
  "claim": {
   "protein_as_written": "TREML2",
   "gene": "TREML2",
   "disease_as_written": "ALD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1548,
    "end": 1848
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2830,
    "end": 3003
   }
  }
 },
 {
  "pmid": "41498379",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses cis-eQTL data of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 312,
   "end": 565
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41498878",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR including plasma pQTLs on isolated REM sleep behavior disorder, with plasma SPOCK3 stated as causally linked.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 919,
   "end": 1129
  },
  "claim": {
   "protein_as_written": "SPOCK3",
   "gene": "SPOCK3",
   "disease_as_written": "iRBD",
   "direction": "raises",
   "estimate": {
    "or": 2.07,
    "low": 1.5,
    "high": 2.84,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 919,
    "end": 1129
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.96,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1301,
    "end": 1514
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41500316",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins using protein GWAS summary data on depression; BTN3A2 is the only pair surviving adjustment, stated without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 507,
   "end": 798
  },
  "claim": {
   "protein_as_written": "BTN3A2",
   "gene": "BTN3A2",
   "disease_as_written": "depression",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1299,
    "end": 1460
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41500471",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is frailty; proteins (MMP12, CRP) enter through observational proteomic and mediation analyses, with no protein's own MR effect on AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1077,
   "end": 1144
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41503834",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Eleven proteins are reported for AAA but none is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 666,
   "end": 858
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41503897",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The analyses pool cis-eQTL and cis-pQTL, and the result rests on 'BTN3A2 expression', which isn't named as a gene's, mRNA's or protein's.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 370,
   "end": 530
  },
  "claim": {
   "protein_as_written": "BTN3A2",
   "gene": "BTN3A2",
   "disease_as_written": "PSC",
   "direction": "lowers",
   "estimate": {
    "or": 0.838,
    "low": 0.792,
    "high": 0.887,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1535,
    "end": 1747
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1535,
    "end": 1747
   }
  }
 },
 {
  "pmid": "41504309",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating proteins (UKB-PPP) on Parkinson's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 311,
   "end": 498
  },
  "claim": {
   "protein_as_written": "BST1",
   "gene": "BST1",
   "disease_as_written": "PD",
   "direction": "raises",
   "estimate": {
    "or": 1.04,
    "low": 1.02,
    "high": 1.06,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1285,
    "end": 1543
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1285,
    "end": 1543
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41504506",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Beside eQTL MR, a validation MR with UK Biobank pQTLs gives BMP6 protein's own effect: elevated BMP6 lowers the risk of every hernia subtype.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1009,
   "end": 1149
  },
  "claim": {
   "protein_as_written": "BMP6",
   "gene": "BMP6",
   "disease_as_written": "diaphragmatic hernia",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1864,
    "end": 1954
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41507915",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR used cis-eQTLs of the NENF gene.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2559,
   "end": 2774
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41508967",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Multi-omic SMR pooling mQTL, eQTL and pQTL; the targets are not tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 196,
   "end": 343
  },
  "claim": {
   "protein_as_written": "RHPN1",
   "gene": "RHPN1",
   "disease_as_written": "IPF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 909,
    "end": 1069
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 909,
    "end": 1069
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 909,
    "end": 1069
   }
  }
 },
 {
  "pmid": "41509664",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of proteins with cis-pQTL instruments on coronary heart disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 707,
   "end": 885
  },
  "claim": {
   "protein_as_written": "ITGB7",
   "gene": "ITGB7",
   "disease_as_written": "CHD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1935,
    "end": 2162
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41510583",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The significant finding rests on genetically elevated \"expression\" of FGF2 without naming it as mRNA or protein or naming its instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1450,
   "end": 1628
  },
  "claim": {
   "protein_as_written": "FGF2",
   "gene": "FGF2",
   "disease_as_written": "spontaneous miscarriage",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1450,
    "end": 1628
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1450,
    "end": 1628
   }
  }
 },
 {
  "pmid": "41514346",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins (MET, CPM, CST6) are named only as mediators of BMI clusters on breast cancer, with no own effect stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2020,
   "end": 2142
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41514881",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Mendelian randomization is mentioned but the abstract states no MR protein-disease pair; DHCR24 findings are expression and experimental.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 230,
   "end": 493
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41517675",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Abstract reports 4 plasma proteins associated with spondylosis but names none.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1254,
   "end": 1393
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41519384",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The MR pools pQTL and whole-blood eQTL datasets and doesn't tie the prioritized proteins to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 800,
   "end": 950
  },
  "claim": {
   "protein_as_written": "PDGFRA",
   "gene": "PDGFRA",
   "disease_as_written": "myopia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1769,
    "end": 1935
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41520077",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma MMP12 on CHD; higher MMP12 lowers CHD risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1062,
   "end": 1287
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "CHD",
   "direction": "lowers",
   "estimate": {
    "or": 0.94,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1062,
    "end": 1287
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1473,
    "end": 1636
   }
  }
 },
 {
  "pmid": "41526531",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 461,
   "end": 571
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41533846",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The abstract attributes the BDH1-myopia finding to methylation-regulated expression, not to the circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1341,
   "end": 1466
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41537569",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR outcome is overall / cancer-specific survival among CRC patients, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 759,
   "end": 1034
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41540382",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "PWAS/MR with ARIC and INTERVAL plasma protein weights on RA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 613,
   "end": 903
  },
  "claim": {
   "protein_as_written": "FCRL3",
   "gene": "FCRL3",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1232,
    "end": 1365
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41540645",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Glucose-lowering drug targets are the MR exposures, with instruments not named (could be eQTLs or biomarker-weighted).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 696,
   "end": 851
  },
  "claim": {
   "protein_as_written": "DPP4",
   "gene": "DPP4",
   "disease_as_written": "IVDD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1104,
    "end": 1178
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1817,
    "end": 2044
   }
  }
 },
 {
  "pmid": "41543138",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on seborrhoeic dermatitis; KRT5 positive OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1005,
   "end": 1144
  },
  "claim": {
   "protein_as_written": "KRT5",
   "gene": "KRT5",
   "disease_as_written": "seborrhoeic dermatitis",
   "direction": "raises",
   "estimate": {
    "or": 1.535,
    "low": 1.092,
    "high": 2.159,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1145,
    "end": 1401
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1145,
    "end": 1401
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1605,
    "end": 1723
   }
  }
 },
 {
  "pmid": "41543776",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Analyses pool expression, methylation, protein, and splicing QTLs; the named genes aren't tied to a circulating protein analysis. No direction stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 302,
   "end": 528
  },
  "claim": {
   "protein_as_written": "IQCE",
   "gene": "IQCE",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 882,
    "end": 1004
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41544041",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on Crohn's disease and ulcerative colitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 846,
   "end": 1038
  },
  "claim": {
   "protein_as_written": "TIMP1",
   "gene": "TIMP1",
   "disease_as_written": "CD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 846,
    "end": 1038
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1039,
    "end": 1154
   }
  }
 },
 {
  "pmid": "41545942",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating adiponectin level on Alzheimer's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1111,
   "end": 1293
  },
  "claim": {
   "protein_as_written": "adiponectin",
   "gene": "ADIPOQ",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": {
    "or": 0.79,
    "low": 0.65,
    "high": 0.96,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1805,
    "end": 1988
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1989,
    "end": 2067
   }
  }
 },
 {
  "pmid": "41548043",
  "eligibility": "E2",
  "e2_kind": null,
  "eligibility_reason": "Methods paper on cis-MR instrument selection; estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 774,
   "end": 1032
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41548323",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome, carotid plaque, is an imaging-defined finding rather than a diagnosed disease; E2 is met or at most unstated (deCODE protein QTLs), so E3 is the first criterion it fails.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 149,
   "end": 351
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41553377",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Genetically proxied 'inhibition' of drug targets; instruments not named in the abstract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 995,
   "end": 1312
  },
  "claim": {
   "protein_as_written": "TUBB6",
   "gene": "TUBB6",
   "disease_as_written": "myocardial infarction",
   "direction": "raises",
   "estimate": {
    "or": 0.951,
    "low": 0.913,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 995,
    "end": 1312
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2028,
    "end": 2167
   }
  }
 },
 {
  "pmid": "41553874",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics MR pooling eQTL, mQTL and pQTL; DBNL's association not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 458,
   "end": 698
  },
  "claim": {
   "protein_as_written": "DBNL (Drebrin-like)",
   "gene": "DBNL",
   "disease_as_written": "HF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1064,
    "end": 1156
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1728,
    "end": 1854
   }
  }
 },
 {
  "pmid": "41555457",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating inflammatory proteins on dementia, with protective effects stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1049,
   "end": 1161
  },
  "claim": {
   "protein_as_written": "TNFSF13",
   "gene": "TNFSF13",
   "disease_as_written": "dementia",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1766,
    "end": 1835
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41559025",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based MR of SERPING1 on COPD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 702,
   "end": 953
  },
  "claim": {
   "protein_as_written": "serpin family G member 1 (SERPING1)",
   "gene": "SERPING1",
   "disease_as_written": "COPD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 702,
    "end": 953
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1583,
    "end": 1814
   }
  }
 },
 {
  "pmid": "41559451",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 41 inflammatory cytokines' GWAS on AMD; pairs stated without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 351,
   "end": 557
  },
  "claim": {
   "protein_as_written": "IL-10",
   "gene": "IL10",
   "disease_as_written": "AMD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1066,
    "end": 1312
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41559658",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UK Biobank Olink plasma proteins supports POLR2F with CHD; the positive direction stated is observational, MR gives none.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1307,
   "end": 1511
  },
  "claim": {
   "protein_as_written": "POLR2F",
   "gene": "POLR2F",
   "disease_as_written": "CHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1307,
    "end": 1511
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41560081",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are tested against AF but none is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 925,
   "end": 1049
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41570284",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma pQTLs (deCODE, UKB, ARIC, Fenland) on sepsis, prioritised by eQTL SMR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 456,
   "end": 781
  },
  "claim": {
   "protein_as_written": "TBCB",
   "gene": "TBCB",
   "disease_as_written": "sepsis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1539,
    "end": 1670
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1539,
    "end": 1670
   }
  }
 },
 {
  "pmid": "41571951",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with deCODE and UKB-PPP plasma pQTLs on papillary thyroid carcinoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 847,
   "end": 1109
  },
  "claim": {
   "protein_as_written": "ITGB2 (integrin β2)",
   "gene": "ITGB2",
   "disease_as_written": "PTC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1501,
    "end": 1663
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1975,
    "end": 2161
   }
  }
 },
 {
  "pmid": "41572713",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma pQTLs on hypertension from FinnGen; the abstract's closing sections name NPPA as a protective target.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 528,
   "end": 749
  },
  "claim": {
   "protein_as_written": "NPPA",
   "gene": "NPPA",
   "disease_as_written": "hypertension",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1383,
    "end": 1533
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 933,
    "end": 1088
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1383,
    "end": 1533
   }
  }
 },
 {
  "pmid": "41573111",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTL-instrumented druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 537,
   "end": 661
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41574537",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR uses BDZ target gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1283,
   "end": 1419
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41574553",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pools blood eQTLs and pQTLs; the abstract does not tie the stroke pairs to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 556,
   "end": 847
  },
  "claim": {
   "protein_as_written": "vascular endothelial growth factor A",
   "gene": "VEGFA",
   "disease_as_written": "stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1229,
    "end": 1368
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41576141",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The proteome-wide MR outcome is a latent genetic factor (mvFibroPsych), not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1768,
   "end": 1930
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41578334",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are citrulline and muscle mass, not a circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1309,
   "end": 1860
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41578456",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR pooling blood mQTLs, eQTLs, and pQTLs; the named pair (DYNLT1) is not tied to the protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 254,
   "end": 530
  },
  "claim": {
   "protein_as_written": "DYNLT1",
   "gene": "DYNLT1",
   "disease_as_written": "IS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1383,
    "end": 1522
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41578465",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteome (35,559 individuals, deCODE) on hepatocellular carcinoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 676,
   "end": 908
  },
  "claim": {
   "protein_as_written": "TMCC3",
   "gene": "TMCC3",
   "disease_as_written": "HCC",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1277,
    "end": 1480
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41580582",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "A peripheral-blood pQTL-MR meets E2, but the only pair (CD300C with lung adenocarcinoma) is stated not to survive multiple-testing correction, so no counting pair remains.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1556,
   "end": 1734
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41581718",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Blood eQTLs and plasma pQTLs were both used, and the ITPR3 result is given as genetically predicted \"expression\" without saying which instruments produced it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 577,
   "end": 828
  },
  "claim": {
   "protein_as_written": "ITPR3",
   "gene": "ITPR3",
   "disease_as_written": "chronic prostatitis",
   "direction": "raises",
   "estimate": {
    "or": 1.328,
    "low": 1.108,
    "high": 1.702,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1332,
    "end": 1612
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2119,
    "end": 2289
   }
  }
 },
 {
  "pmid": "41582318",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from physical activity to protein levels; proteins are mediators from observational analyses, not MR exposures on dementia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 759,
   "end": 897
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41593342",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is COVID-19 severity, a severity, which the codebook says isn't a disease; with E2 at most unsettled, E3 is the definite failure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1364,
   "end": 1598
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41593461",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma proteins as exposures and CRC risk as outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1068,
   "end": 1180
  },
  "claim": {
   "protein_as_written": "FABP2",
   "gene": "FABP2",
   "disease_as_written": "CRC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1068,
    "end": 1180
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2113,
    "end": 2342
   }
  }
 },
 {
  "pmid": "41605333",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on myocarditis; LIF raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 455,
   "end": 661
  },
  "claim": {
   "protein_as_written": "LIF",
   "gene": "LIF",
   "disease_as_written": "myocarditis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1435,
    "end": 1602
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1435,
    "end": 1602
   }
  }
 },
 {
  "pmid": "41606682",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are paired only with the class 'cardiovascular diseases', never with a member disease, so no counting pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 729,
   "end": 847
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41608794",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetic scores for >1500 circulating proteins (UK Biobank, deCODE) on SCAD, a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 666,
   "end": 778
  },
  "claim": {
   "protein_as_written": "ECM1",
   "gene": "ECM1",
   "disease_as_written": "SCAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1928,
    "end": 2168
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1468,
    "end": 1596
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41609852",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR exposure is CD40 'gene/protein expression', which pools gene expression and protein, and the abstract doesn't name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 686,
   "end": 794
  },
  "claim": {
   "protein_as_written": "CD40",
   "gene": "CD40",
   "disease_as_written": "ILD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1261,
    "end": 1314
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1315,
    "end": 1395
   }
  }
 },
 {
  "pmid": "41611629",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR finding is CpG methylation acting on AD through FCER1G expression, not a circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1194,
   "end": 1338
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41613752",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR exposure is gene expression of JAK2, STAT3, and CXCL12, not a circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1073,
   "end": 1274
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41616832",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTLs of 4907 proteins as instruments on thyroid disorders.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 697,
   "end": 849
  },
  "claim": {
   "protein_as_written": "IL2RB",
   "gene": "IL2RB",
   "disease_as_written": "hypothyroidism",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1426,
    "end": 1583
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1426,
    "end": 1583
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41618764",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by gene-region variants associated with LDL cholesterol.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 605,
   "end": 805
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41621513",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-MR on pQTLs of plasma proteins for MAFLD; FURIN is called a causal mediator, which gives no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 721,
   "end": 849
  },
  "claim": {
   "protein_as_written": "FURIN",
   "gene": "FURIN",
   "disease_as_written": "MAFLD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1357,
    "end": 1550
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1551,
    "end": 1697
   }
  }
 },
 {
  "pmid": "41624060",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from lung cancer to pneumonia; the protein candidates come from unspecified drug-target analyses with no MR pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1056,
   "end": 1337
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41624376",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on allergic conjunctivitis; five proteins significant after FDR but none given a direction, so the claim is unsigned (first named, TLR1).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1021,
   "end": 1206
  },
  "claim": {
   "protein_as_written": "TLR1",
   "gene": "TLR1",
   "disease_as_written": "AC",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1021,
    "end": 1206
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41624379",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Inflammatory proteins enter only as mediators of immune-cell effects on AML, and the abstract gives no protein's own effect on the disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1395,
   "end": 1512
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41625910",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of 734 plasma proteins on MN, but the abstract names no protein with MN.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 758,
   "end": 921
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41626871",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on glaucoma with odds ratios.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 469,
   "end": 603
  },
  "claim": {
   "protein_as_written": "COL24A1",
   "gene": "COL24A1",
   "disease_as_written": "glaucoma",
   "direction": "lowers",
   "estimate": {
    "or": 0.85,
    "low": 0.8,
    "high": 0.9,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1176,
    "end": 1390
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.95,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1176,
    "end": 1390
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41627849",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR uses expression and metabolite QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 599,
   "end": 807
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41629825",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma proteins (deCODE, UKB-PPP) on sepsis; conclusions name no protein, results first state SFRP1 as a risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 654,
   "end": 905
  },
  "claim": {
   "protein_as_written": "SFRP1",
   "gene": "SFRP1",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1548,
    "end": 1659
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41630247",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Pairs rest on methylation and expression QTL SMR, not circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1013,
   "end": 1241
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41630303",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on Alzheimer disease; no direction stated (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 426,
   "end": 586
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1987,
    "end": 2099
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41632246",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The pairs come from cis-eQTL MR of gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 902,
   "end": 1249
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41634900",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The main MR exposure is the metabolite CMPF, but a pooled eQTL/pQTL SMR is also run, so E2 is at most unsettled; LGALS3 is named only as a mediator, with no effect of its own on ED given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1271,
   "end": 1376
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41636061",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins (SomaLogic proteomics screen) on incident heart failure; proteins named as possibly causal without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1006,
   "end": 1143
  },
  "claim": {
   "protein_as_written": "NPDC1",
   "gene": "NPDC1",
   "disease_as_written": "HF",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1767,
    "end": 2141
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41640369",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are expression QTLs from brain cells, immune cells and plasma; no protein level is instrumented.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 439,
   "end": 665
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41645249",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are psychoactive substance use, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 913,
   "end": 1031
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41646398",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A GWAS of glaucoma endophenotypes; MR is of genes, with no circulating protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1299,
   "end": 1551
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41646694",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract puts its plasma-protein MR on disease pathogenesis in heart and brain but names no protein-disease pair from it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1073,
   "end": 1226
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41646717",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins appear only as mediators of methylation effects; no protein effect on AAA is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2225,
   "end": 2428
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41646821",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR pairs are with the pace of brain aging (a trait) or with an unnamed class of neurologic diseases, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 947,
   "end": 1152
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41646970",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "TWAS of genetically predicted gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 369,
   "end": 579
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41649226",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins (five pQTL resources) on glaucoma; pairs named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 568,
   "end": 818
  },
  "claim": {
   "protein_as_written": "NRP2",
   "gene": "NRP2",
   "disease_as_written": "overall glaucoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1259,
    "end": 1461
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1974,
    "end": 2172
   }
  }
 },
 {
  "pmid": "41650052",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory cytokines (n = 14,824) on thoracic aortic aneurysm; conclusions name CXCL10 as a risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 571,
   "end": 769
  },
  "claim": {
   "protein_as_written": "CXCL10",
   "gene": "CXCL10",
   "disease_as_written": "TAA",
   "direction": "raises",
   "estimate": {
    "or": 1.149,
    "low": 1.009,
    "high": 1.309,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2426,
    "end": 2537
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2126,
    "end": 2234
   }
  }
 },
 {
  "pmid": "41650078",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma pQTLs on pulmonary hypertension; no direction given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 461,
   "end": 703
  },
  "claim": {
   "protein_as_written": "LYZ",
   "gene": "LYZ",
   "disease_as_written": "PH",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1146,
    "end": 1306
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1672,
    "end": 1959
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41650937",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Enzyme cis-pQTL MR whose outcomes are metabolite levels, measurements, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 751,
   "end": 979
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41652421",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The cathepsin exposure is not named as a circulating level and its instruments are not named in the abstract.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 280,
   "end": 395
  },
  "claim": {
   "protein_as_written": "Cathepsin H (CtsH)",
   "gene": "CTSH",
   "disease_as_written": "PDR",
   "direction": "raises",
   "estimate": {
    "or": 1.059,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1686,
    "end": 1745
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.9999,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1026,
    "end": 1114
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1811,
    "end": 1877
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41655955",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are adiposity, glycaemia and insulin dynamics.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 418,
   "end": 654
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41657222",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Named proteins are paired only with lipids and \"heart diseases\" (a class with no member disease named), without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1570,
   "end": 1874
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41659265",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "2SMR of plasma proteins on LUAD; RACGAP1 named a causal risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 650,
   "end": 766
  },
  "claim": {
   "protein_as_written": "Rac GTPase-activating protein 1 (RACGAP1)",
   "gene": "RACGAP1",
   "disease_as_written": "LUAD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1017,
    "end": 1147
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2038,
    "end": 2216
   }
  }
 },
 {
  "pmid": "41660044",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of druggable genes BPI and CTSG on IDD; the abstract doesn't say whether the instruments are expression or protein QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1184,
   "end": 1258
  },
  "claim": {
   "protein_as_written": "BPI",
   "gene": "BPI",
   "disease_as_written": "IDD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1184,
    "end": 1258
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41662192",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A methods protocol for MR of plasma proteins on OA that presents no estimate of any protein's effect on the disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1416,
   "end": 1675
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41664179",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are named as mediators of genetically proxied beta1-blockers, with no protein's own effect on the diseases stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1763,
   "end": 1913
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41664201",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL SMR found 7 pQTLs but the abstract names no protein paired with PCOS; named genes come from mQTL and eQTL.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1404,
   "end": 1534
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41664207",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The one protein associated with atherosclerosis is not named, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1182,
   "end": 1322
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41664372",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR of TLR2, JAK2 and IL7R rests on \"elevated expression\" without naming the QTL kind or tissue; full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 899,
   "end": 1018
  },
  "claim": {
   "protein_as_written": "TLR2",
   "gene": "TLR2",
   "disease_as_written": "AS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1150,
    "end": 1284
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1411,
    "end": 1493
   }
  }
 },
 {
  "pmid": "41664644",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposures are lipid species.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1012,
   "end": 1258
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41667429",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "pQTLs from two unnamed datasets whose tissue (plasma or brain) the abstract does not state.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 447,
   "end": 625
  },
  "claim": {
   "protein_as_written": "MKRN1",
   "gene": "MKRN1",
   "disease_as_written": "PPD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1819,
    "end": 2027
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1267,
    "end": 1382
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1819,
    "end": 2027
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41667490",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "MR exposure is proteomic organ aging (a clock score), not one protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 582,
   "end": 752
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41673668",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR is run, but the abstract states no protein-disease pair from it; targets are prioritized from pooled TWAS and MR evidence for the shared autoimmune-cardiovascular signal, with no disease named for any protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1182,
   "end": 1366
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41674924",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on pericarditis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 521,
   "end": 683
  },
  "claim": {
   "protein_as_written": "NEU1",
   "gene": "NEU1",
   "disease_as_written": "pericarditis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1363,
    "end": 1535
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41675501",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of vericiguat's drug target genes on CKD is mentioned, but no protein-disease pair or MR result is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 694,
   "end": 804
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41677031",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from telomere length to proteins; GDF15's link to AAA comes from survival and mediation analyses, not MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 785,
   "end": 867
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41677388",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs of mitochondrial-related genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 380,
   "end": 582
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41678453",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma (and CSF) proteins on PBC; plasma MANBA raises risk, Bonferroni-significant.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1826,
   "end": 1947
  },
  "claim": {
   "protein_as_written": "MANBA",
   "gene": "MANBA",
   "disease_as_written": "PBC",
   "direction": "raises",
   "estimate": {
    "or": 1.29,
    "low": 1.2,
    "high": 1.4,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1826,
    "end": 1947
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1696,
    "end": 1813
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 695,
    "end": 916
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1948,
    "end": 2089
   }
  }
 },
 {
  "pmid": "41678870",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UKB-PPP plasma proteins on respiratory tract infections in FinnGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 512,
   "end": 716
  },
  "claim": {
   "protein_as_written": "FKBP1B",
   "gene": "FKBP1B",
   "disease_as_written": "URTI",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1013,
    "end": 1180
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41683918",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Headline CEP68 findings are from predicted expression and methylation SMR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1275,
   "end": 1525
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41684294",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR exposure is proteasome gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1385,
   "end": 1608
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41685341",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are blood cis-eQTLs of druggable genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 305,
   "end": 488
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41686896",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are named only as mediators of MASLD's effect, with no protein's own effect on a named disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1035,
   "end": 1233
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41691680",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 409,
   "end": 555
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41693575",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of identified plasma proteins on VTE risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1161,
   "end": 1292
  },
  "claim": {
   "protein_as_written": "TIMD4 (T-cell immunoglobulin and mucin domain-containing protein 4)",
   "gene": "TIMD4",
   "disease_as_written": "VTE",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1907,
    "end": 2188
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41693713",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL SMR was run, but the abstract names no protein from it; named genes come from methylation and expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1176,
   "end": 1286
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41694229",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of DMARD targets with UKB-PPP blood pQTLs on Alzheimer's disease; higher FCGR3B raises AD risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 564,
   "end": 708
  },
  "claim": {
   "protein_as_written": "FCGR3B",
   "gene": "FCGR3B",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "or": 1.1,
    "low": 1.02,
    "high": 1.19,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 848,
    "end": 992
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 848,
    "end": 992
   }
  }
 },
 {
  "pmid": "41694368",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on diabetic peripheral neuropathy, with protective proteins stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 356,
   "end": 512
  },
  "claim": {
   "protein_as_written": "CAPS",
   "gene": "CAPS",
   "disease_as_written": "DPN",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1285,
    "end": 1469
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41698610",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are whole-blood cis-eQTLs for gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 250,
   "end": 446
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41699549",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL; the named genes come from their intersection.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 3257,
   "end": 3352
  },
  "claim": {
   "protein_as_written": "LY9",
   "gene": "LY9",
   "disease_as_written": "HCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 3353,
    "end": 3539
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41704487",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL, eQTL and mQTL are pooled, and the abstract doesn't say the RNASET2 pQTLs are of the circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1702,
   "end": 1834
  },
  "claim": {
   "protein_as_written": "RNASET2",
   "gene": "RNASET2",
   "disease_as_written": "AIT",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1702,
    "end": 1834
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2539,
    "end": 2683
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41710145",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The pQTL hits are unnamed; the genes named come from mQTL and eQTL analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1159,
   "end": 1269
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41711838",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 plasma proteins (Ferkingstad) on OSA; conclusions name no protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 429,
   "end": 680
  },
  "claim": {
   "protein_as_written": "NTN4",
   "gene": "NTN4",
   "disease_as_written": "OSA",
   "direction": "raises",
   "estimate": {
    "or": 1.076,
    "low": 1.024,
    "high": 1.129,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1301,
    "end": 1493
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41713156",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR from brain and blood tissues without naming the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1021,
   "end": 1133
  },
  "claim": {
   "protein_as_written": "ALDH5A1",
   "gene": "ALDH5A1",
   "disease_as_written": "ASD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1357,
    "end": 1552
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1357,
    "end": 1552
   }
  }
 },
 {
  "pmid": "41713816",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The stated pair is CASP7 expression across blood and skin tissues (multi-tissue eQTL SMR), not a circulating protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1444,
   "end": 1594
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41713944",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcomes are spirometry lung function traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1405,
   "end": 1586
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41717923",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR outcomes are pulmonary function measures (FEV1, FVC); disease associations are observational.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1690,
   "end": 2235
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41719433",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR of plasma proteins on malignant neoplasms of bone and articular cartilage.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1510,
   "end": 1654
  },
  "claim": {
   "protein_as_written": "GNLY",
   "gene": "GNLY",
   "disease_as_written": "malignant neoplasms of bone and articular cartilage",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2044,
    "end": 2413
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1655,
    "end": 1830
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1831,
    "end": 2034
   }
  }
 },
 {
  "pmid": "41721963",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposure is HMGCR inhibition, a statin proxy whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 586,
   "end": 758
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "dyskinesia",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1082,
    "end": 1217
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 586,
    "end": 758
   }
  }
 },
 {
  "pmid": "41722201",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating proteins (pQTLs) on breast cancer; SELE protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1727,
   "end": 1836
  },
  "claim": {
   "protein_as_written": "SELE",
   "gene": "SELE",
   "disease_as_written": "BC",
   "direction": "lowers",
   "estimate": {
    "or": 0.98,
    "low": 0.97,
    "high": 0.98,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1727,
    "end": 1836
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1377,
    "end": 1443
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1444,
    "end": 1525
   }
  }
 },
 {
  "pmid": "41723149",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on fracture risk; ephrin-A1 identified as protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 294,
   "end": 554
  },
  "claim": {
   "protein_as_written": "ephrin-A1",
   "gene": "EFNA1",
   "disease_as_written": "fractures",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 555,
    "end": 752
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1104,
    "end": 1223
   }
  }
 },
 {
  "pmid": "41724112",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating neuro-related proteins via pQTLs on Parkinson's disease risk; pairs named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 291,
   "end": 549
  },
  "claim": {
   "protein_as_written": "CLEC1B",
   "gene": "CLEC1B",
   "disease_as_written": "PD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 872,
    "end": 1012
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41724399",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide two-step mediation MR includes the circulating proteins' own effects on cardiomyopathy, with a direction stated for all mediators.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 256,
   "end": 496
  },
  "claim": {
   "protein_as_written": "KLRC4",
   "gene": "KLRC4",
   "disease_as_written": "cardiomyopathy",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1299,
    "end": 1443
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41728924",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR findings concern single-cell gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1350,
   "end": 1874
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41731859",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is tamoxifen, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1706,
   "end": 1890
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41731883",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41732417",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based SMR (Fenland/UKB-PPP/deCODE) on bladder cancer; conclusions name candidates without direction; the first counting one whose direction the results give is PFKM (AK3 and PFKP come from metabolite-weighted MR or eQTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 772,
   "end": 926
  },
  "claim": {
   "protein_as_written": "PFKM",
   "gene": "PFKM",
   "disease_as_written": "BLCA",
   "direction": "raises",
   "estimate": {
    "or": 1.58,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1434,
    "end": 1629
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1434,
    "end": 1629
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1630,
    "end": 1790
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41736870",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is bone mineral density, a quantitative measurement, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 913,
   "end": 1030
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41737848",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of genetically predicted plasma protein levels on glioblastoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1160,
   "end": 1463
  },
  "claim": {
   "protein_as_written": "S100A4",
   "gene": "S100A4",
   "disease_as_written": "GBM",
   "direction": "raises",
   "estimate": {
    "or": 2.03,
    "low": 1.15,
    "high": 3.58,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1160,
    "end": 1463
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2146,
    "end": 2329
   }
  }
 },
 {
  "pmid": "41739400",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on DLBCL; named proteins are risk factors.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 328,
   "end": 471
  },
  "claim": {
   "protein_as_written": "GOLM1",
   "gene": "GOLM1",
   "disease_as_written": "DLBCL",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 811,
    "end": 1018
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41740536",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR on deCODE plasma proteins shows higher FGFR1 raising hypertrophic scar risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 964,
   "end": 1149
  },
  "claim": {
   "protein_as_written": "fibroblast growth factor receptor 1 (FGFR1)",
   "gene": "FGFR1",
   "disease_as_written": "HS",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 964,
    "end": 1149
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1491,
    "end": 1634
   }
  }
 },
 {
  "pmid": "41741780",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of proteins on Hirschsprung disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 291,
   "end": 593
  },
  "claim": {
   "protein_as_written": "DNER",
   "gene": "DNER",
   "disease_as_written": "HSCR",
   "direction": "lowers",
   "estimate": {
    "or": 0.12,
    "low": 0.04,
    "high": 0.39,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 861,
    "end": 1013
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 861,
    "end": 1013
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1905,
    "end": 2086
   }
  }
 },
 {
  "pmid": "41742941",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating proteins on stroke subtypes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1088,
   "end": 1277
  },
  "claim": {
   "protein_as_written": "HCII",
   "gene": "SERPIND1",
   "disease_as_written": "small vessel stroke",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1849,
    "end": 2128
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41747595",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR uses single-cell eQTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 656,
   "end": 822
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41755790",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Metformin targets are proxied by expression-associated variants weighted by HbA1c (estimates per mmol/mol HbA1c reduction).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 499,
   "end": 755
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41757182",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The MR uses cerebrospinal fluid protein pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 250,
   "end": 392
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41760024",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating (plasma) inflammatory proteins as exposures on cervical cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 624,
   "end": 861
  },
  "claim": {
   "protein_as_written": "CCL19",
   "gene": "CCL19",
   "disease_as_written": "cervical cancer",
   "direction": "raises",
   "estimate": {
    "or": 1.479,
    "low": 1.207,
    "high": 1.813,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1318,
    "end": 1545
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41761370",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Protein MR outcomes are MRI liver traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 519,
   "end": 690
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41766719",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR whose instruments 'proxy the pharmacological effects' of DMARDs without naming them, and 'IL-6R expression' is not named as an mRNA's or a protein's; the first results pair with a direction is sulfasalazine's target PLA2G1B with heart failure, given per drug effect.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 479,
   "end": 706
  },
  "claim": {
   "protein_as_written": "PLA2G1B",
   "gene": "PLA2G1B",
   "disease_as_written": "heart failure",
   "direction": "raises",
   "estimate": {
    "or": 0.86,
    "low": 0.8,
    "high": 0.94,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1039,
    "end": 1343
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1039,
    "end": 1343
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41772215",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Main SMR uses brain sQTLs/eQTLs; a pQTL validation of ZC2HC1A and TRAF3 is named without saying the proteins are circulating.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 923,
   "end": 1050
  },
  "claim": {
   "protein_as_written": "ZC2HC1A",
   "gene": "ZC2HC1A",
   "disease_as_written": "MS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2022,
    "end": 2151
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41773198",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "The instruments are oestrogen receptor gene variants chosen for their association with positive controls (downstream effects of the target), not variants associated with a circulating receptor level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 460,
   "end": 626
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41773243",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "GLP1R variants weighted by HbA1c and BMI.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 602,
   "end": 810
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41775781",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma proteins on immune-mediated diseases, but the abstract names no protein-disease pair, only counts of associations.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1453,
   "end": 1645
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41775839",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of serum FGF23 level instrumented by pQTL data on calcific aortic valve stenosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 730,
   "end": 885
  },
  "claim": {
   "protein_as_written": "FGF23",
   "gene": "FGF23",
   "disease_as_written": "CAVS",
   "direction": "raises",
   "estimate": {
    "or": 3.081,
    "low": 1.649,
    "high": 5.76,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1678,
    "end": 1878
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.96,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1317,
    "end": 1423
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 886,
    "end": 1026
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1879,
    "end": 2003
   }
  }
 },
 {
  "pmid": "41775939",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR in which statin-affected proteins (UKB-PPP, deCODE genome-wide protein associations) are tested on ischemic heart disease; PLA2G7's own effect on IHD is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 697,
   "end": 887
  },
  "claim": {
   "protein_as_written": "PLA2G7",
   "gene": "PLA2G7",
   "disease_as_written": "IHD",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1405,
    "end": 1498
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1499,
    "end": 1670
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1202,
    "end": 1404
   }
  }
 },
 {
  "pmid": "41776041",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A methods framework paper that estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 547,
   "end": 789
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41777075",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on PAH; prioritized proteins named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 111,
   "end": 284
  },
  "claim": {
   "protein_as_written": "CASP10",
   "gene": "CASP10",
   "disease_as_written": "PAH",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1207,
    "end": 1311
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1207,
    "end": 1311
   }
  }
 },
 {
  "pmid": "41778065",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is coronary artery calcification severity, an imaging measure, not a disease (E2 itself unsettled: PCSK9 gene drug-target MR).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1406,
   "end": 1698
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41781684",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein CNTN2 on CAVD; MR gives no direction (protection is from experiments).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 222,
   "end": 370
  },
  "claim": {
   "protein_as_written": "CNTN2",
   "gene": "CNTN2",
   "disease_as_written": "CAVD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1735,
    "end": 1853
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1148,
    "end": 1223
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41785432",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Genetic proxies for circulating thrombin, FXa and FXI levels on cerebral venous thrombosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 667,
   "end": 845
  },
  "claim": {
   "protein_as_written": "FXI",
   "gene": "F11",
   "disease_as_written": "CVT",
   "direction": "raises",
   "estimate": {
    "or": 0.38,
    "low": 0.26,
    "high": 0.55,
    "unit": "per standard deviation",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1361,
    "end": 1457
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1361,
    "end": 1457
   }
  }
 },
 {
  "pmid": "41787256",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR (deCODE/Fenland) on ER+ breast cancer; IL3RA protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 539,
   "end": 738
  },
  "claim": {
   "protein_as_written": "IL3RA",
   "gene": "IL3RA",
   "disease_as_written": "ER+ breast cancer",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 946,
    "end": 1025
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1717,
    "end": 1808
   }
  }
 },
 {
  "pmid": "41787912",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41788971",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Pairs come from SMR pooling mQTL, eQTL, and pQTL; the abstract doesn't tie them to the circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 368,
   "end": 613
  },
  "claim": {
   "protein_as_written": "ERBB3",
   "gene": "ERBB3",
   "disease_as_written": "COPD in never-smokers",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1355,
    "end": 1544
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41789253",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "pQTL instruments, but the outcome is random glucose, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 758,
   "end": 919
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41789843",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with cis-pQTLs of plasma proteins on glaucoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 657,
   "end": 762
  },
  "claim": {
   "protein_as_written": "LTBP2",
   "gene": "LTBP2",
   "disease_as_written": "glaucoma",
   "direction": "raises",
   "estimate": {
    "or": 1.52,
    "low": 1.36,
    "high": 1.71,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1245,
    "end": 1528
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1986,
    "end": 2111
   }
  }
 },
 {
  "pmid": "41795042",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is one of the molecular trait analyses run on blood and brain transcriptomic and proteomic datasets, so E2 isn't plainly failed, but the abstract states no protein-disease pair from MR of a protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 627,
   "end": 766
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41799426",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 circulating plasma proteins (deCODE) on bacterial skin infections; pairs have no direction, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 635,
   "end": 893
  },
  "claim": {
   "protein_as_written": "FN1",
   "gene": "FN1",
   "disease_as_written": "erysipelas",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1383,
    "end": 1567
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41800109",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 83 CVD-related plasma proteins on Parkinson's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1268,
   "end": 1488
  },
  "claim": {
   "protein_as_written": "Fas cell surface death receptors",
   "gene": "FAS",
   "disease_as_written": "PD",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1268,
    "end": 1488
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41801343",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Blood pQTL SMR is one of the analyses, and the abstract ties GRHPR's inverse association with CRC to the pQTL level as well as the m/eQTL levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1037,
   "end": 1217
  },
  "claim": {
   "protein_as_written": "GRHPR",
   "gene": "GRHPR",
   "disease_as_written": "CRC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1887,
    "end": 2162
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1037,
    "end": 1217
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41803955",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL from public databases; the RPS6KA1 protein-abundance pQTLs are not stated to be circulating; full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 520,
   "end": 826
  },
  "claim": {
   "protein_as_written": "RPS6KA1",
   "gene": "RPS6KA1",
   "disease_as_written": "KD",
   "direction": "raises",
   "estimate": {
    "or": 2.82,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1042,
    "end": 1219
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41804813",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UK Biobank plasma proteins on MASLD; genetically predicted higher CDHR2 raises MASLD risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1327,
   "end": 1485
  },
  "claim": {
   "protein_as_written": "CDHR2",
   "gene": "CDHR2",
   "disease_as_written": "MASLD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1327,
    "end": 1485
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1725,
    "end": 1865
   }
  }
 },
 {
  "pmid": "41810366",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "APOC3 'genetically proxied inhibition' in drug-target MR; the abstract does not name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2261,
   "end": 2418
  },
  "claim": {
   "protein_as_written": "APOC3",
   "gene": "APOC3",
   "disease_as_written": "AAA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2261,
    "end": 2418
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2515,
    "end": 2639
   }
  }
 },
 {
  "pmid": "41811388",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "European plasma pQTL MR on IgA nephropathy; CFH protective by its OR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1623,
   "end": 2060
  },
  "claim": {
   "protein_as_written": "complement factor H (CFH)",
   "gene": "CFH",
   "disease_as_written": "IgA nephropathy",
   "direction": "lowers",
   "estimate": {
    "or": 0.54,
    "low": 0.45,
    "high": 0.65,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1623,
    "end": 2060
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1155,
    "end": 1245
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41812891",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with deCODE plasma proteins as mediators; the protein-to-depression step gives an OR for EZR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 748,
   "end": 1056
  },
  "claim": {
   "protein_as_written": "Ezrin (EZR",
   "gene": "EZR",
   "disease_as_written": "depression",
   "direction": "lowers",
   "estimate": {
    "or": 0.96,
    "low": 0.93,
    "high": 1,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1275,
    "end": 1440
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2056,
    "end": 2173
   }
  }
 },
 {
  "pmid": "41814035",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of UKB-PPP individual plasma proteins (and ratios) on autoimmune liver diseases; CD74 raises PSC risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 879,
   "end": 1004
  },
  "claim": {
   "protein_as_written": "CD74",
   "gene": "CD74",
   "disease_as_written": "PSC",
   "direction": "raises",
   "estimate": {
    "or": 1.54,
    "low": 1.24,
    "high": 1.9,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1957,
    "end": 2108
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41815121",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is a disease (IPF) with BCC as outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1131,
   "end": 1283
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41815369",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by expression QTLs and by variants weighted by blood glucose.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 563,
   "end": 776
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41816092",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Metformin target genes' variants are weighted by HbA1c.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 925,
   "end": 1112
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41819524",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Targets come from MR pooling blood/liver cis-eQTLs and pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 493,
   "end": 637
  },
  "claim": {
   "protein_as_written": "CD58",
   "gene": "CD58",
   "disease_as_written": "PBC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1541,
    "end": 1634
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1017,
    "end": 1176
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1541,
    "end": 1634
   }
  }
 },
 {
  "pmid": "41821112",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR is run separately for each kind of QTL (82 methylation sites, 18 genes, 2 proteins), and the abstract ties NFKB1 to the protein (pQTL) analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1245,
   "end": 1453
  },
  "claim": {
   "protein_as_written": "NFKB1",
   "gene": "NFKB1",
   "disease_as_written": "psoriasis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1466,
    "end": 1718
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1245,
    "end": 1453
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41822323",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Includes pQTL-MR of plasma VNN2 (deCODE) on LUAD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 377,
   "end": 780
  },
  "claim": {
   "protein_as_written": "VNN2",
   "gene": "VNN2",
   "disease_as_written": "LUAD",
   "direction": "lowers",
   "estimate": {
    "unit": "not stated",
    "frame": "per higher protein",
    "low": 0.921,
    "high": 0.97,
    "or": 0.946
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 958,
    "end": 1273
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41824808",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "EPO signalling proxied by EPOR cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 471,
   "end": 622
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41825207",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR on RA nominates PAK1 without naming its instruments, after bulk and single-cell RNA analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 596,
   "end": 739
  },
  "claim": {
   "protein_as_written": "PAK1",
   "gene": "PAK1",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1136,
    "end": 1190
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1136,
    "end": 1190
   }
  }
 },
 {
  "pmid": "41825483",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Exposure is GLP1R activation proxied by GLP1R-locus variants scaled to T2D liability; the abstract does not say the variants are associated with circulating GLP1R level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 444,
   "end": 566
  },
  "claim": {
   "protein_as_written": "GLP1R",
   "gene": "GLP1R",
   "disease_as_written": "HF",
   "direction": "lowers",
   "estimate": {
    "or": 0.96,
    "low": 0.95,
    "high": 0.98,
    "unit": "other",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1661,
    "end": 1812
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 67
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41828452",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are single-cell cis-eQTLs, gene expression, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 288,
   "end": 545
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41832569",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Protein-level (pQTL) MR showed BMP6 increased intervertebral disc degeneration risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1694,
   "end": 1883
  },
  "claim": {
   "protein_as_written": "BMP6",
   "gene": "BMP6",
   "disease_as_written": "IVDD",
   "direction": "raises",
   "estimate": {
    "or": 1.19,
    "low": 1.09,
    "high": 1.3,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1694,
    "end": 1883
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.99,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1694,
    "end": 1883
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 629,
    "end": 848
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1992,
    "end": 2093
   }
  }
 },
 {
  "pmid": "41834957",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma proteins on allergic rhinitis, asthma and nasal polyps, after an eQTL screen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 648,
   "end": 780
  },
  "claim": {
   "protein_as_written": "ERBB3",
   "gene": "ERBB3",
   "disease_as_written": "AR",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1656,
    "end": 1849
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.91,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1351,
    "end": 1439
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41835849",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug target genes instrumented by eQTLGen and GTEx expression data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 500,
   "end": 934
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41836545",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "The protein mediators are a brain protein and a cerebrospinal fluid protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1237,
   "end": 1444
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41836659",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein instruments from 35,559 Icelanders, with schizophrenia as the outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 298,
   "end": 554
  },
  "claim": {
   "protein_as_written": "ADAM22",
   "gene": "ADAM22",
   "disease_as_written": "SCZ",
   "direction": "lowers",
   "estimate": {
    "or": 0.85,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1004,
    "end": 1368
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41837484",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins associated with osteoporosis are not named; the one named protein, RABGAP1L, appears only as a mediator without its own effect on OP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1109,
   "end": 1243
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41837520",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41837796",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The plasma pQTL MR on vascular dementia found no causal effect; no protein-disease pair is stated from the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1388,
   "end": 1546
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41837832",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR used SLC2A9 eQTLs/cis-eQTLs as exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 654,
   "end": 809
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41840829",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with blood-derived pQTLs gives HGF protein levels' effect on gastric cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 96,
   "end": 438
  },
  "claim": {
   "protein_as_written": "HGF",
   "gene": "HGF",
   "disease_as_written": "gastric cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 753,
    "end": 1064
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41840960",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The only MR the abstract names has serum copper as its exposure; plasma proteins enter only through a mediation analysis that isn't stated to be MR on protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 532,
   "end": 692
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41841768",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating NAMPT on aortic stenosis; elevated plasma NAMPT raised risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 863,
   "end": 981
  },
  "claim": {
   "protein_as_written": "plasma NAMPT",
   "gene": "NAMPT",
   "disease_as_written": "aortic stenosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1437,
    "end": 1533
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2140,
    "end": 2312
   }
  }
 },
 {
  "pmid": "41842707",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins (pQTLs from Sun 2018) on lung squamous cell carcinoma, a disease, with protein-disease pairs stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1111,
   "end": 1269
  },
  "claim": {
   "protein_as_written": "SPINK2",
   "gene": "SPINK2",
   "disease_as_written": "LUSC",
   "direction": "lowers",
   "estimate": {
    "or": 0.74,
    "low": 0.66,
    "high": 0.84,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1270,
    "end": 1500
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1642,
    "end": 1731
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2236,
    "end": 2415
   }
  }
 },
 {
  "pmid": "41844148",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR proteins for frailty are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 488,
   "end": 577
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41847479",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are sleep traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 520,
   "end": 756
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41849060",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are PPI use and genetic proxies of the H+/K+-ATPase, a complex of two genes' products, not one circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 876,
   "end": 1033
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41855073",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "PCSK9 variants are weighted by LDL cholesterol.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 783,
   "end": 869
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41855608",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on IPF.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 361,
   "end": 529
  },
  "claim": {
   "protein_as_written": "MASP1",
   "gene": "MASP1",
   "disease_as_written": "IPF",
   "direction": "lowers",
   "estimate": {
    "or": 0.46,
    "low": 0.22,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1066,
    "end": 1279
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.92,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1066,
    "end": 1279
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1839,
    "end": 2006
   }
  }
 },
 {
  "pmid": "41859015",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are COPD liability, methylation and gene expression; no protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1146,
   "end": 1291
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41859020",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "SMR prioritises genes; no protein exposure is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1715,
   "end": 1862
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41859349",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2923 circulating proteins on B-cell malignancies; first named pair has no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 592,
   "end": 772
  },
  "claim": {
   "protein_as_written": "TNFSF13 (APRIL)",
   "gene": "TNFSF13",
   "disease_as_written": "multiple myeloma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 592,
    "end": 772
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41861181",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are variants associated with GLP1R gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 563,
   "end": 741
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41861198",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Genetically predicted inhibition of drug targets; instruments are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 313,
   "end": 664
  },
  "claim": {
   "protein_as_written": "3-hydroxy-3-methylglutaryl coenzyme A reductase",
   "gene": "HMGCR",
   "disease_as_written": "epilepsy",
   "direction": "raises",
   "estimate": {
    "or": 0.87,
    "low": 0.82,
    "high": 0.92,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 803,
    "end": 1078
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 313,
    "end": 664
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41861221",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of plasma sclerostin level using a cis-acting instrument on ischemic stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1116,
   "end": 1218
  },
  "claim": {
   "protein_as_written": "sclerostin",
   "gene": "SOST",
   "disease_as_written": "ischemic stroke",
   "direction": "lowers",
   "estimate": {
    "or": 1.32,
    "low": 1.03,
    "high": 1.68,
    "unit": "per unit",
    "frame": "per lower protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1782,
    "end": 2005
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "other",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1649,
    "end": 1781
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1782,
    "end": 2005
   }
  }
 },
 {
  "pmid": "41861669",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Observational mediation analysis of measured proteins; no Mendelian randomization of a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1209,
   "end": 1366
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41863461",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE circulating protein pQTLs on ischemic stroke, a disease; no direction is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 647,
   "end": 859
  },
  "claim": {
   "protein_as_written": "Ppp1r14a",
   "gene": "PPP1R14A",
   "disease_as_written": "ischemic stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2684,
    "end": 2832
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41865070",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is genetically predicted coffee consumption.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 770,
   "end": 972
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41867216",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Protein MR on coronary artery disease is reported only as a count; no named protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1595,
   "end": 1693
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41868721",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The causal genes come from SMR pooling methylation, expression and protein QTLs, and the two-sample MR is of gene expression; the abstract doesn't tie the pair to a circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 456,
   "end": 764
  },
  "claim": {
   "protein_as_written": "GPX1",
   "gene": "GPX1",
   "disease_as_written": "COPD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1834,
    "end": 2063
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1010,
    "end": 1156
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41872385",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are medication classes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 323,
   "end": 451
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41872870",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is social isolation; proteins enter only observational analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 599,
   "end": 760
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41872929",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract gives only background and methods; it states no protein-disease result.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 684,
   "end": 781
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41874668",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is heel bone mineral density, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1164,
   "end": 1275
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41876152",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A cohort profile; it estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 758,
   "end": 1067
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41881997",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR exposure is 'FCRL6 expression', not named as a gene's or protein's, so E2 is unsettled rather than failed; the MR outcome is CMV seropositivity, a serostatus, which is not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1428,
   "end": 1553
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41882153",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The MR exposure is a berberine-response signature; proteins are named only as possibly explaining the signature's association, with no protein's own effect on a disease given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 841,
   "end": 1051
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41884853",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins identified PFDN2 as protective against hypopharyngeal carcinoma; the conclusions' HNSC progression rests on experimental data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1156,
   "end": 1321
  },
  "claim": {
   "protein_as_written": "prefoldin subunit 2 (PFDN2)",
   "gene": "PFDN2",
   "disease_as_written": "hypopharyngeal carcinoma",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1156,
    "end": 1321
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2117,
    "end": 2381
   }
  }
 },
 {
  "pmid": "41885234",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma pQTLs (Zheng, deCODE) on gout.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 945,
   "end": 1076
  },
  "claim": {
   "protein_as_written": "PLAU",
   "gene": "PLAU",
   "disease_as_written": "gout",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1927,
    "end": 2149
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1747,
    "end": 1926
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41886369",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The SMR is tied to SMAD7 as a regulator of ferroptosis; the abstract states no protein-disease pair from MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 918,
   "end": 1108
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41889163",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The proteome-wide MR gives counts of plasma proteins but names none for a disease; the named proteins are tied to progression without attribution to the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 856,
   "end": 1061
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41890164",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (UK Biobank proteomics) on dementia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1607,
   "end": 1871
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "dementia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1607,
    "end": 1871
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41890708",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR; circulating CCS's own causal association with carpal tunnel syndrome is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1648,
   "end": 1755
  },
  "claim": {
   "protein_as_written": "CCS",
   "gene": "CCS",
   "disease_as_written": "CTS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1479,
    "end": 1647
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2099,
    "end": 2195
   }
  }
 },
 {
  "pmid": "41894269",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "The only protein exposure is drug-target MR 'targeting HMGCR' for statins, instruments not named; inhibition protective (OR 0.79), so higher HMGCR raises risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1067,
   "end": 1255
  },
  "claim": {
   "protein_as_written": "HMGCR",
   "gene": "HMGCR",
   "disease_as_written": "craniosynostosis",
   "direction": "raises",
   "estimate": {
    "or": 0.79,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1067,
    "end": 1255
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1067,
    "end": 1255
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41895592",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins instrumented by pQTLs from 9 proteome GWASs on aortic aneurysm (FinnGen).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 500,
   "end": 660
  },
  "claim": {
   "protein_as_written": "AHSG",
   "gene": "AHSG",
   "disease_as_written": "TAA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1898,
    "end": 2222
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41896191",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with blood-based pQTLs; the UNG pair is tied explicitly to the pQTL analysis and passes colocalisation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 254,
   "end": 484
  },
  "claim": {
   "protein_as_written": "UNG",
   "gene": "UNG",
   "disease_as_written": "paediatric asthma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 972,
    "end": 1120
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.84,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 972,
    "end": 1120
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41904330",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are CD4+ T cell eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 321,
   "end": 632
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41905213",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The pQTL-based MR names no protein; ACOT8 comes from transcriptomic and machine-learning analyses and experiments, which the abstract doesn't tie to the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 488,
   "end": 598
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41905540",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of vitamin B12 targets that doesn't name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 518,
   "end": 789
  },
  "claim": {
   "protein_as_written": "ALDH2",
   "gene": "ALDH2",
   "disease_as_written": "post-ischemic fibrotic remodeling",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1010,
    "end": 1167
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 518,
    "end": 789
   }
  }
 },
 {
  "pmid": "41905541",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are expression of druggable genes (eQTL/SMR), not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 835,
   "end": 1152
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41908841",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug target genes are proxied by blood eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 442,
   "end": 594
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41908943",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 1812 UK Biobank plasma proteins on SONFH; CCL17 is causal, with no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1288,
   "end": 1482
  },
  "claim": {
   "protein_as_written": "CCL17",
   "gene": "CCL17",
   "disease_as_written": "SONFH",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2046,
    "end": 2138
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1941,
    "end": 2033
   }
  }
 },
 {
  "pmid": "41912985",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from sleep disturbance to CSF proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 880,
   "end": 1034
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41913250",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The DHX58 estimate comes from MR/SMR integrating eQTLs and pQTLs, without saying which instruments gave it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1469,
   "end": 1553
  },
  "claim": {
   "protein_as_written": "DHX58",
   "gene": "DHX58",
   "disease_as_written": "OC",
   "direction": "raises",
   "estimate": {
    "or": 1.3,
    "low": 1.12,
    "high": 1.51,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1554,
    "end": 1674
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.949,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1675,
    "end": 1746
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2176,
    "end": 2309
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41917768",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Blood pQTLs were among the instruments, but every pair the abstract states comes from splicing, expression, or methylation QTLs; no protein-level pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1458,
   "end": 1630
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41918723",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE plasma proteins on UC names no protein with its effect; KLF4, MAPK11 and PTEN are named only as mediators with no own effect stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1359,
   "end": 1472
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41925857",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "The record has no abstract.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41926080",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR concerns GCKR and a genomic-SEM latent factor of gout, urate, kidney, and metabolic traits, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1222,
   "end": 1376
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41927922",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR pooled transcriptomic and proteomic QTLs, not tying the pairs to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1183,
   "end": 1328
  },
  "claim": {
   "protein_as_written": "ADRB2",
   "gene": "ADRB2",
   "disease_as_written": "HCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1329,
    "end": 1465
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1329,
    "end": 1465
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1329,
    "end": 1465
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41927926",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is said to support causal roles of proteins in unnamed 'disease pathogenesis'; no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 980,
   "end": 1109
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41928086",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins with genetic support for migraine are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1884,
   "end": 2049
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41928789",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating SASP proteins on dementia; TBCA causally associated without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1175,
   "end": 1274
  },
  "claim": {
   "protein_as_written": "Tubulin folding cofactor A protein",
   "gene": "TBCA",
   "disease_as_written": "incident dementia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1175,
    "end": 1274
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1275,
    "end": 1387
   }
  }
 },
 {
  "pmid": "41929023",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The exposure is LACTB expression in myeloid cells.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 943,
   "end": 1163
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41929286",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating AAT level on sepsis; higher level protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 689,
   "end": 857
  },
  "claim": {
   "protein_as_written": "AAT",
   "gene": "SERPINA1",
   "disease_as_written": "sepsis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 689,
    "end": 857
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 689,
    "end": 857
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1506,
    "end": 1715
   }
  }
 },
 {
  "pmid": "41929323",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target instruments are variants near antihypertensive targets weighted by systolic blood pressure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 833,
   "end": 1067
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41931316",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The title names the MR as based on plasma proteins (a proteome-wide MR of plasma proteins) on valvular heart disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 149
  },
  "claim": {
   "protein_as_written": "stathmin 1",
   "gene": "STMN1",
   "disease_as_written": "VHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1017,
    "end": 1153
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41932587",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is the Fried Frailty Score, a continuous score, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 395,
   "end": 541
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41934917",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on ovarian cancer subtypes names FCGR2B as a causal plasma protein for HGSOC, without a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1183,
   "end": 1379
  },
  "claim": {
   "protein_as_written": "FCGR2B",
   "gene": "FCGR2B",
   "disease_as_written": "high-grade serous ovarian cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1183,
    "end": 1379
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1869,
    "end": 2152
   }
  }
 },
 {
  "pmid": "41935040",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteome study in UK Biobank with MR of JAM3 on schizophrenia, positive causal relationship with an uncorrected p-value.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 708,
   "end": 830
  },
  "claim": {
   "protein_as_written": "JAM3",
   "gene": "JAM3",
   "disease_as_written": "schizophrenia",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 708,
    "end": 830
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41936173",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR on unspecified QTL data links quercetin to genes such as PRKCA; the abstract states no protein-disease pair from MR of a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1421,
   "end": 1474
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41937214",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "PARK7's pair comes from integrating mQTL, eQTL and pQTL analyses; the pQTLs' tissue is not stated and no direction is tied to the protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1412,
   "end": 1557
  },
  "claim": {
   "protein_as_written": "PARK7",
   "gene": "PARK7",
   "disease_as_written": "streptococcal septicemia",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2165,
    "end": 2304
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2305,
    "end": 2510
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41938534",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with plasma protein abundance as one layer; FIS1 protective for male infertility.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1535,
   "end": 1754
  },
  "claim": {
   "protein_as_written": "FIS1",
   "gene": "FIS1",
   "disease_as_written": "male infertility",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2392,
    "end": 2634
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41940328",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted circulating protein levels (deCODE, UKB pQTLs) on breast cancer, with protein-disease pairs stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 381,
   "end": 850
  },
  "claim": {
   "protein_as_written": "intestinal alkaline phosphatase (ALPI)",
   "gene": "ALPI",
   "disease_as_written": "BC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 381,
    "end": 850
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 851,
    "end": 926
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41940976",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "No MR of a protein's level; genes are correlated with ESCC prognosis from public data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 702,
   "end": 820
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41941166",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of drug target genes' expression on amnesia.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 505,
   "end": 630
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41943668",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are DNA methylation and gene expression, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 237,
   "end": 434
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41944768",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The MR exposures are genes (DEGs picked by scRNA-seq), and the abstract doesn't name their instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 841,
   "end": 1005
  },
  "claim": {
   "protein_as_written": "S100A6",
   "gene": "S100A6",
   "disease_as_written": "ALS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1199,
    "end": 1354
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1367,
    "end": 1544
   }
  }
 },
 {
  "pmid": "41948706",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins with deCODE pQTL instruments on aortic dissection.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 493,
   "end": 751
  },
  "claim": {
   "protein_as_written": "CCN3",
   "gene": "CCN3",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1782,
    "end": 2069
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1782,
    "end": 2069
   }
  }
 },
 {
  "pmid": "41949600",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR/SMR of genes from transcriptomics, instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 907,
   "end": 1043
  },
  "claim": {
   "protein_as_written": "STAT3",
   "gene": "STAT3",
   "disease_as_written": "AMI",
   "direction": "raises",
   "estimate": {
    "or": 1.417,
    "low": 1.063,
    "high": 1.889,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1332,
    "end": 1505
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1886,
    "end": 2043
   }
  }
 },
 {
  "pmid": "41951043",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from educational attainment to protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 715,
   "end": 830
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41951048",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR proxies sulfonylureas targeting INS without naming the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1590,
   "end": 1848
  },
  "claim": {
   "protein_as_written": "INS",
   "gene": "INS",
   "disease_as_written": "CRC",
   "direction": "lowers",
   "estimate": {
    "or": 0.56,
    "low": 0.35,
    "high": 0.88,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1590,
    "end": 1848
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1590,
    "end": 1848
   }
  }
 },
 {
  "pmid": "41951112",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "TNF inhibition proxied by TNF-locus variants associated with CRP and leukocyte counts.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 816,
   "end": 963
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41953991",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of plasma proteins on BP traits and hypertension; NHERF2 named as putatively causal for hypertension without a direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 736,
   "end": 884
  },
  "claim": {
   "protein_as_written": "NHERF2 (Na+/H+ exchange regulatory cofactor 2)",
   "gene": "NHERF2",
   "disease_as_written": "hypertension",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1606,
    "end": 1758
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1942,
    "end": 2016
   }
  }
 },
 {
  "pmid": "41954291",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Serum proteins appear only as mediators of disease-to-disease effects; the abstract gives no protein's own effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1154,
   "end": 1416
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41961272",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide cis-pQTL MR on SSNS; APOM increases associated with decreased risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1228,
   "end": 1427
  },
  "claim": {
   "protein_as_written": "APOM",
   "gene": "APOM",
   "disease_as_written": "SSNS",
   "direction": "lowers",
   "estimate": {
    "or": 0.4,
    "low": 0.27,
    "high": 0.61,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1228,
    "end": 1427
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.98,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1428,
    "end": 1531
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1870,
    "end": 1980
   }
  }
 },
 {
  "pmid": "41961674",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "LEPR proxied by blood cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 898,
   "end": 1185
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41962653",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Protein-level instruments are tested against metabolite levels, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 664,
   "end": 903
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41963232",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "SGLT2 inhibition is proxied by SLC5A2 variants weighted by HbA1c.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 329,
   "end": 506
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41965693",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Causal inference uses an EFEMP1 plasma pQTL on Alzheimer's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 822,
   "end": 1045
  },
  "claim": {
   "protein_as_written": "EFEMP1",
   "gene": "EFEMP1",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": {
    "or": 7.96,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 822,
    "end": 1045
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 154
   }
  }
 },
 {
  "pmid": "41967779",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of HK3, a target of Fangfeng Decoction, on RA; the instruments are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1344,
   "end": 1418
  },
  "claim": {
   "protein_as_written": "HK3",
   "gene": "HK3",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1344,
    "end": 1418
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1344,
    "end": 1418
   }
  }
 },
 {
  "pmid": "41968825",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The PDGFRB result is called 'expression' without naming it as the protein's, though a pQTL study is used; PDGFRB is protective for pancreatic cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 984,
   "end": 1177
  },
  "claim": {
   "protein_as_written": "PDGFRB",
   "gene": "PDGFRB",
   "disease_as_written": "pancreatic cancer",
   "direction": "lowers",
   "estimate": {
    "or": 0.9179,
    "low": 0.8837,
    "high": 0.9535,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1621,
    "end": 1820
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2354,
    "end": 2523
   }
  }
 },
 {
  "pmid": "41969614",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR of type 2 diabetes on MASLD; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1090,
   "end": 1286
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41972152",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The paper has a plasma cis-pQTL layer, so it meets E2, but the abstract says no association survived FDR correction, so no counting protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1278,
   "end": 1483
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41978582",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is between COPD, GI diseases, and smoking; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1215,
   "end": 1339
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41981742",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The AMIGO1 pair rests on SMR pooling mQTL, eQTL and pQTL; pQTL tissue not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1174,
   "end": 1417
  },
  "claim": {
   "protein_as_written": "AMIGO1",
   "gene": "AMIGO1",
   "disease_as_written": "PD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1520,
    "end": 1622
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41983033",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Genetic validation used eQTLs of drug target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1404,
   "end": 1563
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41984189",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposure is circulating PFOA, a chemical.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 415,
   "end": 672
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41986576",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with deCODE plasma pQTLs on keloid.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 936,
   "end": 1166
  },
  "claim": {
   "protein_as_written": "SRA1",
   "gene": "SRA1",
   "disease_as_written": "keloid",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2209,
    "end": 2314
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41989152",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with pQTLs alongside eQTLs; the abstract ties BMP1's claim to the proteomic-level analysis; MI is a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1175,
   "end": 1364
  },
  "claim": {
   "protein_as_written": "BMP1",
   "gene": "BMP1",
   "disease_as_written": "MI",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1597,
    "end": 1837
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1365,
    "end": 1469
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1027,
    "end": 1174
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1470,
    "end": 1596
   }
  }
 },
 {
  "pmid": "41990104",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR (pQTL) on glomerulonephritis subtypes, reported apart from the transcriptomic MR; MTR protective in chronic GN is the first directed pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1076,
   "end": 1239
  },
  "claim": {
   "protein_as_written": "MTR",
   "gene": "MTR",
   "disease_as_written": "chronic GN",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1076,
    "end": 1239
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 787,
    "end": 940
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "41992251",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is host immune response to CMV, not a protein level on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 782,
   "end": 1165
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41992590",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug target genes proxied by eQTLs; other exposures are behaviours.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 747,
   "end": 938
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41993107",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR exposure is the 'expression' of SLC7A11, not named as mRNA or protein, and the instruments aren't named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1395,
   "end": 1522
  },
  "claim": {
   "protein_as_written": "SLC7A11",
   "gene": "SLC7A11",
   "disease_as_written": "OA",
   "direction": "lowers",
   "estimate": {
    "or": 0.84,
    "low": 0.72,
    "high": 0.98,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1395,
    "end": 1522
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1395,
    "end": 1522
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "41995544",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 129,
   "end": 431
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41996359",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs between diseases (IBD and anterior uveitis); no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 969,
   "end": 1075
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41998673",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is lung function change (FEV1 decline), a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1970,
   "end": 2188
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41999740",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating cytokines names only epigenetic age acceleration and an unnamed class of age-related diseases as outcomes, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 686,
   "end": 958
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "41999825",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR and colocalisation with plasma proteomic QTLs for CHD and IS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 709,
   "end": 907
  },
  "claim": {
   "protein_as_written": "CYR61",
   "gene": "CCN1",
   "disease_as_written": "ischemic stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 0,
    "end": 146
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 146
   }
  }
 },
 {
  "pmid": "42002896",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Beside a GTEx cis-eQTL MR, a separate MR uses deCODE proteomic data, and the abstract ties STAT3 to that proteomic analysis (Bonferroni-significant); no direction is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 544,
   "end": 705
  },
  "claim": {
   "protein_as_written": "STAT3",
   "gene": "STAT3",
   "disease_as_written": "MS",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1660,
    "end": 1816
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.97,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1507,
    "end": 1659
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2483,
    "end": 2611
   }
  }
 },
 {
  "pmid": "42004028",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The exposure is RSK1 without its instruments named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 512,
   "end": 683
  },
  "claim": {
   "protein_as_written": "RSK1",
   "gene": "RPS6KA1",
   "disease_as_written": "IPF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 512,
    "end": 683
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1084,
    "end": 1264
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42004468",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-SMR of plasma proteins on erectile dysfunction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1271,
   "end": 1423
  },
  "claim": {
   "protein_as_written": "FIS1",
   "gene": "FIS1",
   "disease_as_written": "ED",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1424,
    "end": 1579
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42004610",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1871,
   "end": 1962
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42005663",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Mediation MR estimates plasma proteins' effects on the outcome, which meets E2, but the outcome is aging, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1502,
   "end": 1606
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42009889",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug effects (beta-1 adrenergic receptor antagonism) are proxied genetically but the abstract does not name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 287,
   "end": 644
  },
  "claim": {
   "protein_as_written": "beta-1 adrenergic receptor",
   "gene": "ADRB1",
   "disease_as_written": "VaD",
   "direction": "raises",
   "estimate": {
    "or": 0.9,
    "low": 0.8,
    "high": 1.01,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1166,
    "end": 1472
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1166,
    "end": 1472
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42012738",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Drug-target gene pairs come from eQTL/SMR; proteins appear only as mediators of PPARG without their own effect on the cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1586,
   "end": 1655
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42012806",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are brain bulk and single-cell eQTLs only.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 478,
   "end": 657
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42015547",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "ADK is analysed as a druggable gene; the abstract does not name its instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 291,
   "end": 511
  },
  "claim": {
   "protein_as_written": "Adenosine kinase (ADK)",
   "gene": "ADK",
   "disease_as_written": "HCM",
   "direction": "raises",
   "estimate": {
    "or": 1.1,
    "low": 1.02,
    "high": 1.19,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 781,
    "end": 996
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.82,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 781,
    "end": 996
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 291,
    "end": 511
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1574,
    "end": 1642
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42017215",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR runs from HCM to protein levels (reverse direction).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1576,
   "end": 1688
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42017261",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with UKB-PPP plasma cis-pQTLs on hypertensive CKD; conclusions name FOLR1 without a direction, which the results give as raising risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 712,
   "end": 863
  },
  "claim": {
   "protein_as_written": "FOLR1",
   "gene": "FOLR1",
   "disease_as_written": "hypertensive CKD",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1536,
    "end": 1917
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2002,
    "end": 2046
   }
  }
 },
 {
  "pmid": "42017289",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR on diabetic macrovascular complications, but the abstract names no protein paired with the disease from the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 873,
   "end": 1017
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42017899",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of serum DNA repair proteins on liver cancer, a disease, with directed protein-disease pairs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 131
  },
  "claim": {
   "protein_as_written": "NBR1",
   "gene": "NBR1",
   "disease_as_written": "liver cancer",
   "direction": "raises",
   "estimate": {
    "or": 2.28,
    "low": 1.17,
    "high": 4.45,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 587,
    "end": 759
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42018362",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are immune-cell gene expression (single-cell cis-eQTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 453,
   "end": 577
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42019823",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR pooled plasma, brain, and CSF proteins; the pair is not tied to plasma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 604,
   "end": 763
  },
  "claim": {
   "protein_as_written": "CTSB",
   "gene": "CTSB",
   "disease_as_written": "ASD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1782,
    "end": 1886
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1282,
    "end": 1446
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1887,
    "end": 1998
   }
  }
 },
 {
  "pmid": "42021999",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Targets come from MR pooling cis-eQTLs and cis-pQTLs (tissue not named); the abstract doesn't tie ATRAID to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 511,
   "end": 829
  },
  "claim": {
   "protein_as_written": "ATRAID",
   "gene": "ATRAID",
   "disease_as_written": "cirrhosis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1549,
    "end": 1644
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1329,
    "end": 1467
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1468,
    "end": 1548
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42022378",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The plasma-protein MR names none of its 113 proteins with ED; the only stated pair (PPP1R14A, OR 1.27) is explicitly from eQTLs, so no pair from the protein's MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1312,
   "end": 1457
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42024094",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma inflammatory protein IL-16 on AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1462,
   "end": 1610
  },
  "claim": {
   "protein_as_written": "IL-16",
   "gene": "IL16",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": {
    "or": 0.981,
    "low": 0.969,
    "high": 0.994,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1462,
    "end": 1610
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42024114",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma (and CSF) proteins on IBS; the LRP8 finding is stated for plasma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1090,
   "end": 1195
  },
  "claim": {
   "protein_as_written": "LRP8",
   "gene": "LRP8",
   "disease_as_written": "IBS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1090,
    "end": 1195
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 699,
    "end": 815
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 487,
    "end": 698
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1610,
    "end": 1778
   }
  }
 },
 {
  "pmid": "42025296",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of druggable genes' expression (eQTLGen) and methylation on alcohol dependence.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 550,
   "end": 710
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42025426",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTLs from deCODE and UKB-PPP instrument proteins against chronic rhinosinusitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 771,
   "end": 945
  },
  "claim": {
   "protein_as_written": "LAT",
   "gene": "LAT",
   "disease_as_written": "CRS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1211,
    "end": 1423
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42025820",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug target genes instrumented with expression data from eQTLGen and GTEx.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 645,
   "end": 895
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42032825",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR uses blood cis-eQTLs (with mQTL and sQTL), not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 582,
   "end": 708
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42033474",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are brain single-nucleus eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 706,
   "end": 851
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42035214",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Ferritin is a complex of FTL and FTH1 subunits, not one gene's product.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 122
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42035926",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 1,124 plasma proteins on ASD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 567,
   "end": 688
  },
  "claim": {
   "protein_as_written": "MAPKAPK3",
   "gene": "MAPKAPK3",
   "disease_as_written": "ASD",
   "direction": "raises",
   "estimate": {
    "or": 1.046,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1169,
    "end": 1393
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.51,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1394,
    "end": 1528
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42039925",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "pQTLs from CSF, brain, and plasma analysed together; the abstract does not tie ERAP1's pair to the plasma analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 595,
   "end": 782
  },
  "claim": {
   "protein_as_written": "ERAP1",
   "gene": "ERAP1",
   "disease_as_written": "VaD",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2168,
    "end": 2385
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2168,
    "end": 2385
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42040309",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL of plasma cytokines on sepsis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 469,
   "end": 661
  },
  "claim": {
   "protein_as_written": "CCL4",
   "gene": "CCL4",
   "disease_as_written": "critical sepsis",
   "direction": "lowers",
   "estimate": {
    "or": 0.7,
    "low": 0.58,
    "high": 0.84,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1222,
    "end": 1429
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42040572",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins appear only as candidate mediators of COVID-19's effect on polymyositis, with no protein's own effect on the disease stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1676,
   "end": 1782
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42040931",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB plasma proteins, but the outcome is white matter hyperintensity volume.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 553,
   "end": 856
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42045466",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTLs of plasma proteomes as instruments for urological cancers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 569,
   "end": 711
  },
  "claim": {
   "protein_as_written": "PSCA",
   "gene": "PSCA",
   "disease_as_written": "BC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1089,
    "end": 1311
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42045633",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MVMR uses disease endpoints and laboratory traits as exposures for blood donorship.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 963,
   "end": 1320
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42047173",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are tested against ectopic pregnancy but none is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 735,
   "end": 811
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42048681",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR among risk factors, comorbid conditions and ASCVDs; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 586,
   "end": 781
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42051091",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR (deCODE, UKB-PPP) on dystonia, but no protein is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1524,
   "end": 1664
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42051535",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses cis-eQTL and cis-mQTL data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 336,
   "end": 517
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42052171",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract names genes but pairs them only with 'their corresponding cancers', no disease named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1316,
   "end": 1537
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42057688",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is between OSA and periodontitis; the proteins come from salivary proteomics, not MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 461,
   "end": 637
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42064289",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein MR pairs are stated only with CVDs as a class, with no member disease paired to a named protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1636,
   "end": 1741
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42065929",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of SomaScan plasma proteins on incident AF in CKD; no direction given for any protein, so the first named pair, unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1160,
   "end": 1262
  },
  "claim": {
   "protein_as_written": "neural EGF like‑like protein 1",
   "gene": "NELL1",
   "disease_as_written": "incident atrial fibrillation",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1663,
    "end": 1844
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42068645",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure is TTK inhibition by drug-target MR; the abstract doesn't name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 361,
   "end": 535
  },
  "claim": {
   "protein_as_written": "TTK",
   "gene": "TTK",
   "disease_as_written": "breast cancer",
   "direction": "raises",
   "estimate": {
    "or": 0.667,
    "low": 0.543,
    "high": 0.819,
    "unit": "not stated",
    "frame": "per lower protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1574,
    "end": 1700
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 182,
    "end": 267
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42068891",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is said to suggest a causal role for some proteins, none named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1493,
   "end": 1623
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42074584",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL data without saying the pQTLs are circulating; claim coded from the protein-abundance pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 500,
   "end": 768
  },
  "claim": {
   "protein_as_written": "p27Kip1",
   "gene": "CDKN1B",
   "disease_as_written": "SLE",
   "direction": "lowers",
   "estimate": {
    "or": 0.269,
    "low": 0.08,
    "high": 0.904,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1033,
    "end": 1301
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1033,
    "end": 1301
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42077232",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Besides the microbiota MR, an SMR pinpoints STIM1-mediated 'signaling' as causal for AD; the SMR's instruments aren't named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1224,
   "end": 1336
  },
  "claim": {
   "protein_as_written": "STIM1",
   "gene": "STIM1",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1224,
    "end": 1336
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1337,
    "end": 1645
   }
  }
 },
 {
  "pmid": "42078358",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Protein data are from dorsolateral prefrontal cortex, not circulation; main MR exposure is smoking.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 984,
   "end": 1219
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42078427",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "eQTL and pQTL MR are counted separately (35 eQTL genes, 31 pQTL genes), and DKK3 was significant in the pQTL analysis as well.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1102,
   "end": 1266
  },
  "claim": {
   "protein_as_written": "DKK3",
   "gene": "DKK3",
   "disease_as_written": "cataract",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1519,
    "end": 1755
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42082729",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are druggable genes instrumented by eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 556,
   "end": 754
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42085745",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR prioritized PRDX6 as a gene but states no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1560,
   "end": 1650
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42085793",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with pQTLs of APOM on cirrhosis in East Asian data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 824,
   "end": 1101
  },
  "claim": {
   "protein_as_written": "apolipoprotein M (APOM)",
   "gene": "APOM",
   "disease_as_written": "cirrhosis",
   "direction": "raises",
   "estimate": {
    "or": 1.093,
    "low": 1.036,
    "high": 1.153,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1102,
    "end": 1380
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42089751",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of pQTLs on early-onset asthma and COPD; the conclusions name no protein and no counting pair has a direction, so the first counting pair in the results (ITPKA, a disease-specific target from the MR passing eQTL validation) is the claim, unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 667,
   "end": 916
  },
  "claim": {
   "protein_as_written": "ITPKA",
   "gene": "ITPKA",
   "disease_as_written": "EOA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1587,
    "end": 1670
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1587,
    "end": 1670
   }
  }
 },
 {
  "pmid": "42094129",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are prioritized by integrated observational, burden and plasma/CSF MR analyses; no protein-disease pair is attributed to MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 957,
   "end": 1185
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42098041",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 768,
   "end": 956
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42100251",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 4,489 plasma proteins (pQTLs) on knee osteoarthritis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 435,
   "end": 557
  },
  "claim": {
   "protein_as_written": "Galectin-3",
   "gene": "LGALS3",
   "disease_as_written": "KOA",
   "direction": "raises",
   "estimate": {
    "or": 1.07,
    "low": 1.03,
    "high": 1.11,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1222,
    "end": 1555
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.773,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1222,
    "end": 1555
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2192,
    "end": 2324
   }
  }
 },
 {
  "pmid": "42102152",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of inflammatory proteins on SAH; FGF23 is a risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1050,
   "end": 1188
  },
  "claim": {
   "protein_as_written": "FGF23",
   "gene": "FGF23",
   "disease_as_written": "SAH",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1433,
    "end": 1550
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.74,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1433,
    "end": 1550
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42102994",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR names LCN2 as a causal plasma protein for renal fibrosis; no direction from MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1728,
   "end": 1800
  },
  "claim": {
   "protein_as_written": "LCN2",
   "gene": "LCN2",
   "disease_as_written": "renal fibrosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1728,
    "end": 1800
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42104117",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are anti-osteoporosis drugs (denosumab, calcitriol); no protein's level is named as exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1157,
   "end": 1285
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42106685",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of deCODE plasma cis-pQTLs on LADA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 524,
   "end": 776
  },
  "claim": {
   "protein_as_written": "C-X-C motif chemokine ligand 10",
   "gene": "CXCL10",
   "disease_as_written": "LADA",
   "direction": "raises",
   "estimate": {
    "or": 5.49,
    "low": 1.74,
    "high": 17.32,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1218,
    "end": 1529
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1218,
    "end": 1529
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1615,
    "end": 1814
   }
  }
 },
 {
  "pmid": "42106700",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide two-step MR identifies risk proteins for CKD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1075,
   "end": 1245
  },
  "claim": {
   "protein_as_written": "ALDH3A1",
   "gene": "ALDH3A1",
   "disease_as_written": "CKD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2448,
    "end": 2592
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42110225",
  "eligibility": "E1",
  "e2_kind": null,
  "eligibility_reason": "No abstract in the record.",
  "eligibility_quote": null,
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42114461",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL; the HSF1 claim chains methylation, expression and protein levels without tying it to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 477,
   "end": 676
  },
  "claim": {
   "protein_as_written": "HSF1",
   "gene": "HSF1",
   "disease_as_written": "skin fibrosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1281,
    "end": 1434
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 677,
    "end": 840
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42114791",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is one part of a multi-omics screen. RNF149 is called a candidate marker of the whole framework, and no protein-disease pair is attributed to MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 601,
   "end": 895
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42115417",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Pools eQTL, pQTL and sc-eQTL; the pair rests on 'CPNE1 expression'.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 545,
   "end": 776
  },
  "claim": {
   "protein_as_written": "CPNE1",
   "gene": "CPNE1",
   "disease_as_written": "Parkinson's disease",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1006,
    "end": 1166
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42115443",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The exposure is FES eQTL expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 652,
   "end": 766
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42116284",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 2923 circulating proteins on diabetic foot ulcer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 755,
   "end": 932
  },
  "claim": {
   "protein_as_written": "GLB1",
   "gene": "GLB1",
   "disease_as_written": "DFU",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1260,
    "end": 1434
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42116291",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is multisite chronic pain, a count of chronic pain sites from a GWAS of 387,649 samples with no cases or controls, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 456,
   "end": 533
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42116294",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTLs instrument CD40-CD40L (E2 met) and cervical cancer is a disease, but the MR is null and the abstract states no protein-disease association.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1283,
   "end": 1463
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42116389",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood and brain eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 464,
   "end": 713
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42117609",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are immune-cell eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 383,
   "end": 666
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42118257",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are immune-cell gene expression instrumented by eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 517,
   "end": 789
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42119967",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "MR exposure is a proteomic aging score, not one gene's product.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 968,
   "end": 1132
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42120251",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "LPL and other targets proxied by eQTLs and lipid-weighted cis variants, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 792,
   "end": 981
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42121245",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is circulating vitamin C.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1093,
   "end": 1206
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42124391",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "The exposure is a multimodal plasma protein component (NeuroPro-Dep), not one gene product.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1384,
   "end": 1625
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42125268",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL SMR found 5 pQTLs but names no protein-disease pair; the named genes (CREM, MAPT) come from methylation/expression analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1082,
   "end": 1230
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42125665",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 plasma proteins on DN.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 120,
   "end": 349
  },
  "claim": {
   "protein_as_written": "HSPB1",
   "gene": "HSPB1",
   "disease_as_written": "DN",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1868,
    "end": 1972
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1384,
    "end": 1587
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42128045",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are brain cell-type-specific cis-eQTLs (gene expression).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 514,
   "end": 755
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42129562",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "No MR of a protein; MR tests disease effects on sleep.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1217,
   "end": 1372
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42130808",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR with unspecified QTL instruments; EGFR named causal for glioma without a direction from MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 391,
   "end": 630
  },
  "claim": {
   "protein_as_written": "EGFR",
   "gene": "EGFR",
   "disease_as_written": "glioma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1159,
    "end": 1296
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1772,
    "end": 2019
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42133815",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with cis-pQTLs from UKB-PPP and deCODE on cardiovascular events; the results give directions.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 639,
   "end": 992
  },
  "claim": {
   "protein_as_written": "ANGPTL4",
   "gene": "ANGPTL4",
   "disease_as_written": "CVD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1419,
    "end": 1758
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42135799",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target loci instrumented by cis variants weighted for lipid biomarkers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 928,
   "end": 1065
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42136208",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "CTNNB1's MR exposure is the gene, from TwoSampleMR and the SMR database, with instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 752,
   "end": 844
  },
  "claim": {
   "protein_as_written": "CTNNB1",
   "gene": "CTNNB1",
   "disease_as_written": "osteoporosis",
   "direction": "lowers",
   "estimate": {
    "or": 0.950431762,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1522,
    "end": 1652
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 845,
    "end": 994
   }
  }
 },
 {
  "pmid": "42141940",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide SMR with UKB-PPP plasma pQTLs; MI is a disease; APOE-MI pair stated without direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1614,
   "end": 1781
  },
  "claim": {
   "protein_as_written": "apolipoprotein E",
   "gene": "APOE",
   "disease_as_written": "MI",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1614,
    "end": 1781
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42145630",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with UKB-PPP plasma cis-pQTLs on breast cancer; conclusions' proteins have no direction, so the first directed result (DNPH1) is the claim.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 298,
   "end": 656
  },
  "claim": {
   "protein_as_written": "DNPH1",
   "gene": "DNPH1",
   "disease_as_written": "breast cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 844,
    "end": 1008
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42146640",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is neuroticism, a personality trait, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1169,
   "end": 1347
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42146908",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A graph neural network study that runs no MR; it cites another paper's MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1400,
   "end": 1594
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42147228",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteome-wide MR on gastric cancer in EUR and EAS naming proteins, with no direction for the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 584,
   "end": 750
  },
  "claim": {
   "protein_as_written": "SLURP1",
   "gene": "SLURP1",
   "disease_as_written": "GC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1056,
    "end": 1294
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1056,
    "end": 1294
   }
  }
 },
 {
  "pmid": "42147334",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR on DLBCL; proteins named via colocalisation without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 0,
   "end": 99
  },
  "claim": {
   "protein_as_written": "MICB",
   "gene": "MICB",
   "disease_as_written": "DLBCL",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1192,
    "end": 1416
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1192,
    "end": 1416
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1192,
    "end": 1416
   }
  }
 },
 {
  "pmid": "42152093",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with blood pQTLs gives protein-level pairs (AGER, F2, HMOX1) with osteoporosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1183,
   "end": 1404
  },
  "claim": {
   "protein_as_written": "AGER",
   "gene": "AGER",
   "disease_as_written": "osteoporosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1183,
    "end": 1404
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42152289",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Bidirectional MR between sarcopenia and chronic pain; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 438,
   "end": 622
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42152365",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposure instruments are cis-eQTLs from eQTLGen (gene expression).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 912,
   "end": 1025
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42153360",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with deCODE plasma pQTLs (and eQTLs) on nasal polyps; CTSS found in both eQTL and pQTL analyses and increased NP risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 840,
   "end": 931
  },
  "claim": {
   "protein_as_written": "cathepsin S (CTSS)",
   "gene": "CTSS",
   "disease_as_written": "NP",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 932,
    "end": 1088
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 932,
    "end": 1088
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42155607",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR of plasma proteins on diabetic kidney disease, KLK13 validated with deCODE protein-to-DKD MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 997,
   "end": 1153
  },
  "claim": {
   "protein_as_written": "KLK13",
   "gene": "KLK13",
   "disease_as_written": "DKD",
   "direction": "raises",
   "estimate": {
    "or": 1.13,
    "low": 1.02,
    "high": 1.24,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 997,
    "end": 1153
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42157922",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Genetic support pools eQTL, pQTL and mQTL with MR and SMR; the CTSH pair isn't tied to a circulating protein's MR, and it is given no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 498,
   "end": 753
  },
  "claim": {
   "protein_as_written": "CTSH",
   "gene": "CTSH",
   "disease_as_written": "PDR",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1730,
    "end": 2014
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1730,
    "end": 2014
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42157969",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR/SMR pools eQTL, pQTL (deCODE) and mQTL for mitochondrial genes; the GPD2 pair is not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 619,
   "end": 786
  },
  "claim": {
   "protein_as_written": "GPD2",
   "gene": "GPD2",
   "disease_as_written": "endometriosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2211,
    "end": 2393
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2211,
    "end": 2393
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42159853",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "BDH2 appears only as a mediator of ticagrelor's effect, without its own effect on diabetes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 643,
   "end": 855
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42160135",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on hypertension.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 492,
   "end": 637
  },
  "claim": {
   "protein_as_written": "ADM",
   "gene": "ADM",
   "disease_as_written": "hypertension",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 957,
    "end": 1167
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42160433",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "cis-MR of plasma immune-proteins, but the abstract pairs no named protein with a named disease (only with classes of traits).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1033,
   "end": 1194
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42161908",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is gut bacterial abundance (Akkermansia), not a circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 390,
   "end": 632
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42163256",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are tissue-specific GTEx cis-eQTLs proxying gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 867,
   "end": 1039
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42163752",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A review; it estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1908,
   "end": 2195
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42163948",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "eQTL-based MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 511,
   "end": 641
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42170302",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with deCODE pQTLs; ERBB1's own effect on IBS (the mediator step) is stated with a sign.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 703,
   "end": 890
  },
  "claim": {
   "protein_as_written": "ERBB1",
   "gene": "EGFR",
   "disease_as_written": "IBS",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1730,
    "end": 1885
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42170445",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of over 4,000 plasma proteins on ICH; no counting pair has a direction, and the conclusions name AHSP first.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 428,
   "end": 548
  },
  "claim": {
   "protein_as_written": "AHSP",
   "gene": "AHSP",
   "disease_as_written": "ICH",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 975,
    "end": 1174
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42171268",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of 2,545 plasma proteins on MS; DKKL1 is the first stated with a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 490,
   "end": 587
  },
  "claim": {
   "protein_as_written": "DKKL1",
   "gene": "DKKL1",
   "disease_as_written": "MS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1631,
    "end": 1716
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42171750",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "PWAS-MR and SMR on plasma proteomics (deCODE, UK Biobank) for PCOS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 389,
   "end": 695
  },
  "claim": {
   "protein_as_written": "FSHB",
   "gene": "FSHB",
   "disease_as_written": "PCOS",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1313,
    "end": 1482
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1313,
    "end": 1482
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1483,
    "end": 1699
   }
  }
 },
 {
  "pmid": "42173001",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is frailty; PCSK9 comes from observational proteomic analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 924,
   "end": 1028
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42173079",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pools eQTL and pQTL sources; the abstract doesn't tie FN1's MI association to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 610,
   "end": 907
  },
  "claim": {
   "protein_as_written": "FN1",
   "gene": "FN1",
   "disease_as_written": "MI",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2119,
    "end": 2245
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1427,
    "end": 1627
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1174,
    "end": 1426
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2038,
    "end": 2118
   }
  }
 },
 {
  "pmid": "42173842",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are social activities; protein associations are observational.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1433,
   "end": 1620
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42174728",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A GWAS-by-subtraction paper on gestational diabetes; the abstract estimates no protein's effect on a disease by MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1507,
   "end": 1706
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42175399",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating proteins on small vessel stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 301,
   "end": 460
  },
  "claim": {
   "protein_as_written": "GRAMD1C",
   "gene": "GRAMD1C",
   "disease_as_written": "SVS",
   "direction": "raises",
   "estimate": {
    "or": 2.86,
    "low": 1.71,
    "high": 4.76,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 795,
    "end": 954
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1065,
    "end": 1269
   }
  }
 },
 {
  "pmid": "42175412",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of circulating protein levels on atherosclerosis; conclusions name lipoprotein(a) first with no direction, so the claim is unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 334,
   "end": 621
  },
  "claim": {
   "protein_as_written": "lipoprotein (a)",
   "gene": "LPA",
   "disease_as_written": "atherosclerosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 622,
    "end": 779
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 622,
    "end": 779
   }
  }
 },
 {
  "pmid": "42175454",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Mainly protein-protein ratios, but constituent proteins were also analysed individually; MIA with lung cancer is the one individual pair, without a direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1252,
   "end": 1390
  },
  "claim": {
   "protein_as_written": "MIA",
   "gene": "MIA",
   "disease_as_written": "LC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1252,
    "end": 1390
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42175501",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR integrates eQTLs and pQTLs without tying B3GALT6's finding to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 147,
   "end": 371
  },
  "claim": {
   "protein_as_written": "B3GALT6",
   "gene": "B3GALT6",
   "disease_as_written": "sepsis",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 372,
    "end": 485
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1089,
    "end": 1277
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42175707",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-MR of UKB-PPP plasma pQTLs on endometriosis; the conclusions name ALPI first without a direction, and the results give ALPI's OR below 1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1053,
   "end": 1236
  },
  "claim": {
   "protein_as_written": "ALPI",
   "gene": "ALPI",
   "disease_as_written": "EM",
   "direction": "lowers",
   "estimate": {
    "or": 0.89,
    "low": 0.83,
    "high": 0.95,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1237,
    "end": 1503
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 619,
    "end": 778
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1602,
    "end": 1706
   }
  }
 },
 {
  "pmid": "42177912",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "EPS15L1 is named only as a mediator of IBD's effect on psoriasis; its own effect on psoriasis is not given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1379,
   "end": 1549
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42178167",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Blood pQTL SMR included, but the abstract names no protein paired with DN from the protein MR (proteins only counted; named kidney findings are tissue observations).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1074,
   "end": 1164
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42181212",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR exposures are druggable genes whose instruments the abstract doesn't name (likely expression, not stated).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 508,
   "end": 737
  },
  "claim": {
   "protein_as_written": "FOS",
   "gene": "FOS",
   "disease_as_written": "DN",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2399,
    "end": 2516
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2399,
    "end": 2516
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42183069",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs for mTOR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 832,
   "end": 927
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42185861",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR using plasma pQTL data on atrial fibrillation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 875,
   "end": 1067
  },
  "claim": {
   "protein_as_written": "ANXA4",
   "gene": "ANXA4",
   "disease_as_written": "AF",
   "direction": "raises",
   "estimate": {
    "or": 1.17,
    "low": 1.11,
    "high": 1.23,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1639,
    "end": 1881
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1639,
    "end": 1881
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 3323,
    "end": 3479
   }
  }
 },
 {
  "pmid": "42185899",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of circulating CR1 levels on HCC; conclusions name CR1 without an MR direction, results give OR 1.403.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1409,
   "end": 1598
  },
  "claim": {
   "protein_as_written": "CR1",
   "gene": "CR1",
   "disease_as_written": "HCC",
   "direction": "raises",
   "estimate": {
    "or": 1.403,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1409,
    "end": 1598
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2479,
    "end": 2808
   }
  }
 },
 {
  "pmid": "42191940",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR integrated with transcriptomic data identifies genes by expression, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 404,
   "end": 584
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42192968",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pools pQTL and eQTL.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 347,
   "end": 526
  },
  "claim": {
   "protein_as_written": "ACE",
   "gene": "ACE",
   "disease_as_written": "SCLC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1160,
    "end": 1242
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42193325",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Two-sample MR of transcriptomically selected genes whose instruments (expression or protein QTLs) the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1233,
   "end": 1451
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1233,
    "end": 1451
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1233,
    "end": 1451
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1233,
    "end": 1451
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42193397",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Cross-tissue TWAS with GTEx eQTLs; MR of gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 673,
   "end": 794
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42196425",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma-based SMR with UKB-PPP pQTLs confirms GLO1 for RLS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 752,
   "end": 904
  },
  "claim": {
   "protein_as_written": "GLO1",
   "gene": "GLO1",
   "disease_as_written": "RLS",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1187,
    "end": 1385
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.96,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1187,
    "end": 1385
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1594,
    "end": 1804
   }
  }
 },
 {
  "pmid": "42197164",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR of CD163 on COPD; pair stated without a direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1393,
   "end": 1609
  },
  "claim": {
   "protein_as_written": "CD163",
   "gene": "CD163",
   "disease_as_written": "COPD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2179,
    "end": 2259
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42198363",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR exposure is HDAC5 expression, and the outcome serum phosphate.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1463,
   "end": 1568
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42199945",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR pools mQTL, eQTL and pQTL; DCXR and GCDH rest on gene-protein cascades not tied to the circulating protein analysis alone.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1812,
   "end": 1944
  },
  "claim": {
   "protein_as_written": "DCXR",
   "gene": "DCXR",
   "disease_as_written": "GDM",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2078,
    "end": 2249
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42200339",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are T2D and gut microbiota.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 651,
   "end": 805
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42202976",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma protein PWAS with MR and colocalisation on glaucoma; DNAJB14 named, its protective role from experiments, not MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 262,
   "end": 461
  },
  "claim": {
   "protein_as_written": "DnaJ heat shock protein family member B14 (DNAJB14)",
   "gene": "DNAJB14",
   "disease_as_written": "glaucoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 462,
    "end": 597
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 262,
    "end": 461
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1180,
    "end": 1377
   }
  }
 },
 {
  "pmid": "42204731",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "E2 is at most unstated (MR pooling proteins, expression, splicing and metabolites), and the outcome, ovarian aging, is an aging phenotype, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 134,
   "end": 293
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42206520",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SGLT2 inhibition is proxied by SLC5A2 eQTLs and glycemic traits, not plasma pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 564,
   "end": 786
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42206661",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Protein exposures are brain (dorsolateral prefrontal cortex) proteomics.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 256,
   "end": 486
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42206676",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The exposure is 'ABHD10 expression', with no instruments named and no tie to a circulating protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 401,
   "end": 657
  },
  "claim": {
   "protein_as_written": "ABHD10",
   "gene": "ABHD10",
   "disease_as_written": "presbycusis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 401,
    "end": 657
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1351,
    "end": 1595
   }
  }
 },
 {
  "pmid": "42207235",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Besides LDL-weighted analyses, APOB was instrumented by its own levels (apolipoprotein B, a circulating protein); lowering APOB raises AML risk, so higher APOB lowers it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1375,
   "end": 1571
  },
  "claim": {
   "protein_as_written": "APOB",
   "gene": "APOB",
   "disease_as_written": "AML",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1375,
    "end": 1571
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 92
   }
  }
 },
 {
  "pmid": "42209436",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR on psoriasis with Bonferroni-corrected targets; no protein given a direction, so unsigned: the first protein the results name, UBLCP1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 544,
   "end": 664
  },
  "claim": {
   "protein_as_written": "UBLCP1",
   "gene": "UBLCP1",
   "disease_as_written": "psoriasis",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 742,
    "end": 896
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42209523",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target instruments weighted by fasting glucose and HbA1c, or from gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 382,
   "end": 542
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42210767",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteomes were used as MR exposures, but the abstract names no protein-ovarian cancer pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1259,
   "end": 1425
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42211234",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-based MR for NAFLD is mentioned, but the abstract states no protein-disease pair from it.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1331,
   "end": 1613
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42212431",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is amyloid-β PET uptake, an imaging measure, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1476,
   "end": 1615
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42216364",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins on ADHD; CD40 protective and the only one surviving FDR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1025,
   "end": 1320
  },
  "claim": {
   "protein_as_written": "CD40",
   "gene": "CD40",
   "disease_as_written": "ADHD",
   "direction": "lowers",
   "estimate": {
    "or": 0.931,
    "low": 0.894,
    "high": 0.97,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1779,
    "end": 1955
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42216396",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets (HMGCR, PCSK9, NPC1L1) are proxied by variants from the Global Lipids Genetics Consortium, weighted by LDL.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 918,
   "end": 1247
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42216402",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are immune cell traits; genes are from SMR and annotation, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 553,
   "end": 753
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42218280",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SOST inhibition instrumented by trans-pQTLs of circulating SOST, outcome atrial fibrillation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1242,
   "end": 1448
  },
  "claim": {
   "protein_as_written": "circulating SOST",
   "gene": "SOST",
   "disease_as_written": "AF",
   "direction": "lowers",
   "estimate": {
    "frame": "per lower protein",
    "high": 1.701,
    "low": 1.077,
    "unit": "not stated",
    "or": 1.353
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2238,
    "end": 2420
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 87,
    "end": 179
   }
  }
 },
 {
  "pmid": "42219961",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with a pQTL dataset (n = 54,219); the PLA2G1B pair is stated at the protein level, apart from its methylation result, and protein PLA2G1B raises DN risk (OR 3.057).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 380,
   "end": 728
  },
  "claim": {
   "protein_as_written": "PLA2G1B",
   "gene": "PLA2G1B",
   "disease_as_written": "DN",
   "direction": "raises",
   "estimate": {
    "or": 3.057,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1420,
    "end": 1565
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42220486",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MAPRE2 identified by MR pooling cis-eQTL and cis-pQTL instruments; the pQTLs' tissue is not stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 320,
   "end": 586
  },
  "claim": {
   "protein_as_written": "MAPRE2",
   "gene": "MAPRE2",
   "disease_as_written": "HCC",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 596,
    "end": 729
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1585,
    "end": 1850
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42221083",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A multivariate GWAS and gene-mapping study with no MR of a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 720,
   "end": 854
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42223712",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL SMR of 555 plasma proteins on HIV outcomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 504,
   "end": 797
  },
  "claim": {
   "protein_as_written": "WFDC2",
   "gene": "WFDC2",
   "disease_as_written": "HIV",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2836,
    "end": 3031
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2836,
    "end": 3031
   }
  }
 },
 {
  "pmid": "42225233",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are mental health symptom scores and questionnaire measures, not diagnosed diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1125,
   "end": 1215
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42225822",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with cis-pQTL instruments for drug-target proteins on neovascular AMD; no direction stated (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 418,
   "end": 577
  },
  "claim": {
   "protein_as_written": "IGFBP6",
   "gene": "IGFBP6",
   "disease_as_written": "nAMD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 938,
    "end": 1077
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42226484",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Genetically predicted plasma protein concentrations (INTERVAL) on pancreatic cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 623,
   "end": 1073
  },
  "claim": {
   "protein_as_written": "APOF",
   "gene": "APOF",
   "disease_as_written": "PDAC",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1074,
    "end": 1328
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42227366",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Antidiabetic drug targets are genetically proxied by instruments the abstract does not name as the proteins' circulating levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 412,
   "end": 620
  },
  "claim": {
   "protein_as_written": "GIPR",
   "gene": "GIPR",
   "disease_as_written": "pneumonia",
   "direction": "raises",
   "estimate": {
    "or": 1.088,
    "low": 1.022,
    "high": 1.159,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1059,
    "end": 1299
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 412,
    "end": 620
   }
  }
 },
 {
  "pmid": "42227395",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with cis pQTLs of plasma proteins (deCODE, UKB-PPP) on multiple sclerosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 848,
   "end": 1155
  },
  "claim": {
   "protein_as_written": "PARP1",
   "gene": "PARP1",
   "disease_as_written": "MS",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1782,
    "end": 1943
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 2121,
    "end": 2276
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 170
   }
  }
 },
 {
  "pmid": "42227520",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma proteins on pelvic organ prolapse.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 351,
   "end": 501
  },
  "claim": {
   "protein_as_written": "sTie2",
   "gene": "TEK",
   "disease_as_written": "POP",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2051,
    "end": 2262
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42227521",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Protein-target exposures are gene expression (SMR of eQTLs) or OC use, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 814,
   "end": 1081
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42227534",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Main pairs are eQTL-based; the paper's one protein-level (pQTL) MR found no association, so no protein-disease pair from the protein's MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1105,
   "end": 1320
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42230543",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Cis-MR pools pQTLs and eQTLs across blood, CSF, and brain; the abstract does not tie the named targets to circulating protein analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 547,
   "end": 723
  },
  "claim": {
   "protein_as_written": "ACE",
   "gene": "ACE",
   "disease_as_written": "MD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1518,
    "end": 1743
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1518,
    "end": 1743
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42230780",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Analyses pool eQTLs and pQTLs from blood and CSF; the GFPT1 pair is not tied to circulating pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 283,
   "end": 645
  },
  "claim": {
   "protein_as_written": "GFPT1",
   "gene": "GFPT1",
   "disease_as_written": "DSD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1724,
    "end": 1873
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1724,
    "end": 1873
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42231304",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is MS progression, a severity measure rather than a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 360,
   "end": 576
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42231964",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MMP9 is named a causal gene for the depression-psoriasis comorbidity from integrated analyses pooling eQTL and pQTL MR, which the abstract doesn't tie to the circulating protein; full text decides.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 552,
   "end": 777
  },
  "claim": {
   "protein_as_written": "matrix metallopeptidase 9 (MMP9)",
   "gene": "MMP9",
   "disease_as_written": "depression and psoriasis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 552,
    "end": 777
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 857,
    "end": 1058
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42232515",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR uses blood eQTLs of druggable genes, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 667,
   "end": 896
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42238393",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with serum pQTLs implicates circulating protein levels in central serous chorioretinopathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1698,
   "end": 1800
  },
  "claim": {
   "protein_as_written": "TNFRSF10A",
   "gene": "TNFRSF10A",
   "disease_as_written": "CSC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1698,
    "end": 1800
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1698,
    "end": 1800
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42238465",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Lp(a) (LPA) variants instrument the circulating level, but the abstract says no association survived FDR correction, so no counting pair remains.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1088,
   "end": 1235
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42238470",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug target variants are selected and weighted by their association with blood pressure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 680,
   "end": 802
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42239641",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with pQTL instruments links protein biomarkers to silicosis; no direction given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 617,
   "end": 913
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "silicosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 617,
    "end": 913
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42239723",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The only MR exposure is depression; NID2 comes from colocalisation of plasma pQTLs with colorectal neoplasia, not from MR of its level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 516,
   "end": 618
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42244679",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "A methods paper whose PWAS/MR of T2D names no protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1617,
   "end": 1671
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42249421",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "CASP8's MR rests on multi-tissue expression and epigenetic regulation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 3637,
   "end": 3792
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42251386",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Blood pQTL SMR ties SPP1's protein level to esophageal cancer risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1501,
   "end": 1735
  },
  "claim": {
   "protein_as_written": "SPP1",
   "gene": "SPP1",
   "disease_as_written": "EC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1748,
    "end": 1892
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1501,
    "end": 1735
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1748,
    "end": 1892
   }
  }
 },
 {
  "pmid": "42253985",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "GPX7 prioritized by two-sample MR with 'cis-pQTL support'; the abstract does not say the pQTLs are of circulating protein nor what the main MR's instruments were.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 822,
   "end": 950
  },
  "claim": {
   "protein_as_written": "GPX7",
   "gene": "GPX7",
   "disease_as_written": "ulcerative colitis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 822,
    "end": 950
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42257465",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR pooling mQTL, eQTL and pQTL data with pQTL tissue unstated; GPN1 named as colocalised pQTL with OCC, no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 318,
   "end": 384
  },
  "claim": {
   "protein_as_written": "GPN1",
   "gene": "GPN1",
   "disease_as_written": "OCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 658,
    "end": 731
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 658,
    "end": 731
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42260332",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR pools eQTL, sQTL, mQTL, and pQTL instruments; genes not tied to the circulating protein analysis; no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 709,
   "end": 951
  },
  "claim": {
   "protein_as_written": "MEF2D",
   "gene": "MEF2D",
   "disease_as_written": "migraine",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1722,
    "end": 1908
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42260808",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR uses blood eQTLs and the drug-target MR uses blood-pressure SNPs; no protein-level instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 392,
   "end": 561
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42260810",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma cis-pQTLs (deCODE) instrument MMP12 as a mediator, and the abstract gives its own protective effect on ischemic stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 836,
   "end": 1054
  },
  "claim": {
   "protein_as_written": "MMP12",
   "gene": "MMP12",
   "disease_as_written": "ischemic stroke",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1639,
    "end": 1739
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42260829",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UKB-PPP plasma proteins on endometriosis, a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 390,
   "end": 553
  },
  "claim": {
   "protein_as_written": "FSHB",
   "gene": "FSHB",
   "disease_as_written": "endometriosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1002,
    "end": 1192
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1193,
    "end": 1340
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 554,
    "end": 697
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42264446",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of genes on UC with instruments not named (genes, not a circulating protein level); pair PRKCA-UC given without an MR direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 855,
   "end": 1101
  },
  "claim": {
   "protein_as_written": "PRKCA",
   "gene": "PRKCA",
   "disease_as_written": "UC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1252,
    "end": 1326
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42265473",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Every stated pair comes from cis-eQTL MR of gene expression; the pQTL validation states no protein-disease pair of its own.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1127,
   "end": 1419
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42265708",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses cis-eQTL data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 309,
   "end": 491
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42269260",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with pQTL data of palmitoylation-related proteins on Crohn disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 708,
   "end": 863
  },
  "claim": {
   "protein_as_written": "IFITM3",
   "gene": "IFITM3",
   "disease_as_written": "CD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2647,
    "end": 2767
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2873,
    "end": 3122
   }
  }
 },
 {
  "pmid": "42269280",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Single-cell MR uses cell-type expression, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 769,
   "end": 950
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42269324",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Bidirectional MR of plasma proteins on AD; PTPRC's inverse relationship with AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1278,
   "end": 1395
  },
  "claim": {
   "protein_as_written": "PTPRC",
   "gene": "PTPRC",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1822,
    "end": 2031
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42273695",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are immune cell phenotypes; plasma proteins were measured observationally only.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 620,
   "end": 814
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42275142",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR uses renal eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2098,
   "end": 2366
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42277229",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome is a latent sleep factor (nighttime sleep adequacy), a trait, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 741,
   "end": 1113
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42278218",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UK Biobank plasma proteomics MR on POAG; SEL1L named in conclusions, no direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 410,
   "end": 545
  },
  "claim": {
   "protein_as_written": "SEL1L",
   "gene": "SEL1L",
   "disease_as_written": "POAG",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1338,
    "end": 1597
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1338,
    "end": 1597
   }
  }
 },
 {
  "pmid": "42278435",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments for SON not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 476,
   "end": 675
  },
  "claim": {
   "protein_as_written": "SON",
   "gene": "SON",
   "disease_as_written": "OP",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 883,
    "end": 1053
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 676,
    "end": 812
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42278567",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Cis drug-target MR of PPARG and others without naming the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 880,
   "end": 1150
  },
  "claim": {
   "protein_as_written": "PPARG",
   "gene": "PPARG",
   "disease_as_written": "IMOC",
   "direction": "lowers",
   "estimate": {
    "or": 0.18,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1764,
    "end": 1986
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1764,
    "end": 1986
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42281484",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of UK Biobank Olink plasma proteins on incident BPH.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1570,
   "end": 1669
  },
  "claim": {
   "protein_as_written": "TSPAN1",
   "gene": "TSPAN1",
   "disease_as_written": "BPH",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1570,
    "end": 1669
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42281826",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is between adiposity traits and psychiatric disorders, with no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 239,
   "end": 621
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42282184",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is a latent psychiatric common factor built by genomic SEM, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 591,
   "end": 776
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42282992",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with plasma pQTLs (deCODE, UKB-PPP) on pancreatic cancer from FinnGen; every MR exposure is a circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 622,
   "end": 972
  },
  "claim": {
   "protein_as_written": "CLEC4G",
   "gene": "CLEC4G",
   "disease_as_written": "PC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1318,
    "end": 1538
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42283184",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE circulating protein levels on Alzheimer's disease; the MR pairs have no direction (unsigned), first TNFSF13B; the conclusions' TNF comes from network analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1414,
   "end": 1663
  },
  "claim": {
   "protein_as_written": "TNFSF13B",
   "gene": "TNFSF13B",
   "disease_as_written": "Alzheimer's disease",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2301,
    "end": 2415
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42283552",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein pQTLs on retinitis pigmentosa.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 214,
   "end": 431
  },
  "claim": {
   "protein_as_written": "ACP6",
   "gene": "ACP6",
   "disease_as_written": "RP",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1320,
    "end": 1569
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1949,
    "end": 2113
   }
  }
 },
 {
  "pmid": "42288617",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are blood metabolites, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 423,
   "end": 648
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42291452",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "PLAU comes from the overlap of eQTL- and pQTL-supported MR candidates, pooling kinds of QTL.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1539,
   "end": 1678
  },
  "claim": {
   "protein_as_written": "PLAU",
   "gene": "PLAU",
   "disease_as_written": "AAA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1679,
    "end": 1757
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.983,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1758,
    "end": 1960
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42292469",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR instruments are eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1062,
   "end": 1263
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42293830",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are GTEx cis-eQTLs of lipid-lowering drug target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 688,
   "end": 906
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42295059",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR instrumented by eQTLGen expression SNPs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 225,
   "end": 534
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42299131",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Mediation MR with pQTLs gives plasma proteins' own effects on CAD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 510,
   "end": 625
  },
  "claim": {
   "protein_as_written": "LIMA1",
   "gene": "LIMA1",
   "disease_as_written": "CAD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 910,
    "end": 1093
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42299266",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR exposure is 'PPOX levels' in a tissue-expression paper; not named as circulating level and instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2159,
   "end": 2248
  },
  "claim": {
   "protein_as_written": "PPOX",
   "gene": "PPOX",
   "disease_as_written": "ccRCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2159,
    "end": 2248
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1678,
    "end": 1798
   }
  }
 },
 {
  "pmid": "42299446",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating pQTLs (UKB and deCODE) on BCC, but the only proteins named (STAT3, GUCA1A) are mediators with no own effect on BCC given; no counting protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1146,
   "end": 1301
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42302926",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is vascular aging phenotypes, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 792,
   "end": 992
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42304365",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma FTMT (UKB-PPP pQTLs) on NSCLC, a disease; abstract states a directed pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 680,
   "end": 889
  },
  "claim": {
   "protein_as_written": "FTMT",
   "gene": "FTMT",
   "disease_as_written": "NSCLC",
   "direction": "lowers",
   "estimate": {
    "or": 0.91,
    "low": null,
    "high": null,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1637,
    "end": 1828
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42304423",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "MR exposure is liability to a proteomic archetype, not one protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1235,
   "end": 1435
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42304513",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are lipid traits, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 619,
   "end": 845
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42305302",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Primary MR uses eQTLs, and a pQTL dataset of unnamed tissue validates IL2RA at the protein level, so circulating instruments for the pair aren't stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 936,
   "end": 994
  },
  "claim": {
   "protein_as_written": "IL2RA",
   "gene": "IL2RA",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1841,
    "end": 1948
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1429,
    "end": 1571
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1841,
    "end": 1948
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42308999",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR with blood cis-pQTLs (and eQTLs) on coronary atherosclerosis; conclusions name circulating CES2 and TGFA levels as protective.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1618,
   "end": 1719
  },
  "claim": {
   "protein_as_written": "CES2",
   "gene": "CES2",
   "disease_as_written": "ACAD",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1618,
    "end": 1719
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1364,
    "end": 1604
   }
  }
 },
 {
  "pmid": "42314336",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of 'these six genes' on male infertility; instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 950,
   "end": 1092
  },
  "claim": {
   "protein_as_written": "ALDOC",
   "gene": "ALDOC",
   "disease_as_written": "male infertility",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 950,
    "end": 1092
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42314449",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Main exposures are eQTLs; circulating inflammatory proteins appear only as mediators and the abstract states no protein-disease pair from them.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 639,
   "end": 870
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42315799",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma CTSL on AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1318,
   "end": 1588
  },
  "claim": {
   "protein_as_written": "CTSL",
   "gene": "CTSL",
   "disease_as_written": "AD",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1318,
    "end": 1588
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42317103",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Circulating cis-pQTLs meet E2, but cerebral microbleeds are an imaging-defined finding, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 86,
   "end": 218
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42318352",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Antihypertensive drug targets' variants weighted by blood pressure (per SD decreased blood pressure).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 838,
   "end": 1200
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42323475",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with deCODE plasma proteins as mediators, giving proteins' effects on breast cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 590,
   "end": 683
  },
  "claim": {
   "protein_as_written": "ADAM15",
   "gene": "ADAM15",
   "disease_as_written": "breast cancer",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1678,
    "end": 1873
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1461,
    "end": 1575
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1678,
    "end": 1873
   }
  }
 },
 {
  "pmid": "42324819",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A methods paper on post-GWAS software checks that estimates no protein's effect on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 118,
   "end": 256
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42325795",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on DVT; COPS2 named without an MR direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 334,
   "end": 605
  },
  "claim": {
   "protein_as_written": "COP9 signalosome subunit 2 (COPS2)",
   "gene": "COPS2",
   "disease_as_written": "DVT",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 606,
    "end": 819
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1554,
    "end": 1709
   }
  }
 },
 {
  "pmid": "42326004",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with plasma protein QTLs gives TAGLN2 protein abundance's effect on PAH.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 688,
   "end": 958
  },
  "claim": {
   "protein_as_written": "TAGLN2",
   "gene": "TAGLN2",
   "disease_as_written": "PAH",
   "direction": "raises",
   "estimate": {
    "or": 9,
    "low": 1.52,
    "high": 53.16,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1647,
    "end": 1914
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42326749",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Every protein-disease pair is said not to survive Bonferroni correction, so no counting pair remains.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1610,
   "end": 1808
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42327717",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Instruments pool plasma and cerebrospinal fluid protein GWAS without tying the pairs to plasma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 503,
   "end": 763
  },
  "claim": {
   "protein_as_written": "FN1",
   "gene": "FN1",
   "disease_as_written": "IPF",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1054,
    "end": 1265
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42328112",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR instruments are eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 370,
   "end": 514
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42328930",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A stratified GWAS integrated with multi-omics; no MR of a circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 426,
   "end": 686
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42332333",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based SMR (Iceland pQTLs) of TNFAIP6 on pulmonary tuberculosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1048,
   "end": 1256
  },
  "claim": {
   "protein_as_written": "TNFAIP6",
   "gene": "TNFAIP6",
   "disease_as_written": "PTB",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1048,
    "end": 1256
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1574,
    "end": 1647
   }
  }
 },
 {
  "pmid": "42333666",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are eQTLs of druggable genes in brain and blood.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 337,
   "end": 459
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42333675",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR and colocalisation of plasma pQTLs with AF identified SPON1.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 360,
   "end": 603
  },
  "claim": {
   "protein_as_written": "SPON1",
   "gene": "SPON1",
   "disease_as_written": "AF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 953,
    "end": 1198
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.87,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 953,
    "end": 1198
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1953,
    "end": 2070
   }
  }
 },
 {
  "pmid": "42335479",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR of apoA-I concentration (cis APOA1 variants) on cardiovascular outcomes, but every association is null, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1176,
   "end": 1345
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42337223",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR and two-sample MR of drug genes on frailty, with instruments not named (expression or protein).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 706,
   "end": 885
  },
  "claim": {
   "protein_as_written": "GRPEL 1",
   "gene": "GRPEL1",
   "disease_as_written": "physical frailty",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1466,
    "end": 1699
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1274,
    "end": 1465
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1466,
    "end": 1699
   }
  }
 },
 {
  "pmid": "42337887",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 plasma inflammatory proteins on PSC with signed own effects.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 400,
   "end": 594
  },
  "claim": {
   "protein_as_written": "IL-10RB",
   "gene": "IL10RB",
   "disease_as_written": "PSC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 926,
    "end": 1072
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42342966",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of the drug's targets on DN without naming their instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 652,
   "end": 781
  },
  "claim": {
   "protein_as_written": "FYN",
   "gene": "FYN",
   "disease_as_written": "DN",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1251,
    "end": 1361
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42343471",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes of the protein MR are aging phenotypes / epigenetic age acceleration, not diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 543,
   "end": 777
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42346358",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The PLXND1 finding comes from multi-layered MR pooling eQTL and pQTL datasets and isn't tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 640,
   "end": 797
  },
  "claim": {
   "protein_as_written": "PLXND1",
   "gene": "PLXND1",
   "disease_as_written": "MASLD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1158,
    "end": 1227
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2187,
    "end": 2326
   }
  }
 },
 {
  "pmid": "42349085",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Protein mediation is observational; the abstract states no protein-disease pair from MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 728,
   "end": 963
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42351157",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of circulating inflammatory proteins on HNSCC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1311,
   "end": 1507
  },
  "claim": {
   "protein_as_written": "CXCL11",
   "gene": "CXCL11",
   "disease_as_written": "HNSCC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1311,
    "end": 1507
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42358953",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based MR on Crohn's disease; higher GABARAP lowers risk (suggestive).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 668,
   "end": 846
  },
  "claim": {
   "protein_as_written": "GABARAP",
   "gene": "GABARAP",
   "disease_as_written": "CD",
   "direction": "lowers",
   "estimate": {
    "or": 0.563,
    "low": 0.327,
    "high": 0.968,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1377,
    "end": 1588
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42361163",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma GDF15 on AD and related dementias; the MR gives no direction (unsigned claim).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 548,
   "end": 841
  },
  "claim": {
   "protein_as_written": "plasma GDF15",
   "gene": "GDF15",
   "disease_as_written": "AD and related dementias",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 548,
    "end": 841
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42361404",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR outcome is a latent gSEM pan-cancer genetic factor, not a diagnosed disease; no named protein given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1905,
   "end": 2062
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42361942",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of UK Biobank plasma proteins on atherosclerosis; FES named without an MR direction (the protective direction comes from experiments).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 661,
   "end": 807
  },
  "claim": {
   "protein_as_written": "FES",
   "gene": "FES",
   "disease_as_written": "atherosclerosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 661,
    "end": 807
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 661,
    "end": 807
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 661,
    "end": 807
   }
  }
 },
 {
  "pmid": "42363551",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is COVID-19, outcomes brain structure changes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 757,
   "end": 887
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42365225",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures pool cis-eQTL and cis-pQTL instruments, and the abstract doesn't tie the AIM2 pair to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1373,
   "end": 1488
  },
  "claim": {
   "protein_as_written": "AIM2",
   "gene": "AIM2",
   "disease_as_written": "RP",
   "direction": "raises",
   "estimate": {
    "or": 2.9,
    "low": 1.81,
    "high": 4.63,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1665,
    "end": 2046
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42365605",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR between TRS liability and smoking initiation; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1418,
   "end": 1540
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42366417",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "ISOC1 identified by \"integrated multi-omics and Mendelian randomization analyses\" with no instruments named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 337,
   "end": 492
  },
  "claim": {
   "protein_as_written": "isochorismatase domain-containing 1 (ISOC1)",
   "gene": "ISOC1",
   "disease_as_written": "Intervertebral disc degeneration",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 337,
    "end": 492
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 337,
    "end": 492
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42366644",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target variants are weighted by systolic blood pressure, a downstream biomarker.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 454,
   "end": 871
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42366925",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR and SMR pool pQTLs and eQTLs; the abstract doesn't tie the targets to circulating protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 415,
   "end": 700
  },
  "claim": {
   "protein_as_written": "SREBF1",
   "gene": "SREBF1",
   "disease_as_written": "osteoporosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1255,
    "end": 1359
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1143,
    "end": 1242
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1255,
    "end": 1359
   }
  }
 },
 {
  "pmid": "42367123",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Antihypertensive drug-target MR with instruments not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 594,
   "end": 839
  },
  "claim": {
   "protein_as_written": "beta-1 adrenergic receptor (ADRB1)",
   "gene": "ADRB1",
   "disease_as_written": "NAFLD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1112,
    "end": 1381
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2107,
    "end": 2270
   }
  }
 },
 {
  "pmid": "42372928",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR on vascular dementia; SPARCL1 shows a protective effect in MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 683,
   "end": 830
  },
  "claim": {
   "protein_as_written": "SPARCL1",
   "gene": "SPARCL1",
   "disease_as_written": "VaD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1881,
    "end": 2046
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2585,
    "end": 2693
   }
  }
 },
 {
  "pmid": "42375348",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of genes whose instruments the abstract doesn't name; IL4R is the first directed pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 735,
   "end": 773
  },
  "claim": {
   "protein_as_written": "IL4R",
   "gene": "IL4R",
   "disease_as_written": "CRSwNP",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1444,
    "end": 1565
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1285,
    "end": 1443
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42384160",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on cervical cancer with directional pairs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2582,
   "end": 2744
  },
  "claim": {
   "protein_as_written": "DEFB135",
   "gene": "DEFB135",
   "disease_as_written": "cervical cancer",
   "direction": "lowers",
   "estimate": {
    "or": 0.201,
    "low": 0.082,
    "high": 0.492,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2582,
    "end": 2744
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42384774",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma cis-pQTL PWAS supported by SMR on Alzheimer's disease; proteins named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 331,
   "end": 593
  },
  "claim": {
   "protein_as_written": "LILRB1",
   "gene": "LILRB1",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1667,
    "end": 1827
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42386029",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma protein levels on PCOS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 687,
   "end": 811
  },
  "claim": {
   "protein_as_written": "RET",
   "gene": "RET",
   "disease_as_written": "PCOS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1305,
    "end": 1512
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42386713",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The SMR of genes leaves its instruments unnamed, so E2 is not failed on the abstract. Its genes are paired only with cognitive function and with autoimmune disorders as a class, and no member disease is named, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1259,
   "end": 1560
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42387373",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR on druggable genes with instruments not named; SLK is called genetically causal for AIS without an MR direction (proischemic role is experimental).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 425,
   "end": 582
  },
  "claim": {
   "protein_as_written": "SLK",
   "gene": "SLK",
   "disease_as_written": "AIS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1022,
    "end": 1123
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1851,
    "end": 2138
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42389194",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted circulating complement factor H on IgA nephropathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1148,
   "end": 1286
  },
  "claim": {
   "protein_as_written": "complement factor H",
   "gene": "CFH",
   "disease_as_written": "IgA nephropathy",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2021,
    "end": 2183
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1287,
    "end": 1522
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2318,
    "end": 2530
   }
  }
 },
 {
  "pmid": "42390334",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets proxied by cis variants associated with LDL cholesterol.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 581,
   "end": 815
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42393888",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of DEGs pooled eQTL and pQTL analyses; abstract doesn't tie ING4 to a circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 861,
   "end": 1189
  },
  "claim": {
   "protein_as_written": "ING4",
   "gene": "ING4",
   "disease_as_written": "UC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2651,
    "end": 2771
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2651,
    "end": 2771
   }
  }
 },
 {
  "pmid": "42394584",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR pools blood mQTLs, eQTLs and pQTLs; the prioritized genes come from the integrated analyses, not tied to the protein analysis, and the directed results are methylation and expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 398,
   "end": 669
  },
  "claim": {
   "protein_as_written": "PNKD",
   "gene": "PNKD",
   "disease_as_written": "T1D",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2137,
    "end": 2277
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 775,
    "end": 897
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42395344",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR on differentially expressed genes in substantia nigra; no circulating protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 646,
   "end": 899
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42396032",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposures are immune-cell traits, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 750,
   "end": 884
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42396294",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide cis-pQTL MR of circulating proteins on heart failure components.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 608,
   "end": 846
  },
  "claim": {
   "protein_as_written": "CELSR2",
   "gene": "CELSR2",
   "disease_as_written": "overall HF",
   "direction": "lowers",
   "estimate": {
    "or": 0.96,
    "low": 0.94,
    "high": 0.98,
    "unit": "per standard deviation",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1219,
    "end": 1546
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1070,
    "end": 1218
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42396322",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is a BMI-subtracted latent genetic liability component of T2D from GWAS-by-subtraction, a continuous factor rather than a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1276,
   "end": 1340
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42396338",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Protein abundance models built from lung tissue proteomics.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 410,
   "end": 506
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42397503",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of pyroptosis-related plasma proteins instrumented by pQTLs on osteoarthritis, with PLCG1 inversely associated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1041,
   "end": 1175
  },
  "claim": {
   "protein_as_written": "Phospholipase C Gamma 1 (PLCG1)",
   "gene": "PLCG1",
   "disease_as_written": "OA",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1041,
    "end": 1175
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42399650",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins with cis-pQTLs on ischemic stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1032,
   "end": 1222
  },
  "claim": {
   "protein_as_written": "MMUT",
   "gene": "MMUT",
   "disease_as_written": "ischemic stroke",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1383,
    "end": 1648
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1383,
    "end": 1648
   }
  }
 },
 {
  "pmid": "42404994",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR with UKB-PPP plasma proteins, but the outcome is tau pathology on PET.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1128,
   "end": 1261
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42406523",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Abstract does not say the MR exposures are circulating protein levels or name instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1283,
   "end": 1486
  },
  "claim": {
   "protein_as_written": "CNTN5",
   "gene": "CNTN5",
   "disease_as_written": "AVS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1283,
    "end": 1486
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1283,
    "end": 1486
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42407433",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of HSP90AA1 on HCC with no instruments named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1483,
   "end": 1608
  },
  "claim": {
   "protein_as_written": "HSP90AA1",
   "gene": "HSP90AA1",
   "disease_as_written": "HCC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1483,
    "end": 1608
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1483,
    "end": 1608
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1483,
    "end": 1608
   }
  }
 },
 {
  "pmid": "42410617",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "A methods comparison of gene-prioritization strategies; no protein's effect on a disease is estimated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 483,
   "end": 691
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42410793",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins instrumented by cis-pQTLs as mediators, with SLIT2's own effect on atrial fibrillation stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2027,
   "end": 2203
  },
  "claim": {
   "protein_as_written": "SLIT2",
   "gene": "SLIT2",
   "disease_as_written": "atrial fibrillation",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1151,
    "end": 1290
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42410858",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Circulating inflammatory protein pQTLs (14,824 participants) with FinnGen COPD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 549,
   "end": 798
  },
  "claim": {
   "protein_as_written": "CCL28",
   "gene": "CCL28",
   "disease_as_written": "COPD",
   "direction": "lowers",
   "estimate": {
    "or": 0.83,
    "low": 0.69,
    "high": 0.99,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1369,
    "end": 1849
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42410861",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of palmitoylation genes combining eQTLs and pQTLs, ZDHHC13 not tied to a circulating protein analysis; conclusion says it inhibits UC.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 151,
   "end": 359
  },
  "claim": {
   "protein_as_written": "ZDHHC13",
   "gene": "ZDHHC13",
   "disease_as_written": "UC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1370,
    "end": 1493
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42412152",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 372,
   "end": 522
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42417419",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating protein levels on ischemic stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 457,
   "end": 576
  },
  "claim": {
   "protein_as_written": "CDH7",
   "gene": "CDH7",
   "disease_as_written": "IS",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2190,
    "end": 2373
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42419582",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with cis-pQTLs of circulating proteins, validated in osteoporosis case-control data; LRP4 is named as causally implicated in OP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 684,
   "end": 837
  },
  "claim": {
   "protein_as_written": "LRP4",
   "gene": "LRP4",
   "disease_as_written": "OP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2071,
    "end": 2146
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.915,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1426,
    "end": 1566
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1426,
    "end": 1566
   }
  }
 },
 {
  "pmid": "42420700",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcomes are body fat measures and blood lipids, which are traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 872,
   "end": 1208
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42421242",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "PPI target genes are eQTL-instrumented; the four inflammatory proteins with causal associations to asthma are not named, and IL-2 is named only as a mediator without its own effect.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1396,
   "end": 1481
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42421394",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR pools mQTL, eQTL, and pQTL data; ATAD3B's finding isn't tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 321,
   "end": 521
  },
  "claim": {
   "protein_as_written": "ATAD3B",
   "gene": "ATAD3B",
   "disease_as_written": "CKD",
   "direction": "lowers",
   "estimate": {
    "or": 0.95,
    "low": 0.9,
    "high": 1,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1519,
    "end": 1661
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42425734",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR concerns triglyceride levels and IBS; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1091,
   "end": 1236
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42428116",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR implicates ion channel genes; the abstract does not name the instruments (gene-level exposure).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 866,
   "end": 1075
  },
  "claim": {
   "protein_as_written": "CACNA1I",
   "gene": "CACNA1I",
   "disease_as_written": "SCZ",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 866,
    "end": 1075
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42428459",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UKB-PPP plasma protein MR on premature ovarian failure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 425,
   "end": 690
  },
  "claim": {
   "protein_as_written": "C-C motif chemokine 23 (CCL23)",
   "gene": "CCL23",
   "disease_as_written": "POF",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1340,
    "end": 1478
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.721,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1570,
    "end": 1731
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2009,
    "end": 2208
   }
  }
 },
 {
  "pmid": "42429671",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is depression; proteins appear only in observational proteomics.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1461,
   "end": 1582
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42432881",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR across methylation, expression, and protein QTLs; the pQTLs' tissue is not stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 309,
   "end": 584
  },
  "claim": {
   "protein_as_written": "CASP7",
   "gene": "CASP7",
   "disease_as_written": "cataract",
   "direction": "lowers",
   "estimate": {
    "or": 0.597,
    "low": 0.483,
    "high": 0.738,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 903,
    "end": 1274
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42432932",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "ApoB is a circulating protein, but its outcomes are eGFR and albuminuria, measurements rather than diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 555,
   "end": 664
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42433766",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "GLP-1RA exposure proxied by variants in the GLP1R gene region; the abstract doesn't say whether they're pQTLs or eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 268,
   "end": 422
  },
  "claim": {
   "protein_as_written": "GLP-1RA",
   "gene": "GLP1R",
   "disease_as_written": "breast cancer",
   "direction": "lowers",
   "estimate": {
    "or": 0.7096,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 696,
    "end": 1036
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 268,
    "end": 422
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42434318",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with UKB-PPP and deCODE pQTLs on lichen sclerosus; ITGB2 supported by pQTL and eQTL evidence, no direction stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1342,
   "end": 1514
  },
  "claim": {
   "protein_as_written": "ITGB2",
   "gene": "ITGB2",
   "disease_as_written": "LS",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2110,
    "end": 2293
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1946,
    "end": 2097
   }
  }
 },
 {
  "pmid": "42437949",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are lipid traits (TG, HDL-C), not proteins; pQTLs serve only gene identification.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1417,
   "end": 1533
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42439347",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are protein-to-protein ratios.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 520,
   "end": 671
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42439352",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with plasma pQTLs on OA; the conclusions name ITIH4 without a direction, and the Discussion ties genetically elevated ITIH4 to OA risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 401,
   "end": 700
  },
  "claim": {
   "protein_as_written": "ITIH4",
   "gene": "ITIH4",
   "disease_as_written": "OA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1501,
    "end": 1726
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1043,
    "end": 1311
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1739,
    "end": 1926
   }
  }
 },
 {
  "pmid": "42439544",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with UK Biobank plasma protein GWAS on RCC; first directed protein pair TYMP inversely associated, among the FDR-significant proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 816,
   "end": 983
  },
  "claim": {
   "protein_as_written": "TYMP",
   "gene": "TYMP",
   "disease_as_written": "RCC",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1790,
    "end": 1994
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42439983",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR runs between disease liabilities (infections and cancers); the proteome-level analysis is not described as MR of a protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1852,
   "end": 2021
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42443148",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "GLP-1R activation proxied by GLP1R variants weighted by BMI.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 607,
   "end": 998
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42443585",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposure is rare non-coding variants and ncRNA burden.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 582,
   "end": 793
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42449104",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposure is sleeplessness/insomnia; plasma proteins are outcomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 435,
   "end": 617
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42449444",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The SMR includes protein QTLs, so the paper isn't purely expression or methylation, but its two pQTL findings are unnamed and the named genes (DNMT3A, PRKCA) rest on expression and methylation, so no protein-disease pair from protein MR is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 965,
   "end": 1028
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42454014",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR uses eQTLs from blood and brain.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 334,
   "end": 629
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42454155",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (UKB-PPP) on acute kidney injury.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1157,
   "end": 1336
  },
  "claim": {
   "protein_as_written": "CX3CL1",
   "gene": "CX3CL1",
   "disease_as_written": "AKI",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1157,
    "end": 1336
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1157,
    "end": 1336
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1476,
    "end": 1679
   }
  }
 },
 {
  "pmid": "42456406",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of druggable genes uses gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1191,
   "end": 1422
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42456803",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR is reported only as supportive evidence for 170 proteins; no protein-disease pair from MR is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2310,
   "end": 2431
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42458479",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Single-cell immune cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 603,
   "end": 770
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42460151",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The only protein pair stated is LILRB1 with a metabolite level, which isn't a disease; the disease analyses are of metabolites.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2884,
   "end": 3104
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42462526",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Drug-target MR identifies AHR and STAT3 for UC, and the abstract doesn't name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 845,
   "end": 1021
  },
  "claim": {
   "protein_as_written": "aryl hydrocarbon receptor (AHR)",
   "gene": "AHR",
   "disease_as_written": "UC",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 845,
    "end": 1021
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1513,
    "end": 1579
   }
  }
 },
 {
  "pmid": "42464726",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Instruments are brain pQTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 474,
   "end": 792
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42465883",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Includes plasma pQTL MR of ANTXR1 on AD; the abstract gives no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1196,
   "end": 1375
  },
  "claim": {
   "protein_as_written": "ANTXR1",
   "gene": "ANTXR1",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1196,
    "end": 1375
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42465927",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Plasma-protein MR outcome is residual pulmonary vascular obstruction, an imaging measure; PE recurrence is a locus association, not MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1539,
   "end": 1737
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42465939",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR links white-matter genetic effects to disease; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 950,
   "end": 1128
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42465957",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The cis-pQTL MR tests whether biomarkers cause mortality acceleration, so its outcome is mortality, not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 846,
   "end": 1090
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42466378",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Exposures are obesity and lifestyle, but the mediation MR runs plasma proteomes on mouth ulcers; no protein is named, so no protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1301,
   "end": 1511
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42468473",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Multi-omics SMR pooling mQTL, eQTL and pQTL and blood with cardiac tissue.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 412,
   "end": 629
  },
  "claim": {
   "protein_as_written": "PCCB",
   "gene": "PCCB",
   "disease_as_written": "MVD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 822,
    "end": 1019
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42470027",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug targets instrumented by HbA1c-associated cis variants.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 567,
   "end": 823
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42470043",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins are named only as mediators of vitamin D's effect on CAD, with no protein's own effect stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1495,
   "end": 1775
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42476215",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based MR of circulating extracellular-matrix proteins on intervertebral disc degeneration; DCN shows a nominally positive IVW association.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 360,
   "end": 621
  },
  "claim": {
   "protein_as_written": "DCN",
   "gene": "DCN",
   "disease_as_written": "intervertebral disc degeneration",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1169,
    "end": 1463
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42477711",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The only protein-disease pair (CKAP2-LUSC) did not survive Bonferroni correction; no other association.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1113,
   "end": 1258
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42479091",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR pools eQTL and pQTL data; the FAM3D finding isn't tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 310,
   "end": 573
  },
  "claim": {
   "protein_as_written": "FAM3D",
   "gene": "FAM3D",
   "disease_as_written": "CC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1220,
    "end": 1290
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2637,
    "end": 2818
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42481940",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are brain chromatin accessibility QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 711,
   "end": 1018
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42483734",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma pQTL MR of SBDS on primary sclerosing cholangitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1650,
   "end": 1923
  },
  "claim": {
   "protein_as_written": "SBDS",
   "gene": "SBDS",
   "disease_as_written": "PSC",
   "direction": "lowers",
   "estimate": {
    "or": 0.525,
    "low": 0.356,
    "high": 0.773,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1650,
    "end": 1923
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2025,
    "end": 2196
   }
  }
 },
 {
  "pmid": "42484070",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "DPP4 expression, methylation, and protein-level SMR are pooled in the conclusions' pair, and the protein level is never named circulating.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1283,
   "end": 1484
  },
  "claim": {
   "protein_as_written": "DPP4",
   "gene": "DPP4",
   "disease_as_written": "POF",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1283,
    "end": 1484
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1485,
    "end": 1575
   }
  }
 },
 {
  "pmid": "42487515",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Metformin proxied by target-gene expression variants weighted by HbA1c.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 772,
   "end": 1001
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42487957",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of deCODE plasma proteins on primary knee osteoarthritis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 417,
   "end": 712
  },
  "claim": {
   "protein_as_written": "thioredoxin domain-containing protein 12 (TXNDC12)",
   "gene": "TXNDC12",
   "disease_as_written": "PKOA",
   "direction": "raises",
   "estimate": {
    "unit": "not stated",
    "frame": "per higher protein",
    "low": 1.27,
    "high": 1.5,
    "or": 1.38
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1338,
    "end": 1655
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42488633",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with inflammatory protein pQTL GWAS (GCST90274758-GCST90274848) on T2D.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 554,
   "end": 767
  },
  "claim": {
   "protein_as_written": "FGF-21",
   "gene": "FGF21",
   "disease_as_written": "T2D",
   "direction": "raises",
   "estimate": {
    "or": 1.141,
    "low": 1.032,
    "high": 1.261,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1183,
    "end": 1449
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42489810",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins as supportive evidence for post-AF stroke; AMN named first without a direction (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1076,
   "end": 1138
  },
  "claim": {
   "protein_as_written": "AMN",
   "gene": "AMN",
   "disease_as_written": "post-AF stroke",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1866,
    "end": 1953
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42490363",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Multi-omics SMR pooling mQTL, eQTL and pQTL; IER3IP1 not tied to a circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 391,
   "end": 632
  },
  "claim": {
   "protein_as_written": "IER3IP1",
   "gene": "IER3IP1",
   "disease_as_written": "FL",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2257,
    "end": 2387
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2388,
    "end": 2625
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42494396",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteomics on vascular dementia risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1092,
   "end": 1242
  },
  "claim": {
   "protein_as_written": "COX5B",
   "gene": "COX5B",
   "disease_as_written": "VaD",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1092,
    "end": 1242
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2224,
    "end": 2361
   }
  }
 },
 {
  "pmid": "42498029",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The mediator step tests UKB-PPP proteins' own effects on IHD by MR; the abstract gives no protein's direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 706,
   "end": 968
  },
  "claim": {
   "protein_as_written": "complement C1s subcomponent",
   "gene": "C1S",
   "disease_as_written": "IHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1247,
    "end": 1522
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 706,
    "end": 968
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42498671",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The abstract's MR is of smoking initiation on Sjögren's disease; the proteome-informed mediation analyses aren't described as MR of a protein's level, and found no protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1011,
   "end": 1146
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42498900",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR's exposure is genetic liability to sleep disorders; proteins enter only by intersecting gene lists.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1174,
   "end": 1401
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42499219",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of UKB-PPP plasma proteins on hidradenitis suppurativa.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 609,
   "end": 807
  },
  "claim": {
   "protein_as_written": "TNFRSF6B",
   "gene": "TNFRSF6B",
   "disease_as_written": "HS",
   "direction": "lowers",
   "estimate": {
    "or": 0.748,
    "low": 0.666,
    "high": 0.84,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1655,
    "end": 1903
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.648,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 808,
    "end": 1226
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42500061",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins (cis-pQTLs) on CRS/NP; prioritized proteins without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 370,
   "end": 610
  },
  "claim": {
   "protein_as_written": "IL2RB",
   "gene": "IL2RB",
   "disease_as_written": "CRS/NP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1660,
    "end": 1762
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1763,
    "end": 1922
   }
  }
 },
 {
  "pmid": "42500868",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4,907 circulating proteins (deCODE) on TAA; LTBP4's MR association has no direction (the increased expression is observational), so an unsigned claim.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 276,
   "end": 416
  },
  "claim": {
   "protein_as_written": "LTBP4",
   "gene": "LTBP4",
   "disease_as_written": "TAA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1695,
    "end": 1871
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 478,
    "end": 669
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1695,
    "end": 1871
   }
  }
 },
 {
  "pmid": "42500950",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR exposure is transcript levels and outcome is protein levels; no protein exposure on a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 628,
   "end": 839
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42503400",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on anxiety disorders; SERPINA4 named as mediator with its own protective association.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 336,
   "end": 580
  },
  "claim": {
   "protein_as_written": "SERPINA4",
   "gene": "SERPINA4",
   "disease_as_written": "anxiety disorders",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1170,
    "end": 1342
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42507612",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of druggable genes on heart failure; the abstract does not name the instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 436,
   "end": 553
  },
  "claim": {
   "protein_as_written": "CYP11A1",
   "gene": "CYP11A1",
   "disease_as_written": "HF",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 697,
    "end": 878
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 697,
    "end": 878
   }
  }
 },
 {
  "pmid": "42509441",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "CETP pairs come from expression SMR or unstated 'inhibition' instruments, and the abstract says the associations did not survive multiplicity correction, so no counting pair remains.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1334,
   "end": 1575
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42509680",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The abstract attributes the protective and risk plasma proteins to MR of plasma protein levels, separately from SMR of gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 876,
   "end": 1037
  },
  "claim": {
   "protein_as_written": "EPOR",
   "gene": "EPOR",
   "disease_as_written": "peripheral atherosclerosis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 876,
    "end": 1037
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1717,
    "end": 1926
   }
  }
 },
 {
  "pmid": "42509698",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins on AD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1131,
   "end": 1374
  },
  "claim": {
   "protein_as_written": "CR2",
   "gene": "CR2",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2301,
    "end": 2377
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2503,
    "end": 2619
   }
  }
 },
 {
  "pmid": "42509710",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Analyses pool blood, brain, and plasma QTLs; the HLA-G pair is not tied to the circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 571,
   "end": 759
  },
  "claim": {
   "protein_as_written": "HLA-G",
   "gene": "HLA-G",
   "disease_as_written": "insomnia",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2660,
    "end": 2822
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1849,
    "end": 2033
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42510850",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins from four pQTL studies on multiple sclerosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 465,
   "end": 712
  },
  "claim": {
   "protein_as_written": "ALPI",
   "gene": "ALPI",
   "disease_as_written": "MS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 722,
    "end": 917
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42510851",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR runs between circulating proteins (CRP, E-selectin, sICAM-1) and PSGL-1 levels; no outcome is a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1307,
   "end": 1559
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42510868",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR pooled eQTLs and pQTLs; the candidate targets are not tied to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 573,
   "end": 804
  },
  "claim": {
   "protein_as_written": "CXCL6",
   "gene": "CXCL6",
   "disease_as_written": "RA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1630,
    "end": 1745
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1630,
    "end": 1745
   }
  }
 },
 {
  "pmid": "42511522",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UK Biobank plasma pQTLs in SMR on diabetic retinopathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 473,
   "end": 612
  },
  "claim": {
   "protein_as_written": "GSTT2B",
   "gene": "GSTT2B",
   "disease_as_written": "DR",
   "direction": "lowers",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1279,
    "end": 1374
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1810,
    "end": 1999
   }
  }
 },
 {
  "pmid": "42516377",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Pair rests on CD83 'expression' from pooled cis-eQTL and cis-pQTL analyses; instruments unsettled.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 416,
   "end": 699
  },
  "claim": {
   "protein_as_written": "CD83",
   "gene": "CD83",
   "disease_as_written": "asthma",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1216,
    "end": 1468
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1216,
    "end": 1468
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1216,
    "end": 1468
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2106,
    "end": 2244
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42517387",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 serum inflammatory proteins on multiple sclerosis; CD40 is protective and the only pair surviving correction, and the discussion singles it out.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1147,
   "end": 1407
  },
  "claim": {
   "protein_as_written": "CD40",
   "gene": "CD40",
   "disease_as_written": "MS",
   "direction": "lowers",
   "estimate": {
    "or": 0.907,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1147,
    "end": 1407
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42517881",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are cis-eQTLs from eQTLGen.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 729,
   "end": 845
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42518596",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "SMR prioritized gene targets without naming the kind of QTL (multi-omics); E2 unsettled.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 751,
   "end": 868
  },
  "claim": {
   "protein_as_written": "EDEM2",
   "gene": "EDEM2",
   "disease_as_written": "melanoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1335,
    "end": 1580
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1807,
    "end": 1954
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42518793",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein levels on cataract; CRYBB2 genetically predicted levels associated with cataract, with no direction stated for the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1124,
   "end": 1504
  },
  "claim": {
   "protein_as_written": "CRYBB2",
   "gene": "CRYBB2",
   "disease_as_written": "cataract",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1124,
    "end": 1504
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1124,
    "end": 1504
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42518818",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with deCODE plasma pQTLs on gastric cancer; no direction stated (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 443,
   "end": 652
  },
  "claim": {
   "protein_as_written": "TGFB3",
   "gene": "TGFB3",
   "disease_as_written": "gastric cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1217,
    "end": 1440
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 982,
    "end": 1207
   }
  }
 },
 {
  "pmid": "42519006",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "pQTL-based SMR prioritized plasma proteins without naming any protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 976,
   "end": 1157
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42523746",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "BOLA1-POAG is tied to the pQTL layer, but the abstract does not say the pQTLs are of circulating proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 326,
   "end": 788
  },
  "claim": {
   "protein_as_written": "BOLA1",
   "gene": "BOLA1",
   "disease_as_written": "POAG",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1346,
    "end": 1410
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42524807",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTLs of plasma proteins in two-sample MR on IHD; no protein pair is given a direction, so the claim is unsigned: the first protein the results name with IHD, PCSK9.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 927,
   "end": 1217
  },
  "claim": {
   "protein_as_written": "proprotein convertase subtilisin/kexin type 9",
   "gene": "PCSK9",
   "disease_as_written": "IHD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1827,
    "end": 2214
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1827,
    "end": 2214
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1827,
    "end": 2214
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42525381",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR is between RA and psychiatric disorders; no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1660,
   "end": 1933
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42528182",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Apolipoprotein pairs did not survive Bonferroni correction and the remaining finding is NPC1L1 gene expression, so no counting protein-disease pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 589,
   "end": 780
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42528538",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are blood cis-eQTLs of druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 488,
   "end": 697
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42528609",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The abstract lists eleven plasma proteins and five diseases together without saying each protein holds for each disease, so no protein-disease pair is stated; the other outcomes are imaging traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1220,
   "end": 1527
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42533613",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "TLR4 comes from a screen of druggable gene loci whose instruments (eQTL or pQTL) the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1128,
   "end": 1347
  },
  "claim": {
   "protein_as_written": "TLR4",
   "gene": "TLR4",
   "disease_as_written": "gout",
   "direction": "raises",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1348,
    "end": 1551
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1128,
    "end": 1347
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1687,
    "end": 1869
   }
  }
 },
 {
  "pmid": "42534740",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Genetically proxied SGLT2; instruments are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1565,
   "end": 1680
  },
  "claim": {
   "protein_as_written": "SGLT2",
   "gene": "SLC5A2",
   "disease_as_written": "DR",
   "direction": "raises",
   "estimate": {
    "or": 1.21,
    "low": 1.05,
    "high": 1.39,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1565,
    "end": 1680
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 142,
    "end": 405
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42539060",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Protein MR results are on risk factors; disease associations come from missense variants, which are not MR of protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 862,
   "end": 1127
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42540540",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is survival among breast cancer patients, a prognosis rather than a disease's occurrence.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 598,
   "end": 727
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42543067",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR is used to identify miR-30a as a regulator; no circulating protein's effect on a disease is estimated by MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 577,
   "end": 729
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42544320",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Gene-level MR uses peripheral-blood eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 794,
   "end": 1052
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42545500",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on CVDs, but no specific protein-disease pair is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 943,
   "end": 1150
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42546420",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are named only as mediators of UHI and RA, without their own MR effect on RA.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1363,
   "end": 1594
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42548293",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTLs from deCODE plasma on oral cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 189,
   "end": 368
  },
  "claim": {
   "protein_as_written": "TNFSF8",
   "gene": "TNFSF8",
   "disease_as_written": "oral cancer",
   "direction": "raises",
   "estimate": {
    "or": 1.24,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1724,
    "end": 1805
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2431,
    "end": 2505
   }
  }
 },
 {
  "pmid": "42548648",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The FXN pair is attributed to genetically elevated circulating FXN protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 952,
   "end": 1076
  },
  "claim": {
   "protein_as_written": "FXN",
   "gene": "FXN",
   "disease_as_written": "nephrolithiasis",
   "direction": "lowers",
   "estimate": {
    "or": 0.69,
    "low": 0.56,
    "high": 0.84,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 952,
    "end": 1076
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.0239,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1596,
    "end": 1887
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 429,
    "end": 760
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42549601",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The proteins are credited to 'proteomic analyses' that mix mediation and MR, and are tied to AD risk 'in psychiatric populations' (the cohort), so no pair is attributed to MR of the protein's level, and the paper's MR also has non-protein exposures.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1422,
   "end": 1577
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42551443",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR is said to support 44 proteins but the abstract names no protein-disease pair from the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1131,
   "end": 1204
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42552764",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "IL-6R proxied by CRP elevation and IL-18 by gene expression; other exposures are immune cell traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1097,
   "end": 1258
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42552772",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of pQTLs for 5,034 proteins on cardiomyopathy.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 486,
   "end": 642
  },
  "claim": {
   "protein_as_written": "CD163",
   "gene": "CD163",
   "disease_as_written": "cardiomyopathy",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1029,
    "end": 1164
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42553537",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of plasma proteins on preeclampsia; conclusions name KRT18 first without direction, results say positively correlated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 540,
   "end": 612
  },
  "claim": {
   "protein_as_written": "Keratin 18 (KRT18)",
   "gene": "KRT18",
   "disease_as_written": "PE",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1075,
    "end": 1425
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.74,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1475,
    "end": 1626
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2134,
    "end": 2283
   }
  }
 },
 {
  "pmid": "42563458",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with blood-derived pQTLs; POMGNT2 is associated with TN at the protein level, which ties the pair to the circulating protein's analysis; no direction is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 419,
   "end": 656
  },
  "claim": {
   "protein_as_written": "POMGNT2",
   "gene": "POMGNT2",
   "disease_as_written": "TN",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1310,
    "end": 1400
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42568671",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The only protein MR uses ALDOB cis-eQTLs; two-sample MR exposures are glycerol and glucose traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1917,
   "end": 2070
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42569931",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The drug-target MR and the plasma-proteome screen leave their instruments unnamed, so E2 is not failed on the abstract. The abstract pairs drugs, not proteins, with diseases, and the proteome screen names no protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1238,
   "end": 1408
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42570691",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with cis-pQTLs from deCODE and UKB-PPP on osteoporosis; no direction stated (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 655,
   "end": 915
  },
  "claim": {
   "protein_as_written": "NUDT2",
   "gene": "NUDT2",
   "disease_as_written": "OP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1118,
    "end": 1321
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42570703",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Protein associations with CHIP are not attributed to MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1230,
   "end": 1477
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42571730",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of circulating proteins on AD; AIF1 prioritized from it, with no MR direction stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 669,
   "end": 760
  },
  "claim": {
   "protein_as_written": "AIF1",
   "gene": "AIF1",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1717,
    "end": 1949
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42572097",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The stated MR has MASLD as its exposure; AHSG and CPB2 come from integrative multi-omics analyses that the abstract never states as MR of a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1484,
   "end": 1571
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42576535",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTL-instrumented gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1026,
   "end": 1219
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42577736",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "Exposures are plasma protein ratios.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 130,
   "end": 356
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42579238",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-MR of plasma CKAP2 on MDD; plasma protein association opposite to the inverse expression one, so raises.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 964,
   "end": 1246
  },
  "claim": {
   "protein_as_written": "plasma CKAP2 protein levels",
   "gene": "CKAP2",
   "disease_as_written": "MDD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 964,
    "end": 1246
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42580030",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "No protein survived FDR correction; only expression pairs are stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1745,
   "end": 1870
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42580475",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are named only as mediators of MASLD subtypes' effects, with no protein's own MR effect on a named disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1747,
   "end": 1977
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42582114",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTLs of drug target genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 454,
   "end": 546
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42584388",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of plasma proteins with cis-pQTLs on myocardial infarction; FGF5 pair stated without direction, so unsigned.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1838,
   "end": 1927
  },
  "claim": {
   "protein_as_written": "FGF5",
   "gene": "FGF5",
   "disease_as_written": "myocardial infarction",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1838,
    "end": 1927
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42585344",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Key genes from transcriptomics were tested by MR, but the abstract doesn't say what instrumented them.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1174,
   "end": 1375
  },
  "claim": {
   "protein_as_written": "PARP9",
   "gene": "PARP9",
   "disease_as_written": "AD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1174,
    "end": 1375
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1709,
    "end": 1962
   }
  }
 },
 {
  "pmid": "42585774",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of genes prioritized from gene-expression datasets; the MR's instruments are not named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 505,
   "end": 607
  },
  "claim": {
   "protein_as_written": "STAT6",
   "gene": "STAT6",
   "disease_as_written": "MS",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1117,
    "end": 1222
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1899,
    "end": 2060
   }
  }
 },
 {
  "pmid": "42586262",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted plasma protein levels (plasma pQTLs) on a diagnosed composite ovulatory dysfunction phenotype.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1306,
   "end": 1421
  },
  "claim": {
   "protein_as_written": "JUN",
   "gene": "JUN",
   "disease_as_written": "composite ovulatory dysfunction phenotype",
   "direction": "raises",
   "estimate": {
    "or": 1.265,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2025,
    "end": 2343
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42587048",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR includes blood APOE and GCKR protein levels (pQTLs) on MASLD; the conclusions give APOE a direction through its inhibitors.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1461,
   "end": 1574
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "MASLD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1835,
    "end": 2023
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1461,
    "end": 1574
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1835,
    "end": 2023
   }
  }
 },
 {
  "pmid": "42592812",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are prioritised by integrated observational, burden, and plasma/CSF MR analyses; no protein-disease pair is attributed to MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 957,
   "end": 1123
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42592821",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR identified 66 proteins for cirrhosis but the abstract names none.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1355,
   "end": 1452
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42594068",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "The MR exposure is triglyceride levels; no protein's MR estimate is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 331,
   "end": 572
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42601635",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma proteins on AMD, with LAMC2 tied to the protein-level analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1180,
   "end": 1312
  },
  "claim": {
   "protein_as_written": "LAMC2",
   "gene": "LAMC2",
   "disease_as_written": "AMD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1313,
    "end": 1481
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42601728",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL MR of LEPR on osteosarcoma, but tissue of the pQTLs not stated and analysis integrated with mQTLs; LEPR inversely associated with OS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 820,
   "end": 1165
  },
  "claim": {
   "protein_as_written": "LEPR",
   "gene": "LEPR",
   "disease_as_written": "OS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1560,
    "end": 1674
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42601749",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of 4907 plasma proteins (deCODE) on IBS.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 327,
   "end": 455
  },
  "claim": {
   "protein_as_written": "Scavenger Receptor Class A Member 5",
   "gene": "SCARA5",
   "disease_as_written": "IBS",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1050,
    "end": 1211
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42609827",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR is instrumented by eQTLGen expression data.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1070,
   "end": 1288
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42610667",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pooling mQTL, eQTL and pQTL; the genes' pairs are not tied to the circulating protein's analysis, and none has a direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 247,
   "end": 537
  },
  "claim": {
   "protein_as_written": "ACTR1B",
   "gene": "ACTR1B",
   "disease_as_written": "adenomyosis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 913,
    "end": 1149
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42613030",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with adulthood proteomics (n = 35 559) as mediators on T2D; the proteins' own step on T2D is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 397,
   "end": 668
  },
  "claim": {
   "protein_as_written": "GCKR",
   "gene": "GCKR",
   "disease_as_written": "T2D",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1128,
    "end": 1287
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1288,
    "end": 1347
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42613742",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating proteins, but the outcomes are cardiometabolic traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 506,
   "end": 694
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42614597",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on digestive diseases; SULT2A1 increases cholelithiasis risk.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 350,
   "end": 723
  },
  "claim": {
   "protein_as_written": "SULT2A1",
   "gene": "SULT2A1",
   "disease_as_written": "cholelithiasis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 724,
    "end": 842
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 350,
    "end": 723
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1487,
    "end": 1656
   }
  }
 },
 {
  "pmid": "42620263",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is mortality after a cancer diagnosis (survival), not a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 428,
   "end": 810
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42622622",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Immune-cell eQTLs, not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 228,
   "end": 558
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42625604",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are single-cell eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 504,
   "end": 769
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42627905",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of a plasma protein (C1QTNF1, from the plasma proteomics) on heart failure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 995,
   "end": 1164
  },
  "claim": {
   "protein_as_written": "C1q tumor necrosis factor-related protein 1 (C1QTNF1)",
   "gene": "C1QTNF1",
   "disease_as_written": "HF",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 995,
    "end": 1164
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 995,
    "end": 1164
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42629404",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The plasma-protein MR names none of its 18 nominal proteins; the named SRA1 finding comes from gene expression, and no colocalised protein is tied to the MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1090,
   "end": 1373
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42629664",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted inflammatory protein levels on allergic diseases.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2085,
   "end": 2302
  },
  "claim": {
   "protein_as_written": "CD40L receptor (CD40)",
   "gene": "CD40",
   "disease_as_written": "asthma",
   "direction": "lowers",
   "estimate": {
    "or": 0.939,
    "low": 0.906,
    "high": 0.974,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2085,
    "end": 2302
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42629691",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins (4657 proteins in 7213 Europeans) on FinnGen low back pain, a diagnosed condition.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 405,
   "end": 602
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "LBP",
   "direction": "lowers",
   "estimate": {
    "or": 0.86,
    "low": 0.81,
    "high": 0.91,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1629,
    "end": 1723
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1030,
    "end": 1138
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 122
   }
  }
 },
 {
  "pmid": "42629724",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins are named only as mediators of polymyositis on IPF; their own effect on IPF is not given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2196,
   "end": 2394
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42634199",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are cis-eQTLs from eQTLGen (gene expression), not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 823,
   "end": 941
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42634679",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma BLMH protein levels (alongside expression) on psoriasis, a disease; the result is tied to plasma protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1272,
   "end": 1522
  },
  "claim": {
   "protein_as_written": "BLMH",
   "gene": "BLMH",
   "disease_as_written": "psoriasis",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1272,
    "end": 1522
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1272,
    "end": 1522
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 163
   }
  }
 },
 {
  "pmid": "42638160",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins appear only as mediators of T2D clusters' effects on CVDs, with no sign of their own effect on a named disease, so no counting pair.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1475,
   "end": 1607
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42638335",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposure is ODC1 inhibition proxied by variants associated with ODC; whether circulating-level pQTLs is not stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 449,
   "end": 530
  },
  "claim": {
   "protein_as_written": "ODC1",
   "gene": "ODC1",
   "disease_as_written": "NB",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 989,
    "end": 1071
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.15,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 900,
    "end": 988
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 133,
    "end": 439
   }
  }
 },
 {
  "pmid": "42640732",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR outcome for GDF-15 is eGFR, a quantitative trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1299,
   "end": 1485
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42642762",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "GLP1R and GIPR modulation is proxied by variants weighted by HbA1c or BMI lowering.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 814,
   "end": 1389
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42649925",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The MR concerns DSG2's tissue-level expression and a compositional model, not a circulating protein's level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1652,
   "end": 1752
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42650080",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR with UKB-PPP instruments on FinnGen infection endpoints.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 550,
   "end": 783
  },
  "claim": {
   "protein_as_written": "PSCA",
   "gene": "PSCA",
   "disease_as_written": "cystitis",
   "direction": "lowers",
   "estimate": {
    "or": 0.977,
    "low": 0.967,
    "high": 0.987,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1193,
    "end": 1475
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1193,
    "end": 1475
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42651766",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The only MR pair, CRIP2 with MI, did not survive Bonferroni correction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 862,
   "end": 1032
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42652217",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of circulating integrin levels (UK Biobank) on ASCVD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 719,
   "end": 904
  },
  "claim": {
   "protein_as_written": "ITGA11",
   "gene": "ITGA11",
   "disease_as_written": "ASCVD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1569,
    "end": 1703
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42663799",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteomic data (deCODE, UK Biobank) on POI.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 471,
   "end": 673
  },
  "claim": {
   "protein_as_written": "EPHA4",
   "gene": "EPHA4",
   "disease_as_written": "POI",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 674,
    "end": 778
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1066,
    "end": 1350
   }
  }
 },
 {
  "pmid": "42666106",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UKB-PPP cis-pQTL MR on coronary atherosclerosis; named proteins are given no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 568,
   "end": 754
  },
  "claim": {
   "protein_as_written": "PARP1",
   "gene": "PARP1",
   "disease_as_written": "CA",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2064,
    "end": 2241
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1581,
    "end": 1783
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1784,
    "end": 1895
   }
  }
 },
 {
  "pmid": "42667367",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of deCODE plasma proteins on bladder cancer; no named protein given a direction, so the claim is unsigned on the first named, ETFA; the associations are called suggestive.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 742,
   "end": 913
  },
  "claim": {
   "protein_as_written": "ETFA",
   "gene": "ETFA",
   "disease_as_written": "bladder cancer",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1577,
    "end": 1828
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42671122",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The MR links lipoproteins, including Lp(a) (apolipoprotein(a), a circulating protein), to plasma protein levels; its outcomes are measurements, not a disease, and CAD is analysed only by Cox regression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 541,
   "end": 820
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42675179",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are sleep traits, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1859,
   "end": 1951
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42675546",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The only MR is SMR of tissue gene expression on a muscle fat imaging trait.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1262,
   "end": 1441
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42675719",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 4907 plasma proteins on knee osteoarthritis; IGFBP3 is the first directed pair in the results.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 506,
   "end": 667
  },
  "claim": {
   "protein_as_written": "insulin-like growth factor-binding protein 3",
   "gene": "IGFBP3",
   "disease_as_written": "KOA",
   "direction": "raises",
   "estimate": {
    "or": 1.067,
    "low": 1.021,
    "high": 1.115,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1094,
    "end": 1606
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42675748",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically proxied circulating PD-L1 (UKB-PPP, INTERVAL pQTLs) on myocarditis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 570,
   "end": 734
  },
  "claim": {
   "protein_as_written": "PD-L1",
   "gene": "CD274",
   "disease_as_written": "broadly defined myocarditis",
   "direction": "lowers",
   "estimate": {
    "or": 0.834,
    "low": 0.698,
    "high": 0.995,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1142,
    "end": 1497
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1498,
    "end": 1737
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42677314",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR of plasma pQTLs (Fenland, FinnGen SomaScan) on breast cancer; circulating MSP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1386,
   "end": 1531
  },
  "claim": {
   "protein_as_written": "MSP",
   "gene": "MST1",
   "disease_as_written": "breast cancer",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1386,
    "end": 1531
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1284,
    "end": 1385
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 154
   }
  }
 },
 {
  "pmid": "42678580",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR runs from locus-specific methylation to LUAD mediated by QDPR expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1011,
   "end": 1286
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42679757",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The headline MR is of BPHL gene expression (eQTL) in brain tissues, not circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 979,
   "end": 1243
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42681890",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR integrates methylation, expression and protein QTLs; the protein-level estimate's pQTL source and tissue aren't stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 549,
   "end": 726
  },
  "claim": {
   "protein_as_written": "NIT2",
   "gene": "NIT2",
   "disease_as_written": "HCC",
   "direction": "raises",
   "estimate": {
    "or": 4.432,
    "low": 1.783,
    "high": 11.018,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 814,
    "end": 977
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 978,
    "end": 1103
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42682321",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of genetically predicted protein levels on early- and late-onset Alzheimer's disease; no direction is given.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1044,
   "end": 1424
  },
  "claim": {
   "protein_as_written": "APOE",
   "gene": "APOE",
   "disease_as_written": "EOAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1767,
    "end": 1924
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1044,
    "end": 1424
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1767,
    "end": 1924
   }
  }
 },
 {
  "pmid": "42682829",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR outcomes are spirometric lung function traits.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 921,
   "end": 1018
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42683229",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins appear only as mediators of PM2.5's effect; no protein's own effect on asthma is given; MEAF6/RNF40 are TWAS genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1312,
   "end": 1452
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42687616",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "MR, including multivariable MR of genes/proteins with pQTL data, has cognitive function, a trait, as its outcome.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 291,
   "end": 520
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42687758",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of UK Biobank plasma proteins on CAD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 946,
   "end": 1230
  },
  "claim": {
   "protein_as_written": "CDKN2D",
   "gene": "CDKN2D",
   "disease_as_written": "CAD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1377,
    "end": 1566
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42688628",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR of 5,450 plasma pQTLs on salivary gland diseases (FinnGen).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 514,
   "end": 700
  },
  "claim": {
   "protein_as_written": "Transmembrane serine protease 6 (TMPRSS6)",
   "gene": "TMPRSS6",
   "disease_as_written": "benign and broader salivary gland diseases",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1076,
    "end": 1221
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42693724",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "SMR with deCODE plasma pQTLs on AF; C3's protein-level association stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 778,
   "end": 1028
  },
  "claim": {
   "protein_as_written": "C3",
   "gene": "C3",
   "disease_as_written": "AF",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1657,
    "end": 1865
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42694092",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "The SMR pools QTL kinds, but the abstract ties DUT's pair to the protein-level (pQTL) analysis and names no non-circulating tissue's pQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1667,
   "end": 1832
  },
  "claim": {
   "protein_as_written": "DUT",
   "gene": "DUT",
   "disease_as_written": "sepsis",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1667,
    "end": 1832
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42694191",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The paper runs SMR with pQTLs beside eQTLs and mQTLs, so the abstract doesn't show it fails E2, but the prioritized candidate rests on eQTL SMR and the only protein-level association is said to fail HEIDI and is not interpreted, so the abstract states no protein-disease pair from the protein's MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1197,
   "end": 1331
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42698337",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The headline finding rests on SLC22A4 gene expression in blood or brain, not a circulating protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1726,
   "end": 1940
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42698651",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins from UKB-PPP and deCODE on melanoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 334,
   "end": 519
  },
  "claim": {
   "protein_as_written": "Poly(adenosine diphosphate-ribose) polymerase 1 (PARP1)",
   "gene": "PARP1",
   "disease_as_written": "melanoma",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 794,
    "end": 924
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 794,
    "end": 924
   }
  }
 },
 {
  "pmid": "42700015",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "deCODE pQTLs of ferroptosis-related proteins used as exposures on JIA, with directions.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 364,
   "end": 581
  },
  "claim": {
   "protein_as_written": "HSPB1",
   "gene": "HSPB1",
   "disease_as_written": "JIA",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 888,
    "end": 1064
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42700032",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are trace elements (vitamin A), not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 487,
   "end": 605
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42700318",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR runs from stroke liability to plasma PDGFB levels (reverse direction); no protein exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 426,
   "end": 629
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42700783",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "'Systemic expression' of GLP-1R isn't named as a gene's, mRNA's or protein's (E2 unstated, which doesn't stop the paper), and the outcome, clinical revision arthroplasty, is a procedure, not a diagnosed condition.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 371,
   "end": 590
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42700807",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR exposure is TXNIP expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2484,
   "end": 2686
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42700931",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Exposures pool plasma pQTLs (deCODE, UKB-PPP) and eQTLs (eQTLGen) and the abstract doesn't tie the pairs to the protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 383,
   "end": 566
  },
  "claim": {
   "protein_as_written": "MARK3",
   "gene": "MARK3",
   "disease_as_written": "cystitis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1217,
    "end": 1349
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1217,
    "end": 1288
   }
  }
 },
 {
  "pmid": "42703875",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of druggable genes on acute pancreatitis whose instruments the abstract does not name (gene-level exposure).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 90,
   "end": 251
  },
  "claim": {
   "protein_as_written": "ACVR1C",
   "gene": "ACVR1C",
   "disease_as_written": "AP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 422,
    "end": 553
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 422,
    "end": 553
   }
  }
 },
 {
  "pmid": "42708309",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of cis-acting plasma proteins (Fenland, UKB-PPP pQTLs) on lung cancer in never-smokers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 516,
   "end": 712
  },
  "claim": {
   "protein_as_written": "RARRES1",
   "gene": "RARRES1",
   "disease_as_written": "LCINS",
   "direction": "raises",
   "estimate": {
    "or": 1.17,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2468,
    "end": 2653
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.83,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1727,
    "end": 1799
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42710477",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are single-cell eQTLs of gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 718,
   "end": 904
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42713651",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "pQTL-instrumented proteome-wide MR on hypertension; ALDH2 is named among the 28 proteins prioritized by MR and colocalization, with no direction stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 374,
   "end": 737
  },
  "claim": {
   "protein_as_written": "ALDH2 [mitochondrial aldehyde dehydrogenase]",
   "gene": "ALDH2",
   "disease_as_written": "hypertension",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1547,
    "end": 1856
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1423,
    "end": 1546
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42717724",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma protein levels on severe liver disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1067,
   "end": 1216
  },
  "claim": {
   "protein_as_written": "GDF15",
   "gene": "GDF15",
   "disease_as_written": "SLD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1067,
    "end": 1216
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42725617",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposure is BMI, not a protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 334,
   "end": 504
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42726083",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The exposure is GLP-1R agonism in drug-target MR, whose instruments the abstract doesn't name.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 662,
   "end": 809
  },
  "claim": {
   "protein_as_written": "GLP-1R",
   "gene": "GLP1R",
   "disease_as_written": "diabetic foot complications",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1553,
    "end": 1672
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 353,
    "end": 589
   }
  }
 },
 {
  "pmid": "42726788",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-variant MR of circulating proteins on kidney traits including CKD risk; INHBC's own direction is given only for eGFR and BUN, and its CKD role is stated as mediation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 787,
   "end": 1145
  },
  "claim": {
   "protein_as_written": "INHBC",
   "gene": "INHBC",
   "disease_as_written": "CKD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2337,
    "end": 2463
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42727063",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Protein-level MR of plasma CD40 abundance with plasma pQTLs on myasthenia gravis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 293,
   "end": 670
  },
  "claim": {
   "protein_as_written": "CD40",
   "gene": "CD40",
   "disease_as_written": "overall MG",
   "direction": "raises",
   "estimate": {
    "or": 1.31,
    "low": 1.08,
    "high": 1.57,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1095,
    "end": 1371
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 131
   }
  }
 },
 {
  "pmid": "42730883",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "DCXR prioritized by integrative SMR pooling mQTL, eQTL and pQTL.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 531,
   "end": 777
  },
  "claim": {
   "protein_as_written": "DCXR",
   "gene": "DCXR",
   "disease_as_written": "sleep apnea",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1325,
    "end": 1450
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42730913",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are plasma metabolites (phenylalanine).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 575,
   "end": 703
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42736812",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The protein MR is reported only as a count of proteins associated with RA, with no protein named; the named proteins come from target intersection.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 2041,
   "end": 2095
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42741500",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins appear only as candidate intermediates of BMD's effect in two-step MR; no protein's own effect on AMD is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1510,
   "end": 1715
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42743600",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Instruments are immune-cell cis-eQTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 553,
   "end": 817
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42744774",
  "eligibility": "E2",
  "e2_kind": "not circulating",
  "eligibility_reason": "Instruments are skin-tissue pQTLs, not circulating protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 790,
   "end": 1013
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42749890",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are organ biological aging clocks, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 622,
   "end": 844
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42750184",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "cis-MR of plasma proteins on IPAH, but the abstract names no protein as an MR finding with IPAH.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1082,
   "end": 1234
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42753640",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Gene-level MR pools blood cis-eQTLs and cis-pQTLs; the abstract doesn't tie the surviving gene to the circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 510,
   "end": 716
  },
  "claim": {
   "protein_as_written": "ABCC8",
   "gene": "ABCC8",
   "disease_as_written": "hypothermia",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1242,
    "end": 1373
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42754788",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of candidate genes on diabetic nephropathy without naming the instruments (expression or protein).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 626,
   "end": 747
  },
  "claim": {
   "protein_as_written": "APOD",
   "gene": "APOD",
   "disease_as_written": "DN",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1287,
    "end": 1349
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42755691",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposures are systolic blood pressure and antihypertensive drug classes, not one circulating protein.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 690,
   "end": 904
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42757412",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of PAI-1 drawn from analyses of both eQTLs and pQTLs; instruments for the MR not specified.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 566,
   "end": 697
  },
  "claim": {
   "protein_as_written": "PAI-1",
   "gene": "SERPINE1",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1167,
    "end": 1294
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42760138",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The exposure is GLP-1R expression proxied by lung cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 389,
   "end": 702
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42760376",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "The SMR pools pQTL and eQTL data to prioritise genes for sleep disorders, the one outcome analysed; the pairs have no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 325,
   "end": 766
  },
  "claim": {
   "protein_as_written": "BCAN",
   "gene": "BCAN",
   "disease_as_written": "sleep disorders",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1107,
    "end": 1271
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1400,
    "end": 1671
   }
  }
 },
 {
  "pmid": "42760658",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR screened plasma and cerebrospinal fluid proteins together and the abstract does not tie the CTSH finding to plasma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 501,
   "end": 615
  },
  "claim": {
   "protein_as_written": "CTSH",
   "gene": "CTSH",
   "disease_as_written": "sepsis",
   "direction": "raises",
   "estimate": {
    "or": 1.1,
    "low": 1.03,
    "high": 1.17,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 877,
    "end": 1228
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.0585,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1229,
    "end": 1355
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1466,
    "end": 1625
   }
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42761119",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically proxied circulating levels of hub proteins on chronic pancreatitis or pancreatic cancer; one pair named, without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1378,
   "end": 1546
  },
  "claim": {
   "protein_as_written": "MMP9",
   "gene": "MMP9",
   "disease_as_written": "CP",
   "direction": "unstated",
   "estimate": null,
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 2349,
    "end": 2451
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2664,
    "end": 2801
   }
  }
 },
 {
  "pmid": "42765498",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug targets proxied by whole-blood cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 640,
   "end": 844
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42770235",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR with plasma cis-pQTLs (35,559 individuals) on esophageal adenocarcinoma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 368,
   "end": 589
  },
  "claim": {
   "protein_as_written": "CD55",
   "gene": "CD55",
   "disease_as_written": "EAC",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2116,
    "end": 2188
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2116,
    "end": 2188
   }
  }
 },
 {
  "pmid": "42771565",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "SMR pools mQTL, eQTL and pQTL data, and the abstract does not tie the pair to a circulating protein analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 556,
   "end": 713
  },
  "claim": {
   "protein_as_written": "EIF2B2",
   "gene": "EIF2B2",
   "disease_as_written": "EAC",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1952,
    "end": 2098
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2099,
    "end": 2287
   }
  }
 },
 {
  "pmid": "42772042",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of blood proteins (deCODE, UKB cis variants) on osteoarthritis; pairs named without direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 878,
   "end": 1117
  },
  "claim": {
   "protein_as_written": "USP8",
   "gene": "USP8",
   "disease_as_written": "OA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1365,
    "end": 1545
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1365,
    "end": 1545
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42772348",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "ANGPTL inhibition proxied per SD decrease in triglycerides, a biomarker-weighted instrument.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1344,
   "end": 1665
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42772652",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with deCODE cis-pQTLs on cervical cancer; protein pairs reported separately from eQTL genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 743,
   "end": 901
  },
  "claim": {
   "protein_as_written": "EIF2AK2",
   "gene": "EIF2AK2",
   "disease_as_written": "CC",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1397,
    "end": 1490
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1491,
    "end": 1628
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42773283",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with ASGR1 plasma levels as mediator; the abstract states ASGR1's own positive association with IHD, supported by colocalisation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 582,
   "end": 900
  },
  "claim": {
   "protein_as_written": "ASGR1",
   "gene": "ASGR1",
   "disease_as_written": "ischemic heart disease",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 582,
    "end": 900
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.91,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 582,
    "end": 900
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42773293",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "The HGF estimate comes from SMR pooling blood-derived multi-omics QTLs (eQTLs and pQTLs), not tied to a circulating protein's analysis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 317,
   "end": 570
  },
  "claim": {
   "protein_as_written": "HGF",
   "gene": "HGF",
   "disease_as_written": "HNC",
   "direction": "lowers",
   "estimate": {
    "or": 0.37,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 876,
    "end": 1117
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1516,
    "end": 1576
   },
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42774843",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-step MR with circulating proteins as exposures for intracranial aneurysm outcomes; the named mediators are defined as proteins significant in the protein-to-aneurysm step, without the sign of their own effect (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 799,
   "end": 980
  },
  "claim": {
   "protein_as_written": "CD74",
   "gene": "CD74",
   "disease_as_written": "smoking-related intracranial aneurysms",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1998,
    "end": 2190
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42775789",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "Pairs come from multi-omics SMR pooling mQTL, eQTL and pQTL and blood with brain tissue; the abstract does not tie a pair to circulating-protein instruments.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 408,
   "end": 643
  },
  "claim": {
   "protein_as_written": "MAPK3",
   "gene": "MAPK3",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1225,
    "end": 1422
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42778924",
  "eligibility": "E2",
  "e2_kind": "not one gene's product",
  "eligibility_reason": "MR exposures are protein co-expression modules.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 922,
   "end": 1181
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42779539",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on AAA; SMPD1 named as a driver and target, but no MR direction is stated (functional data give the direction).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1349,
   "end": 1710
  },
  "claim": {
   "protein_as_written": "SMPD1",
   "gene": "SMPD1",
   "disease_as_written": "AAA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2312,
    "end": 2523
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1711,
    "end": 1820
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2312,
    "end": 2523
   }
  }
 },
 {
  "pmid": "42780090",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR of plasma protein pQTLs (UKB-PPP) on early-onset stroke.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 462,
   "end": 705
  },
  "claim": {
   "protein_as_written": "Factor XI",
   "gene": "F11",
   "disease_as_written": "EOS",
   "direction": "raises",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1153,
    "end": 1385
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1759,
    "end": 1897
   }
  }
 },
 {
  "pmid": "42780122",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteome-wide MR of genetically predicted plasma protein levels on acute and chronic pancreatitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1215,
   "end": 1442
  },
  "claim": {
   "protein_as_written": "ABO",
   "gene": "ABO",
   "disease_as_written": "AP",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1215,
    "end": 1442
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42780180",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteins are named only as mediators of NAFLD's effect on DR, and the abstract gives no protein's own MR effect on DR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1671,
   "end": 1892
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42782355",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR with UKB-PPP plasma cis-pQTLs on dementia subtypes; conclusions give no named protein, so the results' first directed pair is used.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 505,
   "end": 679
  },
  "claim": {
   "protein_as_written": "NECTIN2",
   "gene": "NECTIN2",
   "disease_as_written": "Alzheimer's dementia",
   "direction": "raises",
   "estimate": {
    "or": 2.65,
    "low": 1.875,
    "high": 3.744,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 1536,
    "end": 1820
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42787065",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "Exposure is shift-work propensity; proteins are outcomes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1120,
   "end": 1360
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42789946",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR of 'druggable genes' whose instruments the abstract doesn't name; CA2 is a core target drawn from the MR-identified proteins, with no direction from MR.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 395,
   "end": 590
  },
  "claim": {
   "protein_as_written": "CA2",
   "gene": "CA2",
   "disease_as_written": "PCOS",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1321,
    "end": 1442
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1321,
    "end": 1442
   }
  }
 },
 {
  "pmid": "42792631",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Receptors are instrumented by cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 565,
   "end": 706
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42792836",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Cis-pQTL MR of plasma proteins on OA; no MR direction is given, so the claim is the first pair the conclusions name, ADM (unsigned).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1248,
   "end": 1403
  },
  "claim": {
   "protein_as_written": "ADM",
   "gene": "ADM",
   "disease_as_written": "OA",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2052,
    "end": 2170
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1600,
    "end": 1793
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1980,
    "end": 2051
   }
  }
 },
 {
  "pmid": "42792954",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of genetically predicted gene expression.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 684,
   "end": 836
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42792961",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR on dystonia, but the abstract names no protein paired with dystonia by MR; TNF appears only from single-cell and docking analyses.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 985,
   "end": 1124
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42792991",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Exposures are lipid traits; plasma proteins appear only as exploratory mediators without their own effect on kidney disease stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1692,
   "end": 1855
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42793049",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The outcome is functional outcome after stroke on the ordinal modified Rankin Scale, not a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 628,
   "end": 698
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42794533",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "UKB-PPP plasma pQTLs in SMR on AMD; conclusions give no direction, results name CSF2 first as a risk factor.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 537,
   "end": 864
  },
  "claim": {
   "protein_as_written": "CSF2",
   "gene": "CSF2",
   "disease_as_written": "AMD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1259,
    "end": 1638
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1259,
    "end": 1638
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2435,
    "end": 2544
   }
  }
 },
 {
  "pmid": "42798608",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Plasma proteins were screened, but the only protein named (promotilin) is a mediator with no own effect on lymphoid malignancies stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1479,
   "end": 1627
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42809100",
  "eligibility": "E2 unstated",
  "e2_kind": null,
  "eligibility_reason": "MR exposures and instruments are not described; candidates are named as genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 971,
   "end": 1207
  },
  "claim": {
   "protein_as_written": "FCGRT",
   "gene": "FCGRT",
   "disease_as_written": "AD",
   "direction": "unstated",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 3140,
    "end": 3409
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 206
   }
  }
 },
 {
  "pmid": "42810526",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "CETP inhibition instrumented by a CETP pQTL in Europeans; AMD is a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 651,
   "end": 864
  },
  "claim": {
   "protein_as_written": "CETP",
   "gene": "CETP",
   "disease_as_written": "AMD",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 2201,
    "end": 2354
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 376,
    "end": 542
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 101,
    "end": 287
   }
  }
 },
 {
  "pmid": "42810599",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are disease liabilities and outcomes are muscle traits; no protein is an MR exposure for a disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 283,
   "end": 443
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42811415",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Drug-target MR of GIP/GIPR cis variants scaled to lower BMI or HbA1c, i.e. weighted by downstream biomarkers.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 472,
   "end": 543
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42811552",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTLs from deCODE used as instruments for POR on CRSwNP.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 570,
   "end": 757
  },
  "claim": {
   "protein_as_written": "POR",
   "gene": "POR",
   "disease_as_written": "CRSwNP",
   "direction": "lowers",
   "estimate": {
    "or": 0.77,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1464,
    "end": 1753
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1973,
    "end": 2159
   }
  }
 },
 {
  "pmid": "42812740",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "One MR analysis instruments GLP-1R with pQTLs for its circulating protein level; its disease result is atrial fibrillation (locus-based T2D-weighted pairs do not count).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1224,
   "end": 1429
  },
  "claim": {
   "protein_as_written": "GLP-1R",
   "gene": "GLP1R",
   "disease_as_written": "atrial fibrillation",
   "direction": "lowers",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2377,
    "end": 2591
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 0,
    "end": 118
   }
  }
 },
 {
  "pmid": "42813637",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are eQTL-instrumented druggable genes.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 691,
   "end": 863
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42815190",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR identified mediating proteins without naming any protein-disease pair; AGER comes from enrichment annotation.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1351,
   "end": 1723
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42828824",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Immune-cell cis-eQTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 408,
   "end": 540
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42830984",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "cis-pQTL MR of UKB-PPP plasma proteins on uterine leiomyoma; PARP1 is named in the conclusions with no direction.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 472,
   "end": 633
  },
  "claim": {
   "protein_as_written": "PARP1",
   "gene": "PARP1",
   "disease_as_written": "Uterine leiomyoma",
   "direction": "unstated",
   "estimate": null,
   "significance": "corrected",
   "quote": {
    "in": "abstract",
    "start": 2177,
    "end": 2385
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1206,
    "end": 1358
   },
   "reports_replication": true,
   "replication_quote": {
    "in": "abstract",
    "start": 1917,
    "end": 1989
   },
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 2177,
    "end": 2385
   }
  }
 },
 {
  "pmid": "42853231",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR assesses the causal relevance of transcriptomic hub genes (MYD88, FGR); no circulating protein level is an exposure.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 305,
   "end": 538
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42857676",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Plasma GPNMB protein level from pQTL data as exposure for Parkinson's disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 745,
   "end": 936
  },
  "claim": {
   "protein_as_written": "GPNMB",
   "gene": "GPNMB",
   "disease_as_written": "PD",
   "direction": "raises",
   "estimate": {
    "or": 1.416,
    "low": null,
    "high": null,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1107,
    "end": 1341
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42860425",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "MR of serum proteins on 79 outcomes, but no protein-disease pair is named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1120,
   "end": 1253
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42861094",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Circulating proteins instrumented by cis-pQTLs from deCODE tested on knee osteoarthritis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 699,
   "end": 803
  },
  "claim": {
   "protein_as_written": "DNAJB12",
   "gene": "DNAJB12",
   "disease_as_written": "KOA",
   "direction": "raises",
   "estimate": {
    "or": 1.55,
    "low": 1.24,
    "high": 1.95,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1060,
    "end": 1261
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.949,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1343,
    "end": 1498
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42864329",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Mediation MR through circulating TNFSF11 gives its own effect on childhood-onset asthma.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 571,
   "end": 919
  },
  "claim": {
   "protein_as_written": "TNFSF11",
   "gene": "TNFSF11",
   "disease_as_written": "childhood-onset asthma",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 571,
    "end": 919
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": 0.886,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 571,
    "end": 919
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42865804",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "The only plasma protein MR pairs are said not to survive FDR correction, so no counting protein-disease pair is stated.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1063,
   "end": 1273
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42871036",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically proxied levels of drug-target proteins on lumbar spinal stenosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 695,
   "end": 933
  },
  "claim": {
   "protein_as_written": "placental alkaline phosphatase (ALPP)",
   "gene": "ALPP",
   "disease_as_written": "lumbar spinal stenosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1121,
    "end": 1307
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "PP.H4",
   "coloc_value": 0.9979,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1121,
    "end": 1307
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": true,
   "drug_target_quote": {
    "in": "abstract",
    "start": 1470,
    "end": 1605
   }
  }
 },
 {
  "pmid": "42871276",
  "eligibility": "E2",
  "e2_kind": "no protein exposure",
  "eligibility_reason": "MR exposures are phthalate metabolites MECPP and MEHHP, not proteins.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 611,
   "end": 715
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42876568",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "The proteins' MR runs through the deCODE proteome, so E2 holds, but the outcome is frailty, a geriatric syndrome measured by severity and index rather than a diagnosed disease, so the paper fails E3 before E4 is reached.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 88,
   "end": 237
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42877317",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Exposures are brain single-cell gene expression (sc-eQTLs).",
  "eligibility_quote": {
   "in": "abstract",
   "start": 816,
   "end": 1031
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42887290",
  "eligibility": "E2",
  "e2_kind": "biomarker-weighted",
  "eligibility_reason": "Lipid-lowering drug targets are proxied by lipid-trait variants from GLGC (plus eQTLs), not protein levels.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 398,
   "end": 539
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42898182",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "ADH7 is named as a mediator of smoking's effect; the abstract gives no MR effect of the protein on the cancer.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1417,
   "end": 1526
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42899187",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of 91 circulating inflammatory proteins (genetically predicted levels) on skin and soft tissue infections.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 631,
   "end": 867
  },
  "claim": {
   "protein_as_written": "IL-10",
   "gene": "IL10",
   "disease_as_written": "SSTI",
   "direction": "lowers",
   "estimate": {
    "or": 0.892,
    "low": 0.842,
    "high": 0.946,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1185,
    "end": 1673
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42902265",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR of 'genetically proxied AHNAK expression' does not say whether the instruments are protein, mRNA or other QTLs.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1125,
   "end": 1270
  },
  "claim": {
   "protein_as_written": "AHNAK",
   "gene": "AHNAK",
   "disease_as_written": "AF",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1965,
    "end": 2124
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42903323",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "Two-sample MR with deCODE SomaScan cis-pQTLs (and FinnGen pQTLs) for ICAM-5 on uveitis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 373,
   "end": 576
  },
  "claim": {
   "protein_as_written": "ICAM-5",
   "gene": "ICAM5",
   "disease_as_written": "uveitis",
   "direction": "raises",
   "estimate": {
    "or": 1.27,
    "low": 1.11,
    "high": 1.46,
    "unit": "not stated",
    "frame": "per higher protein"
   },
   "significance": "nominal",
   "quote": {
    "in": "abstract",
    "start": 1257,
    "end": 1656
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42907830",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of genetically predicted circulating FGF5 levels on CVD and CKD.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1870,
   "end": 2091
  },
  "claim": {
   "protein_as_written": "FGF5",
   "gene": "FGF5",
   "disease_as_written": "CVD",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1870,
    "end": 2091
   }
  },
  "flags": {
   "reports_colocalisation": true,
   "coloc_criterion": "not stated",
   "coloc_value": null,
   "colocalisation_quote": {
    "in": "abstract",
    "start": 1355,
    "end": 1601
   },
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 },
 {
  "pmid": "42907923",
  "eligibility": "E4",
  "e2_kind": null,
  "eligibility_reason": "Proteome-wide MR on AAA names no protein-disease pair; ITIH2 named only as a mediator without its own effect.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 1174,
   "end": 1250
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42907963",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "Drug-target MR of APP without its instruments named.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 722,
   "end": 816
  },
  "claim": {
   "protein_as_written": "APP",
   "gene": "APP",
   "disease_as_written": "OA",
   "direction": "lowers",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1598,
    "end": 1843
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  },
  "e2_resolved_by": "full text"
 },
 {
  "pmid": "42920133",
  "eligibility": "E3",
  "e2_kind": null,
  "eligibility_reason": "Outcome is suicide or intentional self-harm, a behaviour rather than a diagnosed disease.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 156,
   "end": 364
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42922802",
  "eligibility": "E2",
  "e2_kind": "expression or other molecular QTLs",
  "eligibility_reason": "MR exposure is a DNA methylation site (CpG), not a protein level.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 982,
   "end": 1140
  },
  "claim": null,
  "flags": null
 },
 {
  "pmid": "42928267",
  "eligibility": "eligible",
  "e2_kind": null,
  "eligibility_reason": "MR of plasma proteins on cerebral atherosclerosis.",
  "eligibility_quote": {
   "in": "abstract",
   "start": 338,
   "end": 466
  },
  "claim": {
   "protein_as_written": "MICB",
   "gene": "MICB",
   "disease_as_written": "cerebral atherosclerosis",
   "direction": "raises",
   "estimate": null,
   "significance": "not stated",
   "quote": {
    "in": "abstract",
    "start": 1445,
    "end": 1621
   }
  },
  "flags": {
   "reports_colocalisation": false,
   "coloc_criterion": null,
   "coloc_value": null,
   "colocalisation_quote": null,
   "reports_replication": false,
   "replication_quote": null,
   "drug_target_framing": false,
   "drug_target_quote": null
  }
 }
]
